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ABSTRACT 
 
A. baumannii that are resistant to multiple antibiotics are being reported with increasing frequency 
and provide a significant challenge in the treatment of infections. Multiply-antibiotic resistant 
(MAR) isolates mainly belong to two major global clones, GC1 and GC2, and the emergence of 
MAR strains worldwide is largely due to the global spread of strains belonging to these clonal 
groups. The objective of this study was to analyze the causes of antibiotic resistance in Australian 
GC2 isolates.  
 
A. baumannii isolates collected from hospitals in Sydney, Brisbane and Canberra were screened for 
resistance to 23 antibiotics and their clonal group was determined. A total of 83 isolates were placed 
in GC2 and almost all of them were members of ST92/208 (Oxford scheme), but there were two 
SLVs, ST425 and ST195. A small group of isolates were members of ST69/423. The ST92/208, 
ST425 and ST195 isolates contained oxa23 in Tn2006 and two members of ST69/423 had ISAba1 
upstream of oxaAb, which caused carbapenem resistance. All GC2s also had ISAba1 upstream of 
ampC, causing high levels of resistance to 3rd generation cephalosporins. The GC2s were screened 
for the presence of a common set of resistance genes along with a number of aminoglycoside 
resistance genes. The resistance genes, sul2, tetA(B), strA and strB were present in all isolates and 
clustered together alongside ISAba1 and CR2 in a conserved resistance region in the majority of 
isolates. Eight subgroups were identified based on their aminoglycoside resistance patterns and 
genes. The ST195 and ST69/423 isolates were not examined from this point. 
 
The ST92/208 collection, which included the ST425, and the A320 GC2 reference strain were 
examined in more detail. Two types of antibiotic resistance island, designated AbGRI1 and 
AbGRI2, contained almost all of the resistance genes. An AbGRI1 island was found in comM in all 
the Australian isolates as well as A320. A320 had AbGRI1-1 while the Australian GC2 isolates all 
had a larger variant, AbGRI1-2, except for one outbreak group that had a variant with an additional 
 
 
VII 
IS. AbGRI1-2 contained the common resistance region described above along with Tn2006 and a 
novel IS named ISAba17. A second resistance island, named AbGRI2, was found at a second 
position in the chromosome in the ST92/208 collection, but was not investigated in A320. The 
archetype of this island was AbGRI2-1 and it contained blaTEM, aphA1, aacC1, aadA1 and sul1. Six 
variants of AbGRI2 were identified. Four of these variants had lost portions of the island and these 
deletions were caused by IS26. AbGRI2 islands were then examined in the publicly available GC2 
genomes and variants were found in several cases, but there was always at least a single copy of 
IS26 at the same location as AbGRI2-1. 
 
 All of the ST92/208 isolates had at least one plasmid. Most isolates harboured pA91, though a 
subgroup contained a deletion derivative named pC2. Several groups of isolates also harboured an 
additional plasmid. The plasmid that contained aadB was shown to be a unique variant known as 
pRAY*-v1. The aphA6 gene had been acquired by three different groups of isolates carried on three 
related plasmids, in pD72 in isolates from hospital D, pC20 in a single isolate from hospital C and 
pC13 in two other isolates from hospital C. pD72 contained aphA6 at a different location in the 
plasmid backbone relative to pC20/pC13. However, pD72, pC20 and pC13 had a complete transfer 
region, indicating that they should also be conjugative. 
 
Analysis of the genome of an ST25 (Pasteur scheme), D46, revealed that it shared a number of 
features with the main GC2 collection. It contained pieces of the resistance region found in 
AbGRI1, though in D46 this region was in two separate pieces. D46 also had an additional 
resistance region containing macrolide resistance genes and CR2, but its location was not 
determined. The aadB gene was on pRAY* and there was a cryptic plasmid identical to 
p1ABTCDC0715. There was another plasmid, pD46-2, which contained aphA6 in the same position 
as pD72 but also contained Tn2006. This plasmid was shown to be conjugative.  
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ABBREVIATIONS 
 
Units 
 
bp    Base pair 
kb    Kilo base 
Mb   Mega base  
M    Molar 
mol    Moles 
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aa    Amino acid 
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1.1 Antibiotic resistance in bacteria 
1.1.1 Antibiotics and antibiotic resistance 
The use of antibiotics since the middle of the 20th century has had a profound effect on human 
healthcare. Their use has seen a greatly reduced level of morbidity and mortality in bacterial disease 
and has contributed to the increase of human lifespans (248). There are numerous different classes 
of antibiotic, which have been classified based on their mode of action (170). Antibiotics can inhibit 
protein synthesis, interfere with DNA or RNA synthesis, inhibit the synthesis of or damage the cell 
wall and modify the metabolism of the cell (Table 1.1). 
 
Table 1.1 Antibiotic classes and the different mechanisms to kill or inhibit bacterial growth. 
Class Mode of action Antibiotics 
β-lactamsa Inhibition of cell wall synthesis Ampicillin, ceftazidime, imipenem 
Aminoglycosides Inhibition of protein synthesis  
(Binding to 30S rRNA) 
Amikacin, gentamicin, 
streptomycinb, tobramycin 
Tetracyclines Inhibition of protein synthesis  
(Binding to 30S rRNA) 
Tetracycline, minocycline, 
doxycycline  
Quinolones Inhibits DNA synthesis 
(Binding DNA gyrase and 
topoisomerase IV) 
Nalidixic acid, ciprofloxacin, 
levofloxacin  
Trimethoprim Inhibits folic acid metabolism Trimethoprim 
Sulphonamides Inhibits folic acid metabolism Sulphamethoxazole 
Phenicols Inhibition of protein synthesis  
(Binding to 50S rRNA) 
Chloramphenicol, florfenicol 
Rifamycins Inhibition of RNA synthesis  
(Binding to RNA polymerase) 
Rifampicin 
Polymyxins Disruption of cell membranes Polymyxin B, colistin 
a Includes penicillins, cephalosporins, monobactams and carbapenems. 
b Streptomycin and spectinomycin are aminocyclitols, which are related to aminoglycosides. 
 
When antibiotics were introduced, the development of resistance to these agents was not considered 
to be a problem, as it was assumed that the frequency of mutations that would generate resistant 
bacteria was negligible (43). However, now there is resistance to every class of antimicrobial that 
has been developed (139). Indeed, antibiotic resistance emerged even before the prolific use of 
antimicrobials (248). There are a number of different mechanisms that bacteria have developed to 
CHAPTER 1 
 
3 
become resistant to the various antimicrobials (145, 150, 224, 260). These include, changes to cell 
wall permeability that prevent antibiotics from reaching the target site, efflux of the antibiotic from 
the cell, enzymatic modification of the antibiotic, degradation of the antibiotic, development of 
alternative metabolic pathways to those inhibited by an antimicrobial agent, modification of the 
antibiotic target and overproduction of a target enzyme. 
 
Many of these mechanisms did not arise by mutation, but through the acquisition of resistance 
genes from other bacteria, now known as horizontal gene transfer (HGT). Bacteria have a number 
of mechanisms for mobilising beneficial genes, not always resistance genes, and moving them to a 
new host. The acquisition of new genes involves two different types of mobile elements; those that 
are able to transfer between cells, such as conjugative and mobilisable plasmids and integrative 
conjugative elements (ICE) (13, 179) and those that are only able to move genes between different 
DNA molecules, such as transposons, integrons with gene cassettes and CR elements. 
 
1.1.2 The ESKAPE group 
The misuse of antibiotics coupled with the spread of antibiotic resistance genes via HGT has lead to 
the increasing prevalence of organisms that are resistant to multiple classes of antibiotic. These 
multiply-antibiotic resistant (MAR) bacteria are causing an increasingly large burden on the 
healthcare systems in both the developed and developing world (184). The problem of MAR 
bacteria has been highlighted with the classification of the ‘ESKAPE’ group of pathogens (201). 
This group includes Enterococcus faecium, Staphylococcus aureus, Klebsiella pneumoniae, 
Acinetobacter baumannii, Pseudomonas aeruginosa and Enterobacter species (201). These 
organisms are responsible for the majority of nosocomial infections in the United States and are 
able to escape the effects of antibacterial drugs through various resistance mechanisms (18). 
CHAPTER 1 
 
4 
Moreover, there are still very few, if any, novel antibacterial drugs that are in the latter stage of 
development for the treatment of these MAR organisms (18, 184). 
 
A. baumannii is particularly problematic due to its ability to survive for extended periods not only 
on inanimate surfaces but also on the skin of hospital personnel, which leads to a high level of 
transmission within hospitals. In addition, there are a growing number of examples of A. baumannii 
that are resistant to all antibiotics suitable for its treatment, even relatively new agents such as 
tigecycline, and carbapenems, which had previously been thought of as the last-line of antibiotics. 
 
1.1.3 Defining multiple-antibiotic resistance 
As mentioned above, multiple antibiotic resistance in A. baumannii is one of the major reasons this 
organism is a problem in clinical settings. Though there have been many studies of MAR A. 
baumannii, there has been a lack of consensus on the definition of multiple antibiotic resistance 
(183). A recent study has defined a standardised terminology for the classification of several species 
of multiply-resistant pathogens, including Acinetobacter spp. (144). Using selection criteria based 
on what antibiotics are effective for treatment of A. baumannii infections, 9 categories of 
antimicrobial were chosen and these are listed in Table 1.2 (144). MAR has been defined as 
resistance to ≥1 antibiotic in ≥3 out of a total of the 9 categories (Table 1.2), while resistance to ≥1 
antibiotic in all but 2 categories is classified as Extensively Antibiotic Resistant (XAR) and 
resistance to all antibiotics as Pan-resistant (PAR) (144). 
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Table 1.2 Antibiotic categories used to define MAR, XAR and PAR for Acinetobacter spp. 
Antibiotic category Antibiotic 
Aminoglycosides Gentamicin 
Tobramycin 
Amikacin 
Netilmicin 
Carbapenems Imipenem 
Meropenem 
Fluoroquinolones Ciprofloxacin 
Levofloxacin 
Antipseudomonal penicillins 
+β-lactamase inhibitors 
Piperacillin-tazobactam 
Ticarcillin-clavulanic acid 
Cephalosporins Cefotaxime 
Ceftriaxone 
Ceftazidime 
Cefepime 
Folate pathway inhibitors Trimethoprim-sulphamethoxazole 
Penicillins 
+β-lactamase inhibitors 
Ampicillin-sulbactam 
Polymixins Colistin 
Polymixin B 
Tetracyclines Tetracycline 
Doxycycline 
Minocycline 
The contents of this table are taken from reference 144. 
1.1.4 Mobile genetic elements 
1.1.4.1 Plasmids 
Plasmids are one of the key vectors for HGT in bacteria. Plasmids can be defined as DNA 
molecules that are able to independently replicate within a host cell and are usually double-stranded 
and circular (40), but they are also able to utilise the replication machinery of the host (44). They 
can carry a variety of genes, including those for antibiotic and heavy metal resistance, virulence and 
environmental adaptation, though they generally do not encode functions that are vital for the cell 
(13, 222). Hence, they can be lost or gained without deleterious effect. Many of the genes found on 
plasmids are contained within other mobile elements. Thus, they are a major facilitator in the 
horizontal spread of complex resistance and virulence regions (13). The majority of plasmids 
studied to date are circular, double-stranded DNA molecules and can range in size from those with 
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only 2 coding genes, which are usually 2-3 kb in length, to plasmids that have hundreds of genes 
that are almost 10% of the size of their hosts chromosome (13). 
 
There are three mechanisms of replication for circular plasmids, theta type, strand displacement and 
rolling circle (44). Most plasmids studied in Gram-negative organisms replicate via the theta 
mechanism, which involves the formation of a primer RNA that initiates DNA synthesis by the 
extension of this primer (44). There is an essential region in all plasmids that contains the genes 
and/or loci that are involved in replication and its control. The main features of this essential region 
include the origin(s) of replication, usually termed ori, a rep gene that encodes a protein involved in 
the initiation of replication and the plasmid-borne genes involved in replication control (44). 
 
Plasmids can be transferred horizontally via three transfer mechanisms, transformation, 
transduction and conjugation, but conjugation is believed to be the most important for plasmids 
(83). The process of conjugation allows the plasmid to be replicated and transported into the 
recipient cell, while maintaining a copy in the donor (256). Conjugative plasmids tend to be larger, 
generally greater than 30 kb, in order to accommodate the genes required for conjugation. In order 
to be conjugative, the plasmid must contain two sets of genes. The first are mobility (mob) genes 
that are involved in DNA processing prior to transfer (65, 222). The essential relaxase is encoded in 
the mob region and it recognises the origin of transfer (oriT), which is a short segment of DNA that 
is required in cis for a plasmid to be transmissible via conjugation (222). Six MOB families have 
been characterised and can be used in plasmid classification (70). The second set of genes (tra) is 
responsible for the mating channel that is known as the membrane-associated mating pair formation 
(MPF) complex and is a form of type 4 secretion system (T4SS) (65, 222). The process of plasmid 
conjugation involves the relaxase cleaving the transferring DNA at oriT, becoming covalently 
bound at this site and forming a nucleoprotein complex that is then transported to the recipient via 
the T4SS (70, 222). Plasmids that only carry mob genes are still able to conjugate to a recipient cell 
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if they are able to use the T4SS of another element in the cell; these plasmids are termed 
mobilisable rather than conjugative (222). There are also plasmids that contain neither of these 
systems and can spread using transformation or transduction; they are termed non-mobilisable. 
 
1.1.4.2 Transposons 
The term transposon describes a defined segment of DNA that is able to facilitate its movement 
from one genetic location to another often also carrying other genes, such as antibiotic resistance 
genes (79). Indeed, it was the observation of antibiotic resistance genes in transposable elements 
that highlighted the importance of transposons (98), though they also carry genes that encode other 
metabolic functions (25). Though mainly studied in bacteria, transposons have been identified in a 
wide array of eukaryotic and prokaryotic organisms (25), including humans. 
 
Almost all transposons in prokaryotes share a set of common features (79, 121). The ends of 
transposons are the specific sites that are used for recombination, the sequences of these ends are 
identical, or nearly identical, and inverted relative to one another. Hence they are called inverted 
repeats (IR). The sequence and length of IR can vary in different transposons, but the presence of 
both ends is generally required for transposition to occur. Transposons also create a small 
duplication at the site of insertion, a direct repeat (DR), and the size of the DR generated is 
dependent on the particular transposon.  
 
 Two classes of transposon are of particular importance to the spread of antibiotic resistance genes. 
The first, often referred to as class I or composite transposons, contain two copies of an insertion 
sequence (IS; see Section 1.1.4.5 for more detail) that flank an intervening portion of DNA that 
would not be otherwise mobile (79). The IS can be either directly or inversely oriented. It is 
possible for both IS to retain their ability to transpose and for only one to be active (25). For 
example, the well characterised transposon Tn10, a 9,147 bp composite transposon harbours a 
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tetracycline resistance determinant, tetA(B), flanked by two inversely oriented copies of IS10 
(Figure 1.1) (96, 122, 123, 131). Only the right hand copy of IS10 contains a functional transposase 
(124). Though the copies of IS10 share 98% DNA sequence identity, this difference in sequence 
caused four amino acid changes that appear to play a role in the normal function of the IS10 
transposase (131). 
 
 
Figure 1.1 Structure of Tn10, a class 1 or composite transposon. The two copies of IS10 are shown on either side by 
pink boxes. The location and orientation of the tetB determinant, including the tetA(B) and tetR genes, is shown by the 
arrows above the centre line.  
 
Class 2 transposons, also referred to as Tn3 family transposons, are characterised by flanking IR of 
approximately 38 bp, the carriage of two genes, tnpA and tnpR, which encode a transposase and 
resolvase, respectively, and create a 5 bp duplication at the site of insertion (78, 81). They also 
contain a res site, which is where the resolvase acts. The TnpA and TnpR proteins of subgroups 
within in this family generally share greater than 70% amino acid identity and the transposases of 
Tn21, Tn501 and Tn1721 are able to facilitate transposition of one another (80, 81). However, this 
complementary action of transposases was not shared with Tn3, as its transposase and IR sequences 
are too divergent from those of Tn21, Tn501 and Tn1721 (80). The transposase of Tn3, and its 
close relatives Tn1 and Tn2, only share 30% amino acid identity with that of Tn21 (81). Many class 
2 transposons harbour multiple resistance genes, in particular those that are closely related to Tn21 
(81, 152). Tn21 itself is 19.7 kb and contains the transposition genes described above, a mercury 
resistance operon (mer), a class 1 integron containing an aadA1 (streptomycin and spectinomycin 
resistance) gene cassette as well as two additional IS, IS1353 and IS1326 (Figure 1.2) (24, 81). This 
complex structure was identified on a plasmid and has been implicated in the global spread of 
mercury resistance and antibiotic resistance (140).  
 
tetR
IS10 >
tetA(B)Tn10 < IS10
catA1
Tn9 IS1IS1
TcR
chloramphenicol
Class I transposons
Tn3
tnpA tnpR
orf2 merE merD merA merP merT merR
Tn501
tnpA tnpR
ampicillin
mercuric ion
blaTEM
Class II trans osons
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Figure 1.2 The structure of Tn21. The IRs that define the ends of Tn21, IRtnp on the left and IRmer on the right, are 
indicated by blue vertical lines. The brown line represents the transposition region; with the res site a black vertical line. 
The extent of the class 1 integron, In2, is indicated by a bracketed line above. The 5'-CS, gene cassette and 3'-CS are 
indicated by a pink line, green box and orange line, respectively. The clear boxes show IS, with an arrow indicating 
their orientation. The mer region is shown as the grey line. The position and orientation of all genes are shown below 
the central line by arrows. 
 
The In2 within Tn21 (Figure 1.2) is in fact a deletion derivative of a third class of transposon. This 
transposon class uses tni transposition genes, has a terminal IR of approximately 21 bp and 
generates a 5 bp DR. 
 
1.1.4.3 Integrons and gene cassettes 
Integrons are a large family of genetic elements that are able to capture mobile genes, known as 
gene cassettes, using site-specific recombination. Gene cassettes consist of an open reafing frame, 
usually an antibiotic resistance gene, and a unique recombination site known as an attC site. The 
integron itself is comprised of two parts, an intI gene, which encodes a site-specific recombinase 
belonging to the tyrosine recombinase or integrase family, along with an attI recombination site 
(Figure 1.3) (19, 84, 86). Integrons can be separated into different classes based on the sequence of 
the integrase encoded by intI. The most well defined integrons come from classes 1, 2 and 3, which 
have an intI that encodes IntI1, IntI2 and IntI3, respectively, though with the advent of genome 
sequencing there are now over 100 integron classes (84). Each different IntI has strong specificity 
for its partner attI and is unable to recognise the attI of more distantly related IntI proteins (37, 54, 
133).  
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Figure 1.3 General structure of a class 1 integron. The 5'-CS is shown by a purple box, with the position and orientation 
of intI1 shown by an arrow beneath. The attI site is shown as the open end of the box. The 3'-CS is shown as an open 
orange box. The gene cassette is shown in green, with a black box representing the attC. An arrow indicates the 
acquisition of a circularised gene cassette and its insertion adjacent to the attI site. The arrow is bidirectional as gene 
cassettes can also be excised from the integron. 
 
Integrons act in trans to mobilise gene cassettes (Figure 1.3). The IntI is able to recognise the attC 
site, on the gene cassettes, and then splice the cassette into the attI site, with the newest cassettes 
being proximal to the attI. Though IntI proteins are specific for their attI site, they are able to 
recognise a diverse array of attC sites, allowing gene cassettes to be readily exchanged between the 
different classes of integron (84).  
 
Class 1 integrons are the most common integrons found in antibiotic resistant organisms (179). The 
region that contains intI1 and attI1 is identical, or nearly identical, in class 1 integrons and is 
commonly referred to as the 5'-conserved segment (5'-CS; Figure 1.3) (85). This region is quite 
distinct from the corresponding regions in class 2 and 3 integrons, and it can be used to specifically 
detect a class 1 integron. Ever since their initial characterisation, the sul1 sulphonamide resistance 
gene has been identified within class 1 integrons (225, 229). The region containing this sul1 gene is 
well conserved in the majority of class 1 integrons and has been designated as the 3'-conserved 
segment (3'-CS; Figure 1.3) as it is located downstream of any integrated cassettes (86, 225). A 
truncated antiseptic resistance gene, qacE∆1, is also found in the 3'-CS of class 1 integrons.  
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Gene cassettes are among the smallest and simplest mobile elements, but are unable to mobilise 
themselves (198). Many gene cassettes identified to date contain antibiotic resistance genes, though 
there are some cassettes that have been characterised as only containing orfs, which may or may not 
encode a protein (19, 85). Gene cassette integration into a secondary site not associated with attI has 
been rarely observed (36, 199).  
 
1.1.4.4 CR elements 
Initially identified as common regions (CR), these unusual small mobile elements were first 
reported during the characterisation of two complex class 1 integrons, In6 and In7 (227). 
Comparison of the CR sequence in In6 and In7 with other sequences available at the time revealed 
that a related sequence was present in a small plasmid, RSF1010 (227). The CR fragment in 
RSF1010 was not identical to the sequences in In6 and In7, but was also directly adjacent to a 
resistance gene, in this case sul2 (Figure 1.4). Subsequently, these two variants were named CR1, in 
In6 and In7, and CR2, in RSF1010 (235). CR elements have been identified in a number of 
clinically relevant Gram-negative bacteria, as well as several Gram-positives (6). There have been 
12 related CR elements identified, all of which have a single orf that encodes a protein of 
approximately 500 amino acids, and the proteins encoded by these orfs share 40 to 88% amino acid 
identity (235). Since this initial study the number of CR elements identified has been steadily 
increasing. The ends of a CR are defined as ori and ter, which are located downstream and 
upstream of the orf, respectively (Figure 1.4) and the sequence of ori is conserved. 
 
 
Figure 1.4 Structure of CR2 adjacent to sul2. The CR element is shown as the orange box, with the length and 
orientation of the rcr orf shown by the arrow below. The ori and ter ends of CR2 are shown above their respective 
locations. An arrow beneath the centre line shows the orientation of sul2. 
 
rcr2
CR2
sul2
oriter
CHAPTER 1 
 
12 
It is believed that CR elements replicate via a rolling-circle transposition mechanism, where the ori 
end serves as the origin of replication and ter is a replication terminator (69, 230). Hence, the name 
rcr, for rolling circle replicase, has been proposed for the orf present in CR elements (Figure 1.4) 
(137). This mechanism allows a CR element to transpose together with an adjacent segment of 
DNA, mediated only by a single copy of the element, which does not create a DR (230). It has been 
hypothesised that a CR2 element could mobilise a chromosomal gene by first transposing directly 
adjacent to it, followed by a second transposition event that mobilises the CR and adjacent sequence 
onto a plasmid (235).  
 
CR elements have also been associated with many different antibiotic resistance genes (180, 235). 
In particular, CR2 has been found on various plasmids that carry chloramphenicol and 
sulphonamide resistance genes, such as sul2, and has also been associated with the dfrA9, dfrA18, 
dfrA20, floR and tetA(31) resistance genes (180, 233, 234). Unlike CR1, CR2 elements have never 
been found associated with class 1 integrons (235). Indeed, the CR2-sul2 configuration (Figure 1.4) 
has been observed in both the chromosome and in plasmids of various genera of bacteria 
worldwide, suggesting that the association of sul2 with CR2 has played an important role in the 
global spread of sulphonamide resistance (173, 233). When it was seen in the chromosome, it was 
found within a 15 kb genomic island, named GIsul2 (Figure 1.5) (173). GIsul2 was identified in two 
separate isolates, an Enterobacter cloacae isolated in 1890 and a Shigella flexneri isolated in 1954. 
This shows that CR2 and sul2 have been associated with one another since before the onset of the 
antibiotic era and suggests that the movement of GIsul2 rather than the independent mobilisation of 
CR2 could have caused the global dissemination of the CR2-sul2 structure. 
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Figure 1.5 The structure of GIsul2. CR2 is shown as a yellow box, with the ori end indicated above. The length and 
orientation of genes are shown with arrows below the central line. The orfs are numbered 1-4 and orf2 represents a bile 
acid-sodium symporter, while the others are hypothetical proteins. 
 
1.1.4.5 Insertion sequences (IS) 
Insertion sequences are small and genetically compact sequences that only encode the enzymes 
required for their transposition (147). This includes recombinationally active sequences that define 
the ends of the IS, along with a transposase (Figure 1.6), which can recognise these ends. The 
transposase gene spans the majority of the IS and the transposase is usually encoded by a single 
open reading frame (orf), but it can also be encoded by two or three (147). The active sequences at 
the ends of an IS are short terminal inverted repeats (IR), which are usually between 10 to 40 bp in 
length. Upon insertion, IS usually generate a direct repeat (DR) of the target flanking sequence 
(Figure 1.6). The length of the DR is characteristic of a particular IS and this length will generally 
be the same for different copies of the same IS (147). The majority of IS transposases have a 
conserved DDE motif, which is involved in the coordination of divalent metal ions involved in the 
reactions required for transposition (221). If there are multiple orfs in an IS, the transposase will 
often be assembled from these consecutive orfs by translational frameshifting (147). 
 
 
Figure 1.6 General structure of an IS. The IRs, which define the ends of an IS, are shown in blue. The green arrow 
represents the single orf within the IS that encodes its transposase. The direct repeats generated by IS insertion are 
represented by the boxed letters XYZ. 
 
While all IS share the same overall structure, they can be separated into different families based on 
various features. As of August 2013, there are 25 IS families that have been identified and 
characterised in the ISFinder database (www-is.biotoul.fr). Each family can be defined as having a 
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closely related transposase, conservation of the catalytic site, conservation of organisation, similar 
IRs and usually generate a DR of a specific length (33).  
 
There are two main systems for the nomenclature of IS. The first system, instituted in 1978, gives 
each IS a single number, e.g. IS26. However, this proved inadequate for the large number of IS 
identified at present. The second scheme includes the initials of the organism in which the IS was 
first identified, along with a number, e.g. ISAba1 for Acinetobacter baumannii. There are some IS 
that have been named with no regard to either system.  
 
Complete or truncated copies of IS have also been identified on multiple plasmids, often clustered 
relatively closely together, which suggests that they are important in creating modular assemblies of 
genes (221). Interestingly, many IS can activate the expression of neighbouring genes, due to the 
formation of a hybrid promoter where a -35 hexamer within the IR is inserted at the correct distance 
from a native -10 sequence (33). IS are frequently associated with antibiotic resistance genes often 
through the formation of composite transposons, in which two copies of an IS flank a resistance 
gene or region and facilitate its mobilisation (see Section 1.1.4.2) (148). IS are also an important 
factor in forming resistance regions as they can cause deletions of DNA adjacent to one side of the 
IS (147). In particular, IS26 has been associated with the construction of complex resistance regions 
in a number of plasmids as well as in the chromosomes of various species (29, 30, 53, 61, 115, 132, 
155, 159, 262). A member of the IS6 family, IS26 is 820 bp in length with a 14 bp terminal IR and 
generates an 8 bp DR upon insertion (33, 157). IS26 was originally identified in a kanamycin 
resistance transposon, Tn2680, in Proteus vulgaris, but a number of homologous IS, namely IS15, 
IS15∆, IS46 and IS140, have also been identified on other plasmids and bacterial chromosomes 
(156, 157). 
 
CHAPTER 1 
 
15 
1.2 The genus Acinetobacter 
1.2.1 General taxonomy and characteristics 
The classification of the genus Acinetobacter originated from a bacterium named Micrococcus 
calcoaceticus, which was isolated in 1911 (12). In the decades that followed, similar organisms 
were described and assigned to many different genera and species (99). Originally proposed in 
1954, Acinetobacter, which stems from the Greek akinetos meaning non-motile, was used to 
separate motile and non-motile members of the genus Achromobacter (23). The Acinetobacter 
genus designation became more widely accepted after it was found that many of the different 
species that shared properties with Micrococcus calcoaceticus belonged to a single genus, namely, 
Acinetobacter (11) and it was officially acknowledged in 1971 (134). In 1974, the genus 
Acinetobacter was first listed in Bergey’s Manual of Systematic Bacteriology with descriptions of 
two species, A. calcoaceticus and A. lwoffii (130). 
 
The current definition of the genus Acinetobacter places it within subclass γ-Proteobacteria, family 
Moraxellaceae, comprising Gram-negative, non-motile, oxidase-negative, glucose non-fermenting, 
strictly aerobic, catalase positive bacteria with a G+C content of 39-47% (205). Typically, 
Acinetobacters are rod shaped, ranging from 1-1.5 by 1.5-2.5 µm during growth phase, often 
becoming more coccoid in shape during stationary phase (15). On solid media, Acinetobacters 
generally form smooth, sometimes mucoid colonies, of approximately 2 mm, which are pale yellow 
to greyish-white, though some species can produce a diffusible brown pigment (15, 255). The 
temperature range for optimal growth is typical of mesophiles, with clinically relevant species 
growing at 37°C or higher, while other species will only grow at lower temperatures (15). Some 
species show haemolytic activity on blood agar (255). 
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1.2.2 Species identification 
Identification of Acinetobacters to the species level has historically been difficult, as phenotypic 
typing schemes, often used to group bacteria, proved inadequate and/or unreliable for this genus 
(15, 255). During the mid-1980s, the genus of Acinetobacter was delineated into 12 groups or 
genomic species using DNA-DNA hybridisation, some of which were given formal names (20). 
Independently, further work identified a number of additional species, and assigned formal names 
to the previously identified groups (21, 32, 161, 162, 167-169, 175, 232, 249).  
 
A. baumannii, A. calcoaceticus, A. pittii (genomic species 3) and A. nosocomialis (genomic species 
13TU) are very closely related and are almost impossible to distinguish using both DNA-DNA 
hybridisation and phenotypic methods. This has lead these 4 species to be referred to as members of 
the A. calcoaceticus – A. baumannii (Acb) complex (73, 74), with A. pittii and A. nosocomialis 
most often referred to as genomic species 3 and genomic species 13TU, respectively, as formal 
names for these species were only proposed in 2011 (167). However, this designation is 
undesirable, as it groups the three most clinically important species (A. baumannii, A. pittii and A. 
nosocomialis) with A. calcoaceticus, an environmental species that has never been associated with 
infection. Distinguishing between A. baumannii, A. pittii and A. nosocomialis is important in a 
clinical setting, in order to properly study the epidemiology of these organisms and for effective 
infection control. Unfortunately, many of the currently available identification systems used in 
clinical laboratories are not able to effectively distinguish between members of the Acb complex, 
and in fact often uniformly identify A. baumannii, A. pittii and A. nosocomialis as A. baumannii 
(183). However, primers that amplify species-specific regions have proven valuable in 
distinguishing members of the Acb complex (255), particularly for the identification of A. 
baumannii, the most significant nosocomial pathogen in the genus (15, 183, 255). Amplification of 
the A. baumannii specific oxaAb carbapenemase gene has enabled the quick identification of this 
organism in a clinical setting (discussed in greater detail in Section 1.3.2.2) (244). Amplification of 
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a specific region in the gyrB gene followed by sequencing has also been effective in distinguishing 
between all members of the Acb complex (105, 108). 
 
1.2.3 Natural habitats 
Members of the Acinetobacter genus are ubiquitous in the environment and can be recovered from 
almost all soil and water samples (10). However, this has lead to the common misconception that A. 
baumannii is also ubiquitous in the environment and is a frequent commensal of human skin (236). 
In fact, though A. baumannii can be sampled from the skin of patients and hospital surfaces during 
outbreaks, and occasionally from non-clinical environmental sources, the natural source or habitat 
of this species is still unknown (236, 255).  
 
Some Acinetobacters, mainly A. johnsonii, A. lwoffii and A. radioresistens, are part of the normal 
human commensal skin flora and have also been found in food, contributing to its spoilage. Isolates 
found in soil and wastewater tend to be either A. calcoaceticus or A. johnsonii. For most of the 
remaining identified species, their natural habitats are not as well defined (236). 
 
1.2.4 A. baumannii as a nosocomial pathogen 
Acinetobacters have gained attention as significant opportunistic, nosocomial pathogens. A. 
baumannii is the main cause of nosocomial infections, particularly in intensive care units (ICU), 
though A. pittii and A. nosocomialis have been implicated as well (255). Strains of A. baumannii 
can cause a wide array of infections, particularly in those who are critically ill and/or 
immunocompromised. This is exacerbated by a high level of resistance to drying and disinfectants, 
which leads to long-term persistence in hospitals and outbreaks involving large numbers of patients 
(236). Many of these infections are caused by MAR isolates and many studies have shown an 
increasing incidence of MAR A. baumannii infection, though the actual rates of MAR isolates can 
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vary between individuals, hospitals and countries (236).  Several members of the other named 
species have also been shown to cause disease, but this is very rare and has been limited to catheter-
related bloodstream infections (257).  
 
There are a number of risk factors associated with A. baumannii infection. Surgery, trauma, burns, 
premature birth, previous hospitalisation, length of hospital and/or ICU stay, mechanical 
ventilation, indwelling foreign devices, number of invasive procedures performed and previous 
antimicrobial therapy can predispose patients to A. baumannii infection (68). Ventilator-associated 
pneumonia is the most frequent infection associated with A. baumannii, while nosocomial 
pneumonia, skin and soft tissue infections, wound infections, blood stream infections and, to a 
lesser extent, urinary tract infections have also been observed (183). Community acquired 
infections have been reported, though they are quite rare and have only been observed in tropical 
areas of South-East Asia and Australia (183). In these cases, the patients had severe underlying 
disease leading to a high mortality rate (255). 
 
The MAR phenotypes that are increasingly observed have developed over several decades, most 
likely as a consequence of the extensive use of broad-spectrum antibiotics worldwide. When 
members of the Acinetobacter genus were first recognised as nosocomial pathogens during the 
1970s, most clinical infections could be treated with a number of antimicrobials, such as ampicillin, 
gentamicin, and naladixic acid (15). As a consequence of the increased prevalence of MAR A. 
baumannii, carbapenems have become the treatment of choice for most infections. However, 
resistance to carbapenems first appeared in 1985 (181) and reports of carbapenem resistant 
infections have been increasing since the early 2000s (236). In the UK, the incidence of carbapenem 
resistance has increased from <0.5% in 1990 to 24% in 2007 (236). In some cases, MAR A. 
baumannii infections are only treatable with tigecycline and/or colistin, but resistance to these 
agents is also increasing.  
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1.3 Multiple antibiotic resistance in A. baumannii 
1.3.1 Intrinsic resistance 
It has been reported that A. baumannii isolates are intrinsically resistant to several commonly used 
antibiotics, namely aminopenicillins, 1st and 2nd generation cephalosporins and chloramphenicol 
(48). However, this is based upon earlier studies of Acinetobacter isolates (216, 251) and it is not 
always clear if the observed resistance profiles are due to intrinsic genes or whether the resistance 
genes have been acquired. However, it is probable that these intrinsic resistances are caused by the 
chromosomally encoded AmpC cephalosporinase and CraA efflux pump (described below). 
 
1.3.2 Resistance to cephalosporins and carbapenems 
1.3.2.1 The naturally occurring cephalosporinase, AmpC 
A chromosomally encoded cephalosporinase, known as AmpC, is usually detected in A. baumannii 
(17, 183). The ampC gene is an Ambler class C β-lactamase that causes reduced susceptibility to 
ampicillin, and to cefotaxime and ceftazidime at levels that are not clinically relevant (17). The 
region directly upstream of ampC has been shown to differ between isolates that were susceptible 
and resistant to ceftazidime, and an IS was found in isolates with higher resistance (38, 215). This 
IS was identified as ISAba1 and was shown to increase the level of expression of ampC by 
supplying a promoter that appears stronger than the naturally occurring one (88, 103). It has also 
been demonstrated that the presence of ISAba125 upstream of ampC can also increase its 
expression (90). This increased expression of the ampC gene causes high levels of resistance to 
ceftazidime and cefotaxime that results in treatment failure with these antibiotics. Sequence 
variation of ampC has been seen in several different isolates of A. baumannii (88, 111, 204). 
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1.3.2.2 Carbapenem resistance 
In A. baumannii, resistance to carbapenems can be gained via the acquisition of either metallo-β-
lactamase (MBL) genes or Ambler class D β-lactamase genes. While the activity of MBLs can be 
100-1000 fold higher than that of class D β-lactamases, they are rarely observed in A. baumannii, 
with only four different MBLs having been reported in the species (190, 194). The class D beta-
lactamases are the most common and widespread cause of carbapenem resistance in A. baumannii 
(194). This class of β-lactamase genes was first identified by the faster hydrolysis of cloxacillin and 
oxacillin compared to benzylpenicillin (28), hence they are often referred to as oxacillinases or 
OXA-type beta-lactamases. 
 
Oxacillinases are a very diverse group of enzymes that are all able to hydrolyse amoxicillin, 
methicillin, cephaloridine and cephalothin, while not being inhibited by clavulanic acid, tazobactam 
or sulbactam (194). Some are able to hydrolyse extended spectrum cephalosporins, but none of 
these enzymes have been seen in A. baumannii. Others have carbapenemase activity (194), and they 
are most frequently observed in A. baumannii. Carbapenem-hydrolysing oxacillinases, called 
carbapenemases, generally hydrolyse carbapenems at a low level, but are not able to inactivate 
extended spectrum cephalosporins, indicating that the enzymes identified to date are unable to 
effectively hydrolyse both substrates (193). Generally, the hydrolysis of imipenem is faster than that 
of meropenem and the affinity for imipenem is quite high (100, 192, 193). 
 
A. baumannii contains a naturally occurring carbapenemase gene, oxaAb, that is present in the 
chromosome. The oxaAb gene was initially identified in a collection of A. baumannii isolates from 
Argentina (26). These isolates produced a novel carbapenemase, named OXA-51. The oxaAb gene 
is found in A. baumannii that are geographically and temporally distinct (101, 153), and is rarely 
observed in other species of the Acinetobacter genus, indicating that oxaAb was intrinsic and 
specific for A. baumannii. Since the identification of OXA-51, more than 40 allelic variants have 
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been found (193), often leading to confusion in the nomenclature, hence this gene will always be 
referred to as oxaAb, with differing alleles indicated by their protein name. Detection of the oxaAb 
gene has become widely used as a quick and accurate way of identifying A. baumannii, as it is 
consistently found only in this species (244).  
 
Most, if not all, of the different oxaAb alleles have the same biochemical properties as OXA-51, 
thus none of the alleles of oxaAb are able to confer clinically relevant carbapenem resistance (26, 
101, 193). However, much like ampC, when an ISAba1 was inserted upstream of oxaAb there was a 
large increase in the MIC of both imipenem and meropenem, which suggests that ISAba1 is 
providing the same strong promoter and increasing the expression of oxaAb (243). A later study 
investigating two isolates from the same patient, one before and one after treatment with 
carbapenems, also identified that the insertion of an ISAba1 directly upstream of oxaAb coincided 
with an increase in resistance (60). Using quantitative RT-PCR, they showed that the insertion of 
ISAba1 increased the expression of oxaAb 50x and that an oxaAb knockout of this isolate returned 
the carbapenem susceptible phenotype (60), showing that ISAba1 is indeed required for oxaAb to 
provide resistance to carbapenems. 
 
There are three main groups of acquired class D carbapenemases that are frequently observed in A. 
baumannii, OXA-23, OXA-24/OXA-40 and OXA-58 (193, 194). Recently, two additional 
subgroups have been identified, the OXA-143 (107) and OXA-235 (106) groups, but it remains to 
be established how widespread these enzyme groups actually are. The most widespread group of 
class D carbapenemase is the OXA-23 group (193). 
 
1.3.2.2.1 The OXA-23 carbapenemase 
OXA-23 was the first reported oxacillinase that was able to hydrolyse carbapenems. Initially named 
ARI-1, it was found in an A. baumannii isolated from Scotland in 1985 (52, 181). The oxa23 gene 
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in this isolate was later found to be located on a plasmid, after successful transfer of imipenem-
resistance to an A. junii isolate (209). Two carbapenem hydrolysing oxacillinaes that are minor 
variants OXA-23 have been identified in A. baumannii. The first was OXA-27, from an isolate in 
Singapore, and second was OXA-49 from an isolate in China, both of which differ from OXA-23 
by only two amino acids (3, 194). Recently, it has been shown that oxa23 has become globally 
disseminated and is present in both major clonal groups, GC1 and GC2, along with carbapenem 
resistant isolates that were not GC1 or GC2 (158, 193). In Australia, the oxa23 gene was found to 
be responsible for outbreaks of carbapenem resistant A. baumannii in 5 separate Sydney hospitals 
(149, 245) and one hospital in Brisbane (206). 
 
The oxa23 gene has most often been observed in several closely related structures, namely the 
transposon Tn2006, and Tn2007 and Tn2008 (Figure 1.7) (39, 158). While Tn2007 and Tn2008 
have been named as transposons, they do not contain a second IS and as there is no evidence for 
their transposition they are merely transposon remnants. However, they will continue to be referred 
to by their published names for simplicity. Recently, a fourth structure, Tn2009, was identified 
within the genomes of two Chinese GC2 isolates (Figure 1.7) (110, 263). In each of these structures 
there is an IS, either ISAba1 (Tn2006, Tn2008 and Tn2009) or ISAba4 (Tn2007), directly upstream 
of the oxa23 gene, with the remnant of an ATPase downstream (39, 191). In Tn2006 and Tn2009, 
the oxa23 and downstream sequence are flanked by two copies of ISAba1, with the ISAba1s 
inversely oriented in Tn2006 and directly oriented in Tn2009 (39, 263). Tn2006 has been seen on 
both the chromosome and on a plasmid, while Tn2007 and Tn2008 have only been observed on 
plasmids (158). Five separate locations of Tn2006 were identified, but sequence was only available 
for one of them (158).  
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Figure 1.7 Structures of oxa23 containing transposons Tn2006-Tn2009. ISAba1 and ISAba4 are shown by pink and 
purple boxes, respectively, with their orientation indicated by an arrow. Arrows beneath the central line show the 
position and orientation of the genes in each transposon. The orfs a, b, and c correspond to an AAA ATPase, DEAD 
helicase and yeeA, respectively. 
 
As described above, the insertion of an ISAba1 directly upstream of the chromosomal ampC 
cephalosporinase provides a promoter that drives its expression, enabling the gene to cause 
clinically relevant levels of resistance to cephalosporins (90, 215). It has also been demonstrated 
that the ISAba1 upstream of oxa23 provides a promoter that is able to drive its expression of this 
gene (214), enabling it to provide clinically relevant levels of carbapenem resistance. The transfer 
of a recombinant plasmid, containing only the oxa23 gene, into a carbapenem susceptible A. 
baumannii did not cause a significant increase in resistance to imipenem and meropenem (102). 
However, the transfer of the naturally occurring plasmid pFER, which contained oxa23 and most 
likely ISAba1 directly upstream, into the same carbapenem susceptible isolate did cause resistance 
to both imipenem and meropenem at levels that are clinically relevant (102), suggesting that the 
insertion of an ISAba1 next to oxa23 does increase its expression.  
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Poirel et al. hypothesised that the oxa23 gene originated from another species in the Acientobacter 
genus and that it had been mobilised by ISAba1 (191), so they screened 14 different species of 
Acinetobacter for the presence of oxa23 and found it was only present in the chromosome of A. 
radioresistens, which is a commensal of human skin (191). An analysis of five A. radioresistens 
isolates revealed that two contained oxa23 while the remaining three contained genes that were very 
closely related, all located on the chromosome. There was only a single nucleotide difference 
between the oxa23 in the A. radioresisens isolates when compared to the standard sequence of 
oxa23 that is in A. baumannii (191). Analysis of the sequence downstream of oxa23 in A. 
radioresistens revealed that it was in a 1,367 bp segment that is also found in the internal portion of 
Tn2006. The resistance profiles of the A. radioresistens isolates revealed that they were not 
carbapenem resistant. There was no carbapenemase activity detected in these A. radioresistens 
isolates, indicating that the expression of oxa23 was quite weak when compared to A. baumannii. 
As there were no ISAba1 or ISAba4 present in A. radioresistens, this suggests that the promoter 
supplied by these IS is necessary for adequate expression and, as a consequence, clinically relevant 
levels of resistance. 
 
1.3.3 Aminoglycoside resistance 
The most common mechanism of aminoglycoside resistance in A. baumannii involves the 
production of aminoglycoside modifying enzymes (AMEs) (219). A number of different AMEs 
have been identified in A. baumannii (Table. 1.3), with all of the major enzyme classes, 
acetyltransferases, nucleotidyltransferases and phosphotransferases, observed in plasmids, 
transposons or integrons (183, 219). The genes that have been most commonly observed in isolates 
from Europe and the United States are aacC1, aacC2, aphA1, aphA6, aacA4, aadA1 and aadB (112, 
163, 164, 219, 242). In European isolates, aacC1, aadA1, aphA1, aphA6 and aadB are the most 
common, though aphA6 is observed less frequently and a similar pattern was seen in the US 
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isolates, but the incidence of aphA6 was higher than that of the other genes (112, 164). The aacA4 
and aacC2 genes were only rarely observed in both Europe and the United States. 
 
Table 1.3 Aminoglycoside resistance genes and their typical phenotypes. 
Gene Predicted phenotype 
aacC1 Gm 
aacC2 Gm, Ne, Tm 
aphA1 Km, Nm 
aphA6 Ak, Km, Nm 
aacA4aa Ak, Ne, Tm 
aacA4ba Gm, Ne, Tm 
aadA1 Sm, Sp 
aadB Km, Gm, Tm 
aac(6')-Im Ak, Ne, Tm 
armA All aminoglycosides 
a Variants of aacA4 differ by a single base that results in an amino acid change causing a change in substrate specificity. 
The aacC1, aadA1, aacA4 and aadB genes have all been observed in class 1 integron structures in 
A. baumannii. It was first noted by Seward et al. that the same aminoglycoside resistance genes, in 
similar integron structures, were not geographically restricted and were distributed within multiple 
countries throughout the world (218, 219). This finding was echoed in similar studies of European 
isolates that identified the aacC1 and aadA1 genes always associated with one another and located 
within a relatively stable class 1 integron structure (164, 241). Amplification of the gene cassettes 
produced products of 2.5 or 3 kb in all cases (164, 166, 241). This corresponded to what had been 
annotated as the aacC1-orfX-orfX’-aadA1 and aacC1-orfX-orfX-orfX’-aadA1 cassette arrays, for 
the 2.5 and 3 kb amplicons, respectively (218, 241, 242). Both cassette configurations have also 
been observed in isolates from hospitals in Sydney and Brisbane in Australia (149, 196, 197, 245). 
The orfX and orfX’ cassettes have also been referred to as orfP and orfQ (196, 197, 245), 
respectively, and will be henceforth referred to as such. 
 
The aacA4 gene was observed in the aacA4-catB8-aadA1 cassette array in isolates from the UK or 
as a single gene cassette (241, 242). The presence of aacA4 in an integron was also observed in the 
pan-European collection studied by Nemec et al., but they only determined that aacA4 produced 
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amplicons of 0.8 and 2.2 kb when joined by PCR to the 5'-CS (164). Another class 1 integron 
structure was observed in A. baumannii from Italy and France, which contained the aacA4-orfO-
blaOXA-20 cassette array (76, 189). A similar integron was also observed in a French isolate, but it 
contained blaOXA-37, a minor variant of blaOXA-20, and the sequence terminated after this cassette so 
there may be additional genes present (160). The aadB gene cassette has only rarely been observed 
within an integron in European isolates (164). When aadB was present in US isolates, it was never 
in an intergon structure (241). Seward et al., had shown that aadB was located on a plasmid, and 
had also never observed aadB within an integron (219). 
 
Investigation of gentamicin and tobramycin resistance in an Acinetobacter strain named SUN 
revealed that the aadB gene, which was located on a 6 kb plasmid named pRAY, was responsible 
(212). There was no integrase present on pRAY, indicating that aadB had been recombined into a 
secondary site on pRAY rather than integrated as part of an integron, which is known to occur at 
very low frequencies (198). Once fully sequenced, the plasmid pRAY was 6,076 bp with 10 orfs, 
including aadB (211). While none of the additional orfs had any similarity to known plasmid 
replicase genes, one was similar to a mobilisation protein. pRAY was not successfully 
transformable in E. coli, which suggests that it is unable to replicate in this organism and may be 
specific to Acinetobacters (212). It has recently been shown that the previously published sequence 
of pRAY (211) contained a number of errors, and that there were in fact several different sequence 
variants of pRAY, which were named pRAY*, pRAY*-v1 and pRAY*-v2 (92). 
 
The aphA1 gene has almost always been observed in European and Australian A. baumannii that 
contain both aacC1 and aadA1 (149, 164, 166, 196, 197). It has also been observed on its own, or 
only with aphA6 or aadB. A context for aphA1 in A. baumannii was first described in an analysis of 
the whole genome of the GC1 strain AYE, which identified two directly oriented copies of IS26 
flanking the gene (62), suggesting it is within a composite transposon. However, a more detailed 
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analysis of this region in an Australian GC1 isolate, D3208, revealed that the central fragment 
containing aphA1 was 1,254 bp and that this differed from other, similar transposons that harbour 
aphA1 flanked by IS26 (196). There is an additional fragment of IS26 adjacent to the complete copy 
of IS26 that is downstram of aphA1 (Figure 1.8) (196). This transposon was 3,069 bp and named 
Tn6020. Tn6020 is found directly adjacent to the aacC1-P-P-Q-aadA1 cassette array within a 
genomic resistance island (see Section 1.5), which explains why aphA1 has been so commonly 
observed with aacC1 (196, 197).  
 
 
Figure 1.8 The structure of Tn6020, which contains the aphA1 kanamycin resistance gene. The pink boxes represent 
IS26, with the interior arrow showing its orientation. The box containing the ∆ is the small fragment of IS26. An arrow 
beneath the central lines represents the position and orientation of aphA1. 
 
Unlike the other aminoglycoside resistance genes mentioned above, aphA6 was first identified in a 
kanamycin resistant A. baumannii clinical isolate, on a 63 kb plasmid named pIP1841 (129). 
Interestingly, much like pRAY, pIP1841 was transferable to other Acinetobacters but not to E. coli 
(129). The aphA6 gene has a coding sequence of 777 bp, but there was no significant homology 
with the aphA1-aphA5 genes. Since the mid 1980s infections of amikacin resistant A. baumannii, 
and Acinetobacter spp., have been reported throughout Europe and in almost all instances, aphA6 
was the cause of this resistance phenotype (27, 128, 164, 166).  
 
The aac(6')-Im gene, which confers resistance to amikacin, netilmicin and tobramycin (97, 250), 
has been observed in imipenem resistant A. baumannii strains isolated from South Korea (95, 118) 
and shared 99.59% sequence identity with the first aac(6')-Im that was identified in a Citrobacter 
freundii strain isolated in Belgium (95, 97). It was located in a class 1 integron found on the 
chromosome along with an aadA1 gene cassette that was interrupted by the insertion of an IS26 356 
IS26 IS26
aphA1
∆
2,121 bp
1,199 bp
RH601 RH880
RH881 IS26-F
500
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bp downstream from its start codon (Figure 1.9) (95). This atypical class 1 integron structure was 
named integron-IS26.  
 
 
Figure 1.9 The structure of integron-IS26. The pink box represents IS26, with the interior arrow showing its 
orientation. Arrows beneath the central line represents the position and orientation of each gene. 
 
More recently, 16S rRNA methylation, mediated by armA, has been observed in A. baumannii from 
Japan, Korea and the United States (190). The armA gene on its own confers resistance to all 
clinically relevant aminoglycosides (50). The context of armA is similar across many species of 
Gram-negatives, including A. baumannii, as it is within a large composite transposon named 
Tn1548 that is flanked by two copies of IS26, which is found on a plasmid (49, 67). A class 1 
integron, also associated with CR1, has also been identified near the armA gene in Tn1548 (190). 
 
Efflux may also play a role in resistance to aminoglycosides. The AdeABC efflux pump, which is a 
member of the resistance-nodulation-division (RND) family, is able to transport aminoglycosides, 
though the efflux of amikacin and kanamycin is less effective (146). Another pump, AbeM, which 
is a member of the multidrug and toxic compound extrusion (MATE) family, has also been 
implicated in the efflux of aminoglycosides, in particular gentamicin and kanamycin (228).  
 
1.3.4 Resistance to other antibiotic classes 
1.3.4.1 Tetracyclines and glycylcyclines 
Resistance to tetracyclines is mainly mediated by a group of related efflux pumps that specifically 
target tetracyclines, namely Tet(A) – Tet(E). However, the tet(A) and tet(B)  determinants are the 
most common in A. baumannii (82, 113, 166, 200). The tet(A) determinant is only effective against 
500
IS26
intI1∆ aac(6')-Im aadA1∆ aadA1∆ qacE∆1 sul1
L1 796 bp
1,018 bp
941 bp
1,600 bp
2,202 bp
2,572 bp
RH570
RH522 RH601
IS26F RH531
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tetracycline, while tet(B) confers resistance to both tetracycline and minoclycline, which has greater 
activity against A. baumannii (183). The tet(A) determinant is normally seen within Tn1721, and 
tet(B) is usually found in Tn10. The multidrug efflux pump AdeABC has also been implicated in 
contributing to resistance to tetracyclines in A. baumannii (146). 
 
Glycylcyclines are a novel class of antimicrobial that are derived from tetracyclines. Tigecycline, 
the first commercially available glycylcycline, has shown encouraging activity against A. 
baumannii, though resistance has been increasingly reported worldwide (186). In particular, MAR 
A. baumannii isolates from as early as 1996 in Australian hospitals were reported to be resistant to 
tigecycline (117). While the specific tetracycline efflux pumps described above can interfere with 
the action of tigecycline, the AdeABC efflux system has been implicated in resistance to this 
antimicrobial (186). Overexpression of the adeABC locus correlated with an increased MIC of 
tigecycline, and disruption of the regulatory system of AdeABC by the insertion of an ISAba1 in 
the adeB gene was observed in tigecycline resistant strains, but remained intact in susceptible 
strains (207). 
 
1.3.4.2 Quinolones and fluoroquinolones 
Both quinolones and fluoroquinolones act by binding the bacterial gyrase and topoisomerase IV 
enzymes, which are encoded by the gyrA and gyrB, and parA and parC genes, respectively (190). 
Modifications to these enzymes by specific mutations in those genes, particularly gyrA and parC, 
lower the affinity for the binding of the quinolone to the enzyme-DNA complex, which leads to 
resistance to these agents (186). In particular, a single mutation resulting in a Ser-83-Leu 
substitution in GyrA leads to quinolone resistance, while another single mutation in parC leads to a 
Ser-80-Leu substitution, causing resistance to fluoroquinolones, such as ciprofloxacin (252, 253). 
The RND family efflux pumps, namely AdeABC, AdeIJK and AdeFGH, the small-multidrug 
(SMD) efflux pump AbeS and MATE efflux pump AbeM can also contribute to quinolone 
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resistance in A. baumannii (41). Both mechanisms described here are chromosomally located and 
no plasmid borne quinolone resistance determinants have been observed in A. baumannii to date. 
 
1.3.4.3 Sulphonamides and trimethoprim 
Resistance to sulphonamides is highly prevalent in A. baumannii in many geographic regions, due 
to the common occurrence of class 1 integrons, which harbour the sul1 gene in the 3'-conserved 
segment (183). Sulphonamide resistance due to other mechanisms has not been widely studied. 
Resistance to trimethoprim is often mediated by dfr genes that are widely distributed among gram-
negative bacteria, particularly as gene cassettes associated with integron structures in A. baumannii 
(190). Overexpression of the intrinsic efflux pumps AdeABC, AdeFGH and AbeM may also 
contribute to trimethoprim resistance in A. baumannii (41).  
 
1.3.4.4 Chloramphenicol 
Gene cassettes associated with integrons, such as the cmlA or catB cassettes, which encode an 
efflux pump and chloramphenicol-modifying enzyme, respectively, often cause chloramphenicol 
resistance (190). The intrinsic CraA efflux pump specifically transports chloramphenicol in A. 
baumannii (203), while the AbeM and AbeS efflux pumps also contribute to resistance (41). A. 
baumannii is therefore intrinsically resistant to chloramphenicol due to the ubiquitous presence of 
CraA, hence the presence of the cmlA or cat gene cassettes is superfluous. 
 
1.4 The spread of MAR A. baumannii clones 
During the typing of Acinetobacter outbreaks that occurred between 1985 and 1990 in several 
countries in northern Europe, it was independently noted that isolates from apparently unrelated 
outbreaks shared similar characteristics (47). This observation lead to the analysis of outbreak and 
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non-outbreak A. baumannii isolates collected between 1982 and 1990 using a number of typing 
methods. This collection was split into four distinct groups that were highly similar based on one or 
more of the typing methods used. Two of these groups, I and II, were mainly comprised of isolates 
from outbreaks in different parts of Europe, which indicated that they had a common clonal origin 
(47). However, it was also noted that not all outbreak strains were part of these two clones.  
 
Using similar typing methods, a study of clinical A. baumannii-calcoaceticus complex isolates 
collected between 1991 and 1997 from Czech hospitals also separated their collection into two 
distinct groups (165). Both groups comprised both sporadic and outbreak isolates and together they 
accounted for 85% of MAR isolates observed. The features of these groups corresponded to clones 
I and II identified previously in northern Europe (47, 165). Nemec et al. subsequently performed a 
more in-depth comparison between the two clones identified in the Czech hospitals and the 
previously identified clones I and II (163). This study included 70 MAR isolates from 30 Czech 
hospitals collected between 1991 and 2001, 15 susceptible Czech strains from 1991-1996 along 
with 13 reference strains of clones I and II from 1982-1990. Using amplified fragment length 
polymorphisms (AFLP), two major clusters were identified. Cluster 1 included all the reference 
clone I isolates as well as 41 MAR Czech strains while cluster 2 contained all the clone II 
references along with 21 MAR Czech strains. There was a similar correlation using alternate typing 
methods, which confirmed that clones I and II were predominant in Czech hospitals during the 
1990s (163). The 8 remaining MAR and all 15 susceptible isolates formed heterogeneous groups 
that were distinct from clones I and II.  
 
A concurrent study, using ribotyping, AFLP and pulsed-field gel electrophoresis (PFGE) analyses, 
showed that clones I and II were not limited to north-western Europe, identifying clone I in Spain, 
Poland, Italy and South Africa, and clone II in Spain, Portugal, France, Greece, Turkey and South 
Africa (247). A third ribogroup was also identified, which corresponded to a new clone, found in 
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France, The Netherlands, Italy and Spain. Interestingly, there was a great deal of intraclonal 
diversity within clones I and II, which was discerned using PFGE, but clone III was quite 
homogeneous (247). This suggested that clones I and II had emerged earlier than clone III, allowing 
more time for divergence. As these clonal types had been identified throughout all of Europe, they 
became known as European clones (EC) I, II and III. The identification of EC I and EC II in South 
Africa was the first indication that these clones may be spread outside Europe (247). 
 
In 2008, a study of 96 isolates from 17 European countries, collected between 2001 and 2004, 
investigated the diversity of carbapenem resistant A. baumannii, using AFLP, PFGE and a new 
PCR based method that differentiates each EC into a sequence group (SG; Described in Chapter 2), 
where SG2 corresponds to EC I, SG1 corresponds to EC II and SG3 corresponds to EC III (238). 
The spread of clonal A. baumannii isolates and their relation to the previously described clonal 
groups became a focus of many studies published from the mid-2000s, and it became widely 
recognised that the population of carbapenem resistant isolates was increasing. Again, it was 
observed that the majority of isolates that caused infection belonged to EC I and EC II and that the 
majority of carbapenem resistant isolates (84%) were also members of these clones (238). The PCR 
based method, devised by Turton et al. (240), was consistent with both the AFLP and PFGE 
methods, successfully identifying EC I and EC II.  
 
Several other studies around the same period, 2007-2008, also observed a correlation between 
clonal MAR A. baumannii and carbapenem resistance, where EC I and EC II isolates contained the 
majority of carbapenem resistant isolates (42, 166, 240). However, these studies also noted that the 
majority of MAR and carbapenem resistant isolates were members of EC II. There is a stark 
contrast in comparison to the population structure seen in Czech hospitals during the 1990s and 
mid-2000s (166). During the 1990s, Nemec et al. observed 41 EC I and 21 EC II (163), while their 
later study included 5 EC I and 66 EC II isolates, collected from 2005-2006 (166). While the data 
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are not directly comparable, due to different strain selection criteria, it still suggests a shift in 
population towards EC II. 
 
Newer, simple PCR and sequence based methods, such as the sequence group PCR (240), rep-PCR 
(104) and multi-locus sequence typing (MLST) (9, 46), enabled multiple groups around the world 
to begin analysing larger, more diverse strain collections. In a number of publications from 2009-
2010, examination with these newer methods showed that European clones I and II were in fact 
responsible for carbapenem resistant and MAR A. baumannii infections in hospitals worldwide (46, 
66, 104, 158, 185, 196, 197). EC III was found in the United States and South Africa, but it was not 
as predominant as EC I and II (104). Henceforth the European clones, I and II, will be referred to as 
global clones (GC) 1 and 2. Two MLST schemes have been developed for A. baumannii, one 
hosted at Oxford (9) and the other by the Institut Pasteur (46), though in both schemes there was a 
clear correlation between specific sequence types, and related single and double locus variants, and 
the previously identified clones (9, 46, 94). In particular, using the Pasteur based scheme, ST1 
corresponded to GC1, ST2 corresponded to GC2 and ST3 corresponded to EC III (46). It is also 
possible to identify members of GC1, GC2 and EC III by determining the sequence of the naturally 
occurring oxaAb allele. Members of GC1 contain the allele that encodes OXA-69 and members of 
GC2 have the allele that encodes OXA-66 (56). Sequencing oxaAb is a reliable indicator of clonal 
relatedness, which has been effective in discriminating between globally disseminated members of 
GC1 and GC2, and identification of other, potentially epidemic, clonal lineages (94). 
 
Of the three clonal lineages, GC2 is the most numerous and widespread (104, 158).  In a study of 
492 carbapenem non-susceptible isolates, collected from hospitals worldwide, 246 belonged to GC2 
(104). These isolates were from the United States, Israel, Australia, South Africa, pan-Europe and 
South East Asia and had acquired carbapenem resistance via the acquisition of various 
carbapenemase genes, either oxa23, oxa40 or oxa58 (104). Of these genes, oxa23 was the most 
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common. Other studies have shown that oxa23 the most commonly seen carbapenemase in GC2 
outbreaks in China and Australia (66, 104, 158, 206). 
 
Other clonal groups have been identified as causing MAR and carbapenem-resistant A. baumannii 
infections using MLST. While these other clonal groups are not as globally predominant, they have 
been observed with increasing frequency (46, 104). However, this may only be due to a recent 
acquisition of carbapenem resistance, leading to the isolates being detected in the large multi-centre 
studies that focus on carbapenem resistant isolates. There has been one report of a novel clonal 
group, centred on ST78 (Pasteur), which was the predominant cause of carbapenem resistant A. 
baumannii in an Italian hospital from 2006-2007 (75). GC2 isolates were present in the hospital 
during this time, but they made up only a small portion of the population. This highlights that these 
other clonal lineages also have the potential to cause outbreaks or epidemics. 
 
1.4.1 Epidemiology of Australian A. baumannii infections 
The first reports of A. baumannii in Australia were from community-acquired infection in the 
Northern Territory (4, 5). The epidemiology of these infections was not the same as what is usually 
observed in clinical isolates, with differing risk factors and the isolates were more susceptible to 
antimicrobials (4). 
 
The first reported outbreak of nosocomial A. baumannii infection occurred in the ICU of Sir 
Charles Gairdner Hospital in Perth, Western Australia, during 1993-1994 (202). While these 
isolates were not carbapenem resistant, they were found to be resistant to gentamicin, 
cephalosporins and ticarcillin, with some also resistant to ciprofloxacin. Since then, there have been 
outbreaks of carbapenem resistant A. baumannii in Sydney, Brisbane and Melbourne (142, 149, 
182, 187, 188, 206, 245). In each case, the isolates responsible for these outbreaks were closely 
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related. In isolates from hospitals in Sydney and Brisbane, a more in depth analysis revealed that 
the oxa23 gene was found to be responsible for carbapenem resistance and isolates that were 
gentamicin resistant were shown to harbour the aacC1-P-P-Q-aadA1 cassette array (245).  
 
A study performed by Mak et al. (149) characterised a collection of 32 carbapenem resistant A. 
baumannii from 4 Sydney hospitals and grouped them into two distinct types using REP-PCR. A 
subsequent study used the sequence group PCR developed by Turton et al. (240) to determine that 
all members of REP type II belonged to GC1, while 5 integron containing members of REP type I 
belonged to GC2 (197). Using the same sequence group PCR scheme, a collection of 52 clinical A. 
baumannii mostly from hospitals in Adelaide, but also including several isolates from Sydney, 
Brisbane and Darwin, revealed that 32 of these isolates were members of GC2 and 6 belonged to 
GC1 (55). 
 
1.5 Genomic resistance islands in A. baumannii 
1.5.1 Genomic islands in GC1 
Genomic islands that contain resistance genes were first characterised in MAR GC1 isolates. The 
first of these islands was found in the genome of AYE, which was part of an outbreak in a French 
hospital (62). Named AbaR1, this 86.2 kb island was shown to contain a large number of antibiotic 
and heavy metal resistance genes that were often within fragments of mobile elements, such as 
transposons and all of the resistance genes were found between two copies of what was called 
ISPpu12-like (62), which contains cadmium and zinc resistance determinants. ISPpu12-like is 
actually a transposon not an IS and was later renamed Tn6018 (196). The region containing the 
resistance genes, called the multiple-antibiotic resistance region (MARR), and the flanking copies 
of Tn6018 (Figure 1.10) form a transposon. This MARR containing transposon is inserted into 
another ‘backbone’ transposon, named Tn6019 (Figure 1.10), interrupting the uspA gene and 
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generating an 8 bp duplication (196). Tn6019 is bounded by imperfect 26 bp IR and is inserted in 
the chromosome (Figure 1.10) (196).  
 
 
Figure 1.10 The structure of Tn6019. The chromosomal comM gene is shown by a dashed blue line on either side of 
each backbone, while the position and orientation of genes is shown by arrows beneath the central lines. IR are 
indicated by short vertical lines. The insertion points of the arsenate resistance region and Tn6018 flanked MARR, 
unique to Tn6019, are indicated. 
 
Though Tn6019 did not contain any resistance genes it was originally reported as including sul1 
(62), but this was later found to be a misannotation and the gene is in fact a sulphate permease that 
was renamed sup to avoid further confusion (196). The first five genes in Tn6019 (tniC-tniA-tniB-
tniD-tniE; Figure 1.10) are homologs of transposition genes found in the same order in other 
transposons, indicating that they are likely important for the transposition of Tn6019 (87). There is 
also a block of genes that encode arsenate resistance next to the tni genes (Figure 1.10), that is not 
found in a related transposon described below. AbaR1 interrupts a chromosomal ATPase, later 
renamed comM, and generates a 5 bp duplication (ACCGC) at the site of insertion (62, 196).  
 
Since the discovery of AbaR1 a number of related AbaRs have been found, all of which were 
observed at the same location in comM (2, 126, 127, 174, 196, 197). Each AbaR included Tn6019 
with most of the variation occurring in the MARR. All of the variants were smaller than AbaR1 and 
contained fewer resistance genes. AbaR1 was in fact the only variant that had acquired a large block 
of additional resistance genes, relative to other AbaR islands (137, 196, 197). During a comparison 
between AbaR5 (196), from an Australian isolate, AbaR3 (2), from an American isolate, and 
AbaR1 it was concluded that AbaR3 was in fact the ancestral form relative to all of the islands that 
had been characterised, as there was a portion of the MARR that was present in AbaR3 that had 
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been deleted in both AbaR5 and AbaR1 (196). However, no other island had the longer 
configuration seen in AbaR1.  
 
However, it has recently been noted that there was a 108 bp deletion in the 5'-CS of the class 1 
integron with the aacC1-P-Q-aadA1 cassette array in the MARR of AbaR3 and that the 5'-CS is 
intact (i.e. this deletion was not present) in AbaR5 or AbaR1 (93). An Australian GC1 isolate was 
shown to contain an island, named AbaR0, which was almost identical to AbaR3. AbaR0 did not 
have the 108 bp deletion, hence it is likely that AbaR0 is in fact the ancestor of AbaR3 (93). The 
MARR of AbaR0 was 40,551 bp long and contained a mercuric ion resistance region along with the 
tetA(A), catA1, blaTEM, aphA1b, aacC1, aadA1 and sul1 resistance genes (Figure 1.11). Almost all 
of these resistance genes are in fragments of characterised transposons (62, 196). However, aphA1b 
is in a complete copy of Tn6020 and there is a class 1 integron that contains a complete 5'-CS, the 
aacC1-P-P-Q-aadA1 cassette array along with a copy of sul1. There is another copy of sul1 in a 
second fragment of the 3'-CS (Figure 1.11). 
 
 
Figure 1.11 The MARR of AbaR0, with the flanking copies of Tn6018. The thin central line represents the MARR, 
while the thick lines represent Tn6018. IR are indicated with vertical lines. Numbered open boxes represent the IS, with 
the number indicating the identity of the IS. The attI site of the integron is shown as a tall open box and gene cassettes 
are represented with small open boxes followed by a bar indicating the attC site. The lines above represent the regions 
derived from known transposons, with vertical lines showing the boundaries between segments and X indicating a 
recombination crossover. 
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There are three complete copies of IS26 in the MARR of AbaR0, one adjacent to blaTEM and the 
two flanking aphA1b to form Tn6020 (Figure 1.11). Almost all of the AbaR variants, derived from 
either AbaR3 or AbaR0, have lost segments to one side of an IS26 (126, 196, 197), altering the 
sequence of the MARR and in some cases removing portions of Tn6019 as well. Thus, the variation 
in AbaRs is due to deletions that are mediated by IS26. 
 
1.5.1.1 AbaR4 and Tn6022 
Another island, similar to Tn6019 has been observed in comM of a GC1 isolate (87). This island is 
named AbaR4 and was first found at a secondary location in the genome of another GC1, AB0057, 
which has AbaR3 in comM (1). AbaR4 contains tni genes closely related to those seen in Tn6019, 
but it lacks the arsenate resistance region and does not contain the MARR (Figure 1.12). AbaR4 
only contains a single resistance gene, oxa23, which is in Tn2006 and is inserted near the 5'-end of 
sup (1) (Figure 1.12). Removing the Tn2006 from AbaR4 leaves an uninterrupted ‘backbone’ 
transposon that was named Tn6022 (87). Hence, Tn6022 and Tn6019 are part of the same family of 
transposons, and can be differentiated by the presence or absence of the arsenate resistance genes. 
 
 
Figure 1.12 The Tn6022 ‘backbone’ transposon. The chromosomal comM gene is shown by a dashed blue line on 
either side of each backbone, while the position and orientation of genes is shown by arrows beneath the central lines. 
IR are indicated by short vertical lines. The Tn6022 backbone is shown by the single black line while the green Tn2006 
shows its insertion point in AbaR4. 
 
1.5.1.2 Tn6021 
Tn6021 was found in comM in the genome of ATCC 17978 (197, 223), which is not a member of 
GC1 or GC2. Tn6021 had a backbone similar to Tn6022, but there is a 531 bp patch in the tniC-tniA 
genes that only shares 90.8% identity with Tn6022 (87). There was also a novel IS, ISAba11, 
tniB comMcomM tniA uspA sup orf4
ISAba11
tniC tniD tniE orf
Tn2006
tniB comMcomM tniA uspA sup orf4tniC tniD tniE
trkA trxB arsH arsB arsC arsR arsC
cadR cadA lspA tnpA cadR cadA lspA tnpA
MARR
Tn6018 Tn6018
(a) Tn6019
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interrupting tniC. Tn6021 did not harbour any resistance genes, though the sup gene had been 
misannotated as sul1 (223).  
 
1.5.2 Genomic islands in GC2 
AbaR islands have been described primarily in GC1 isolates, but there is a single report of one in 
the same position in comM in a GC2 isolate. This island, named AbaR2, is found in of the genome 
of the Italian isolate ACICU, the first GC2 isolate to be sequenced (114). However, AbaR2 includes 
only part of an AbaR, relative to the other variants. It contains a fragment of Tn6020 adjacent to a 
class 1 integron and one copy of Tn6018 followed by the sup gene and the remainder of Tn6019. 
The aacC1-P-P-Q-aadA1 cassette array, usually seen in the integron at this position in AbaRs, had 
been replaced by aacA4-orfO-blaOXA-20 (114). 
 
When this work began, very little was known about the structures of genomic islands in other GC2s 
and ACICU was the only GC2 with a characterised structure (2, 114). However, it had been shown 
that the comM gene was interrupted in members of GC2, indicating that there was an island present 
in the same location as the AbaRs (197, 220). However, the sequence of comM differed between 
each clone, regardless of what transposon was present (Figure 1.13). A comparison of the sequence 
of the left (J1) and right (J2) hand junctions with comM between the AbaR variants, GC2s and 
Tn6021 revealed that there was also variation in the sequence of the transposon (Figure 1.13) (197). 
For J1, the GC2 GI sequence was identical to Tn6021 and Tn6022, and had 6 base differences 
relative to the Tn6019 in GC1 isolates (197) (Figure 1.13). For J2, the GI sequence from the GC2 
isolates was differed from Tn6019 by 11 bases, and Tn6021/Tn6022 by 8 bases (197). A 
preliminary analysis of some of the features of AbaR islands in a small collection of Australian 
GC2 isolates revealed that they lacked Tn6018 and arsC, while containing an intact uspA (197). 
This indicated that the GC2s could not have Tn6019 and that they did not contain the MARR of 
CHAPTER 1 
 
40 
AbaRs. Thus, the GC2s likely had an island with a backbone similar to Tn6022 rather than an 
AbaR. This also raised the possibility that the presence of AbaR2 in ACICU does not represent 
what is normally present in GC2 isolates. 
 
 
Figure 1.13 J1 and J2 junctions of the transposons inserted in comM. The AbaR in the top line corresponds to the AbaR 
variants, while GC2 GI represents the GI identified in the GC2 isolates studied by Post et al. (197). The coloured lines 
represent the different sequences of comM that were identified while the black lines of different thicknesses represent 
the variant sequences of the transposon. The vertical lines are the IR that bound the extremities of the island. The 
presence of Tn6018, uspA and arsC, and clonal lineage are also indicated. This figure was modified from Figure 4 in 
Post et al. (197) 
 
It had also been noted that the sequence of the island at J2 in the GC2 isolates was a perfect match 
for what had been described as a ‘distant locus’ in the sequence of ATCC 17978 (197, 220). This 
‘distant locus’ was actually within a large genomic island in ATCC 17978 (173, 223). This island 
contained the majority of GIsul2 (described in Section 1.1.4.4) and was bordered on one end by an 
ISAba1 and by an IR at the other (173). This IR was identical to the right hand IR of Tn6019 and 
Tn6022 (173), and it was adjacent to a gene that shared 85% identity with orf4 and was named 
orf4b.  
 
From the sequence comparison described above, it is clear that GC2s contain an island different to 
the AbaRs. ACICU, which contains AbaR2 (114), is an outlier as it is the only GC2 studied so far 
that contains an AbaR. While the GC2s share one junction with Tn6021/Tn6022, the second 
junction is different. Hence, the GC2s contain a transposon in comM that has not yet been 
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characterised. It was possible that the GC2s contain a mosaic island related to Tn6022 with orf4b 
replacing orf4 adjacent to the right-hand portion of comM. 
 
1.6 A. baumannii genomics 
In August 2013, 15 completed and annotated genome sequences of A. baumannii (Table 1.4) (2, 34, 
57, 62, 110, 114, 141, 178, 223, 246, 263, 264). ATCC 17978 was the first completed A. baumannii 
genome (223) and a comparison to the genome of the environmental A. baylyi ADP1 (7) led to the 
identification of 28 putative ‘alien’ islands present in ATCC 17978. These islands were defined as 
genomic regions of greater than 10 kb that had likely been acquired by horizontal gene transfer 
(223). Twelve of these alien islands contained genes that were homologous with genes known to 
enhance virulence in other pathogenic bacteria (223). 
 
Table 1.4 Completed A. baumannii genomes as of August 2013. 
Isolate Accession 
No. 
GC Country Submission  
year 
Size  
(Mb) 
G+C 
(%) 
Genes Plasmids 
ATCC 17978 CP000521 - France 2007 4.00 38.9 3,469 2 
AB0057 CP001182 1 United States 2008 4.06 39.2 3,923 1 
AB307-0294 CP001172 1 United States 2008 3.76 39 3,542 - 
ACICU CP000863 2 Italy 2008 4.00 38.9 3,845 2 
AYE CU459141 1 France 2008 4.05 39.3 3,890 4 
SDF CU468230 - France 2008 3.48 39.1 3,664 3 
1656-2 CP001921 2 South Korea 2011 4.02 39.1 3,913 2 
AB0715 CP002522 2 Taiwan 2011 4.22 38.9 4,010 2 
MDR-ZJ06 CP001937 2 China 2012 4.01 39 3,975 1 
MDR-TJ CP003500 2 China 2012 4.15 39.1 4,047 2 
TYTH-1 CP003856 2 Taiwan 2012 3.96 39 3,770 - 
D1279779 CP003856 - Australia 2013 3.71 39 3,487 1 
BJAB07104 CP003846 2 China 2013 4.04 39 3,953 2 
BJAB0715 CP003847 - China 2013 4.05 38.9 3,999 1 
BJAB0868 CP003849 2 China 2013 4.01 38.9 3,912 3 
 
A comparison of the GC1 AYE to the non-pathogenic SDF and ADP1 revealed that AYE had a 
large number of genes that encode catabolic functions and also had a number of putative 
pathogenicity determinants that were not present in SDF or ADP1 (246). Comparison of ACICU, a 
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GC2 (114), to ATCC 17978 and ADP1 also identified a number of pathogenicity islands in ACICU, 
8 of which were unique to ACICU. Much like the islands identified in AYE, several of them 
harboured genes believed to be involved in virulence and drug resistance (114).  
 
1.6.1 Defining the core and accessory genomes of A. baumannii 
The core genome represents the genes that have been identified in all members of that species, 
while the accessory genome contains genes that are absent in at least one member of the species, so 
it could be concluded that these accessory genes are not essential for bacterial growth and function, 
but may offer a selective advantage in a particular niche (151). The pan genome of a species 
represents the sum of all genes identified in that species, corresponding to the sum of its core and 
accessory genomes (59, 151, 231).  
 
A recent comparison of 12 A. baumannii genomes has provided insight into the pan, core and 
accessory genome of this organism (116). This analysis identified a total of 8,818 coding sequences, 
of which 1,455 were part of the core genome and 7,363 were accessory genes. Approximately 25% 
of these accessory genes were unique to each isolate and were defined as singletons. Thus, this 
indicated that the core genome of A. baumannii was quite small, and included <40% of the coding 
sequences in each genome (116). However, if the two outlier isolates, ATCC 17978 and SDF, are 
removed from this analysis the number of genes in the core genome rises to 2,406, which is 
approximately 65% of each genome (116). With such a large number of singletons and other 
accessory genes relative to core genes, A. baumannii can be described as having an open pan 
genome, where gain and loss of genes plays a pivotal role in host and niche adaptation. This lead to 
the conclusion that A. baumannii, while currently a low-grade pathogen, has the ability to readily 
acquire genes from more pathogenic bacteria and evolve to become more virulent (116). 
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The majority of the A. baumannii core genome contains genes responsible for metabolic and 
general cellular functions, but a significant portion contained orfs that encoded hypothetical 
proteins without a predicted function. The remaining core genes mostly encode adhesion and 
motility, quorum sensing, iron metabolism and drug resistance (116). Many of these genes affect 
virulence, and the majority of these virulence genes were also present in ATCC 17978 (116), which 
was isolated in 1951. An analysis of the accessory genome present in members of GC1 and GC2 
showed that there were no additional genes that directly affected virulence, when compared to A. 
baumannii that were not members of these clones (116).  
1.7 Aims and scope 
Clonal MAR A. baumannii, in particular GC2, is a global threat. While there have been studies of 
Australian outbreaks, none so far had focused on the genetic context of antibiotic resistance genes 
in GC2 isolates. Moreover, the majority of studies tend to focus on resistance to a single group of 
antibiotics, such as carbapenems or aminoglycosides, and ignore all of the other antibiotic families. 
Both GC1 and GC2 had been identified in Australia, but it was not clear which of these lineages 
was dominant in Australian hospitals or how closely Australian A. baumannii isolates were related 
with those studied elsewhere. AbaR-type islands in GC1 isolates are quite well understood. 
However, it is not clear whether islands in this location played an important role in antibiotic 
resistance in GC2s. Hence, the work presented in this thesis had 4 general aims: 
• To assemble a collection of GC2 isolates from different Australian hospitals and determine 
their resistance profiles and their compliment of resistance genes  
• To find the contexts of all of the antibiotic resistance genes 
• To determine the structure(s) of the genomic island in comM for all GC2 isolates and 
characterise any variation in structure 
• To locate and define the structures of any other resistance regions, on the chromosome or 
plasmids. 
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2.1 Materials 
2.1.1 Chemicals and reagents 
The chemicals used in the project were purchased from Sigma-Aldrich (St Louis, MO, USA), 
Promega (Madison, MI, USA) and Bio-Rad (Hercules, CA, USA) and were of molecular biology 
grade. 
 
2.1.2 Buffers and other solutions 
Buffers and solutions were made up using H2O treated by reverse osmosis, according to the 
protocols in Sambrook et al. (208). 
 
0.5X TBE buffer 45 mM Tris 
 45 mM boric acid 
 1 mM EDTA 
  
1X TAE buffer 40 mM Tris 
 20 mM acetic acid 
 1 mM EDTA 
  
TE buffer 10 mM Tris-HCl, pH 7.5 
 1 mM EDTA, pH8 
  
Loading dye 0.1% (w/v) bromophenol blue 
 0.2% (w/v) xylene 
 20 mg/ml ficoll 
  
Saline 0.9% (w/v) NaCl 
  
Elution Buffer (EB) 10 mM Tris-HCl, pH 8.5 
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2.1.3 Growth media 
BactoTM Yeast extract and BactoTM agar were purchased from Becton Dickinson (Cockeysville, 
MD, USA).  Tryptone and Sensitest Agar were acquired from Oxoid (Basingstoke, Hampshire, 
UK). Growth media was prepared according to the instructions provided by the manufacturer. 
 
Luria-Bertani Broth (LB) 1% (w/v) tryptone 
 0.5% (w/v) yeast extract 
 1% NaCl 
  
Luria-Bertani Agar (LA) LB containing 1.5% (w/v) agar 
  
Sensitest Agar 3.2% (w/v) Sensitest Agar in H2O 
 
2.1.4 Enzymes 
Taq polymerase and all restriction endonucleases with the appropriate buffers were obtained from 
New England Biolabs (Ipswich, USA). High fidelity PhusionTM polymerase was acquired from 
Finnzymes (Vantaa, Finland). RNase A and lysozyme were purchased from Sigma-Aldrich (St 
Louis, MO, USA). Proteinase K was obtained from Promega (Madison, MI, USA). 
 
2.2 Bacterial Isolates 
A total of 111 Acinetobacter baumannii isolates, isolated between 1999 and 2011, were collected 
from 9 Australian hospitals, but experimental work was conducted on a subset of 83 A. baumannii 
isolates from 8 hospitals (Isolates will be described in Chapter 3), which included 29 isolates 
collected from Prince of Wales (Hospital A), St. George (Hospital B), Concord (Hospital C) and 
Royal North Shore (Hospital D) hospitals in Sydney, which had been previously characterised (149) 
and were kindly supplied by Dr. Peter White (UNSW). Additional isolates from Hospital A, 
Hospital B and hospital D were kindly supplied by Ian Carter, Kerry Varettas and Peter 
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Huntington/Dr. Clarence Fernandez, respectively. Ian Paulsen kindly supplied a single isolate from 
Westmead Hospital. Isolates from Woden Valley Hospital in Canberra were also kindly supplied by 
Dr. Peter Collignon. Isolates from the Royal Brisbane Women’s Hospital and the single isolate 
from Mater Hospital in Brisbane were kindly supplied by Dr. Mohammad Katouli. A European 
isolate, the reference strain RUH134/A320, was also studied. This isolate was kindly supplied by 
Dr. Kevin Towner. These isolates were screened for resistance to a limited number of clinically 
relevant antibiotics in the hospitals prior to their acquisition, however a more complete profile of 
resistance to 23 antibiotics was generated during this study (Section 2.3.2).  
 
2.3 Bacterial Characterisation and manipulation 
2.3.1 Bacterial growth conditions and storage 
Upon collection from the hospital, isolates were restreaked on LA media to obtain single colonies 
and incubated at 37°C overnight. Two single colonies were subsequently selected at random for use 
in antibiotic resistance phenotyping and long-term storage at -80°C. These two colonies, along with 
a colony sized portion of mixed growth, were then cultured as described above. 750 µl of culture 
was then mixed with an equal volume of 50% (w/v) glycerol and placed in the -80°C freezer. LB 
was inoculated using the freezer stock and incubated overnight at 37 with shaking at 200 rpm for 
further experiments. 
 
2.3.2 Antibiotic resistance phenotype determination using disk diffusion 
To quantify the level of resistance each isolate has to a set of 23 antibiotics, the Calibrated 
Dichotomous Sensitivity (CDS) disk diffusion assay was used. Single colonies from an isolate of A. 
baumannii were resuspended in 4 ml saline which was then successively poured onto four plates 
each made up with 20 ml Sensitest Agar. Once dry, the plates were stamped with the set of 23 
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different antibiotic discs (up to 6 per plate) and incubated overnight at 37°C. The antibiotics used 
were ampicillin (25 µg), streptomycin (25 µg), spectinomycin (25 µg), trimethoprim (5 µg), 
tetracycline (30 µg), compound sulphonamides (300 µg), chloramphenicol (30 µg), kanamycin (30 
µg), neomycin (30 µg), cefotaxime (30 µg), ceftazidime (30 µg), gentamicin (10 µg), florfenicol 
(30 µg), netilmicin (30 µg), amikacin (30 µg), tobramycin (10 µg), ciprofloxaxin (5 µg), nalidixic 
acid (30 µg), imipenem (10 µg), meropenem (10 µg), Timentin (ticarcillin-clavulanic acid; 85 µg), 
ampicillin-sulbactam (20 µg) and rifampicin (30 µg) (Oxoid, Basingshire, UK). The annular radius 
of the zone of clearing was measured from the edge of each disk. Isolates with an annular radius of 
less than 6 mm were resistant, according to the CDS guidelines 
(http://web.med.unsw.edu.au/cdstest). 
 
2.3.3 Conjugation 
A plasmid was conjugated from a donor strain into a rifampicin resistant mutant of the A. 
baumannii strain ATCC 17978. This mutant was generated by plating ATCC 17978, which is also 
resistant to sulphamethoxazole, onto LA supplemented with rifampicin (100 µg/ml). After 
overnight growth at 37°C, spontaneous rifampicin resistant mutants were selected at random and 
tested for resistance to antibiotics using CDS disk diffusion (Section 2.3.2). Two of these rifampicin 
resistant mutants were frozen at -80°C (Section 2.3.1) for use as recipients for conjugation. 
 
Equal volumes of donor and recipient cells were mixed on a LA plate and incubated overnight at 
37°C. Cells were harvested in 0.9% saline and serially diluted from 10-1 to 10-7. 100 µl of each 
dilution was plated onto LA supplemented with rifampicin (100 µg/ml) and an antibiotic that the 
target plasmid confers resistance to in order to isolate transconjugants, in this case kanamycin (20 
µg/ml). To ensure the randomly selected transconjugants were not spontaneous rifampicin mutants 
of the donor, colonies were purified and screened for growth on LA agar containing antibiotics to 
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which the donor was resistant, kanamycin (20 µg/ml), and the recipient was susceptible, naladixic 
acid (25 µg/ml). The complete antibiotic resistance profile for the purified transconjugants was then 
determined using CDS disk diffusion (Section 2.3.2). 
 
2.4 DNA preparation and analysis 
2.4.1 DNA extraction 
2.4.1.1 Genomic DNA 
A single colony was cultured (Section 2.3.1) and 1.5 mL of cell culture was then spun at 9,391 rcf 
(G-force) in a benchtop centrifuge for 30 seconds to pellet the cells. The supernatant was discarded 
and the pelleted cells were resuspended in 630 µl TE, to which 10 µl of both Lysozyme (10 mg/ml) 
and RNase A (10 mg/ml) were added followed by 5 ul of Proteinase K (10 mg/ml) and then 40 µl of 
10% SDS solution. The mixture was incubated at 37°C for 1 hour followed by a second incubation 
at 50°C for another hour. 200 µl of 5 M NaCl followed by 100 µl of 10% CTAB (cetyl 
trimethylammonium bromide) was added and the mixture was incubated at 65°C for a further 10 
minutes. The solution was extracted with an equal volume of chloroform:isoamyl alcohol (24:1) 
solution, followed by a second extraction using phenol:chloroform:isoamyl alcohol (25:24:1). The 
DNA was then precipitated using 0.6 volumes of isopropanol, followed by a wash with 70% 
ethanol. The ethanol was removed and the pellet was dried. It was then resuspended in TE. The 
concentration and purity of the extracted DNA was verified using gel-electrophoresis and the 
Thermo Scientific Nanodrop spectrophotometer (Thermo Fisher Scientific, Wilmington, Delaware, 
USA). This genomic DNA was then stored at 4°C. The DNA was diluted to a concentration of 10-
50 ng/µl in sterile MilliQ H2O for use in PCR (see Section 2.4.2). 
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2.4.1.2 Plasmid DNA 
Plasmid DNA was extracted using a Wizard plus SV Miniprep kit (Promega, Madison, MI, USA) 
according to the manufacturers instructions. 
 
2.4.2 Polymerase Chain Reaction (PCR) 
2.4.2.1 Primers 
Primers were synthesised by Integrated DNA Technologies (Coralville, Iowa, USA), received in 
lyophilised form and were made up to a concentration of 500 µM in TE and stored at -20°C. 
Working stocks were made up by dilution with sterile MilliQ H2O to a final concentration of 50 
µM. The primers made during the course of this study were designed to have a standard annealing 
temperature of 60°C and be approximately 20-23 bp in length, using the Primer 3 program 
(http://bioinfo.ut.ee/primer3-0.4.0/primer3/). Primers used in this project are listed in Appendix II. 
 
2.4.2.2 Standard PCR  
PCR amplification reactions were performed in a total volume of 12.5 µl of 1x ThermoPol PCR 
reaction buffer (New England Biolabs, Ipswich, USA) containing 200 µM dNTP mix, 1 µM of each 
primer, 1 U Taq polymerase (New England Biolabs, Ipswich, USA) and 1 µl of diluted DNA 
(Section 2.4.1.1) as the template. Reactions were run in an Eppendorf Mastercycler (Eppendorf, 
Hamburg, Germany) or an Eppendorf Mastercycler Nexus with an initial denaturation time of 3 
minutes at 94°C, followed by 30 cycles of 94°C for 30 seconds, 60°C for 30 seconds and 72°C for 
1-3 minutes (extension time varied based on expected amplicon size, where 1 minute was allowed 
for 1 kb of sequence) with a final extension time of 72°C for 5 minutes. For gradient PCR, the 
reactions were run using a Biorad MyCyclerTM (BioRad, Hercules, USA) with a temperature range 
of 52°C-65°C replacing the standard annealing temperature. Amplicons were visualised using gel 
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electrophoresis (see Section 2.4.4) and the products were identified by comparison to known 
standards. When available a known control for the target region was used and a DNA-free negative 
control was always included. If the PCR amplicon was used for sequencing, a 25 µl reaction was 
used. 
 
2.4.2.3 Long-range PCR 
For PCR amplicons that were expected to be greater than 3 kb, a high fidelity polymerase was used. 
This reaction was made up to a total volume of 10 µl of 1x HF buffer (Finnzymes, Vantaa, Finland) 
containing 200 µM dNTP mix, 0.5 µM of each primer and 0.02 U of Phusion® polymerase 
(Finnzymes, Vantaa, Finland). DNA was diluted to 10-50 ng/ul and used as the template. Reactions 
were run in an Eppendorf Mastercycler or Eppendorf Mastercycler Nexus with an initial 
denaturation time of 30 seconds at 98°C, followed by 35 cycles of 98°C for 10 seconds, 60°C for 30 
seconds and 72°C for 1.5-4 minutes (the extension time varied based on expected amplicon size 
where 30 seconds were allowed for 1 kb of sequence) with a final extension at 72°C for 10 minutes. 
Amplicons were visualised using gel electrophoresis (see Section 2.4.4) and the products were 
identified by comparison to known standards. If the PCR amplicon was used for sequencing, the 
reaction was made up to 20 µl. 
 
2.4.3 Restriction endonuclease digestion 
PCR amplicons were used as templates for digestion with 5-10 U of restriction endonuclease in 1x 
buffer and 1x BSA, if required, as recommended by the manufacturer (New England Biolabs, 
Ipswich, USA) in a total volume of 20 µl. The digestion mix was incubated at 37°C in a water-bath 
for 1-4 hours. After incubation, the digestion was separated and visualised using agarose gel 
electrophoresis (Section 2.4.4). 
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2.4.4 Agarose gel electrophoresis 
0.8%-2% (w/v) agarose gels were made by boiling molecular grade agarose (Bioline, London, UK) 
in 0.5x TBE. The percentage of agarose used was dependant on the predicted size of the DNA to be 
separated; for 0.5-4 kb amplicons, 1% (w/v) agarose was used, for restriction digests of PCR 
amplicons 1.5% (w/v) agarose was used, for products of <0.5 kb 2% (w/v) agarose was used, for >4 
kb or undiluted gDNA 0.8% (w/v) was used. Gels were stained with 1 µg/ml Ethidium Bromide 
(EtBr), which was added to liquid agarose, which had been allowed to cool. Once set, the gel was 
loaded with the sample (5 µl of PCR product, 20 µl of restriction digest or 1 µl of undiluted gDNA) 
that was mixed with 2 µl of loading dye. Molecular weight markers 1 kb or 100 bp (New England 
Biolabs, Ipswich, USA) were added to the gel based on the predicted product sizes to estimate the 
size and concentration of the DNA. The agarose gels were run in 0.5x TBE at 180V for 40 minutes 
for PCR products, 180V for 20 minutes for undiluted gDNA or 150V for 50 minutes for restriction 
digests. DNA bands were then visualised using a UV transilluminator and imaged using the Gel 
Doc XR program (BioRad, Hercules, USA). 
 
2.4.5 DNA purification 
If multiple bands were observed in the agarose gel, the products were rerun and the desired band 
was excised using visualisation under long range UV (to prevent DNA damage). The excised band 
was then purified using a QIAquick Gel Extraction kit (QIAGEN Inc, Valencia, CA, USA) with the 
spin column protocol and resuspended in 30 µl EB, according to the manufacturers instructions. 
Otherwise, DNA was purified using ethanol precipitation where 2 volumes of 100% ethanol and 
1/10 volume of sodium acetate (3 M, pH 5.2) were added to the DNA, mixed and spun at 20,238 rcf 
for 15 minutes in an Eppendorf 5424 benchtop centrifuge (Eppendorf, Hamburg, Germany). The 
pellet was washed with 70% ethanol and then resuspended in 20 µl TE, or EB if used for 
sequencing. The DNA concentration and purity was then estimated using a Thermo Scientific 
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Nanodrop ND-1000 spectrophotometer (Thermo Fisher Scientific, Wilmington, USA). DNA with 
an A260/A280 ratio between 1.8-1.9 was considered suitable for DNA sequencing. 
 
2.5 DNA sequencing and bioinformatic analysis 
2.5.1 Sanger sequencing 
DNA sequencing reactions were made up to a total volume of 12 µl and contained 12-18 ng (PCR 
product 400-600 bp), 18-30 ng (PCR product 600-800 bp) or 30-75 ng (PCR product >800 bp) of 
purified DNA with 9.6 pmol of primer. The sequencing reaction was then sent to the Sydney node 
of the Australian Genome Research Facility (AGRF) where automated sequencing was performed 
on an Applied Biosystems 3730xl DNA Analyser using the Big Dye system. 
 
2.5.2 Whole genome sequencing 
Genomic DNA for sequencing was extracted as described in section 2.4.1.1, however at the 
phenol:chloroform:isoamyl alcohol extraction step a Heavy Phase Lock Gel (PLG) (5prime, 
Gaithersburg, USA) tube was used to ensure complete separation of the organic and aqueous 
phases. The DNA was then diluted with TE to a concentration of 20-50 ng/µl and visualised on a 
1% agarose gel (see section 2.4.4) with a λ DNA-HindIII digest ladder (New England Biolabs, 
Ipswich, USA). 100 µl aliquots of the diluted DNA, containing 2-5 µg DNA, were then shipped to 
the Wellcome Trust Sanger Institute and were sequenced using Illumina HiSeq, generating paired-
end reads of 100 bp. 
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2.5.3 Basic bioinformatic analyses 
DNA chromatograms from Sanger sequencing runs were viewed using FinchTV 1.4 (Geospiza, 
Seattle, USA) and then trimmed manually. The trimmed DNA sequences were then analysed using 
the online BLAST facility (http://blast.ncbi.nlm.nih.gov/Blast.cgi) or stand-alone BLAST version 
2.2.25+ (31). Pairwise or multiple sequence alignments were performed using ClustalW2 
(http://www.ebi.ac.uk/Tools/msa/clustalw2/). Sequences were assembled using Sequencher 5.1 
(Gene Codes Corp, Ann Arbor, MI, USA) and then visualised and annotated using Gene 
Construction Kit 4.0 (Textco, West Lebanon, NH, USA). The fastq reads generated by Illumina 
paired-end sequencing were assembled using Velvet 1.2.03 by Dr. Kathryn Holt (University of 
Melbourne). The contigs were then used to form a database of our genomic data for use with the 
stand-alone BLAST command line application. 
 
2.6 Molecular characterisation of A. baumannii isolates 
2.6.1 PCR based species confirmation 
To confirm that the isolates were within the Acinetobacter genus, a PCR targeting the recA gene 
was performed. The primers used in this PCR target a highly conserved region in recA that is 
Acinetobacter specific. To confirm that the isolates were A. baumannii the oxaAb gene was 
amplified using PCR. oxaAb is present in A. baumannii isolates, but absent from other members of 
the Acinetobacter genus, allowing for quick species level identification of this organism. These 
PCRs were performed as described in section 2.4.2.2 and have been used previously (196). 
 
2.6.2 Determination of clonal lineage 
The clonality of A. baumannii was initially determined using an allele specific multiplex PCR, 
which was developed by Turton et al. (240). This PCR targets three conserved genes present in A. 
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baumannii, ompA, csuE and oxaAb (See Appendix II; Table II.4 for primers). Two sets of primers 
specifically target the alleles of these genes present in Global Clone 1 and Global Clone 2, the two 
major clonal lineages responsible for MAR A. baumannii infections. The PCR was performed using 
the same reaction mixture as described in section 2.4.2.2, except for the addition of the extra 
primers (the reaction volume was adjusted by adding less H2O). Amplification was conducted in an 
Eppendorf Mastercycler (Eppendorf, Hamburg, Germany) or an Eppendorf Mastercycler Nexus 
with an initial denaturation at 94°C for 3 minutes, followed by 30 cycles of 94°C for 45 seconds, 
57°C for 45 seconds and 72°C for 1 minute, with a final extension at 72°C for 5 minutes (240). The 
amplicons were visualised using gel electrophoresis as described in section 2.4.4. Sequencing of the 
recA and oxaAb genes (see Section 2.6.1) was also performed and used in clonal identification.  
 
2.6.3 Multi-Locus Sequence Typing (MLST) 
The MLST scheme designed by Bartual et al. (9) was used to characterise the relatedness of the A. 
baumannii isolates studied in the project. Seven conserved housekeeping genes, gltA (citrate 
synthase), gyrB (DNA gyrase subunit B), gdhB (glucose dehydrogenase B), recA (homologous 
recombination factor), cpn60 (60-kDa chaperonin), gpi (glucose-6-phosphate isomerase) and rpoD 
(RNA polymerase sigma factor), were amplified and sequenced as described previously (9). The 
sequences were then compared to a database of alleles (http://pubmlst.org/abaumannii/) and 
assigned a sequence type (ST). After the genome sequences of the GC2 collection became 
available, MLST was performed bioinformatically by employing a python script, mlstBLAST 
(http://sourceforge.net/projects/srst/files/mlstBLAST/), which uses blastn to extract the MLST 
profiles from complete genomes or assembled contigs.  
 
Sequence types using the second A. baumannii MLST scheme, hosted by the Institut Pasteur 
(http://www.pasteur.fr/recherche/genopole/PF8/mlst/Abaumannii.html), were also determined 
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bioinformaticlly once the genome sequences became available, using the same script described 
above. This scheme also targets 7 conserved housekeeping genes, cpn60 (60-kDa chaperonin), fusA 
(elongation factor EF-G), gltA (citrate synthase), pyrG (CTP synthase), recA (homologous 
recombination factor), rplB (50S ribosomal protein L2) and rpoB (RNA polymerase subunit B). 
This scheme differs from that of Bartual et al. by 4 genes, fusA, pyrG, rplB and rpoB. 
  
  
 
 
 
 
 
 
 
 
 
 
CHAPTER 3  
 
Antibiotic resistance in Australian GC2 A. baumannii 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
  
 CHAPTER 3 
 
58 
3.1 Introduction 
The study performed by Mak et al. (149) collected 32 isolates from four Sydney hospitals between 
2002 and 2007 and grouped them into two distinct types using REP-PCR. These types were 
subsequently shown to correspond to GC1 and GC2 (197). However, this collection only contained 
the multiply-antibiotic resistant (MAR) A. baumannii isolates from these hospitals, where MAR is 
defined as resistance to antibiotics in three or more of the categories listed in Table 1.2. This is a 
problem inherent in many of the older collections of Australian A. baumannii isolates kept in long-
term storage. This bias was initially addressed by the acquiring an additional 31 isolates, collected 
between 2008 and 2009, from Royal North Shore Hospital (RNSH; hospital D in Mak et al. (149)). 
This set contained all isolates identified as A. baumannii collected during this time period that were 
processed at RNSH, which screens isolates from 7 hospitals in the region. The initial screening of 
these isolates was performed with assistance from Virginia Post, and consisted of resistance 
phenotype determination using the CDS disk diffusion assay followed by genus and species 
confirmation by PCR of the Acinetobacter-specific recA gene (125, 176) and A. baumannii-specific 
oxaAb gene (26, 101, 244). Of these 31 isolates, 10 were MAR with 7 belonging to GC1 and 2 
belonging to GC2 (195). All the GC1 and GC2 isolates were MAR. In addition, 27 isolates were 
obtained from Woden Valley Hospital in Canberra (hospital E). The hospital E isolates were 
initially screened as part of my honours project with the assistance of Virginia Post, following the 
methodology described above. Of these 27 isolates, only two were MAR and both were found to be 
members of GC2 (172).  
 
The aim of the work described in this chapter was to collect A. baumannii isolates from further 
Australian hospitals and identify which were MAR and belonged to one of the globally 
disseminated clones. Those isolates identified as GC2 were then taken for further study, initially for 
the presence of acquired resistance genes that cause resistance to carbapenems.  
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3.2 The clinical A. baumannii isolate collections 
A total of 111 isolates were collected from 7 Australian hospitals during the course of this study. 
Resistance phenotypes using the CDS disk diffusion assay were determined for all isolates 
(Appendix I).  Each isolate was screened for the A. baumannii specific oxaAb gene, to confirm their 
species assignment and clonal type was determined using the multiplex PCR devised by Turton et 
al. (240), which uses two sets of primers to amplify GC1 and GC2 specific alleles of the csuE, 
ompA and oxaAb genes (Figure 3.1).  
 
 
Figure 3.1 Multiplex PCR used to differentiate between GC1 and GC2. Two GC1 (red) and two GC2 (blue) isolates are 
shown. The GC1 PCR is shown in (a), with amplicons of 580, 343 and 162 bp produced for the GC1 specific alleles of 
csuE, ompA and oxaAb, respectively. For the GC2 PCR (b), amplicons of 702, 355 and 599 bp are produced for csuE, 
ompA and oxaAb, respectively.  
 
3.2.1 MAR A. baumannii collections 
The isolates described below were part of collections kept by the hospitals because they had been 
identified as MAR, or were resistant to specific antibiotics of clinical relevance, such as 
meropenem, imipenem or amikacin. As such, they do not represent the true numbers of 
Acinetobacters seen in these institutions and contain a larger number of clonal isolates than would 
otherwise be identified. 
 
D
36
D
81
4
kb
3
2
1.5
csuE
csuE
ompA
ompA
oxa69
oxa66
D
72
D
92
D
72
D
92
D
81
D
36
GC1 PCR GC2 PCR
702 bp
355 bp
599 bp580 bp
162 bp
343 bp
(a) (b)
 CHAPTER 3 
 
60 
3.2.1.1 Hospital A (Prince of Wales Hospital, Sydney) 
A set of 5 MAR GC2 isolates (A91, A93, A94, A96 and A97) collected from this hospital in 2005 
was previously characterised (149, 197). An additional 18 earlier isolates, collected between 2001 
and 2004, that had been kept because they were MAR, along with single isolates from 1999 and 
2010, were obtained from hospital A (Table 3.1). Of these additional isolates, 16 were positive for 
oxaAb, indicating that they were A. baumannii. A total of 14 belonged to GC2 and 2 were GC1.  
 
Table 3.1 Isolates obtained from Prince of Wales Hospital (A). 
Isolate Isolation 
year 
MAR oxaAb GC Information supplied by the hospital 
A72 2001 + + 2 Resistant to IPM Ap CTX SmTpCmGmNe AMC 
A73 2001 + + 2 ND 
A74 2002 + + 2 ND 
A75 2002 + + 2 Only susceptible to AkNe 
A76 2002 + + 2 Only susceptible to AkNe 
A77 2002 + + 2 Only susceptible to AkNe 
A78 2002 + + 2 Only susceptible to AkNe 
A79 2002 + + 2 Only susceptible to AkNe 
A80 2002 + + 2 Only susceptible to AkNe 
A81 2002 + + 2 Only susceptible to AkNe 
A82 2002 + + 2 Resistant to IPM ApCTXSuTpCmGm AMC CTT 
NOR F 
A83 2002 + + 1 Resistant to Ap CTX SuTpCmGm CIP FEP 
A84 2002 + + 2 Resistant to IPM Ap CTX SuTpCmGmNe CIP 
TIM FEP 
A85 2003 + + 1 Only susceptible to AkNe 
A87 2004 + + 2 Resistant to IPM Ap CTX SuTpCmGn CTT AMC 
NOR F 
A88 1999 + - - Susceptible to Tp SXT 
A89 2005 + - - Resistant to ApCTXTpCmGmAk FEP K2 
A111 2010 + + 2 ND 
Ak, amikacin; AMC, amoxicillin-clavulanic acid; Ap, ampicillin; CIP, ciprofloxacin; Cm, chloramphenicol; CTT, 
cefotetan; CTX, cefotaxime; F, nitrofurantoin; FEP, cefepime; Gm, gentamicin; IPM, imipenem; Ne, netilmicin; NOR, 
norfloxacin; Su, sulphamethoxazole; SXT, sulphamethoxazole-trimethoprim; Tp, trimethoprim; ND, no data provided. 
 
3.2.1.2 Royal Brisbane and Women’s Hospital (F) 
12 isolates, that were part of a larger collection that had been previously studied (142), had been 
collected between 1999 and 2002 at Royal Brisbane and Women’s Hospital (RBH; hospital F; 
Table 3.2). All 12 isolates were positive for oxaAb, 10 were GC2 and there was a single GC1 
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isolate. The isolate F11 was included in an earlier study (Jon Iredell, personal communication), 
where it was designated RB01 (245). F11 had been shown to be resistant to gentamicin, 
ciprofloxacin, ceftazidime, cefotaxime, ticarcillin, ticarcillin-clavulanate and imipenem, and contain 
the oxa23 gene and aacC1-orfP-orfP-orfQ-aadA1 cassette array (245). 
 
Table 3.2 Isolates obtained from Royal Brisbane and Women’s Hospital (F). 
Isolate Isolation year Sourcea MAR oxaAb GC Available informationb 
F1 28/6/2002 CVL tip + + 2 ND 
F2 1999 Other + + - Pan resistant 
F3 16/10/2002 EA + + 1 IMI MEM sensitive 
F4 18/10/2002 BA + + 2 IMI MEM sensitive 
F11c 19/3/2001 B + + 2 ND 
F18 20/6/2002 RS + + 2 ND 
F36 26/3/2001 RS + + 2 ND 
F38 27/12/2000 EA + + 2 ND 
F44 1/11/2002 Burns + + 2 IMI MEM sensitive 
F45 8/4/2002 RS + + 2 ND 
F46 1999 Other + + 2 Pan resistant 
F48 ND EA + + 2 ND 
a B, blood; BA, bronchial aspirate; CVL tip, central venous line tip; EA, endotracheal apspirate; RS, rectal swab. 
b According to Long et al., these isolates were screened for resistance to 15 antibiotics (amikacin, amoxicillin-clavulanic 
acid (AMC), ampicillin (AM), cefotaxime (TAX), ceftazidime (TAZ), cephalothin (CF), ciprofloxacin, gentamicin 
(GM), imipenem (IMI), meropenem (MEM), nitrofurantoin (FD), norfloxacin (NOR), ticarcillin-clavulanic acid (TCC), 
tobramycin (NN) and trimethoprim (TMP)) using a Vitek gram-negative Identification card (142). ND, no data 
provided. 
c F11 corresponds to RB01 (245) 
 
 
3.2.2 A complete A. baumannii collection from Royal North Shore Hospital (D) 
The 5 previously studied MAR GC2 isolates (D1, D5, D8, D9, D12) from hospital D were collected 
between 2006 and 2008 (149). An additional 70 isolates collected between 2010 and 2011, as well 
as a single 2009 isolate, were obtained from hospital D in Sydney. In addition, the wards in which 
each isolate was collected were also provided. 51 isolates were positive for oxaAb, 23 were GC2 
and 6 were GC1 (Table 3.3). There was a single MAR isolate, D46, that did not belong to GC1 or 
GC2, which will be described in greater detail in Chapter 7. MAR isolates of both clones were often 
associated with particular wards. The severe burns injury unit (SBIU) contained four different GC2 
isolates during 2010, but ward 7D, a spinal injury unit, was the most common origin for MAR 
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isolates, with 10 GC2s and 3 GC1s originating from this ward. Furthermore, patients from 7D were 
often sent to Ryde Rehabilitation Centre (RRC) for long-term care and recovery, and the single 
GC1 and GC2 isolates seen there may be related to those isolated from 7D. Isolates from some 
hospitals in the same region as hospital D were sent there for screening and have been included as 
part of hospital D for simplicity (Table 3.3). 
 
Table 3.3 Isolates collected from Royal North Shore Hospital (D) that were GC1 or GC2. 
Isolate Isolation date Sourcea Wardb MAR oxaAb GC 
D24 1/1/2008 MSU 8B + + 2 
D37 17/7/2008 MSU 7C + + 2 
D51 2010 Bronchial washing  6NI + + 2 
D52 2010 Tip SBIU + + 2 
D54 2010 Wound swab SBIU + + 2 
D56 2010 Wound swab SBIU + + 2 
D57 2010 Wound swab SBIU + + 2 
D58 2010 MSU MON + + 2 
D72 2010 MSU 7D + + 2 
D77 2010 MSU RRC + + 2 
D79 2010 MSU EA + + 2 
D84 23/11/2010 MSU 7D + + 2 
D85 11/12/2010 Trap sputum 6NI + + 2 
D86 12/12/2010 Wound swab EA + + 2 
D87 22/12/2010 Tip 7D + + 2 
D88 10/2/2011 Wound swab 7D + + 2 
D92 19/2/2011 Tip 7D + + 2 
D93 27/2/2011 Wound swab 7D + + 2 
D96 2011 Wound swab 7D + + 2 
D97 2011 Rectal 7D + + 2 
D98 2011 Rectal 7D + + 2 
D101 2011 MSU MON + + 2 
D107 2011 Wound swab 7D + + 2 
D112 2011 B/C-stab RNSP + + 2 
D114 2011 Trap sputum 6NI + + 2 
       
D45 2010 B/C-stab 7D + + 1 
D48 2010 MSU 7D + + 1 
D62 2010 MSU RRC - + 1 
D78 2010 Isolate COFH + + 1 
D81 2010 Wound swab 6NI + + 1 
D108 2011 MSU 7D + + 1 
       
D46 2010 MSU EA + + - 
Isolates highlighted in orange represent those screened with Virginia Post. 
a B/C-stab, blood culture stab; MSU, midstream urine; Tip, central venous line tip. 
b In some cases, isolates were collected from hospitals connected with RNSH; COFH, Coffs Harbour Hospital; MON, 
Mona Vale Hospital; RNSP, Royal North Shore Private Hospital; RRC, Ryde Rehabilitation Centre. SBIU, severe 
burns injury unit; EA, emergency admission. 
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3.2.3 Additional isolates 
3.2.3.1 Westmead Hospital, Sydney (WM) 
A single isolate, WM99c, collected in 1999 from Westmead Hospital in Sydney was also included 
in this study. This isolate was previously shown to be MAR, contain the oxa23 carbapenemase gene 
along with the aacC1-orfP-orfP-orfQ-aadA1 cassette array and an oxaAb that was interrupted by a 
large (>1 kb) insertion (245). Here, it was identified as GC2 and its resistance profile was extended 
using CDS (Appendix I). WM99c was acquired after a draft genome sequence for this strain had 
been released into the WGS database in 2011 (GenBank accession No. AERY00000000) (55). 
 
3.2.3.2 St. George Hospital, Sydney (B) 
A set of 8 isolates (B1-B8) from a MAR outbreak at this hospital during 2006-2007 had been 
studied previously and were found to be GC2 (149, 172). An additional 6 isolates, collected 
sporadically in 2010, and representing all Acinetobacters identified in this institution during 2010 
were examined (Table 3.4). Only 3 contained oxaAb while a single isolate was a MAR GC2.  
 
Table 3.4 Isolates obtained from St. George Hospital (B). 
Isolate Isolation date Source MAR oxaAb GC Resistancesa 
B9 8/3/2010 - - + - Ap Cep CTX Tp 
B10 8/3/2010 - + + 2 Ap Cep Aug CTX IPM Su 
Tp CIP TIM 
B11 12/4/2010 Sputum + - - Ap Cep CTX Gm Ak 
B12 14/4/2010 Sputum - - - Ap Cep CTX Tp Ak 
B13 5/4/2010 Blood culture - - - Tp 
B14 18/4/2010 Blood culture - + - Ap Cep CTX Tp 
aThese isolates were tested by the hospital for resistance to ampicillin (Ap), cephalothin (Cep), augmentin (Aug), 
ceftriaxone/cefotaxime (CTX), imipenem (IPM), sulphafurazole (Su), trimethoprim (Tp), gentamicin (Gm), 
ciprofloxacin (CIP), Timentin (TIM) and amikacin (Ak). 
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3.2.3.3 Other Brisbane hospitals 
Two isolates from Royal Children’s Hospital (RCH) and one isolate from Mater Hospital (MH) in 
Brisbane had also been partially characterised (142) (Table 3.5). However, there were no isolation 
dates or source for these isolates. The isolate from MH was identified as a MAR GC2, the two 
isolates from RCH were MAR but they did not belong to GC1 or GC2. As there were so few 
isolates from these hospitals and each had a unique resistance pattern, they could be correlated back 
to the study performed by Long et al. (142).  
 
Table 3.5 Isolates acquired from RCH and MH in Brisbane. 
Isolate MAR oxaAb GC 
RCH51 + + - 
RCH52 + + - 
MH50 + + 2 
 
3.3 Antibiotic resistance in the Australian GC2 A. baumannii 
Each isolate was screened for resistance to a range of antibiotics belonging to different families, 
namely β-lactams (ampicillin, ampicillin-sulbactam, ticarcillin-clavulanate, ceftazidime, 
cefotaxime, imipenem and meropenem), aminoglycosides (amikacin, kanamycin, gentamicin, 
neomycin, netilmicin, spectinomycin, streptomycin and tobramycin), quinolones (ciprofloxacin and 
naladixic acid), phenicols (chloramphenicol and florfenicol), tetracycline, trimethoprim, 
sulphamethoxazole and rifampicin using disk diffusion (Table 3.6). The annular radii of inhibition 
are listed in Appendix I. 
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Table 3.6 Antibiotics tested using CDS disk diffusion. 
Antibiotic category Antibiotic  
Penicillins Ampicillin  
Penicillins 
+β-lactamase inhibitors 
Ampicillin-
sulbactam 
 
Antipseudomonal penicillins 
+β-lactamase inhibitors 
Ticarcillin-
clavulanic acid 
 
Cephalosporins Cefotaxime 
Ceftazidime 
 
Carbapenems Imipenem 
Meropenem 
 
Aminoglycosides Gentamicin 
Tobramycin 
Amikacin 
Netilmicin 
Kanamycin 
Neomycin 
Streptomycin 
Spectinomycin 
Fluoroquinolones Ciprofloxacin 
Naladixic acid 
 
Folate pathway inhibitors Trimethoprim 
Sulphonamides 
 
Tetracyclines Tetracycline  
Phenicols Chloramphenicol 
Florfenicol 
 
Rifamycins Rifampicin  
Antibiotic categories in red are those used to classify Acinetobacter spp. as MAR, XAR or PAR (144).  
 
3.3.1 β-lactam resistance in MAR GC2 isolates 
3.3.1.1 β-lactam resistance phenotypes 
All of the 31 Australian GC2 isolates studied previously were resistant to both imipenem and 
meropenem, and the 3rd generation cephalosporins ceftazidime and cefotaxime as determined by 
MIC (149) (Appendix I; Table I.6). However, they were retested using CDS disk diffusion along 
with the 52 Australian GC2 isolates identified here and the GC2 reference strain A320 (Appendix I 
and Table 3.7). When comparing the MICs determined by Mak et al. (149) and annular radii of the 
zone of inhibition determined here (Appendix I; Table I.6), there was a clear correlation between 
the two, validating the CDS disk diffusion for detecting both carbapenem and cephalosporin 
resistance and setting a baseline for what annular radius should be recorded as resistant. 
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Table 3.7 Inhibition zones for imipenem, meropenem, ticarcillin-clavulanate, amplicillin, 
ceftazidime and cefotaxime for the Australian GC2 A. baumannii. 
Isolate Isolation Annular Radius (mm) 
 year IPM  MER  TIM Ap SAM CAZ CTX 
A72, A73 2001 3-3.5 2.5-3 0 0 3 1 0 
A74-A82, A84 2002 2.5-4 1.5-2.5 0 0 2.5-5 1-2 0 
A87 2004 4 3 0 0 4.5 1 0 
A111 2010 3 2.5 0 0 4 1 0 
         
B10 2010 2.5 2 0 0 3 1 0 
         
D24 1/1/08 1.5 1 0 0 2 2 0 
D37 17/7/08 2.5 2 0 0 3 2 0 
D51, D52, D54 
D56-D58, D72, D77 
D79, D84-D87 
2010 1-3 1-3 0 0 2-4.5 0.5-2 0 
D88, D92, D93 
D96-D98, D101 
D107, D112, D114 
2011 2-3 1.5-2.5 0 0 3-5 1-2 0 
         
F1 28/6/02 3 2.5 0 0 3 0 0 
F11 19/3/01 3 2 0 0 2.5 0 0 
F18 20/6/02 3 2.5 0 0 3 1 0 
F36 26/3/01 3 2.5 0 0 3 0 0 
F38 27/12/00 3 2.5 0 0 2.5 0 0 
F45 8/4/02 3 2 0 0 3 1 0 
         
WM99c 1999 2 1.5 0 0 2 1.5 0 
         
MH50 NK 3 2 0 0 3 0 0 
         
F4 18/10/02 11 9 4.5 0 4 2 0 
F46 1999 11 10 5.5 0 5 5 0.5 
F44 1/11/02 7.5 6.5 0 0 3.5 4.5 0 
F48 NK 8 5 0 0 3 1 0 
         
A320 1982 13 9.5 5 0 4 7 5 
aAp, ampicillin; CAZ, ceftazidime; CTX, cefotaxime; IPM, imipenem; MER, meropenem; SAM, ampicillin-sulbactam 
TIM, ticarcillin-clavulanate. NK, not known. 
 
All GC2 isolates from hospitals A, B, D, and E were resistant to both imipenem and meropenem, 
and had similar zones of inhibition (Appendix I and Table 3.7). Only 7 of the 11 isolates from 
Brisbane were resistant to both imipenem and meropenem at the same level as isolates from 
hospitals A, B, C, D and E. Two isolates (F4 and F46) were susceptible, with an annular radius of 
11 mm for imipenem and 9 or 10 mm for meropenem. These zones were similar in size to the A320 
reference strain, which had zones of 13 and 9.5 mm for imipenem and meropenem, respectively. 
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Two further isolates (F44 and F48) had annular radii of 7.5-8 mm for imipenem and 5-6.5 mm for 
meropenem (Table 3.7), which was smaller than the susceptible isolates, suggesting that they had 
reduced susceptibility to carbapenems. All Australian GC2 isolates were resistant to both 
ceftazidime and cefotaxime, with little variation in the zone of inhibition (Appendix I and Table 
3.7). In almost all cases, the zone size for ceftazidime was larger than for cefotaxime, ranging from 
0-5 and 0-0.5 mm, respectively. This trend was echoed in the susceptible A320, which had annular 
radii of 7 mm for ceftazidime and 5 mm for cefotaxime. 
 
All isolates were also resistant to ampicillin, including the A320 control strain, with zones of 0 mm 
(Table 3.7). The majority of A. baumannii isolates, including those that were not members of GC1 
or GC2, were resistant to ampicillin or had annular radii of 6 mm or less (Appendix I). All but one 
of the Australian GC2 isolates collected here, along with A320, harboured the blaTEM gene, which 
confers resistance to ampicillin. However, the only isolate without blaTEM, C1, had an ampicillin 
zone of inhibition of 0 mm (Appendix I; Table I.1), which was the same as the isolates with blaTEM. 
This suggests that blaTEM is not essential for the high level of ampicillin resistance observed in the 
A. baumannii collection. All GC2 isolates, including the A320 control, had zones of 2-4.5 mm for 
ampicillin-sulbactam (Table 3.7). However, only the GC2 collection was screened for this 
combination and there were no susceptible GC2 isolates that could be used for comparison. 
 
Almost all isolates were resistant to ticarcillin-clavulanate, with no zone of inhibition (Table 3.7). 
However, two isolates from hospital F, F4 and F46, had annular radii of 4.5 and 5.5mm, 
respectively, similar in size to those observed for A320 (Table 3.7). This suggested that this zone 
size was indicative of susceptibility to this antibiotic/β-lactam inhibitor combination, even though 
the defined cut off for susceptibility is 6 mm. 
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3.3.1.2 The ampC cephalosporinase  
It was previously shown that the isolates studied by Mak et al. (149) and the two GC2 isolates from 
Canberra (E1 and E16) had an ISAba1 upstream of the chromosomal ampC gene. The presence of 
an ISAba1 directly adjacent to ampC is known to supply a promoter that enhances its expression, 
causing clinically relevant levels of cephalosporin resistance (38, 88, 215). This correlates with the 
findings of Mak et al. and the CDS results, which had MICs of 64-128 mg/L and 64->128 mg/L for 
ceftazidime and cefotaxime, respectively along with annular radii of 1-3 and 0-2 mm (Appendix I; 
Table I.6). The majority of Australian GC2s studied here had similar zone sizes, suggesting that an 
ISAba1 was directly upstream of ampC. A PCR joining ISAba1 to ampC produced an amplicon of 
1.7 kb in all the Australian GC2 isolates (Figure 3.2).  
 
 
Figure 3.2 Position of ISAba1 upstream of ampC. The arrow beneath the central line represents the length and 
orientation of ampC, while the purple box represents ISAba1 with the internal arrow showing its orientation. The PCR 
used to link ISAba1 and ampC with its predicted size is displayed below the gene. 
 
3.3.1.3 Carbapenem resistance genes 
In the isolates studied by Mak et al. the presence of ISAba1 upstream of oxa23, which confers 
resistance to carbapenems, was correlated with an MIC of 8-16 mg/L for imipenem and 8-32 mg/L 
for meropenem. Here, an annular radius of 2.5-4 mm for both imipenem and meropenem was 
observed for the isolates studied by Mak et al. (Appendix I; Table I.6). The presence of ISAba1 
upstream of oxa23, in the same orientation, can supply oxa23 with the same promoter shown to 
increase ampC expression (Figure 3.3).  As the majority of the Australian GC2 isolates identified 
here also had annular radii in this range, the entire collection was also screened for the oxa23 gene 
oxaAb
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with ISAba1 upstream. ISAba1-oxa23 was present in all isolates that were resistant to meropenem 
and imipenem, with annular radii between 1.5-4 mm (Table 3.8).  
 
 
Figure 3.3 Position of ISAba1 upstream of oxa23 and oxaAb. The arrow beneath the central lines represents the length 
and orientation of each gene, while the purple box represents ISAba1 with the internal arrow showing its orientation. 
The PCR used to link ISAba1 and either oxa23 or oxaAb is displayed below the gene with its predicted size. 
 
Though oxa23 is almost always observed with an ISAba1 upstream, it is often also associated with 
a second ISAba1 downstream in the inverse orientation, which forms the composite transposon 
Tn2006 (Section 1.3.2.2.1) (158). A PCR linking oxa23 to the downstream ISAba1 of Tn2006 was 
used to determine if this structure was present (Figure 3.4). In all oxa23-containing isolates, this 
PCR amplified a product of 2.7 kb, which was indicative of Tn2006.  
 
 
Figure 3.4 The structure of Tn2006.  The arrows beneath the line represent the orientation of genes. The a, b and c 
genes refer to what has been annotated as an ATPase, a DEAD helicase and yeeA, respectively (39, 239). The purple 
boxes represent ISAba1, with the orientation of each IS indicated by the arrow inside. The extent of PCR products used 
to identify if Tn2006 is present are shown with their respective primers and sizes below the genes. 
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Table 3.8 Carbapenem resistance genes in all GC2 isolates. 
Isolate Year City ISAba1- oxa23 Tn2006 
ISAba1- 
oxaAb 
ISAba1- 
ampC 
A72, A73 2001 Sydney + + - + 
A74-A82, A84 2002 Sydney + + - + 
A87 2004 Sydney + + - + 
A91, A93, A94, A96, A97 2005 Sydney + + - + 
A111 2010 Sydney + + - + 
       
B1-B8 2007 Sydney + + - + 
B10 2010 Sydney + + - + 
       
C1-C5, C8 2007 Sydney + + - + 
C13, C14, C15 2006 Sydney + + - + 
C18, C20 2002 Sydney + + - + 
       
D1, D5, D8, D9 2006 Sydney + + - + 
D12 2007 Sydney + + - + 
D24, D37 2008 Sydney + + - + 
D51, D52, D54 
D56-D58, D72 
2010 Sydney + + - + 
D77, D79, D84-D87 2010 Sydney + + - + 
D88 2011 Sydney + + - + 
D92, D93, D96-D98 
D101, D107, D112, D114 
2011 Sydney + + - + 
       
WM99c 1999 Sydney + + - + 
       
E1 2006 Canberra + + - + 
E16 2009 Canberra + + - + 
       
F1, F18, F45 2002 Brisbane + + - + 
F11, F36 2001 Brisbane + + - + 
F38 2000 Brisbane + + - + 
MH50 NK Brisbane + + - + 
       
F4 2002 Brisbane - - - + 
F44 2002 Brisbane - - + + 
F46 1999 Brisbane - - - + 
F48 NK Brisbane - - + + 
       
A320 1982 Rotterdam - - - - 
Isolates highlighted in blue represent those screened previously (149, 172). NK, not known. 
 
At the time this work was undertaken, Tn2006 had been observed in five distinct locations (158). 
One of these was in AbaR4, where Tn2006 is inserted near the 5'-end of the sup gene in a Tn6022 
backbone (Section 1.5.1.1) (2, 158). Sequence was only available for one other location, in 
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GenBank accession number GQ861439, which contained 205 bp on the left and 282 bp on the right 
of Tn2006 (Figure 3.5). Primer RH737, located in the sequence on the left of Tn2006 in GQ861439, 
was made and used to determine if Tn2006 was in this position. Pairing RH737 with a primer 
within Tn2006 produced an amplicon of 2.3 kb in 78 of the 79 isolates that contained Tn2006 
(Figure 3.5). Following this, the primer RH738 in the sequence on the right also amplified a product 
of 2.7 kb in 78 of the 79 isolates that harboured Tn2006 when it was paired with RH743, which is 
within Tn2006. The position of Tn2006 in D86, the only Tn2006 containing isolate negative for the 
PCRs described above was not investigated further. 
 
 
Figure 3.5 The context of Tn2006. Arrows below the central line represent the length and orientation of genes. ISAba1 
is represented with a purple box containing an arrow that indicates its orientation. PCRs are indicated below the genes 
with their respective primers and predicted sizes. 
 
The sequence on either side of Tn2006 in GQ861439 was used as a BLAST query and was found to 
be identical to positions 21,693 to 22,170 in the genome of ATCC 17978 (GenBank accession no. 
CP000521). The sequences of the 2.3 and 2.7 kb amplicons from a representative isolate, A91, 
revealed that the region surrounding Tn2006 in A91 was identical to that in both GQ861439 and 
ATCC 17978, and that there was a 9 bp duplication at the point of insertion. 
 
All isolates were also screened for an ISAba1 upstream of the chromosomal oxaAb gene, which has 
also been shown to reduce susceptibility to carbapenems (243), presumably by supplying the same 
promoter that drives ampC expression. Two isolates from Brisbane, F44 and F48, which showed 
reduced susceptibility to imipenem and meropenem (Table 3.7), produced an amplicon of 1.2 kb for 
the PCR linking ISAba1 and oxaAb (Table 3.8 and Figure 3.3). No isolate that contained Tn2006 
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also had an ISAba1 upstream of oxaAb (Table 3.8). Isolates F4 and F46, which were susceptible to 
imipenem and meropenem, did not harbour oxa23 nor was an ISAba1 associated with their oxaAb 
gene (Table 3.7 and Table 3.8). The GC2 collection was not screened for other acquired 
carbapenemase genes by PCR. However all isolates were screened for these genes bioinformatically 
when whole genome data became available and did not contain any other carbapenemase genes.  
 
Both oxa23 and oxaAb are class D beta-lactamases, which are generally not inhibited by clavulanate 
or sulbactam (Section 1.3.2.2). Furthermore, it has been demonstrated that oxa23 also confers high 
levels of resistance to ticarcillin and other β-lactams (102). Almost all isolates that had no zone of 
clearance for ticarcillin-clavulanate also harboured ISAba1-oxa23, indicating it was contributing to 
this high level of resistance. However, isolates F44 and F48 also had radii of 0 mm for ticarcillin-
clavulanate, but had ISAba1-oxaAb instead of oxa23. It is probable that ISAba1-oxaAb is also 
contributing to this resistant phenotype in F44 and F48. As F4, F46 and A320 are susceptible to 
ticarcillin-clavulanate, but lack oxa23 and ISAba1-oxaAb, this suggests that the chromosomal 
oxaAb gene alone is not enough to cause resistance. 
 
3.3.2 Aminoglycoside resistance 
Aminoglycoside resistance varied between isolates, allowing the collection to be subdivided into 
eight distinct groups (Table 3.9). Most of the groups contained isolates that were from different 
hospitals collected in different years. The most widespread was group 2, which had been identified 
in 3 cities and all but 1 of the Sydney hospitals. The four isolates that did not contain oxa23 (F4, 
F44, F46, F48) formed two groups that were distinct from the rest of the collection, with a 
combination of amikacin (3-4.5 mm), tobramycin (0-2 mm) and netilmicin (0-1.5 mm) resistance 
that was not observed in any of the groups formed by the oxa23 containing isolates (Table 3.9). The 
control strain A320 was resistant to kanamycin, gentamicin and neomycin, which was the same 
phenotype as group 4 of the Australian isolates (Table 3.9). Several isolates displayed reduced 
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susceptibility to netilmicin, with annular radii ranging between 4-5 mm, while a single isolate, D72, 
had a zone of 2 mm (Appendix I and Table 3.9). During the resistance gene screening, described 
below, the cause of this reduced susceptibility to netilmicin could not be attributed to any resistance 
genes, which suggests that there may be other mechanisms, such as efflux, that are responsible.  
Table 3.9 Aminoglycoside resistance phenotype groups. 
Group Isolates Year Aminoglycoside  
resistance phenotypea 
1 A73 2001 Susceptible 
 A111 2010 Susceptible 
 B1-B8 2007 Susceptible 
 B10 2010 Susceptible 
 D1, D5 2006 Susceptible 
 D24 2008 Susceptible 
 D51, D52, D54, D56-D58 2010 Susceptible 
 D101, D112 2011 Susceptible 
2 A72 2001 KmGmTm(Ne) 
 A87 2004 KmGmTm(Ne) 
 C2-C5, C8 2007 KmGmTm 
 C15 2006 KmGmTm 
 C18 2002 KmGmTm 
 D8, D9 2006 KmGmTm 
 D12 2007 KmGmTm 
 D37 2008 KmGmTm 
 E1 2006 KmGmTm 
 E16 2009 KmGmTm 
 F1, F18, F45 2002 KmGmTm 
 F38 2000 KmGmTm 
3 C13, C14 2006 KmNmAk 
4 F11, F36 2001 KmNmGm 
 A74, A78, A81, A84 2002 KmNmGm(Ne) 
 A75-A77, A79, A80, A82 2002 KmNmGm 
 A91, A93, A94, A96, A97 2005 KmNmGm 
 C1 2007 KmNmGm 
 MH50 NK KmNmGm 
 WM99c 1999 KmNmGm 
5 C20 2002 KmNmGmAk 
 D72 2010 KmNmGmAk(Ne) 
 D77, D79, D84, D85, D87 2010 KmNmGmAk 
 D88, D92, D93, D96-D98, D107, D114 2011 KmNmGmAk 
6 D86 2010 KmNm 
7 F4, F44 2002 KmGmNeAkTm 
8 F46 1999 KmNmGmNeAkTm 
 F48 NK KmNmGmNeAkTm 
    
- A320 1982 KmNmGm 
Isolates highlighted in blue represent those screened previously (149, 172). NK; not known. 
a Brackets surrounding an antibiotic indicate reduced susceptibility, rather than resistance and were not considered when 
defining the aminoglycoside resistance groups. 
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3.3.2.1 Aminoglycoside resistance genes 
Several aminoglycoside resistance genes were chosen for screening because their phenotypes 
suggested they could be responsible for the observed aminoglycoside resistance patterns seen in the 
GC2 collection (Table 3.10). In addition, the intI1 and sul1 genes, which are indicative of class 1 
integrons, were tested. The 22 aminoglycoside susceptible isolates in group 1 (Table 3.9) did not 
contain any of the aminoglycoside resistance genes that were tested. 
 
Table 3.10 Aminoglycoside resistance genes and their resistance phenotypes. 
Gene Resistance phenotype 
 Ak Km Gm Ne Nm Tm Sm Sp 
aphA1  Km   Nm    
aphA6 Ak Km   Nm    
aadB  Km Gm   Tm   
aacC1   Gm      
aacC2   Gm Ne  Tm   
aacA4aa Ak Km  Ne  Tm   
aacA4ba  Km Gm Ne  Tm   
aac(6')-Im Ak   Ne  Tm   
aadA1       Sm Sp 
aadA2       Sm Sp 
armA Ak Km Gm Ne  Tm   
a Variants of aacA4 differ by a single base that results in an amino acid change causing a change in substrate specificity. 
3.3.2.1.1 Aminoglycoside resistance genes in a class 1 integron 
It had been previously shown that the aacC1 and aadA1 gene cassettes were present in 7 isolates 
with a class 1 integron (highlighted in blue in Table 3.11), in the configuration aacC1-orfP-orfP-
orfQ-aadA1 (Figure 3.6a), along with the aphA1 resistance gene (149, 197). This cassette array had 
also been detected in WM99c (245) (Green in Table 3.11). Of the 46 oxa23 containing isolates 
identified here, 28 that belonged to groups 4 and 5 contained both intI1 and sul1, indicating that a 
class 1 integron was present (Table 3.11 and Figure 3.6). Furthermore, all 28 of these isolates also 
contained the aacC1 and aadA1 gene cassettes within the integron, suggesting that there was a 
cassette array similar to that described above. A PCR that joined the attI1 with aadA1 amplified a 
product of 2.7 kb in 27 of the 28 integron containing isolates. This amplicon was indicative of the 
aacC1-orfP-orfP-orfQ-aadA1 configuration (Figure 3.6a). However, a single isolate (D96) 
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produced an amplicon of 2.2 kb, which was indicative of the aacC1-orfP-orfQ-aadA1 cassette array 
(Figure 3.6b). The A320 control strain also harboured a class 1 integron with an aacC1-orfP-orfP-
orfQ-aadA1 cassette array. 
 
Figure 3.6 Class 1 integrons with the (a) aacC1-orfP-orfP-orfQ-aadA1 and (b) aacC1-orfP-orfQ-aadA1 cassette arrays. 
The IRi is represented by a vertical line. A thick line indicates the 5'-CS, containing intI1 and attI1, and the 3'-CS, 
containing qacE∆1, sul1 and orf5. The open box represents the attI1 site, while arrows below the line represent genes 
and gene cassettes with black boxes indicating attC sites. The extent of PCR products are shown beneath the gene along 
with their respective primers and sizes. The size for HS464-HS463a, amplifying intI1, is 472 bp. 
 
Table 3.11 Aminoglycoside resistance genes in integron containing, oxa23 positive isolates. 
Group Isolates Aminoglycoside  
resistances  
Aminoglycoside  
resistance genes 
Cassette array 
4 F11, F36 KmNmGm aacC1 aadA1 aphA1 aacC1-P-P-Q-aadA1 
 A91, A93, A94,  
A96, A97 
KmNmGm aacC1 aadA1 aphA1 aacC1-P-P-Q-aadA1 
 A74, A78, A81, 
A84 
KmNmGm(Ne) aacC1 aadA1 aphA1 aacC1-P-P-Q-aadA1 
 A75-A77, A79,  
A80, A82 
KmNmGm aacC1 aadA1 aphA1 aacC1-P-P-Q-aadA1 
 C1 KmNmGm aacC1 aadA1 aphA1 aacC1-P-P-Q-aadA1 
 MH50 KmNmGm aacC1 aadA1 aphA1 aacC1-P-P-Q-aadA1 
 WM99c KmNmGm aacC1 aadA1 aphA1 aacC1-P-P-Q-aadA1 
     
5 C20 KmNmGmAk aacC1 aadA1 aphA1 aphA6 aacC1-P-P-Q-aadA1 
 D72 KmNmGmAk(Ne) aacC1 aadA1 aphA1 aphA6 aacC1-P-P-Q-aadA1 
 D77, D79, D84,  
D85, D87, D88 
KmNmGmAk aacC1 aadA1 aphA1 aphA6 aacC1-P-P-Q-aadA1 
 D92, D93, D97,  
D98, D107, D114 
KmNmGmAk aacC1 aadA1 aphA1 aphA6 aacC1-P-P-Q-aadA1 
 D96 KmNmGmAk aacC1 aadA1 aphA1 aphA6 aacC1-P-Q-aadA1 
     
- A320 KmNmGm aacC1 aadA1 aphA1 aacC1-P-P-Q-aadA1 
Isolates highlighted in blue and green represent those screened previously (149, 245). 
IRi
IRtintI1
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aadA1
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3.3.2.1.2 The transposon Tn6020 containing aphA1b 
All of the integron containing isolates also harboured aphA1 (Table 3.11). The aphA1b gene had 
previously been observed in a composite transposon known as Tn6020 in a collection of GC1 
isolates from Sydney hospitals (196, 197). Tn6020 has a 1,254 bp segment containing the aphA1 
gene, flanked by two directly oriented copies of IS26, and one partial IS26 (Figure 3.7). All aphA1 
containing isolates were screened for Tn6020 using two PCRs that join the IS26 on either side to 
the aphA1 (Figure 3.7). Both PCRs produced products of the predicted sizes, 2.1 and 1.2 kb, for 21 
group 4 and 5 isolates, from hospitals A, C, F, MH and WM, as well as the A320 control strain, 
indicating they had a structure identical to Tn6020.  
 
 
Figure 3.7 The structure of Tn6020. The arrows beneath the line represent the orientation of genes. The coloured boxes 
represent IS26, with the orientation of each IS indicated by the arrow inside. The boxed ∆ is the truncated fragment of 
IS26. The extent of PCR products used to identify if Tn6020 is present are shown with their respective primers and 
sizes below the genes. 
 
A single isolate, D86, contained only the aphA1 gene but lacked a class 1 integron (Table 3.12). 
D86 was screened for Tn6020 using the primer pairs described above (Figure 3.7). The right-hand 
PCR produced an amplicon of the expected size (Figure 3.9a), unlike the integron containing 
isolates from hospital D, while the amplicon in the left-hand PCR was approximately 200 bp 
smaller than predicted (Figure 3.8). Sequencing of this amplicon revealed that the 175 bp fragment 
of IS26  (IS26∆; ∆ in Figure 3.7) that separates the complete IS26 from the non-coding region 
internal to Tn6020 was absent in D86. 
 
IS26 IS26
aphA1
∆
2,121 bp
1,199 bp
RH601 RH880
RH881 IS26-F
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Figure 3.8 Gel image of the RH601 to RH880 PCR for D86. Isolates are named above their respective wells and M 
shows the lane containing the molecular weight marker. 
 
A total of 14 group 5 isolates mainly from ward 7D in hospital D that were collected between 2010-
2011 produced the expected amplicon for the left-hand PCR (Figure 3.7), but the RH881 and IS26F 
primer pair amplified two products, one at the predicted 1.2 kb and a larger 1.4 kb (Figure 3.9a). 
Analysis of the sequence of each amplicon revealed that the sequence of the 1.2 kb product was 
identical to that of Tn6020, but the 1.4 kb product included a complete copy of IS26 followed by 14 
bp of additional sequence. This additional sequence was identical to the first 14 bp of the IS26∆ 
fragment that is adjacent to IS26 on the other side of Tn6020 and the IS26∆ includes the sequence 
of the primer IS26-F. This suggested that there was an additional IS26-IS26∆ fragment next to 
aphA1 in this group of 14 isolates. Using the primers RH881 and RH830 (Figure 3.9b), which are 
both within Tn6020 but would not amplify unless there were two adjacent copies of aphA1, a 
product of 2 kb was amplified. An amplicon of this size indicated that there was an additional copy 
of the internal fragment of Tn6020 directly adjacent to a complete Tn6020 (Figure 3.9b). It is 
possible that there are copies of IS26 flanking this region, but it was impossible to confirm this 
using the PCR mapping described here due to the duplications of the internal Tn6020 fragment. 
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Figure 3.9 PCR results for the right-hand Tn6020 linkage PCR (RH881-IS26-F) for hospital D isolates (a), and the 
structure of the duplicated Tn6020 (b). In (a), all aphA1 containing isolates are shown above their respective wells and 
the size standard, M, shown on the left. In (b), The arrows beneath the line represent the orientation of genes. The 
coloured boxes represent IS26, with the orientation of each IS indicated by the arrow inside. The boxed ∆ is the 
truncated fragment of IS26. The extent of PCR products used are shown with their respective primers and sizes below 
the genes.  
 
3.3.2.1.3 Amikacin resistance caused by aphA6 
The 15 integron containing isolates in group 5 also contained the aphA6 gene (Table 3.11), while 
two additional isolates (C13 and C14) harboured only aphA6 (Table 3.12). The complete sequence 
of the aphA6 gene was found in two GenBank entries (X07753 and DQ315788; June 2010). 
Analysis of these entries revealed that X07753 had a fragment of ISAba125 on one end, while 
DQ315788 had a fragment of ISAba125 on the other end, relative to aphA6 (Figure 3.10). This 
suggested that aphA6 was flanked by two directly oriented copies of ISAba125. PCRs using primers 
in copies of ISAba125 upstream and downstream of aphA6 combined with those in aphA6 produced 
amplicons of 1.4 and 1.7 kb, respectively in all 17 isolates that harboured this gene (Figure 3.10). 
This indicated that the aphA6 gene was part of a composite transposon, which was named TnaphA6 
(Figure 3.10). These PCR amplicons were sequenced in a representative isolate (D72), revealing 
that aphA6 was located in an 898 bp region. This 898 bp sequence was identical to that obtained by 
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combining X07753 and DQ315788, suggesting that these isolates also contained a structure 
identical to TnaphA6. The sequence of TnaphA6 from D72 was deposited in the GenBank database 
with the accession number JF343537. 
 
 
Figure 3.10 The structure of TnaphA6. The arrows beneath the line represent the orientation of genes. The coloured 
boxes represent ISAba125, with the orientation indicated by the arrow. The extent of PCR products used to determine if 
TnaphA6 is present are shown with their primers at each end and sizes below. The extent of the regions in DQ315788 
and X07753 are shown above. 
 
3.3.2.1.4 The aadB gene cassette in a secondary site 
It had been previously shown that the aadB gene, located in the small plasmid pRAY (Figure 3.10), 
was the cause of gentamicin and tobramycin resistance in 12 isolates (172). These isolates did not 
contain a class 1 integron (highlighted in blue in Table 3.12). Here, an additional 7 isolates, that did 
not harbour an integron, were found to carry aadB in pRAY, using a PCR that amplifies a 1 kb 
segment of the plasmid that contains aadB (Table 3.12). If aadB was not present the product would 
only be approximately 400 bp. 
 
Figure 3.11 Circular map of the plasmid pRAY. Arrows within the circle show the location and orientation of genes 
and orfs identified in pRAY. The thickened portion of the circle indicates the location of the aadB gene cassette. The 
extent of the PCR is shown outside the circle. 
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Table 3.12 Aminoglycoside resistance genes in integron negative, oxa23 positive isolates. 
Group Isolates Aminoglycoside  
resistance phenotype 
Aminoglycoside resistance 
genes 
3 C13, C14 KmNmAk aphA6 
    
2 A72, A87 KmGmTm(Ne) aadB 
 C2-C5, C8, C15, C18 KmGmTm aadB 
 D8, D9, D12 KmGmTm aadB 
 D37 KmGmTm aadB 
 E1, E16 KmGmTm aadB 
 F1, F18, F38, F45 KmGmTm aadB 
    
6 D86 KmNm aphA1 
Isolates highlighted in blue represent those screened previously (149, 172). 
 
3.3.2.1.5 Aminoglycoside resistance genes in isolates without oxa23 
F4, F44, F46 and F48, which did not contain oxa23, contained sul1 though it was not possible to 
amplify a complete copy of intI1 using HS463a-HS464 (as in Figure 3.6). This indicated that a class 
1 integron was present, but that the intI1 gene was truncated. Hence, the integron in these isolates 
was incomplete. PCRs amplifying the aacC1 and aac(6')-Im gene cassettes produced products of 
the expected 450 and 430 bp, respectively (Table 3.13). However, amplification of the aadA1 gene 
cassette only produced a product that was approximately 850 bp larger than predicted (516 bp) in 
F4, F44, F46 and 650 bp larger in F48 (Table 3.13).  
 
Table 3.13 Aminoglycoside resistance genes in isolates that lack oxa23. 
Isolates intI1∆ sul1 Aminoglycoside  
resistance phenotype 
Aminoglycoside resistance  
genes 
F4, F44 +a + KmGmNeAkTm aacC1 aadA1b aac(6')-Im 
F46 +a + KmNmGmNeAkTm aacC1 aadA1b aphA1 aac(6')-Im 
F48 +a + KmNmGmNeAkTm aacC1 aadA1c aphA1 aac(6')-Im 
aDetected using the alternate primer pair L2-L3, shown in Figure 3.12. 
bPCR product approximately 850 bp larger than predicted, due to the insertion of an IS26. 
cPCR product approximately 650 bp larger than predicted. 
  
The aac(6')-Im gene cassette has been previously found in a class 1 integron along with an aadA1 
that was interrupted by IS26, this structure was tentatively named integron-IS26 (DQ861641) (95, 
118) (Figure 3.11). The insertion of IS26 into the aadA1 would increase the amplicon by 820 bp, 
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suggesting this cassette array was present here. PCRs linking aadA1 to IS26 produced amplicons of 
1 kb for the left-hand side (RH522-RH601) and 950 bp for the right-hand side (IS26F-RH531). 
However, the amplicon produced by IS26F-RH531 in F48 was 200 bp smaller than F4, F44 and 
F46, which indicated that there was a deletion on this side. The aac(6')-Im cassette was also linked 
to IS26 by PCR in F4, F44, F46 and F48 (Figure 3.12). Furthermore, PCRs joining aac(6')-Im to the 
3'-CS and intI1 to aadA1 produced products of 2.2 kb and 2.6 kb, respectively which was indicative 
of the integron-IS26 cassette array (Figure 3.12). This also demonstrated that aacC1 was not 
present in this cassette array, and that it must be located in a second integron.  
 
 
Figure 3.12 Structure of integron IS26. Arrows beneath the line represent the position and orientation of genes. IS26 is 
shown as a pink box containing an arrow that indicates its orientation. PCRs used to map this structure are indicated 
below the genes with their respective primers and amplicon sizes. The size for L2-L3 is 297 bp. In F48, the size for 
IS26F-RH531 was 777 bp.  
 
A PCR joining intI1 to aacC1 produced an amplicon of 550 bp, which confirmed that it was 
adjacent to intI1 in a second class 1 integron that also contained a truncated intI1. Furthermore, 
aadA1 could not be linked to aacC1 using PCR, which indicated that there was only 1 copy of 
aadA1 in F4, F44, F46 and F48 and that it was only present in the integron containing aac(6')-Im. 
The complete cassette array for the integron containing aacC1 could not be determined using PCR 
mapping. 
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Only two of the isolates that lack oxa23, F46 and F48, additionally harboured the aphA1 gene. Both 
isolates produced amplicons of the correct size for the left and right hand linkages that were 
indicative of Tn6020 (Figure 3.7). 
 
3.3.3 Resistance to other antibiotics 
All Australian GC2 isolates were also resistant to streptomycin, spectinomycin, sulphamethoxazole, 
tetracycline, trimethoprim, chloramphenicol, florfenicol, ciprofloxacin and naladixic acid 
(Appendix I) and were subsequently screened for a selection of commonly seen antibiotic resistance 
genes which had been observed in previous Australian isolates (149, 172), namely sul2, tetA(B), 
strA and strB. Resistance to chloramphenicol, and by extension florfenicol, has been shown to be 
intrinsic in A. baumannii and is caused by a chromosomally located gene that encodes the CraA 
efflux pump (203). A number of isolates were also resistant to rifampicin (Appendix I). 
Interestingly, all of the isolates from hospital D in group 5 (Table 3.9) were rifampicin resistant, but 
the cause of this resistance was not investigated. 
 
Isolates that were added to the collection during 2010-2012 contained the tetA(B), strA linked to 
strB and sul2 resistance genes along with the CR2 mobile element (Table 3.14). This correlated 
with the previously studied oxa23 containing Australian GC2 isolates, which also have this set of 
genes (blue in Table 3.14). In the previously studied collection, the tet(B) determinant was located 
between sul2 and CR2, with an additional fragment of CR2, named CR2∆ (Figure 3.13). This was 
also the case in the collection studied here. 45 of the 46 oxa23 containing isolates had the 3.4 kb 
sul2-CR2 PCR product and also produced amplicons of the predicted size for PCRs joining tet(B) to 
CR2 and sul2 to tet(B), 2.6 kb and 1.5 kb, respectively which are indicative of the sul2-CR2Δ-
tet(B)-CR2 configuration (Table 3.14 and Figure 3.13). The sul2 gene has been previously 
associated with ISAba1 in Acinetobacter, in the orientation shown in Figure 3.13 (213). A primer in 
ISAba1 along with sul2 produced an amplicon of 1.1 kb in several representatives of the Australian 
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GC2 collection. Thus, ISAba1 was directly adjacent to the resistance region, giving a configuration 
of ISAba1-sul2-CR2Δ-tet(B)-CR2 (Figure 3.13).  
 
 
Figure 3.13 The structure of the resistance region containing the sul2, strA, strB genes and tet(B) resistance 
determinant. The arrows beneath the line represent the orientation of genes, while inverted repeats are shown as vertical 
lines. The extent of PCR products used to map this region are shown, with their specific primer pairs and sizes, below 
the genes. An orange box represents CR2, with the ori end indicated on one side. The piece of CR2 highlighted in red is 
the fragment duplicated in CR2∆. 
 
D86 and the four oxa23 negative isolates did not amplify sul2-CR2 or the sul2-tet(B) linkage, but 
they did produce a product of the predicted 2.6 kb for tet(B)-CR2 (Table 3.14 and Figure 3.13). 
However, D86 and F4, a representative of the 4 isolates that did not contain oxa23, did produce an 
amplicon of 1.1 kb for the PCR joining ISAba1 to sul2. From this point onwards, the previously 
characterised GC2 collection was joined with the current collection and all analyses were performed 
on the complete collection of Australian GC2 isolates. 
 
An analysis of the partial genome assembly of a resistance region in an A. baumannii isolate from 
Brisbane (not included in this study) suggested that strA and strB were located near a CR element 
(Scott Beatson, personal communication). A PCR linking CR2 to strA, produced an amplicon of 2 
kb in all Australian GC2 isolates, which indicated that strA and strB were located near the ter end of 
CR2 (Figure 3.13). The sequence of this product revealed that the IR of Tn5393 was located 25 bp 
downstream of strB, towards CR2, and that this IR was separated from CR2 by a 330 bp region that 
is identical to a segment of GIsul2 (173). A PCR joining tet(B) to strB produced a product of 4 kb 
in all isolates that contained the 3.4 kb sul2-CR2 product, confirming that strA and strB are present 
next to the sul2-CR2∆-tet(B)-CR2 resistance region (Figure 3.13 and Table 3.14).   
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Table 3.14 Common resistance genes and linkage PCR results for the Australian GC2 isolates. 
Isolates tet(B) sul2 strAB CR2 sul2- 
CR2 
CR2- 
tet(B) 
tet(B)- 
sul2 
CR2- 
strA 
tet(B)- 
strB 
A73, A111 + + + + + + + + + 
B1-B8 + + + + + + + + + 
B10 + + + + + + + + + 
D1, D5 + + + + + + + + + 
D24 + + + + + + + + + 
D51, D52, D54, D56-D58 + + + + + + + + + 
D101, D112 + + + + + + + + + 
          
A72, A87 + + + + + + + + + 
C2-C5, C8, C15, C18 + + + + + + + + + 
D8, D9, D12 + + + + + + + + + 
D37 + + + + + + + + + 
E1, E16 + + + + + + + + + 
F1, F18, F38, F45 + + + + + + + + + 
          
C13, C14 + + + + + + + + + 
          
F11, F36 + + + + + + + + + 
A91, A93, A94, A96, A97 + + + + + + + + + 
A74, A78, A81, A84 + + + + + + + + + 
A75-A77, A79, A80, A82 + + + + + + + + + 
C1 + + + + + + + + + 
MH50 + + + + + + + + + 
WM99c + + + + + + + + + 
          
C20 + + + + + + + + + 
D72 + + + + + + + + + 
D77, D79, D84, D85, D87, D88 + + + + + + + + + 
D92, D93,  
D96-D98,  
D107, D114 
+ + + + + + + + + 
          
D86 + + + + - + - + + 
          
F4, F44, + + + + - + - + + 
F46, F48 + + + + - + - + + 
          
A320 + - + + - + - + + 
Isolates highlighted in blue represent those screened previously (149, 172). 
 
Like the Australian GC2s, A320 contained tet(B) and strA linked to strB, as well as the CR2 mobile 
element (Table 3.14). However, it did not harbour sul2. The PCR between tet(B) and CR2 produced 
an amplicon of 2.5 kb while strA and strB were linked to CR2 and tet(B) using the PCRs described 
above (Figure 3.13 and Table 3.14), producing amplicons of the same size observed in the 
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Australian GC2s. These PCRs suggest that A320 contains a resistance region similar to that 
described in the main GC2 collection. The structure of this region in A320 will be discussed in 
greater detail in Chapter 4. 
 
3.4 Multi-locus Sequence Typing (MLST) 
Initially, MLST was performed only on select GC2 isolates (A91, C2, F18, F44 and WM99c) that 
were representatives of some of the different aminoglycoside resistance groups. Using the Oxford 
based scheme (http://pubmlst.org/abaumannii/), the gltA, gyrB, gdhB, recA, cpn60, gpi and rpoD 
genes were amplified and sequenced. The isolates A91, C2 and F18 all had the same allelic profile 
of 1-3-3-2-2-7-3, which corresponded to ST92. However, F44 differed at the gyrB and gpi alleles 
and had the profile 1-46-3-2-2-58-3, which corresponded to ST69. The gyrB-46 allele had 8 single 
base changes relative to gyrB-3, while there were 6 single base changes between gpi-58 and gpi-7. 
At this time, it was hypothesised that the remaining isolates in the same groups would have the 
same MLST profile as their representative. 
 
The ST of WM99c was initially identified bioinformatically using the publicly available draft 
genome sequence (AERY00000000). From the genome data, it was determined to have the profile 
1-3-3-2-2-97-3, which corresponds to ST208. The difference between ST92 and ST208 is in gpi, 
which had the gpi-7 and gpi-97 alleles, respectively. There was only a single nucleotide difference 
between these alleles, a TàC change at position 3 in the analysed sequence. The gpi allele was 
subsequently amplified using the specified MLST primers and resequenced to confirm the allele 
assignment. According to the sequence of the PCR product, the gpi of WM99c was allele 7; hence 
this would change WM99c to ST92. 
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The gyrB allele in A320 was also resequenced here, as there was a discrepancy in the reported ST in 
two separate publications. A320 had been reported as ST6 (1-4-3-2-2-3-3) (9) and ST98 (1-12-3-2-
2-3-3) (94). The sequence of the amplicon produced using the specified primers for gyrB was 
identical to gyrB-12, indicating that the assignment of ST98 was correct. 
 
When the whole genome sequences became available during 2012 for the Australian GC2 isolates 
and A320, the MLST profile of each isolate was determined using a script that identifies the 
analysed portion of each gene within the contigs of each isolate and then assigns allele numbers and 
the resulting ST. Using this method, 68 of the Australian GC2 isolates belonging to groups 1-5 were 
ST208 (1-3-3-2-2-97-3; Table 3.15). This included A91, C2, F18 and WM99c, which had been 
found to be ST92, with gpi-7, according to the PCR based MLST.  
 
This discrepancy was due to the presence of one of the primers used for PCR amplification in the 
first 14 bp of the region analysed for MLST (Mohammad Hamidian, personal communication). 
Thus, this indicated that the T at position 3 in gpi-7 arises from the primer sequence, and does not 
represent the true sequence of these isolates. The gpi observed using the genome data, be it the 
publicly available draft of WM99c or the GC2 genomes generated here, which contains a C at 
position 3, and is allele 97, represents the correct sequence that has not been altered using PCR. 
Hence, these 68 Australian GC2 isolates should be classified as ST208, according to the region of 
gpi included in the Oxford MLST scheme as of October 2013. 
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Table 3.15 STs, for both schemes, for the GC2 isolates. 
Group Isolatesa City PCR
b Genomesb 
STO STO STP 
1 A73, A111 Sydney  208 2 
 B1-B8 Sydney  208 2 
 B10 Sydney  208 2 
 D1, D5 Sydney  208 2 
 D24 Sydney  208 2 
 D51, D52, D54, D56, D57 Sydney  208 2 
 D58 Sydney  208 2 
 D101, D112 Sydney  ND ND 
      
2 A72, A87 Sydney  208 2 
 C2-C5, C8, C15, C18 Sydney 92 208 2 
 D8, D9, D12, D37 Sydney  208 2 
 E1, E16 Canberra  208 2 
 F1, F18, F38, F45 Brisbane 92 208 2 
      
3 C13, C14 Sydney  208 2 
      
4 F11, F36 Brisbane  208 2 
 A74-A82, A84 Sydney  208 2 
 A91, A93, A94, A96, A97 Sydney 92 208 2 
 C1 Sydney  208 2 
 MH50 Brisbane  208 2 
 WM99c Sydney 92 208 2 
      
5 C20 Sydney  425 2 
 D72, D77, D79, D84, D85, D87, D88 Sydney  208 2 
 D92, D93, D96-D98, D107, D114 Sydney  ND ND 
      
6 D86 Sydney  195 2 
      
7 F4, F44 Brisbane 69 423 2 
      
8 F46, F48 Brisbane  423 2 
      
- A320 Rotterdam 98 350 2 
  Isolates in grey did not have genome sequence data available. ND, no data. 
a The isolates in bold were the representatives that had MLST performed using PCR. 
b STO refers to the Oxford based scheme, while STP is the Institut Pasteur scheme. 
 
A single isolate from group 5 was not ST208 (Table 3.15). The isolate C20 had the profile 1-3-3-2-
2-100-3, which corresponds to ST425. ST425 is a single locus variant (SLV) of ST208, in which 
the gpi allele is different. There are 23 single nucleotide differences between gpi-97 and gpi-100, 
indicating that the alleles are very different. The isolate D86 was also an SLV of ST208 and it had 
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the profile 1-3-3-2-2-96-3, which corresponded to ST195. Again, the difference occurred at the gpi 
allele, with 13 single nucleotide differences between gpi-96 and gpi-97. 
 
The four Brisbane isolates that were members of group 7 and 8 had the profile 1-46-3-2-2-142-3, 
which corresponded to ST423. Again, this differs from the ST that was previously determined here 
using the PCR based method, at the gpi allele. There was only a single nucleotide difference 
between gpi-142 and gpi-58, in ST69, the same TàC change described above.  
 
The ST of A320 also differed when comparing the sequence determined using PCR to that in the 
whole genome sequence. From the genome data, A320 had the profile 1-12-3-2-2-102-3, which 
corresponded to ST350. This ST is also a SLV of ST98 (1-12-3-2-2-3-3), determined using PCR, 
which differs at the gpi allele. These two gpi alleles only differ by 1 nucleotide change, the same 
TàC difference that was observed between gpi-7 and gpi-97. This suggests that the same problem 
is affecting A320 and that it is truly ST350. 
 
The STs according to the second MLST scheme, based at the Institut Pasteur, were also determined 
using the genome sequences. This MLST scheme analyses regions in the cpn60, fusA, gltA, pyrG, 
recA, rplB and rpoB genes. All of the Australian GC2 isolates and A320 had the same MLST 
profile of 2-2-2-2-2-2-2, which corresponds to ST2 (Table 3.15). 
 
3.5 Discussion 
The collection of isolates from RNSH (D) is the only one that provides an accurate representation 
of the population structure of Acinetobacters in any of the hospitals studied. Of the 71 total 
Acinetobacters acquired from this hospital, 51 (72%) were A. baumannii. Furthermore, all of the 
isolates that were carbapenem resistant or could be classified as XAR were identified as A. 
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baumannii. This also correlates with other observations that the majority of multiple and extensive 
antibiotic resistance along with carbapenem resistance in this genus is seen in A. baumannii and not 
the other species (258). The figures seen here are similar to those observed in other hospitals. Most 
notably, a study of 295 Acinetobacters from 52 different US hospitals found that 63% of isolates 
were A. baumannii while 21% were A. nosocomialis and 8% were A. pittii (258).  The species that 
made up the remaining 28% of the RNSH isolates studied here were not identified. It is probable 
that the 20 remaining isolates also mainly consisted of A. nosocomialis and A. pittii, which are the 
other species most often responsible for nosocomial infections (255).  
 
For the isolates from hospital D, the ward of isolation was supplied. This information in 
combination with their clonal type and resistance genotypes allowed a closer analysis of outbreaks 
in this hospital. During early 2010, there was an outbreak of GC2 A. baumannii centred in the 
severe burns injury unit. All 6 of these isolates (D51, D52, D54, D56-D58) were aminoglycoside 
susceptible (Group 1 in Table 3.9). A second outbreak of GC2 isolates began during the latter part 
of 2010 and continued throughout all of 2011, and was centred around the spinal injury unit (ward 
7D). Isolates with the same phenotype were also seen in the Ryde Rehabilitation Centre (RRC). 
RRC takes patients from 7D for longer-term care (Peter Huntington, personal communication). 
These isolates were resistant to almost all clinically relevant aminoglycosides and belonged to 
aminoglycoside resistance group 5 (Table 3.9). Preliminary data from 2012 isolates from this 
hospital suggests isolates from this outbreak are still present but are no longer dominant among the 
A. baumannii population (unpublished). The isolate D86, which exhibited a unique aminoglycoside 
resistance pattern, was collected from an emergency admission, suggesting that it was introduced 
into hospital D from either the community or another hospital. This may explain why its resistance 
phenotype and genotype was different. 
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The isolates obtained from hospital F in Brisbane were included in a larger study that was published 
after the onset of this work (206). Runnegar et al. studied 483 A. baumannii-A. calcoaceticus 
isolates with ‘non-wild type susceptibility patterns’ that were collected during 1998-2008 from the 
same hospital, with more than 50% of these collected during two separate outbreaks during 2001-
2002 (n=204) and 2006 (n=84) (206).  The dominant ST among MAR isolates was ST92, but there 
were also some members of ST69 (206), which correlates with the Brisbane isolates studied here. 
Eight of the ST92/208 isolates examined here were from the 2001-2002 outbreak (Table 3.2). 
However, due to different naming and a lack of phenotypic information in Runnegar et al., it was 
not possible to correlate the isolates presented here back to that study. No isolates from the second 
outbreak observed in 2006 could be obtained. Interestingly, all the GC2 isolates identified here 
were from the 2001-2002 RBH outbreak, correlating with the PFGE results in Runnegar et al., 
which showed that a number of the representative isolates they selected were closely related to the 
outbreak strain (206). 
 
All of the GC2 isolates studied here, including the A320 reference strain, were ST2 according to the 
Institut Pasteur scheme, but there is little intra-clonal variability observed using this MLST scheme, 
thus it cannot be used to truly examine the extent of diversity within a clonal lineage (46). However, 
there has been much more intra-clonal diversity observed using the Oxford based scheme, in which 
single locus variants, and on occasion double locus variants, of common ST types have been 
attributed to a single clonal group (94, 158, 206). Much of this diversity is caused by different 
alleles of gpi, which is located in the capsule locus (119). In particular, it has been reported that 
ST92/ST208 is the most common ST observed in GC2 isolates worldwide (158, 206). This is 
reflected in the Australian GC2 collection where 68 of the 74 sequenced isolates are ST208 
according to the genome data. The two Sydney GC2 isolates that were not ST208, C20 (ST425) and 
D86 (ST195), are both single locus variants with different gpi alleles. Interestingly, both of these 
isolates have a different capsule locus to that in the ST208 group (Johanna Kenyon, personal 
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communication). This suggests that the capsule locus has been replaced in these isolates, which has 
been observed in other members of GC2 (119), causing them to have a different gpi and hence alter 
their ST. Such little variation in the ST types highlighted the homogeneous nature of the Australian 
GC2 isolates and suggests that those belonging to ST92/208 and ST425 may all stem from a single 
ancestor that has diverged upon the acquisition of different aminoglycoside resistance genes. 
 
All of the members of ST208 in this homogeneous Australian collection shared a common set of 
resistance genes. Most of these shared genes, sul2, tetA(B), strA and strB were clustered together in 
the same resistance region along with an ISAba1 and CR2. The isolate C20 also has this common 
set of genes, suggesting that the event that caused the replacement of its capsule locus occurred 
relatively recently, after the acquisition of these genes. Furthermore, each of these isolates, 
including C20, also harboured Tn2006, which contains oxa23, in the same location. The presence of 
this resistance region presented the possibility that it was present in a genomic island, much like the 
multiple antibiotic resistance region that is present in AbaR-type islands that have been classified in 
GC1 isolates (196, 197). This hypothesis is explored in Chapter 4. 
  
  
 
 
 
 
 
 
 
 
 
 
CHAPTER 4  
 
The structures of AbGRI1 in GC2 A. baumannii 
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4.1 Introduction 
At the time this work was conducted, very little was known about the genomic islands present in 
GC2 isolates. It had been shown that there was an insertion at the same position in comM in GC2 
isolates and that the sequence of the GI adjacent to comM at both junctions was distinct from the 
AbaR-type islands observed in GC1, while differing from Tn6022 at just the right junction (Figure 
1.13) (197, 220). This suggested that the GI in comM of GC2 represented a new type, distinct from 
those previously observed that will be referred to as the AbGRI1-type (for A. baumannii genomic 
resistance island). It was shown that 7 of the Australian GC2 isolates (A91, A93, A94, A96, A97, 
C1, C20) lacked Tn6018 and arsC while containing an intact uspA (197). This indicated that these 
isolates did not harbour Tn6019, which is found in AbaR3-type islands. However, the published 
studies did not determine the internal structure of these islands. 
 
The aim of the work presented in this chapter was to examine the structure(s) of the genomic island 
present in comM in the Australian GC2 collection. The structure of AbGRI1 in the European A320 
reference strain from 1982 was also examined to determine if it was ancestral to that in the 
Australian isolates.  
 
4.2 Screening for the presence a genomic resistance island in comM 
The entire GC2 collection, including A320, was initially screened for the presence of a genomic 
island in comM in the same position as AbaR3-type islands. A PCR for the intact comM gene did 
not produce an amplicon in any GC2 isolate, suggesting that the gene was interrupted. Following 
this, the J1 and J2 PCRs (197) were used to determine whether the interrupted comM gene was 
directly adjacent to a conserved transposon sequence. Both the J1 and J2 junction PCRs produced 
products of the size predicted if the backbone was present in all GC2s (Figure 4.1b), indicating that 
there was a similar island interrupting the comM gene at the same location observed previously.  
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Figure 4.1 The intact comM (a) and the J1 and J2 junctions for the GI in comM (b). The blue lines represent the comM 
gene, while the inner black lines represent the backbone transposon. The vertical lines represent the IR of the backbone 
transposon. The extent of the J1 (left) and J2 (right) amplicons are shown beneath the central line with their respective 
primers and predicted sizes. 
 
4.3 AbGRI1-1 in the European isolate A320/RUH134 
4.3.1 The structure of the backbone transposon 
Using an internal PCR for the arsB gene and a PCR linking lspA and tnpA in Tn6018, which have 
been described previously (197), it was determined that several features indicative of a Tn6019 
backbone were not present in A320. These PCRs did not amplify products, indicating that the 
arsenate resistance region and Tn6018 were both absent in A320. Furthermore, the uspA gene, 
which is interrupted by the Tn6018-flanked MARR in AbaR3-type, was intact. These results 
suggested that a Tn6022-like backbone was present in comM.  
 
A PCR mapping strategy developed using Tn6022 as a guide was used to determine the structure of 
the backbone in A320. The primer pairs used are listed in Table 4.1. The left-hand side of the 
chromosomal comM gene was first linked to tniB with a PCR product of 3.1 kb, matching the 
predicted size (Figure 4.2b). However, PCRs linking tniB to tniD or tniD to uspA both failed, 
suggesting that this region was not present. Primers RH910 and RH587 linking tniB to tniE 
produced a PCR amplicon of only 560 bp, which is much smaller than the predicted 3,410 bp, 
suggesting there was a deletion somewhere between these genes. The sequence of this PCR product 
comM
IRl
comM
IRr
RH916 RH928
GI
RH927 RH792846 bp
796 bp
J1 J2
500
comM
RH928RH927 880 bp
(a) (b)
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revealed that a 2.85 kb deletion had removed the tniD gene and truncated both tniB and tniE (Figure 
4.2). 
 
 
Figure 4.2 Structures of (a) Tn6022 and (b) the backbone in A320. The black line represents the backbone transposons, 
while the dotted blue arrows beneath the central lines represent the length and orientation of genes in both backbones. 
The vertical lines represent IR. The region in A320 that ahs been deleted relative to Tn6022 is indicated by the red lines 
between (a) and (b). The extent of the PCR products used to map the backbone of A320 are shown in (b) with their 
respective primer pairs and sizes. 
 
Table 4.1 Primers used to map the backbone of AbGRI1-1. 
Region Primers Sequence Amplicon size (bp) 
   A320 Tn6022 
comM-tniB∆ RH791 TGCTGCAATGAGCTGAAAGT 3,119 3,119 
 RH909 GCGATTCAAAATATCGGTCAA   
tniB-tniD RH910 GCGATAGTGAACGGATTGAGA - 2,010 
 RH584 TCAATATGCCTCGCTCCACT   
tniD-uspA RH583 TCCTGTCTCTCGTGTAGCAAT - 3,577 
 RH919 TGTCAAAAATTATTGCATGT   
comM-orf/uspAa RH791 TGCTGCAATGAGCTGAAAGT 4,632 7,482 
 RH592 AAGCTTATCGAAAAGGCGTAGA   
tniB-tniE RH910 GCGATAGTGAACGGATTGAGA 560 3,410 
 RH587 TTGCCCATTAAGCACAACAG   
uspA-sup RH793 CCCAAGAGAGCTGATTTTGC 1,280 1,280 
 RH771 TGTAAAATCTGGTGGTCGTAC   
tniB∆-sup RH910 GCGATAGTGAACGGATTGAGA 3,267 3,267 
 RH771 TGTAAAATCTGGTGGTCGTAC   
uspA-orf4 RH589 CATAAGCCCCAACCACAATC 3,388 3,388 
 RH788 ATACTATTTCAAAGCCTGATGAG   
orf4b-comM RH594 GGCGGATTATCAGTTGTTTCA 1,844 - 
 RH928 GCCAGCAAGCTCAGCATAA   
Rows highlighted in red indicate the linkage PCRs that did not produce an amplicon. 
aPrimer RH592 is located between the orf and uspA 
tniA tniB∆ ∆tniE orf uspA sup orf4tniCcomM
strBtetB* tetR rcr2 strA orf4b comM
CR2
IRl IRr
IR IRori
∆ 2.85 kb
500
RH791 RH909
RH910 RH771
RH772
RH916
tetBF
LECR2
RH702
RH791
RH928
tniBtniA uspA sup orf4tniC tniD tniE orf
Tn6022
RH791 RH592
RH910 RH587
RH771RH793
RH589 RH788
IRl IRr
?
(a)
(b) A320
orf4b comM
IRr
RH594 RH9283,119 bp
4,632 bp
1,280 bp
3,267 bp
3,388 bp
1,844 bp
560 bp
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Primers RH791 and RH592 linking the left portion of comM to the non-coding region between the 
orf and uspA produced an amplicon of 4.6 kb (Figure 4.2), confirming that this version of Tn6022 
with the 2.85 kb deletion was directly adjacent to comM. Further PCRs shown in Figure 4.2 joined 
uspA to sup and uspA to orf4, suggesting that the remainder of the Tn6022 backbone was present. 
This structure was named Tn6022Δ1. However, primers RH585 in orf4 and RH928 in comM failed 
to produce an amplicon, indicating that Tn6022Δ1 was not directly adjacent to comM on the right 
hand side.  
 
To better understand the right hand junction with comM, the J2 amplicon was sequenced. The 
sequence was identical to that of Tn6019/Tn6022 for the 100 bp of non-coding DNA directly 
adjacent to the right hand junction with comM, which included the 25 bp IRr. The start codon of 
orf4 was identified, however there were 7 base changes in the sequenced amplicon, when compared 
to the sequence of J2 in GC1s. A BLAST search revealed that this sequence was identical to the 
right hand end of the genomic island containing the majority of GIsul2 in ATCC 17978 (173). This 
part of the genomic island in ATCC 17978 contained a relative of orf4, orf4b, which shares only 
86% DNA sequence identity with orf4. The primer RH585 could not anneal to the same position in 
orf4b, which explains why J2 produced a product while RH585 and RH928 failed. A primer 
specific to orf4b, RH594, was designed and used to link orf4b to comM. This PCR produced an 
amplicon of 1.8 kb, indicating that orf4b was directly adjacent to comM on the right hand side of 
the genomic island in A320. However, it was not possible to link orf4 to orf4b, suggesting that there 
was a large segment of DNA in-between orf4 in Tn6022∆1 and orf4b adjacent to comM. 
 
4.3.2 Location and structure of the resistance region 
As described in Chapter 3, A320 contained the tet(B)-CR2-strB-strA resistance region. The 
possibility that the tet(B)-CR2-strB-strA region in A320 could be located between the Tn6022Δ1 
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and orf4b segments of the backbone was examined. To determine if tet(B)-CR2-strB-strA was 
adjacent to Tn6022∆1, PCRs linking sup to tetA(B) and orf4 to CR2 were performed. Primers 
RH772 in sup and tetBF in tetA(B) produced an amplicon of 4 kb, while the PCR linking orf4 to 
CR2 produced a product of 4.5 kb, suggesting that the resistance region was indeed present adjacent 
to Tn6022∆1 (Figure 4.3 and Table 4.2). Primers strBR and RH599 that link strB to orf4b produced 
an amplicon of 2.6 kb and the sequence of this PCR product revealed that there was 382 bp of DNA 
separating strA from orf4b (red line in Figure 4.3). PCRs linking CR2 or strA to comM produced 
products of 5 kb and 3.5 kb, respectively (Figure 4.3), confirming that the tet(B)-CR2-strB-strA was 
adjacent to orf4b and present in the AbGRI1. 
 
 
Figure 4.3 Structure of the resistance region between Tn6022∆1 and orf4b in A320. The central line represents the 
transposon while the blue dotted line is the 5'-fragment of the chromosomal comM gene. The vertical lines represent IR 
and the CR2 element is shown as a yellow box with the ori and ter ends indicated above. The direction and orientation 
of genes are shown below the central line by arrows. The extent of the PCR products used to map this region are 
indicated below the genes with their respective sizes and primer pairs. The red line between orf4b and strA represents 
the 374 bp from non-coding DNA derived from the genomic island containing the majority of GIsul2 in ATCC 17978. 
 
Table 4.2 PCRs to map the resistance region in AbGRI1-1. 
Region Primers Sequence Amplicon  
size (bp) 
sup-tetA(B) RH772 GCAGCCATAGGAATGACTTTTA 3,961 
 tetBF TTGGTTAGGGGCAAGTTTTG  
orf4-CR2 RH916 CCCAAATACTGCCATGTTGA 4,466 
 LECR2 CACTGGCTGGCAATGTCTAG  
strB-orf4b strBR GGATCGTAGAACATATTGGC 2,620 
 RH599 ATACTGTTTCAAAAACTGATGAA  
strA-comM strAR CCAATCGCAGATAGAAGGC 3,509 
 RH928 GCCAGCAAGCTCAGCATAA  
CR2-comM RH702 CTCGTCAACGATCTGATAGAGAAGGG 5,021 
 RH928 GCCAGCAAGCTCAGCATAA  
 
The entire genomic island was sequenced and named Tn6166  (Figure 4.4). The island was 17,630 
bp in length and the sequence was submitted to GenBank with the accession number JN247441. 
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The sequence confirmed that Tn6022Δ1 was identical to Tn6022, except for the 2.85 kb deletion. 
The tet(B) determinant, comprised of the tetA(B) and tetR(B) genes, was in a 2,289 bp fragment 
derived from Tn10, and this was directly adjacent to the ori end of CR2 (Figure 4.4). The tetA(B) 
gene was also adjacent to the IRr of Tn6022Δ1, but the final 6 bp of the gene are missing. The 
termination codon of the tetA(B) gene was replaced by one located 18 bp inside IRr. This minor 
alteration of the protein did not appear to affect the tetracycline resistance in A320 when compared 
to other GC2 isolates with tetA(B), as A320 had a zone of inhibition of 0 mm for tetracycline 
(Appendix I), indicating that it was resistant to this antibiotic. The 330 bp region adjacent to the ter 
end of CR2 (region 1 in Figure 4.4) is identical to the corresponding sequence in GIsul2. The 1,754 
bp region adjacent to this is derived from Tn5393, which contains the strB and strA genes and an IR 
from this transposon. The 2,262 bp segment adjacent to the Tn5393 derived piece, containing orf4b 
and IRr, was identical to a region of the genomic island that contains the majority of GIsul2 in 
ATCC 17978 (region 2 in Figure 4.4). 
 
 
Figure 4.4 The complete structure of AbGRI1-1, named Tn6166. IR are shown as vertical lines and regions with 
different origins are indicated by lines of various types and thicknesses. The origin of each segment is shown above the 
central line, where 1 is a 330 bp region found in GIsul2 and a number of IncA/C plasmids and 2 has originated from a 
portion of the GIsul2 found in ATCC 1978. The length and orientation of genes are shown as arrows below. An orange 
box represents the CR2 element with the ori end indicated above. 
 
tniA tniB∆ tniE∆ orf uspA sup orf4tniCcomM
strBtetA(B)* tetR(B) rcr2 strA orf4b comM
Tn10 CR2 1 Tn5393
IRl IRr
IR5393 IRrori
Tn6022∆1
5002
∆
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4.4 The structure AbGRI1-2, in the Australian isolate A91 
4.4.1 Comparison to AbGRI1-1 (Tn6166) 
4.4.1.1 The backbone transposon 
It had been shown that A91, like A320, did not contain an intact comM while the J1 and J2 
junctions were present (197), indicating the presence of a genomic resistance island. Initially, the 
PCR mapping strategy devised for AbGRI1-1 in A320 was used to examine the structure of the 
island in A91. The PCR linking comM to tniBΔ produced an amplicon of the predicted size, while 
the tniBΔ to tniEΔ PCR produced the smaller 560 bp product seen in A320, which indicated that 
A91 also had Tn6022Δ1 directly adjacent to the left hand fragment of comM (Figure 4.5 and Table 
4.3). However, the primers RH791 and RH592 that link comM to the non-coding region between 
the orf and uspA produced an amplicon of 7.2 kb, much larger than the predicted 4,632 bp (Figure 
4.5 and Table 4.3). A PCR linking tniBΔ to the same position also amplified a product 
approximately 2.5 kb larger then predicted. These results suggested that there had been an insertion 
in this region. The sequence of these PCR products was determined and revealed that a novel IS, 
named ISAba17, was inserted in the 3'-end of the orf located between tniEΔ and uspA (Figure 4.5). 
A detailed description of ISAba17 is in Section 4.4.1.2. 
 
 
Figure 4.5 The Tn6022∆1::ISAba17 backbone in A91. IR are indicated by vertical lines and the chromosomal comM is 
shown with a dotted blue line. The ∆ arrow above the backbone represents the position of the 2.85 kb deletion relative 
to Tn6022. Arrows below the central line show the length and orientation of genes. ISAba17 is shown as a blue box, 
containing an arrow showing its orientation. The dotted black line represents unknown sequence separating the 
backbone from the resistance region. The extent of PCR products used to map this region are shown below the genes 
with their respective primer pairs and predicted sizes. 
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Table 4.3 PCRs to map AbGRI1-2 in A91. 
PCRa Primers Sequence Amplicon size (bp) 
   A320 A91 
CR2-sul2 RH553 GGCTCAAGCGTGTTTTCAAT - 3,430b 
 RH603 ACTTCATCCGCACACACGAG   
comM-tniB∆ RH791 TGCTGCAATGAGCTGAAAGT 3,119 3,119 
 RH909 GCGATTCAAAATATCGGTCAA   
comM-orf/uspA RH791 TGCTGCAATGAGCTGAAAGT 4,632c 7,234c 
 RH592 AAGCTTATCGAAAAGGCGTAGA   
tniB∆-tniE∆ RH910 GCGATAGTGAACGGATTGAGA 560d 560d 
 RH587 TTGCCCATTAAGCACAACAG   
tniB∆-orf/uspA RH910 GCGATAGTGAACGGATTGAGA 1,611 4,213 
 RH592 AAGCTTATCGAAAAGGCGTAGA   
tniB∆-ISAba17 RH910 GCGATAGTGAACGGATTGAGA - 2,673 
 RH1309 GTCATGAATACGCTGCCTGA   
ISAba17-uspA RH1308 CCGTCAGTTGATGTTGGTTG - 3,744 
 RH588 CAAAAGCAAAAGCACCACAA   
ISAba17 RH1308 CCGTCAGTTGATGTTGGTTG - 1,312 
 RH1309 GTCATGAATACGCTGCCTGA   
orf-orf4 RH1310 TTGCTCAAGTGTACCCCTTTG 3,436 3,436 
 RH773 GGGCGAAAATTATTGTTCTTA   
uspA-orf4 RH589 CATAAGCCCCAACCACAATC 3,378 3,378 
 RH788 ATACTATTTCAAAGCCTGATGAG   
uspA-orf4/IRr RH589 CATAAGCCCCAACCACAATC 4,415 4,415 
 RH790 CTAGAGCAAGAATAAAAATTATA   
sup-tetA(B) RH772 GCAGCCATAGGAATGACTTTTA 3,961 - 
 tetBF TTGGTTAGGGGCAAGTTTTG   
orf4-CR2 RH916 CCCAAATACTGCCATGTTGA 4,466 - 
 LECR2 CACTGGCTGGCAATGTCTAG   
ISAba1-sul2 ISAba1B CATGTAAACCAATGCTCACC - 1,125 
 sul2R ATGCCGGGATCAAGGACAAG   
ISAba1-CR2 ISAba1B CATGTAAACCAATGCTCACC - 6,156e 
 LECR2 CACTGGCTGGCAATGTCTAG   
tetR(B)-strB RH892 ACAGCGCATTAGAGCTGCTT 3,983 3,983 
 strB-F ATCGTCAAGGGATTGAAACC   
orf4b-comM RH594 GGCGGATTATCAGTTGTTTCA 1,844 1,844 
 RH928 GCCAGCAAGCTCAGCATAA   
CR2-comM RH702 CTCGTCAACGATCTGATAGAGAAGGG 5,021 5,021 
 RH928 GCCAGCAAGCTCAGCATAA   
a PCRs highlighted in blue represent those that were used in the mapping of AbGRI1-1 and AbGRI1-2. Those in red 
failed to produce an amplicon in A91. 
b 852bp when CR2∆-tet(B) is not present 
c 7,482bp in Tn6022, distinguished by digestion in A91 
d 3,410bp in Tn6022 
e 3,575bp in GIsul2 in ATCC 17978 
 
The remainder of the Tn6022∆1 backbone was intact, as PCRs joining orf∆ to orf4, uspA to orf4 
and uspA to the region between orf4 and IRr (Figure 4.5) all produced amplicons of the size 
predicted for Tn6022/Tn6166. The structure of the backbone adjacent to the 3'-end of comM in A91 
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was almost identical to the corresponding region in AbGRI1-1 except for the insertion of ISAba17; 
hence this structure in A91 will be referred to as Tn6022∆1::ISAba17.  
 
4.4.1.2 ISAba17 
At the time this work was undertaken (October 2011) there were no matches for the IS that 
interrupted Tn6022∆1 in A91 in the GenBank non-redundant database or the ISFinder database. 
The sequence if this IS of was submitted to the ISFinder database and assigned the name ISAba17. 
ISAba17 is 2,594 bp in length and is a member of the IS66 family. It is bounded by imperfect 21 bp 
IRs (19/21) and created a DR of 8 bp at the site of insertion. ISAba17 encodes 3 proteins, TnpA 
(142 aa), TnpB (111 aa) and TnpC (548 aa) (Figure 4.6). The relative closest to ISAba17 in 
GenBank was ISPpu19 (GenBank accession no. AB238971). The TnpB and TnpC proteins of 
ISAba17 shared 52 and 64% identity, respectively, with their counterparts in ISPpu19, while the 
TnpA was not significantly related. In ISAba17, the TnpC protein contains a DDE motif, suggesting 
it is the transposase responsible for the movement of this IS (77). The role(s) of the other proteins 
are not known. 
 
 
Figure 4.6 Structure of ISAba17. The blue bars on either end represent the 21 bp IR. Arrows indicate the tnpA, tnpB 
and tnpC orfs. The tnpC is green as it contains the DDE motif. 
 
4.4.1.3 The resistance region 
A91 contained a resistance region with the structure sul2-CR2Δ-tet(B)-CR2-strB-strA, which is 
similar to the region in AbGRI1-1 (Tn6166), suggesting it was in the same location adjacent to 
orf4b. Primers RH594, specific for orf4b, along with RH928, in comM, produced a product 
identical to that in AbGRI1-2, indicating that in A91 orf4b was also directly adjacent to the 5'-
100tnpA tnpB tnpC
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fragment of comM.  Primers RH702 and RH928 that link CR2 to comM produced a product of 5 kb, 
which was identical to Tn6166 (Table 4.3 and Figure 4.7), indicating that the resistance region was 
also adjacent to orf4b in A91. However, PCRs linking sup to tetA(B) and orf4 to CR2 failed to 
amplify in A91 (Table 4.3), indicating that the resistance region was not adjacent to 
Tn6022∆1::ISAba17 and that there was likely to be a large insertion separating the backbone and 
resistance region. 
 
As described in Chapter 3, ISAba1 was linked to sul2 at the same position observed in the genomic 
island that contained the majority of GIsul2 in ATCC 17978. ISAba1 was then linked to tetA(B) and 
CR2, producing amplicons of 3.8 kb and 6 kb, respectively, confirming that ISAba1 was adjacent to 
the resistance region in the configuration ISAba1-sul2-CR2Δ-tet(B)-CR2-strB-strA (Figure 4.7). 
However, it was still not possible to join ISAba1 to Tn6022∆1::ISAba17 using PCR. 
 
 
Figure 4.7 The resistance region of ABGRI1-2 in A91. IR are indicated by vertical lines and the chromosomal comM is 
shown with a dotted blue line. Arrows below the central line show the length and orientation of genes. ISAba1 is shown 
as a purple box containing an arrow showing its orientation. The yellow boxes represent the complete CR2 and CR2∆. 
The dotted black lines represent unknown sequence separating Tn6022∆1::ISAba17 from the resistance region. The 
extent of PCR products used to map this region are shown below the genes with their respective primer pairs and 
predicted sizes. 
 
Like Tn6166, the tet(B) determinant was within a fragment of Tn10 that was next to CR2. 
However, the fragment of Tn10 in A91 was 97 bp larger than that in A320 and was adjacent to the 
CR2∆ fragment, which is not present in Tn6166. The tetA(B) gene in A91 was not truncated, as in 
A320. The CR2∆-tet(B) region was most likely inserted via homologous recombination between the 
CR2∆ fragment and the ori end of CR2. As there was a deletion in the tetA(B) of Tn6166, this 
suggests that it arose from a structure similar to that observed in the AbGRI1 of A91. 
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4.4.2 An AbGRI1 variant in 1656-2 
At this point, the second complete genome sequence of a GC2 isolate, 1656-2 from South Korea, 
was released (CP001921). This genome has an AbGRI1 variant in comM but it had not been 
identified or analysed (178). A bioinformatic analysis of this genome was undertaken, which 
revealed that the structure in comM was related to Tn6166 and it was named AbGRI1-3 (Figure 
4.8a). 1656-2 harboured Tn6022Δ1 and orf4b in the same positions as AbGRI1-1 in A320 and 
AbGRI1-2 in A91. It also contained a resistance region similar to that observed in A91. However, 
1656-2 lacked tet(B), so an ISAba1-sul2-CR2-strB-strA configuration was present (Figure 4.8a). 
The CR2∆-tet(B) region could also be lost relatively easily via recombination between CR2∆ and 
the ori end of CR2. An additional region, unique to 1656-2, was inserted directly after the Tn5393 
derived fragment containing strB-strA (Figure 4.8a). This region was 6,916 bp and contained 
blaPER-1, encoding an ESBL, along with a second copy of strA. 
 
Figure 4.8 The complete structure of AbGRI1-3 in 1656-2 (a) and the junction between tniB∆2 and the GIsul2 segment 
(b). In (a), IR are shown as vertical lines and regions with different origins are indicated by lines of various types and 
thicknesses. The ∆ arrow above the backbone indicates the position of the 2.85 kb deletion relative to Tn6022. ISAba1 
is represented by a purple box, ISPal12-14 are shown as light blue boxes and ISAba14 is indicated with a light green 
box, all containing an arrow indicating their orientation. CR2 is shown as a yellow box. Arrows beneath the line 
represent the length and orientation of genes. The insertion point of the 6.9 kb region containing blaPER-1 and a second 
copy of strA is shown above. In (b), the sequence of an uninterrupted tniB from Tn6022 is shown as the top line and the 
sequence of GIsul2 from the genome of Shigella flexneri ATCC 700930 is the bottom sequence, with the start of 
GIsul2, as defined in Nigro et al. (173) in bold. 
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There was a 9,385 bp segment separating the IRr of Tn6022Δ1 from ISAba1 in the resistance 
region. This 9,385 bp segment could be split into three regions. The first was a 6,205 bp region 
(white in Figure 4.8a) that was identical to the fragment of the ATCC 17978 genome that is 
interrupted by Tn2006 in the Australian GC2 isolates and GQ861439 (Section 3.3.1.3). This 6.2 kb 
region contained 7 hypothetical orfs (numbered 5-11) and an integrase (Figure 4.8a). The following 
2,890 bp contained a region that shared 95% identity with the tni end of Tn6022. It consisted of an 
identical copy of the IRl of Tn6022 followed by relatives of the tniC, tniA and tniB genes, which 
were named tniCb, tniAb and tniBΔ2. The tniCb and tniAb genes were 95.8% (681/711 bp) and 
94.4% (1804/1912 bp) identical to the tniC and tniA of Tn6022, respectively. tniB∆2 was a 111 bp 
fragment of the 5'-end of tniB that shared 96.4% identity (107/111 bp) with the tniB of Tn6022. The 
remaining 290 bp segment of this region, located between tniB∆2 and ISAba1 in AbGRI1-3, was 
identical to the first 290 bases of GIsul2. A comparison of the sequences of tniB and GIsul2 
identified the exact junction between the fragments of these regions present in AbGRI1-2 (Figure 
4.8b). The final 9 bp of this 290 bp region was repeated on the other side of ISAba1, indicating that 
the IS was acquired recently. The ISAba1, 12 bp away from sul2 and in the same orientation, is also 
present at the equivalent position in ATCC 17978, but the 290 bp was not present. 
 
The segment containing sul2 and CR2 that is adjacent to strB in AbGRI1-3 is also identical to a 
portion of GIsul2. As the 290 bp region was only separated from sul2 by a single ISAba1, this 
suggests that this portion of the island originated from GIsul2 and that GIsul2 was then truncated, 
with the latter portion of the island replaced by pieces of Tn5393 and the ATCC 17978 GI, forming 
the structure that is observed in AbGRI1-3 (Figure 4.9). 
 
 CHAPTER 4 
 
105 
 
Figure 4.9 Origin of segments of the resistance region. IR are represented by vertical lines while the position and 
orientation of genes are indicated by arrows beneath the lines. A purple box containing an arrow that indicates its 
orientation represents ISAba1. A yellow box represents CR2. The grey segments between each island indicate regions 
that are shared between AbGRI1-3 and either GIsul2 or ATCC 17978, while the orange represents that shared with 
Tn5393c. 
 
4.4.3 Assembly of the complete structure of AbGRI1-2 
Using the sequence of 1656-2 as a guide, primers were designed to map the region separating 
Tn6022Δ1::ISAba17 and ISAba1-sul2-CR2Δ-tet(B)-CR2-strB-strA-orf4b in A91 (Table 4.4). The 
tniCb gene was linked to both ISAba1 and sul2 using PCR, with both products being the predicted 
size, 3.5 and 4.2 kb, respectively (Figure 4.10 and Table 4.4). The tniCb to sul2 amplicon was 
sequenced, which confirmed that A91 had the Tn6022-like fragment containing tniCb, tniAb and 
tniB∆2 along with the 290 bp segment from GIsul2 that was adjacent to ISAba1 and the resistance 
region. This sequence was identical to the equivalent region in 1656-2. Primers RH597 and RH792 
joined orf9 to tniCb, producing an amplicon of 1.6 kb, which indicated that the region containing 
tniCb-tniAb-tniB∆2 was also adjacent to the central orf region in A91. The sequence of this 
amplicon revealed that the IRl was indeed present and the junction between the orf region and 
Tn6022-like fragment was identical to that in 1656-2. The Tn6022∆1::ISAba17 backbone was 
joined to orf6 using RH585 and RH596, amplifying a 3.5 kb product as predicted (Figure 4.10). 
Again, this product was sequenced, revealing that the junction between the orf region and the IRr of 
Tn6022∆1::ISAba17 in A91 was identical to the equivalent sequence in 1656-2.  
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Figure 4.10 Structure of the segment separating Tn6022∆1:ISAba17 and the resistance region of ABGRI1-2 in A91. 
Arrows beneath the central line represent the length and orientation of genes, while the vertical lines represent IR. A 
purple box containing an arrow that shows its orientation indicates ISAba1. The extent of PCR products used to map 
this region and join it to the backbone and resistance region are shown below the genes with their respective primer 
pairs and predicted sizes. 
 
 
Table 4.4 PCRs to map the central region in AbGRI1-2. 
PCR Primers Sequence Amplicon  
size (bp) 
orf4-orf6 RH585a TTCCATTCATCAGGTGTTGC 3,460 
 RH596 GGGCGGCAAATATAAAGGTT  
orf6-orf7 RH1302 CAAATCGGGAAGGTTCAAAA 1,573 
 RH1303 CGGGAAAATTACTGCGATTG  
orf7-int RH1304 TTAGCCAGCAGTCTAGCGTTAT 6,486b 
 RH1305 TTTCTTCTCTTAAAGGCAACCA  
orf6-ISAba1 RH1302 CAAATCGGGAAGGTTCAAAA 2,199 
 RH1301 TGGCAATTTTAAGAAGGCAGA  
orf7-Tn2006 RH1304 TTAGCCAGCAGTCTAGCGTTAT 2,908 
 OXA23R TCACAACAACTAAAAGCACTG  
oxa23-int oxa23LF GATCGGATTGGAGAACCAGA 4,268 
 RH1305 TTTCTTCTCTTAAAGGCAACCA  
 ISAba1-tniCb RH1301 TGGCAATTTTAAGAAGGCAGA 3,680 
 RH1314 TCCCTCATAACCAACAACCA  
int-orf11 RH1306 GCATACTCATGTGGTTTAAGACTTG 1,638 
 RH1307 TTAATTGCTTCATCATTTGAGC  
orf9-tniCb RH597 TTTGAAGAAATTGAGCATGAGG 1,566 
 RH792 TTCGAGCTTGAAAACTGCAC  
tniCb-ISAba1 RH590 GCACTAGTGGCAAAGCGAAT 3,460 
 ISAba1A GTGCTTTGCGCTCATCATGC  
tniCb-sul2 RH590c GCACTAGTGGCAAAGCGAAT 4,150 
 sul2R ATGCCGGGATCAAGGACAAG  
aThis primer is specific for orf4. 
bThis PCR failed using short range conditions and would be 1,672 bp without the insertion of Tn2006. 
cThis primer is specific for tniCb. 
 
Using PCR, linkages between orf6 and orf7 along with int to orf11 amplified products of 1.5 and 
1.6 kb, respectively, but the orf7 to int linkage failed to produce a product under the same, short 
range, conditions (Table 4.4 and Figure 4.10), indicating that the orf region present in A91 was 
similar to the equivalent region in 1656-2 but there was an additional insertion. This corresponded 
with the position of Tn2006 identified in Chapter 3 (Section 3.3.1.3). The left ISAba1 of Tn2006 
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was linked with orf6, amplifying a product of 2.2 kb and oxa23 was also linked to orf7 and the int 
gene, as PCR products of 2.9 and 4.2 kb, respectively, were amplified (Figure 4.10). The right hand 
ISAba1 of Tn2006 was then joined to tniCb, producing an amplicon of 3.7 kb, which confirmed that 
Tn2006 was inserted within the orf region that separated Tn6022∆1::ISAba17 and the segment that 
contains tniCb-tniAb-tniB∆2 (Figure 4.10 and Figure 4.11).  
 
 
Figure 4.11 The complete structure of AbGRI1-2 in A91, named Tn6167. IR are shown as vertical lines and lines of 
various types and thicknesses indicate regions with different origins. The length and orientation of genes are shown as 
arrows below. A yellow box represents the complete CR2 element and CR2∆. Blue and purple boxes represent ISAba17 
and ISAba1, respectively, containing arrows that indicate their orientation. The structure of Tn2006 is shown above an 
arrow that indicated its insertion point within one end of orf7. 
 
The amplicons of the PCRs described above were all sequenced, confirming that the sequence of 
the entire orf region and Tn6022 fragment was identical to the equivalent segment in 1656-2, with 
the exception of the 9 bp duplication at the insertion point of Tn2006. This closed the gap 
separating Tn6022∆1::ISAba17 and the resistance region. The resulting sequence of AbGRI1-2 in 
comM was 37,068 bp (Figure 4.11) and the transposon was initially named Tn6167.  
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4.5 The structure of AbGRI1 in the Australian GC2 collection 
4.5.1 Unique markers of AbGRI1-2 in the Australian GC2s 
The position of Tn2006 in AbGRI1-2 could be used to determine whether AbGRI1-2 was present 
and it was shown in Chapter 3 that most of the Australian GC2 isolates had Tn2006 in this location. 
As described above, the presence and position of ISAba17 is unique to AbGRI1-2 in A91 and the 
collection was also screened for ISAba17 in this position (Table 4.5), which would generate a PCR 
amplicon of 2.7 kb using primers RH910 and RH1309. 78 of the 79 Australian GC2 isolates also 
had ISAba17 in the position observed in A91, which suggested that these isolates contained an 
island similar in structure to AbGRI1-2. However, a single isolate, D86, harboured parts of 
AbGRI1-2 but did not have ISAba17 and must contain Tn2006 at a different location in the 
genome. D86 was not analysed further. 
Table 4.5 AbGRI1-2 features in Australian GC2 isolates. 
Group Isolates tniB∆- 
ISAba17 
orf7- 
Tn2006 
No. of  
contigs 
1 A73, A111 + + 5 
 B1-B8 + + 6 
 B10 + + 5 
 D1, D5, D24, D58 + + 5 
 D51, D52, D54, D56, D57 + + 4 
 D101, D112 + + NDa 
2 A72, A87 + + 5 
 C2-C5, C8, C15, C18 + + 5 
 D8, D9, D12, D37 + + 5 
 E1, E16 + + 5 
 F1, F18, F38, F45 + + 5 
3 C13, C14 + + 5 
4 F11, F36 + + 5 
 A74-A82, A84 + + 4 
 A91, A93, A94, A96, A97 + + 5 
 C1 + + 4 
 MH50 + + 5 
 WM99c + + 5 
5 C20 + + 5 
 D72, D77, D79, D84, D85, D87, D88 + + 5 
 D92, D93, D96-D98, D107, D114 + + NDa 
6 D86 - - 7b 
a ND; No data. Whole genome data is not available for these isolates. 
b Data available but not analysed.  
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4.5.2 AbGRI1-2 is also in WM99c 
The draft genome of an Australian isolate, WM99c, recovered at Westmead Hospital in 1999 
became available during 2011 (55). Initially, the genome was searched using the sequence of 
AbGRI1-2 (Tn6167). At this stage, WM99c was incorporated into the collection and shown to be 
closely related to A91 (described in Chapter 3). The search identified 6 contigs, 4 of which 
contained the backbone of AbGRI1-2 and the resistance region, one containing the internal 
fragment of Tn2006 and another with the sequence of ISAba17 (Table 4.6). When aligned with the 
sequence of AbGRI1-2, it was revealed that the contigs had split at the exact locations of the IS, 
namely ISAba17 in Tn6022∆1 and the three copies of ISAba1. Primers RH910 and RH592, which 
span ISAba17, produced a PCR amplicon of 4.2 kb, identical in size to the corresponding region in 
A91.  The PCRs spanning the three copies of ISAba1 in AbGRI1-2 (Figure 4.10 and Table 4.4), two 
in Tn2006 and one adjacent to sul2, also produced products identical in size to those observed in 
A91. This indicated that in WM99c the island in comM was identical to AbGRI1-2. 
 
Table 4.6 Contigs from the WM99c draft genome that contain fragments of AbGRI1-2. 
Contig Accession No. Size (bp) Description 
00115 AERY01000108 35,542 LHS chromosome and Tn6022∆1 
00021 AERY01000020 2,597 Internal ISAba17 
00111 AERY01000104 8,874 Tn6022∆1, orf region 
00105 AERY01000098 2,444 Internal Tn2006 
00015 AERY01000014 5,850 Orf region, Tn6022 fragment 
00131 AERY01000120 39,919 Resistance region, RHS chromosome 
 
4.5.2.1 A second ISAba17 in WM99c 
It had been previously shown that a PCR for oxaAb in WM99c produced an amplicon 
approximately 1 kb larger than predicted (245). A search for oxaAb in the draft genome confirmed 
that the entire gene was present but that the two ends of it were in different contigs, 00023 and 
00020, which were 18,270 and 76,171 bp, respectively. This suggested that the oxaAb in WM99c 
was interrupted by an IS. However, the publicly available contigs had been trimmed to remove IS 
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fragments. A search of the original reads of WM99c with a fragment of oxaAb retrieved one with a 
piece of ISAba17 adjacent to part of the gene. PCRs joining the 5'- and 3'-fragments of oxaAb to 
ISAba17 produced amplicons of 2 and 2.2 kb, respectively, confirming that a second copy of 
ISAba17 interrupted oxaAb in WM99c (Figure 4.12). The sequence of these amplicons also showed 
that the insertion of ISAba17 generated an 8 bp DR, which is the same length observed at the 
insertion point in AbGRI1-2. 
 
 
Figure 4.12 ISAba17 interrupting oxaAb in WM99c. ISAba17 is represented by a blue box and the contigs that contain 
the two pieces of oxaAb, 00023 and 00020, are shown as the central line, with arrow heads indicating that each contig 
extends beyond the bounds of the figure. The pieces of oxaAb and the tnp genes of ISAba17 are indicated by arrows 
below the line. Primer pairs along with their amplicon sizes are shown below the genes. 
 
4.5.3 AbGRI1 in the Australian collection revealed using whole genome data 
In April 2012, the draft genome sequences of 70 Australian GC2 isolates (Table 4.5) became 
available through collaboration with Gordon Dougan and Derek Pickard at the Wellcome Trust 
Sanger Institute and Kathryn Holt at Melbourne University (see Section 2.5 for details). The 
sequence of AbGRI1-2 from A91 was used as a query against a database comprised of these 
contigs. All of the Australian GC2 isolates analysed contained contigs that matched the regions in 
AbGRI1-2 (Table 4.5). These contigs were then assembled, with the AbGRI1-2 sequence as a 
scaffold, using Sequencher 5.1. Almost all isolates contained 5 contigs that had sequence identical, 
or almost identical, to the sequence of AbGRI1-2 (Figure 4.13 and Table 4.5).  
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Figure 4.13 Contig coverage of AbGRI1-2 for the majority of the Australian GC2 isolates. The structure of AbGRI1-2 
is shown as the central black lines. IR are shown as vertical lines and the dotted blue line shows the chromosomal 
comM gene. The length and orientation of genes are shown as arrows below. A yellow box represents the complete CR2 
element and CR2∆. Blue and purple boxes represent ISAba17 and ISAba1, respectively, containing arrows that indicate 
their orientation. The coverage of each contig, named A-E, is shown directly below the genes with coloured lines. The 
extent of contig AB that contains ISAba17 is also shown above contigs A and B. Contigs A, AB and E have an arrow 
on one side, indicating that there is chromosomal DNA that extends beyond the region shown. PCRs used to close the 
gaps in contigs or identify the position of IS are shown beneath the contig lines. 
 
The extent of these 5 contigs, labelled A-E, is shown in Figure 4.13. The first contig (A) contained 
a large portion of chromosomal DNA ending with the 3'-end of comM followed by part of 
Tn6022∆1, and a fragment of ISAba17; the second (B) had a fragment of ISAba17, the remainder 
of Tn6022∆1 followed by orfs 5-7 and a fragment of ISAba1. Contig C included the internal region 
of Tn2006, flanked by inversely oriented fragments of ISAba1. Contig D was also flanked by 
inversely oriented fragments of ISAba1 and contained the remainder of the orf region followed by 
IRl and tniCb-tniAb-tniB∆2; the fifth contig (E) had a fragment of ISAba1 followed by the 
resistance region, orf4b then IRr and the 5'-end of comM along with 66 kb of chromosomal DNA. 
Each break in the contigs corresponded to the location of an IS, either ISAba17 or ISAba1. Thus 
ISAba17 and Tn2006 appeared to be in the same location in all isolates. Using PCR to join the 
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contigs closed each of these gaps; with each PCR producing an amplicon identical to the size 
predicted using AbGRI1-2 (Figure 4.13).  
 
There were 15 isolates (D51, D52, D54, D56, D57, A75-A82, A84, C1) where there was no split 
across ISAba17 and this longer first contig, named AB, contained sequence identical to contigs A 
and B described above (Figure 4.13). This suggested that these 15 isolates only had a single copy of 
ISAba17, while the other Australian GC2s had more than one. A BLAST search of the contigs 
using ISAba17 as a query confirmed that these 15 isolates only contained a single copy. The PCR 
mapping described above showed that these 15 isolates also contained an AbGRI1 identical to 
AbGRI1-2 in structure (Figure 4.13). However, the location of the additional copies of ISAba17 in 
the remainder of the collection was not investigated. 
 
4.5.3.1 An AbGRI1-2 variant in a single outbreak group 
The only variant of AbGRI1-2 that was found was in isolates B1-B8, which yielded 6 contigs that 
contained sequence matching the island (Table 4.5 and Figure 4.14a). In this case contig B was split 
near the 3'-end of orf7 (B-1 and B-2 in Figure 4.14a). Both B-1 and B-2 had an extra 60 bp on one 
end that did not match AbGRI1-2, but corresponded to one of the ends of ISAba125. PCRs joining 
orf6 and orf8, which are on either side of the interrupted orf7, to ISAba125 produced amplicons of 
1.8 and 1.7 kb, respectively, indicating that ISAba125 was inserted at this position. A PCR joining 
orf6 to orf8 produced an amplicon of 2.6 kb, which was the size predicted if only a single ISAba125 
was inserted in orf7 (Figure 4.14b), confirming that only this IS and nothing additional was present. 
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Figure 4.14 Contig coverage of the AbGRI1-2::ISAba125 in B1-B8 (a). The structure of AbGRI1-2::ISAba125 is 
shown as the central lines. IR are shown as vertical lines and the dotted blue line shows the chromosomal comM gene. 
The length and orientation of genes are shown as arrows below. A yellow box represents the complete CR2 element and 
CR2∆. Blue, green and purple boxes represent ISAba17, ISAba125 and ISAba1, respectively, containing arrows that 
indicate their orientation. The coverage of each contig, named A-E (with B split into B1 and B2 by the insertion of 
ISAba125), is shown above the central black line with coloured lines. Contig A and Contig E have an arrow on one 
side, indicating that there is chromosomal DNA that extends beyond the region shown. PCRs used to close the gaps in 
contigs or identify the position of IS are shown beneath the contig lines. The PCR joining orf 6 to orf7 (RH1302-
RH1303) is shown in (b). Isolates are indicated above their respective wells and the size standard is shown on the left. 
The predicted size of the PCR with and without the insertion of ISAba125 is 2.6 and 1.5 kb, respectively. 
 
4.5.4 AbGRI1-2 is also present in the isolates with no genome data 
The isolates collected from late 2011 from hospital D (D92-D114) were acquired after the initial 
collection was sent for sequencing. However, they were included in the PCR mapping described 
above, shown in Figure 4.13. All of these isolates also produced amplicons identical in size to 
AbGRI1-2, which suggests that they also have AbGRI1-2 inserted in comM. 
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4.6 Discussion 
AbGRI1 is comprised of fragments of transposons that have been integrated and truncated in 
multiple insertion and deletion events. In particular, the segment containing tniCb-tniAb-tniB∆2, the 
resistance region and orf4b (Figure 4.15a) is comprised of truncated forms of GIsul2, Tn10 and 
Tn5393 integrated into a tni transposon similar in structure to Tn6022.  
 
Figure 4.15 Structure of the right arm of AbGRI1-2 (Tn6167) (a) and a possible mechanism for its construction (b). IR 
are shown as vertical lines and the length and orientation of genes are shown as arrows below. A yellow box represents 
the complete CR2 element and CR2∆. The purple box represents ISAba1and contains an arrow indicating its 
orientation. In (b) the highlighted portion of GIsul2 and Tn5393 represents the fragments observed in AbGRI1-2, with 
colours matching the regions with different origins and shown in (a). 
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This hypothetical tni transposon, a precursor to what is observed in AbGRI1-2 (Tn6167), would 
have contained tni genes that were approximately 95% identical to those in Tn6022 along with 
orf4b, which shares 88% identity with orf4 in Tn6022. This mosaic structure could have arisen via 
homologous recombination between Tn6022 and/or related transposons and the tni genes and orf4b 
may have been separated by different regions of DNA of indeterminate size (Figure 4.15b). 
 
The order of the events proposed in Figure 4.15b is only one of multiple possibilities. In step 1, a 
complete GIsul2 would have been integrated into tniBb, and then Tn5393 incorporated into GIsul2. 
Following this, a single deletion could have removed the majority of GIsul2 and Tn5393 along with 
some of the tni genes (Figure 4.15b). Finally, an ISAba1 was inserted next to sul2 and a fragment of 
Tn10 containing the tet(B) determinant, which had acquired a piece of the ori end of CR2 (CR2∆ in 
Figure 4.15b) was integrated via homologous recombination between the CR2∆ and ori end of the 
CR2 that was next to sul2.  
 
There is almost no variation in the structure of the AbGRI1 in the Australian GC2 isolates studied 
here. Most carried AbGRI1-2 and only one variant that was caused by the insertion of a single 
ISAba125 was found. This variant occurred in 8 isolates (B1-B8) from an outbreak in a single year 
in hospital B and was not present in a sporadic GC2 isolate (B10) collected from the same hospital 
3 years later. The lack of diversity in structure suggests that the Australian GC2 isolates studied 
here had a common ancestor that contained AbGRI1-2 that was then able to spread throughout 
several hospitals on the eastern seaboard of Australia where they acquired, and/or lost, additional 
aminoglycoside resistance genes, which is where the majority of variation lies in this collection of 
GC2 isolates. 
 
The transposons Tn6166 (AbGRI1-1) and Tn6167 (AbGRI1-2) share several features (Figure 4.16). 
Both contain Tn6022∆1 adjacent to the 3'-end of comM, though AbGRI1-2 has an additional 
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insertion, along with the segment containing orf4b at the IRr end adjacent to the 5'-fragment of 
comM. Furthermore, both transposons have a similar resistance region that contains the tet(B) 
determinant adjacent to CR2. However, as the tetA(B) gene has been truncated in Tn6166, this 
suggests that a deletion event has occurred and that an ancestor of A320 may have had a larger 
resistance region that also contained sul2, as observed in AbGRI1-2. AbGRI1-1 is also missing the 
orf region and tniCb-tniAb-tniB∆2, which is further evidence that a deletion has occurred. 
 
 
Figure 4.16 Comparison between AbGRI1-2 and AbGRI1-1. Coloured lines represent different sections of AbGRI1. 
Red represents the Tn6022 or Tn6022∆1 backbone, with an arrow above indicating the position of the 2.85 kb deletion. 
The green represents the orf region, orange is the Tn6022-like fragment, blue is the resistance region and burgundy 
represents the segment derived from the genomic island containing the majority of GIsul2 in ATCC 17978. The purple 
box represents ISAba1, while the yellow box represents CR2. 
 
A backbone and potential ancestor of the closely related islands in A91 and 1656-2, AbGRI1-2 
(Tn6167) and AbGRI1-3, respectively, can be deduced by removing ISAba17 and Tn2006 from 
AbGRI1-2 and the blaPER-1 region from AbGRI1-3 (Figure 4.17). AbGRI1-3 lacks the tet(B) 
determinant, which may have been lost via homologous recombination between CR2∆ and CR2. 
This precursor will be referred to as AbGRI1-A. 
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Figure 4.17 AbGRI1-A, an ancestor to AbGRI1-2 and AbGRI1-3. IR are shown as vertical lines and lines of various 
types and thicknesses indicate regions with different origins. The length and orientation of genes are shown as arrows 
below. A yellow box represents the complete CR2 element and CR2∆. The purple box represents ISAba1and contains 
an arrow indicating its orientation. 
 
After the work described in this chapter was completed, several other AbGRI1 islands were 
described. Three separate A. baumannii isolated in Lithuania contained three different AbGRI1 
variants (217). One was identical to Tn6166, while two were close relatives of Tn6166. The isolate 
LT-V1 had a complete Tn6022 instead of Tn6022∆1. In the third Lithuanian isolate (LT-11) there 
was a Tn2006 inserted near the 5'-end of sup in the Tn6022∆1 backbone, in the position of Tn2006 
in AbaR4 (217).  
 
The structure of AbGRI1 in the complete genome of a Chinese GC2 A. baumannii named MDR-TJ 
(CP003500) (110), released in 2012, provided a possible explanation for some of the other variants 
that have been observed. The variant in MDR-TJ was identical to AbGRI1-2, except that there was 
a complete copy of Tn6022 near the 3'-end of tetA(B) (110) (Figure 4.18). This additional Tn6022 
was at the exact site where tetA(B) is truncated in AbGRI1-1 and MDR-TJ has the same tetA(B)* 
sequence as in A320, with a new stop codon found in the IRr of Tn6022∆1. The remainder of the 
tetA(B) gene was on the other side of the complete Tn6022 and there was a 5 bp duplication 
flanking the Tn6022, which is indicative of an insertion event. 
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Figure 4.18 Structure of the island in MDR-TJ, AbGRI1-B. IR are shown as vertical lines and lines of various types 
and thicknesses indicate regions with different origins. The length and orientation of genes are shown as arrows below. 
A yellow box represents the complete CR2 element and CR2∆. The purple box represents ISAba1, containing an arrow 
that indicating its orientation. 
 
The configuration observed in MDR-TJ, will henceforth referred to as AbGRI1-B (Figure 4.19a), as 
it is likely to have arisen from AbGRI1-A via the incorporation of Tn6022 (Figure 4.19a). 
Additional variants seen so far have arisen from either AbGRI1-A or AbGRI1-B (Figure 4.19b and 
c). Specifically, AbGRI1-2 (Tn6167) and AbGRI1-3 have arisen from AbGRI1-A, with AbGRI1-2 
acquiring ISAba17 and Tn2006 while AbGRI1-3 has lost the CR2∆-tet(B) region and gained the 
blaPER-1 segment (Figure 4.19b). AbGRI1-B is the likely ancestor of AbGRI1-1 (Tn6166), which 
could have arisen via homologous recombination between the two copies of orf4, one in Tn6022∆1 
and the other in the second Tn6022, that removed the entire middle segment of the island (Figure 
4.19c). A similar event, involving recombination between the two copies of either tniC, tniA or the 
5'-end of tniB would have given rise to the variant observed in LT-V1 (Figure 4.19c), as it contains 
a complete Tn6022 hence the site of recombination must have been in a region preceding the 
deletion in Tn6022∆1. Furthermore, the variant in LT-11 could have arisen from AbGRI1-1 via 
either the insertion of Tn2006 into Tn6022∆1 or recombination with AbaR4, which has Tn2006 in 
the same position (Figure 4.19c). 
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Figure 4.19 Structures of (a) the two ancestral islands, AbGRI1-A and AbGRI1-B and the variants derived from (b) 
AbGRI1-A and (b) AbGRI1-B. Coloured lines represent different sections of AbGRI1. Red represents the Tn6022 or 
Tn6022∆1 backbone, with an arrow above indicating the position of the 2.85 kb deletion. The green represents the orf 
region, orange is the Tn6022-like fragment, blue is the resistance region and burgundy represents the segment derived 
from the genomic island containing the majority of GIsul2 in ATCC 17978. The purple box represents ISAba1, while 
the yellow box represents CR2. In (a), the lines joining AbGRI1-A and AbGRI1-B show the insertion point of the 
second Tn6022 that is present in AbGRI1-B. In (b) and (c) labelled arrows above the lines indicate the positions of 
ISAba17, Tn2006 and the blaPER-1/strA regions in the isolates that contain them. 
 
An island similar to AbaR4, that contained the 2.85 kb deletion in Tn6022, was reported to be 
located in comM in a collection of GC2 A. baumannii isolates from several hospitals in the United 
Kingdom (239). There is a draft genome available for a representative of these isolates, named 
AB210 (109). However, when the contigs of AB210 were analysed here, there was a contig that 
contained a piece of orf4 followed by IRr and tet(B)*-CR2-strB-strA-orf4b adjacent to comM, 
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which suggested that there was a derivative of AbGRI1-B inserted in comM. Furthermore, there 
were two additional contigs that contained sequence of the Tn6022 backbone adjacent to DNA that 
matched regions from A. baumannii plasmids. This suggests that there is an AbaR4 or an island 
similar to AbaR4 in this secondary location in AB210, not in comM as concluded by the authors, 
possibly carried on a plasmid. 
 
Another AbGRI1 variant had been identified in the genome of the Chinese GC2 isolate MDR-ZJ06 
(263). The structure deduced from the genome sequence is shown in Figure 4.20. This variant 
contained a complete Tn6022 followed by the orf region and tniCb-tniAb-tniB∆2 that was part of a 
hybrid Tn6022, instead of being adjacent to the region from GIsul2, as in AbGRI1-2 (Figure 4.20). 
This hybrid Tn6022 could have been formed by recombination between the second Tn6022 that is 
present in AbGRI1-B and the tniCb-tniAb-tniB∆2 region. However, the presence of a complete 
Tn6022 adjacent to the left fragment of comM indicates that the island in MDR-ZJ06 is derived 
from a relative of AbGRI1-B that did not have the 2.85 kb deletion. 
 
Figure 4.20 Structure of AbGRI1 in MDR-ZJ06. IR are shown as vertical lines and lines of various types and 
thicknesses indicate regions with different origins. The length and orientation of genes are shown as arrows below. A 
yellow box represents the complete CR2 element and CR2∆. 
 
AbGRI1 has been involved in A. baumannii resistance for over 30 years, as A320 was isolated in 
1982. Indeed, this provides evidence for the hypothesis that the majority of globally disseminated 
MAR GC2 isolates evolved from a single ancestral cell that developed the complex resistance 
islands AbGRI1-A then AbGRI1-B early and became predominant due to the additional resistance 
genes found in the AbGRI1 variants. 
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5.1 Introduction 
As described in Chapter 3, the Australian GC2 isolates have a number of antibiotic resistance genes 
that are all located within transposons or adjacent to other mobile elements. In Chapter 4, the sul2, 
tetA(B), strB, strA and oxa23 genes were located on a novel genomic resistance island named 
Tn6167 or AbGRI1-2 that is located in the comM gene. However, the location of the aacC1-P-P-Q-
aadA1 cassette array, aphA1 and blaTEM genes, in the isolates that contained them, were still 
unknown (Table 5.1). In GC1 isolates, the aacC1-P-P-Q-aadA1 cassette array and Tn6020, 
containing aphA1, are adjacent to one another and located in AbaR3-type islands inserted in comM 
(196, 197). The MARR of AbaR3-type islands also contain numerous copies of IS26 around the 
resistance genes and transposon remnants. In almost all cases where the aacC1-P-P-Q-aadA1 array 
was present in the Australian GC2 collection, Tn6020 was also present.  
Table 5.1 Genes in the Australian GC2 isolates that have not been assigned a location. 
Group Isolates Genes not in Tn6167 
1 A73, A111 blaTEM 
 B1-B8, B10 blaTEM 
 D1, D5 blaTEM 
 D24, D51, D52, D54, D56, D57, D58 blaTEM 
 D101, D112 blaTEM 
2 A72, A87 blaTEM, aadB 
 C2-C5, C8, C15, C18 blaTEM, aadB 
 D8, D9, D12, D37 blaTEM, aadB 
 E1, E16 blaTEM, aadB 
 F1, F18, F38, F45 blaTEM, aadB 
3 C13, C14 blaTEM, aacC1, aadA1, aphA1, aphA6 
4 F11, F36 blaTEM, aacC1, aadA1, aphA1 
 A74-A82, A84 blaTEM, aacC1, aadA1, aphA1 
 A91, A93, A94, A96, A97 blaTEM, aacC1, aadA1, aphA1 
 C1 blaTEM, aacC1, aadA1, aphA1 
 MH50 blaTEM, aacC1, aadA1, aphA1 
 WM99c blaTEM, aacC1, aadA1, aphA1 
5 C20 blaTEM, aacC1, aadA1, aphA1, aphA6 
 D72, D77, D79, D84, D85, D87, D88 blaTEM, aacC1, aadA1, aphA1, aphA6 
 D92, D93, D96-D98, D107, D114 blaTEM, aacC1, aadA1, aphA1, aphA6 
 
WM99c was isolated at Westmead Hospital in 1999 and is one of the earliest GC2s found in 
Australia (245). It underwent the same phenotypic and genotypic typing as the main collection of 
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Australian GC2 isolates, as described in Chapters 3 and 4. In summary, it contained the sul2, 
tetA(B), strA, strB, blaTEM, oxa23 resistance genes along with the aacC1-P-P-Q-aadA1 cassette 
array, in a class 1 integron with sul1, and aphA1 in Tn6020. This suite of resistance genes was 
identical to that observed in A91, in which AbGRI1-2 was sequenced (Chapter 4), and the other 
members of aminoglycoside resistance group 4. However, a draft genome sequence for WM99c 
was available (55). This made it an ideal strain to determine the structure(s) surrounding the aacC1-
P-P-Q-aadA1 cassette array, Tn6020 and the blaTEM gene. 
 
The aim of the work presented in this chapter was to locate the aacC1-P-P-Q-aadA1 cassette array, 
Tn6020 and the blaTEM gene in the WM99c draft genome and then to determine whether similar 
regions were in the rest of the Australian GC2 collection. 
 
5.2 Resistance genes in the WM99c draft genome 
The blaTEM, aphA1, aacC1, aadA1 and sul1 genes were found on four different contigs in the draft 
genome of WM99c (Table 5.2). The blaTEM gene was in a 1,578 bp contig within a fragment of Tn1 
(Figure 5.1a). aacC1, aadA1 and sul1 were on an 8,261 bp contig with the orfP-orfQ cassette array 
in a fragment of an In4-type integron, which included the 5'- and 3'-conserved segments (CS) with a 
truncated IS6100 and the 5'-CS was adjacent to an incomplete Tn21 transposition module, that 
contained tnpM, tnpR and a 979 bp fragment of tnpA (Figure 5.1b).  
 
Table 5.2 Contigs that contain the remaining resistance genes in WM99c. 
Contig Accession No. Size (bp) Description 
00027 AERY01000026 1,578 blaTEM in a fragment of Tn1 
00060 AERY01000058 8,261 In4-type integron and Tn21 fragment 
00043 AERY01000042 896 aphA1 and IS26 fragment 
00025 AERY01000024 533 aphA1 
 
 CHAPTER 5 
 
124 
 
Figure 5.1 Contigs from the draft genome of WM99c that contain (a) blaTEM, (b) the class 1 integron and (c) aphA1. 
Inverted repeats are shown as vertical lines, the fragments of IS6100 and IS26 are represented by a grey and pink box, 
respectively. The position and orientation of genes are indicated by arrows beneath the central lines. The grey portion of 
the line in (c) represents the extent of contig 00025. 
 
It had been previously reported that WM99c had the P-P-Q configuration (245), which is not 
consistent with the draft genome sequence. However, as orfP is repeated, it was possible that the 
lack of the 2nd orfP was an assembly error. A PCR that amplifies the cassette array of a class 1 
integron amplified a product of 3 kb, which was indicative of the aacC1-P-P-Q-aadA1 
configuration, confirming that it was indeed present in WM99c (Chapter 3; Section 3.3.2.1.1). The 
aphA1 gene was found fragmented into 2 contigs that matched the internal fragment of Tn6020. In 
Chapter 3 the presence of the flanking copies of IS26 was confirmed by the sequence of PCR 
amplicons that span Tn6020, showing that aphA1 was intact and present within an uninterrupted 
Tn6020, joining contigs 00043 and 00025 (Figure 5.1c). The split in the contigs was most likely due 
to incomplete or insufficient coverage of this region. 
 
It was not possible to determine which other contigs were directly adjacent to IS26 from the 
publicly available draft sequence, as they had been removed. However, Professor Ian Paulsen 
kindly supplied the unassembled reads for WM99c, together with the output of a BLAST search 
using IS26 as the query against a database comprised of the unassembled reads. A total of 97 reads, 
with an average length of 432.8 bp, included a fragment of IS26 and enough adjacent sequence for 
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identification. Of these reads, 62 were found to match the ends of the contigs containing resistance 
genes (Table 5.3) and each resistance region was flanked by IS26. The remaining reads contained 
sequence that matched three further contigs (Table 5.3).  
Table 5.3 Contigs ending with fragments of IS26 in the WM99c draft genome. 
Contig Description IS26 to the left IS26 to the right 
00027 blaTEM in Tn1 8 14 
00060 In4-type integron 7 5 
00043 aphA1 and IS26 fragment 9 - 
00025 aphA1 - 19 
00026 Tn1000-like and Tn5393c fragments 6 8 
00164 Chromosomal DNA - 7 
00024 Chromosomal DNA 9 - 
  
Contig 00026 was 3,569 bp long and was identical to a fragment found in the AbaR0 island that 
includes the tnpA of Tn1000-like and a fragment of the tnpR from Tn5393c (Table 5.3). In AbaR0 
two copies of IS26 also flanked it. Fragments of IS26 were also present at one end of contig 00164 
(28,107 bp) and contig 00024 (25,059 bp). The sequence of these contigs matched chromosomal 
DNA from the genomes of other A. baumannii in GenBank, suggesting that the regions flanked by 
IS26 were located in between contigs 00164 and 00024. Thus, this suggested the presence of a 
single island that was comprised of 4 regions (A-D) that are all flanked by IS26 (Table 5.4). This 
type of island was named AbGRI2 and the island in WM99c AbGRI2-1. 
 
Table 5.4 Internal regions that make up AbGRI2 in WM99c. 
Contig Region Size (bp) Description 
00027 A 1,578 blaTEM in Tn1 
00026 B 3,568 Tn1000-like and Tn5393c fragments 
00043/00025 C 1,429 aphA1 and IS26 fragment 
00060 D 8,801 In4-type integron 
  
5.2.1 The location of AbGRI2-1 
Comparison of contigs 00164 and 00024 with sequenced genomes of other A. baumannii confirmed 
that AbGRI2 was in the chromosome. In contig 00164, the IS26 abuts part of an orf, which is 
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annotated as a D-serine/D-alanine/glycine transporter in AB0057 (AB57_1175∆). Similarly, part of 
a flavin-binding monooxygenase (AB57_1209∆) was found adjacent to the right hand junction of 
AbGRI2 (Figure 5.2b).  
 
Figure 5.2 Relative positions of AbGRI1 and AbGRI2 in the A. baumannii genome (a) and the location of AbGRI2-1 
relative to AB0057 (b). In (a), the arrows indicate the positions of AbGRI1 and AbGRI2 in a circular representation of 
the A. baumannii genome. The numbers represent genomic coordinates in Mb. In (b), the extent of AbGRI2 in WM99c 
is shown above, with IS26 represented by a pink box. The dotted lines show the extent of the deletion relative to 
AB0057, with the chromosomal positions of AB0057 indicated.  
 
Compared to the GC1 strains AB0057 and AB307-0294, AbGRI2 has replaced a 40.9 kb segment 
of chromosomal DNA, corresponding to positions 1,258,357-1,299,260 in AB0057 and 2,568,231-
2,609,132 in AB307-0294 (Figure 5.2); these genomes were opened at different positions and hence 
their numbering differs. A search for this 40.9 kb region revealed that no portion of it was present in 
the draft genome of WM99c. A DR was not seen in the sequence of WM99c. Hence, a second event 
must have occurred after AbGRI2-1 was inserted, altering the sequence to one or both sides. 
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5.3 Assembly of AbGRI2 
The sequences of contigs 00027 (A), 00026 (B) and 00043/00025 (C) were identical to regions 
found in the AbaR-type islands found in comM in GC1 isolates. In AbaR0, these segments were 
found adjacent to one another, separated by single copies of IS26 as shown in Figure 5.3. 
 
 
Figure 5.3 Possible assembly of contigs based upon the similarity to AbaR0 and the orientation of IS26. Contigs are 
shown as coloured lines with their number above and the region name below with IR represented as small vertical lines. 
Pieces of IS26 found adjacent to the sequence of each end of each contig are shown as pink boxes with an arrow above 
indicating orientation. The origin of different DNA segments is shown above the lines. 
 
The arrangement of regions A, B and C, in the same configuration as in AbaR0, was confirmed 
using published PCRs devised for AbaR3 (197). Primers RH605 and RH759, joining A to B, 
produced a PCR amplicon of 2.7 kb while primers 520 and 880 produced an amplicon of 2.3 kb, 
joining B to C (Figure 5.4). The size of these amplicons was consistent with a single IS26 
separating each region. Each of these PCR amplicons was then sequenced. As expected from the 
published sequence of Tn6020 (196), the IS26 next to IS26∆ in Tn6020 differed by three bases 
when compared to the IS26 sequence in the ISFinder database (www-is.biotoul.fr). The difference 
in nucleotide sequence resulted in an amino acid change at position 184 in the IS26 transposase, 
where a glycine has been replaced with an asparagine.  
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Figure 5.4 Segment from AbaR0 found in WM99c. IR are shown as vertical lines and IS26 is represented by a pink box 
containing an arrow that shows its orientation. The * marks the IS26 with altered sequence. A line of a different colour 
represents each region, with its origin shown above. The location of primers used for PCRs are shown below the line 
along with the size of the amplicon. 
 
The possible arrangements of the remaining contigs, 00164, 00060 (D) and 00024, are constrained 
by the orientation of the IS26 fragments, which were discerned from the reads. These contigs, could 
then be joined with the A-B-C region by matching together the segments that had IS26 in the same 
orientation. Initially, region D, which contains the class 1 integron and a fragment of Tn21, was 
arranged next to the A-B-C segment. In AbaR0, a small piece of Tn21, smaller than what is in 
WM99c, followed by the 5'-CS of the class 1 integron is found on the other side of Tn6020 (region 
C). A PCR joining Tn6020, region C, and Tn21, in region D, failed to produce an amplicon. The 
IS26 near the 3'-CS was also in the correct orientation to join with the A-B-C region, and primers 
RH881, in aphA1 (region C), and RH751, in the 3'-CS (region D), produced an amplicon of 2.7 kb 
(Figure 5.5). The sequence of this amplicon confirmed that the 3'-CS side of region D was adjacent 
to region C, separated by a single IS26, which was identical to the sequence of IS26 in ISFinder 
(www-is.biotoul.fr). 
 
 
Figure 5.5 Assembly of region D to the segment from AbaR0 in WM99c. IR are shown as vertical lines and IS26 is 
represented by a pink box containing an arrow that shows its orientation. A line of a different colour represents each 
region. The origin of different DNA segments is shown above the line and the 9 kb region also found in AbaR3-type 
islands is shown above this. The location of primers used for PCR are shown below the line along with the size of the 
amplicon. 
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Finally, the contigs containing the chromosomal DNA, 00164 and 00024, were joined to either side 
of the island. Primer RH1315 in contig 00164 and RH1316 in 00024 were paired with primers on 
either side of AbGRI2, either RH539 in region A or RH668 in region D. Primers RH1315 and 
RH539 produced an amplicon of 1 kb (1 in Figure 5.6), while primers RH668 and RH1316 
amplified a product of 1.2 kb (5 in Figure 5.6). The other two primer combinations failed to amplify 
products. This confirmed that the sequence of 00164 was adjacent to region A and 00024 was 
adjacent to the Tn21 end of region D as shown in Figure 5.6. The successful primer pairs used to 
map the structure of AbGRI2-1 are summarised in Table 5.5 and Figure 5.6, labelled PCRs 1-5. 
 
 
Figure 5.6 PCRs used to join the contigs that comprise AbGRI2 in WM99c. IRs are shown as vertical lines and IS26 is 
represented by a pink box containing an arrow that shows its orientation. A line of a different colour represents each 
contig, with the number below. The location of primers used for PCRs are shown below the line along with the size of 
the amplicon. Primers RH1315-RH539 amplify a 1,051 bp product and RH668-RH1316 generates a 1,219 bp product. 
 
Table 5.5 PCRs used to join the contigs that make up AbGRI2-1. 
PCR Location Contig Region Primers Sequence (5'-3') size 
(bp) 
1 AB57_1175a 00164 Chromosome RH1315 AGGAGATCTTCTTGGCAGTCA 1,051 
 tnpR1 00027 A RH539 CCAGCCCTTCCCGATCTGTTG  
2 blaTEM 00027 A RH605 TTTCGTGTCGCCCTTATTCC 2,650 
 tnpA1000 00026 B RH759 GCCAGCTCATTTACCTTGCCGA  
3 tnpR5393c 00026 B RH520 CATGGCCCAGCGCGATACTTCAG 2,297 
 aphA1 00025 C RH880 CAACGGGAAACGTCTTGCTC  
4 aphA1 00025 C RH881 ATTCGTGATTGCGCCTGAG 2,712 
 sul1 00060 D RH751 GCGGAACTTCACGCGATC  
5 tnpA21 00060 D RH668 CACCAGAACCGCCTGCTCAA 1,219 
 AB57_1209a 00024 Chromosome RH1316 CATCTGCCATCCAGTTTGTG  
aLoci in the genome of AB0057 (GenBank accession number CP001182) 
 
The genomic resistance island, named AbGRI2-1, was 19,475 bp and contained all 5 copies of IS26 
present in the genome of WM99c (Figure 5.7). There are similarities in the structure of AbGRI2-1 
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when compared to AbaR-type islands, which interrupt comM in GC1. The 9 kb segment spanning 
the Tn1 fragment to Tn6020 is identical to a region in AbaR-type islands (Figure 5.7). This 9 kb 
region is directly adjacent to a class 1 integron that has the same cassette array as in many AbaRs, 
but in AbGRI2-1 the fragment containing the integron is in the opposite orientation. 
 
 
Figure 5.7 Structure of AbGRI2-1 in WM99c. The central black line represents the resistance island, while the dotted 
blue lines show the adjacent chromosomal sequence. Pink boxes represent IS26 and they contain an arrow indicating 
their orientation, while the grey box represents IS6100∆. IR are shown as vertical lines. Arrows below the central line 
show the position and orientation of genes. The origin of different DNA segments is shown above the line and the 9 kb 
region also found in AbaR3-type islands is shown above this. 
 
5.4 AbGRI2 in Australian GC2 isolates with a class 1 integron 
5.4.1 PCR mapping for AbGRI2-1 
WM99c belongs to a group of 20 Australian isolates that all contain the aacC1-P-P-Q-aadA1 
cassette array as well as the aphA1 gene in Tn6020 (Group 4; Table 5.1) and an additional 15 
isolates, belonging to group 5 (Table 5.1) have aphA6 in addition to this combination. However, 14 
of the latter isolates are from hospital D and have two or more copies of aphA1 that are adjacent to 
one another (Chapter 3; Section 3.3.2.1.2). Only a single isolate, C1, out of the 35 isolates from 
groups 4 and 5 does not also contain the blaTEM gene (Table 5.1). As these isolates are all closely 
related, the possibility that they also harboured a structure identical to, or very closely related to, 
AbGRI2-1 was explored. The PCR mapping shown in Table 5.5 and Figure 5.6 was performed. A 
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total of 32 of these 35 isolates produced amplicons identical in size to those in WM99c for all 5 
PCRs (Table 5.6), indicating that these isolates harboured a structure similar to AbGRI2-1. 
However, this included the 14 isolates from hospital D that have additional copies of Tn6020. This 
indicated that in these 14 isolates, the additional copy of Tn6020 is next to the Tn6020 in AbGRI2-
1, in the same orientation, though their island was indistinguishable from AbGRI2-1 using the PCR 
mapping strategy described in Table 5.5 (Table 5.6) and it was not possible to determine the total 
number of copies of Tn6020 using PCR. Cloning or Southern hybridisation experiments should be 
able to resolve this. 
 
Table 5.6 PCR mapping of Australian GC2 isolates in groups 4 and 5. 
Group Isolates PCR
a 
1 2 3 4 5 
4 WM99c + + + + + 
 F11, F36 + + + - + 
 A74-A82, A84 + + + + + 
 A91, A93, A94, A96, A97 + + + + + 
 C1 - - - + + 
 MH50 + + + + + 
5 C20 + + + + + 
 D72, D77, D79, D84, D85, D87, D88 + + + + + 
 D92, D93, D96-D98, D107, D114 + + + + + 
a These PCRs correspond with those shown in Figure 5.3 and Table 5.5. 
 
Two isolates, F11 and F36, failed to amplify a product for PCR 4, which links Tn6020 to the 3'-CS 
of the class 1 integron, though they produced amplicons identical to WM99c for the other PCRs 
(Table 5.6). As these isolates have a complete copy of Tn6020, region C, (Chapter 3; Section 
3.3.2.1.2), this suggests that there may be a deletion at one end of region D, or that there is an 
insertion between regions C and D or an inversion that has caused the PCR to fail. 
 
The isolate C1, which did not have blaTEM, only produced amplicons for PCR 4 and 5 (Table 5.6), 
and the products were identical in size to those observed in the rest of the Australian isolates 
described above. This indicates that C1 harbours one end of AbGRI2-1 and that the junction to the 
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chromosome on the right is also identical while there has been a deletion that removed regions A, 
containing blaTEM, and B and altered the junction to the chromosome on the left. 
 
5.4.2 Structures of AbGRI2 from whole genome data 
When the draft genomes for the Australian GC2 isolates became available during 2012 their 
sequences were examined for the presence of an AbGRI2-like island in the position as AbGRI2-1. 
The sequence of AbGRI2-1 was used as a query sequence against a database comprised of the 
assembled contigs of the Australian GC2 isolates, in order to identify all contigs that contained a 
region present in AbGRI2-1 or fragments of IS26. However, genome data was not available for 
isolates D92, D93, D96-D98, D107 and D114 as they were acquired later in the project. Thus, these 
isolates are not included in the following analysis. 
 
5.4.2.1 Chromosomal boundaries 
Initially, the left and right junctions of AbGRI2-1 with the chromosome were investigated. 
According to the PCR mapping all of the integron containing isolates should have the same junction 
to the right of AbGRI2-1, while all isolates except for C1 should also have the same junction to the 
left of AbGRI2-1. These isolates all contained a contig that ended with a small fragment of IS26, 
and the junction between IS26 and the chromosome to the right was identical to that observed in 
AbGRI2-1. This contig was 25 kb in all isolates except for F11 and F36, where it was only 599 bp. 
An analysis of this 599 bp contig revealed that there was another fragment of IS26 on the other end, 
indicating that there was an additional IS26 in the chromosomal DNA 477 bp away from the right-
hand junction of AbGRI2 in F11 and F36 (Figure 5.8). 
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Figure 5.8 Comparison of the chromosome to the right for AbGRI2-1 and the AbGRI2 in F11/F36. The dotted blue line 
shows the chromosome to the right of AbGRI2 while the green line is region D. Pink boxes represent IS26 and they 
contain an arrow indicating their orientation. Arrows below the central line show the position and orientation of genes. 
The positions of the chromosomal segment in AB0057 are shown above the central line. 
 
All isolates except for C1 had a 72 kb contig with an IS26 to chromosome junction identical to that 
seen to the left of AbGRI2-1, confirming that the junction to the left of AbGRI2 in all these isolates 
was the same. A 74 kb contig with a fragment of IS26 on one end was identified in the C1 genome 
assembly. Comparison of this contig with the chromosomal sequence found to the left of AbGRI2-1 
revealed that it was from the same region but a 16.4 kb region of the chromosomal DNA had been 
lost. A deletion mediated by IS26 has altered the boundary to the left of the island and may have 
removed part of AbGRI2 along with the adjacent chromosomal sequence. The region that borders 
the IS26 on the left in C1 is not present in AB0057 but is found in the draft of WM99c as well as 
the genome MDR-TJ and several other GC2 isolates. The region deleted in C1 corresponds to 
positions 2,676,386-2,692,794 in the genome of MDR-TJ. However, the first 12.9 kb in this region 
is also homologous (94.1% identical) to AB0057. 
 
5.4.2.2 Structures predicted to be identical to AbGRI2-1 
The isolates that contained the aacC1-P-P-Q-aadA1 cassette array and Tn6020 (in AgR groups 4 
and 5; blue in Table 5.6) generally had 6 contigs that matched the sequence of AbGRI2-1. Three of 
these contigs contained sequence identical to regions A-C of AbGRI2-1 (Table 5.7), but they were 
approximately 120 bp larger than the corresponding regions in WM99c due to the presence of 
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fragments of IS26 on each end, approximately 60 bp in length. However region D, which contains 
the class 1 integron, was separated into 3 contigs (Figure 5.9 and Table 5.7). This is due to the 
repeat of orfP, but the structure of the cassette array was previously shown using PCR to contain 
two copies of orfP (Chapter 3; Section 3.3.2.1.1).  
 
 
Figure 5.9 Contigs that make up region D. The central green line represents the resistance island, while the dotted blue 
line shows the adjacent chromosomal sequence. Pink boxes represent IS26 and they contain an arrow indicating their 
orientation, while the grey box represents IS6100∆. IR are shown as vertical lines. Arrows below the central line show 
the position and orientation of genes. The origin of different DNA segments is shown above the line and the extent of 
the contigs is shown in blue below. 
 
Table 5.7 Contigs that contain regions within AbGRI2-1. 
Contig Size (kb) Description 
A 1.6 Tn1 fragment 
B 3.6 Tn1000-like and Tn5393c fragments 
C 2.2 Internal Tn6020 
D-1 3.8 IS6100∆, 3'-CS, aadA1 and orfQ 
D-2 0.5 orfP 
D-3 4 aacC1, 5'-CS and Tn21 fragment 
 
The contigs were assembled using the PCR mapping strategy described in Section 5.4.1, confirming 
that 18 of these 20 Australian GC2 isolates that contain an integron contained an AbGRI2-1 that 
was identical to that in WM99c (Figure 5.10). WM99c was also included with the other Australian 
isolates for whole genome sequencing and was among the integron containing Australian isolates 
described above (Table 5.6). The sequence for AbGRI2-1 from the whole genome sequencing 
performed here was identical to that observed in the publicly available genome of WM99c, which 
was sequenced using a different method (55). 
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Figure 5.10 The structure of AbGRI2-1 in the Australian isolates. The coloured lines represent the different regions of 
the resistance island, with its letter below, while the dotted blue lines show the adjacent chromosomal sequence. Pink 
boxes represent IS26 and they contain an arrow indicating their orientation, while the grey box represents IS6100∆. IR 
are shown as vertical lines. Arrows below the central line show the position and orientation of genes. The extent of the 
contigs used to assemble the island are shown directly above the central line, while the origin of different DNA 
segments is shown above the contigs.  
 
5.4.2.3 AbGRI2-7, formed by an inversion of AbGRI2-1 
The isolates F11 and F36, had failed to produce an amplicon for PCR 4, which joins the aphA1 in 
region C with the 3'-CS of the class 1 integron in region D (Table 5.6). However, the contigs 
containing regions A, B, C and D were identical to those in isolates with AbGRI2-1. The presence 
of the additional IS26 in the chromosome (Section 5.4.2.1) indicated that it was possibly an 
inversion, rather than a deletion or insertion, which had caused PCR 4 to fail. To determine whether 
this was the case, primers RH881 in region C and RH668 in the Tn21 portion of region D were 
used. This PCR produced an amplicon of 2.9 kb (Figure 5.11a). Examination of the sequence of this 
PCR product revealed that the 477 bp segment of the chromosome to the right, which contains the 
usual AbGRI2-1 junction, was present between region C and region D, and that region D was in the 
inverse orientation relative to AbGRI2-1 (Figure 5.11), indicating that the additional IS26 in the 
chromosome to the right has caused an inversion (Figure 5.11b). Though this portion of the 
chromosome is now in the middle of the island, it did not affect PCR 5 as the primer sequence was 
within the inverted chromosomal fragment (Figure 5.11a). 
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Figure 5.11 PCRs used to map AbGRI2-7 (a) and the formation of AbGRI2-7 from AbGRI2-1 (b). The central 
coloured lines represent the resistance island, while the dotted blue lines show the adjacent chromosomal sequence. 
Pink boxes represent IS26 and they contain an arrow indicating their orientation, while the grey box represents 
IS6100∆. IR are shown as vertical lines. The origin of different DNA segments is shown above the line. In (a) the 
positions of primers used to join the contigs is shown below the central line along with amplicon size. Primers RH1315-
RH539 amplify a 1,051 bp product and RH668-RH1316 generates a 1,219 bp product. The genomic positions in 
AB0057 of the pieces of the chromosome usually to the right of AbGRI2 are shown in blue above the corresponding 
region. In (b), arrows below the central line show the position and orientation of genes. The arrows between each 
structure show the steps necessary to form AbGRI2-7  
 
Primers RH1583, in the integron portion of region D, and RH1564 further along in the sequence of 
the chromosome to the right amplified a product of 4.1 kb. This confirmed that the integron portion 
of region D was now adjacent to the chromosome on the right at a position 477 bp away from the 
junction in AbGRI2-1. 
 
5.4.2.4 A variant of AbGRI2-1 with multiple copies of aphA1 
The seven TnaphA6 containing isolates from hospital D (D72, D77, D79, D84, D85, D87, D88), 
which were part of an outbreak centred around the spinal injury ward (7D), also contained 6 contigs 
identical to those described in Table 5.7 and produced PCR amplicons identical in size to WM99c 
for PCRs 1-5 shown in Figure 5.10. However, as shown in Chapter 3, these isolates have a second 
fragment of Tn6020 that contains a second aphA1 gene (Section 3.3.2.1.2; Figure 5.12a).  
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Figure 5.12 Structure of AbGRI2-1a. The central coloured lines represent the resistance island, while the dotted blue 
lines show the adjacent chromosomal sequence. Pink boxes represent IS26 and they contain an arrow indicating their 
orientation, while the grey box represents IS6100∆. IR are shown as vertical lines. The origin of different DNA 
segments is shown above the line. In (a) the positions of primers used to join the contigs is shown below the central line 
along with amplicon size. Primers RH1315-RH539 amplify a 1,051 bp product and RH668-RH1316 generates a 1,219 
bp product. In (b), arrows below the central line show the position and orientation of genes. 
 
From the genome data, it is not possible to determine how many times this fragment of Tn6020 was 
repeated, but as the primer pairs joining Tn6020 to AbGRI2 produced products of the correct size, 
the multiple Tn6020 fragments must be present within AbGRI2 (Figure 5.12b). The island in these 
isolates was designated AbGRI2-1a and has been depicted with two copies of aphA1 (Figure 
5.12b).  
 
The 7 additional isolates from hospital D (D92, D93, D96-D98, D107 and D114) that were not 
sequenced but are also in group 5, and were part of the same outbreak in ward 7D, produced 
amplicons for PCRs 1-5 that were identical in size to the other isolates that harboured AbGRI2-1 or 
AbGRI2-1a (Table 5.6). Furthermore, as discussed in Chapter 3, these isolates also produced a 1.9 
kb amplicon that joined the two fragments of Tn6020. This suggests that these isolates also harbour 
an island similar, or identical, to AbGRI2-1a. However, further work will be needed to determine 
the number of copies of aphA1. Thus, their island was also tentatively classified as AbGRI2-1a. 
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5.4.2.5 A deletion variant of AbGRI2-1 in the isolate C1 
The isolate C1, which also contains a class 1 integron and Tn6020 and was the only isolate without 
blaTEM, only contained four contigs that matched regions in AbGRI2-1. These four contigs 
corresponded to C and D-1 to D-3 described in Table 5.7 and Figure 5.9. Thus, region A and region 
B were not present in C1. As described above, C1 produced amplicons for PCRs 4 and 5, indicating 
that regions C and D were in the same configuration as in AbGRI2-1 (Figure 5.13). Hence, there 
was a deletion in AbGRI2 in C1, altering the islands junction with the chromosome to the left. The 
fragment of IS26 at the end of the 74 kb contig identified in Section 5.4.2.1 was in the same 
orientation as the left copy of IS26 in Tn6020, so the primer RH1579 was designed at this new 
chromosomal location and used to link to aphA1 in Tn6020 (Figure 5.13). This produced an 
amplicon of 2.3 kb, indicating that the left hand IS26 of Tn6020 (as in Figure 5.13) was directly 
adjacent to the chromosome, confirming that the portion of AbGRI2-1 containing regions A and B 
had been deleted along with the 16.4 kb segment of chromosomal DNA. The variant in C1 was 
named AbGRI2-8 and is 12,690 bp in length. 
 
 
Figure 5.13 The structure of AbGRI2-8 in C1. The central coloured lines represent the resistance island, while the 
dotted blue lines show the adjacent chromosomal sequence. Pink boxes represent IS26 and they contain an arrow 
indicating their orientation, while the grey box represents IS6100∆. IR are shown as vertical lines. Arrows below the 
central line show the position and orientation of genes. The origin of different DNA segments is shown above the line. 
The position of the 16.4 kb deletion relative to AbGRI2-1 is shown with an arrow. 
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5.5 AbGRI2 in isolates without an integron 
The draft genome sequences of 41 isolates that did not contain an integron (groups 1, 2 and 3 in 
Table 5.1) were also examined for the presence of an AbGRI2 in the same position as AbGRI2-1. 
No genome data was available for isolates D101 and D112, in group 1, as they were acquired later 
in the project. The sequence of AbGRI2-1 was used as a query sequence against a database 
comprised of the assembled contigs of the Australian GC2 isolates, to identify all contigs that 
contained a region present in AbGRI2-1. All isolates in groups 1, 2 and 3 contained contigs that 
matched at least one of the regions found in AbGRI2-1 (Table 5.8), which indicates that variants of 
AbGRI2 in these isolates may be derivatives of AbGRI2-1.  
 
Table 5.8 Contigs that match regions of AbGRI2-1 in the Australian isolates with no integron. 
Group Isolates Region Size (bp) Junctions A B C D L R 
 WM99c 1,578 3,568 1,254 8,801 + + 
1 D24, D51, D52, D54, D56, D57 1,578 3,568 - 2,220 + + 
 A73, A111 1,578 3,568 - - + + 
 B10 1,578 3,568 - - + + 
 D1, D5, D58 1,578 3,568 - - + + 
 B1-B8 1,578 - - - + + 
2 A72, A87 1,578 3,568 - - + + 
 C2-C5, C8, C15, C18 1,578 3,568 - - + + 
 D8, D9, D12, D37 1,578 3,568 - - + + 
 E1, E16 1,578 3,568 - - + + 
 F1, F18, F38, F45 1,578 3,568 - - + + 
3 C13, C14 1,578 3,568 - - + + 
 
Initially, the contigs that contained the left and right junctions with the chromosome were identified 
and compared to those in AbGRI2-1. The genomes of all 41 isolates contained two contigs that had 
a piece of the chromosome and a fragment of IS26 at one end. These contigs contained sequence 
that was identical to the regions found to the left and right of AbGRI2-1 (Table 5.8), indicating that 
these isolates had an AbGRI2 in the same position as AbGRI2-1. This indicated that all the 
differences between different variants were internal to the island. 
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5.5.1 AbGRI2-9, a variant unique to hospital D 
The genomes of a group of 6 aminoglycoside susceptible isolates from an outbreak in a severe 
burns unit in hospital D (D24, D51, D52, D54, D56, D57) contained 2 contigs that were identical to 
regions A and B (Table 5.8) and a third that corresponded to a 2,220 bp fragment of region D 
bounded by fragments of IS26 that were inversely oriented (Figure 5.14).  
 
 
Figure 5.14 Comparison of region D in AbGRI2-9 with that in AbGRI2-1. The central coloured line represents the 
resistance island and the grey dotted line shows the deletion. Pink boxes represent IS26 and they contain an arrow 
indicating their orientation, while the grey box represents IS6100∆. IR are shown as vertical lines. Arrows below the 
central line show the position and orientation of genes. The origin of different DNA segments is shown above the line. 
 
PCRs 1, 2 and 5 produced amplicons of 1, 2.6 and 1.2 kb, respectively, indicating that contigs A 
and B in these 6 isolates were in the same position as in AbGRI2-1 and that the fragment of region 
D was next to the chromosome to the right (Figure 5.15). Primers RH668 and RH754, linking the 
tnpR of Tn5393c (region B) to tnpM of Tn21 (region D), produced an amplicon of 1.3 kb, 
indicating that these two regions were separated by a single copy of IS26 (Figure 5.15). The 
AbGRI2 structure in these 6 isolates appears to be a derivative of AbGRI2-1, were an IS26 
mediated deletion has removed an 8,830 bp segment that included Tn6020 and the majority of the 
class 1 integron. This variant was named AbGRI2-9 and was 10,646 bp in length. 
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Figure 5.15 The structure of AbGRI2-9. The central coloured lines represent the resistance island, while the dotted blue 
lines show the adjacent chromosomal sequence. Pink boxes represent IS26 and they contain an arrow indicating their 
orientation. IR are shown as vertical lines. Arrows below the central line show the position and orientation of genes. 
The origin of different DNA segments is shown above the line. 
 
5.5.2 AbGRI2-10, the most widespread variant 
The most widespread variant of AbGRI2, named AbGRI2-10, was observed in the genomes of 27 
isolates from hospitals A, B, C, D, E and F and belonged to groups 1 (aminoglycoside susceptible), 
2 (aadB in pRAY) and 3 (aphA6). These isolates had only two contigs that matched AbGRI2-1, one 
identical to region A and one identical to region B, suggesting that there were only 3 copies of IS26. 
PCRs 1 and 2 amplified products of the predicted 1 and 2.6 kb, respectively, indicating that region 
A was adjacent to the left junction with the chromosome and region B was adjacent to A, as in 
AbGRI2-1 (Figure 5.16).  
 
 
Figure 5.16 The structure of AbGRI2-10. The central coloured lines represent the resistance island, while the dotted 
blue lines show the adjacent chromosomal sequence. Pink boxes represent IS26 and they contain an arrow indicating 
their orientation. IR are shown as vertical lines. Arrows below the central line show the position and orientation of 
genes. The origin of different DNA segments is shown above the line. 
 
However, the contig that contained region B was approximately 100 bp larger than that in AbGRI2-
1. This was due to an additional 105 bp segment from a truncated IS26 directly adjacent to the tnpR 
of Tn5393c (region B; Figure 5.16). This IS26∆1 is in the same orientation as the equivalent 
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complete IS26 observed at this position in Tn6020 in AbGRI2-1 and the other variants described 
above. However, the contig with region B also had an additional 60 bp fragment of IS26 adjacent to 
the 105 bp IS26∆1, indicating that a complete copy of IS26 was present next to IS26∆1. The 60 bp 
IS26 fragment was in the same orientation as that on the contig with the chromosomal junction on 
the right. A PCR linking the tnpR of Tn5393c with the chromosome produced a product of 1.2 kb, 
indicating that there was only a single IS26 separating region B with the segment of the 
chromosome observed to the right of AbGRI2-1 (Figure 5.16). AbGRI2-10 was 7,712 bp in length. 
 
5.5.3 AbGRI2-11, found in outbreak isolates from hospital B 
The final variant of AbGRI2 that was observed in the genomes of the Australian GC2 isolates, 
named AbGRI2-11, was found in a group of 8 isolates from an outbreak in hospital B (B1-B8) that 
occurred in 2007. AbGRI2-11 was the smallest variant that was seen and only had a single contig 
that matched region A of AbGRI2-1 (Table 5.8). PCR 1 produced an amplicon of 1 kb, indicating 
region A was in the same position relative to AbGRI2-1 (Figure 5.17). A second PCR using primers 
RH605 in blaTEM and RH1316, to the right of AbGRI2-1, produced a product of 1.8 kb. This 
indicated that AbGRI2-11 was indeed only comprised of region A, containing blaTEM, flanked by 
two inversely oriented copies of IS26 (Figure 5.17). This variant was only a total of 3,218 bp in 
size. 
 
Figure 5.17 The structure of AbGRI2-11. The central red line represents the resistance island, while the dotted blue 
lines show the adjacent chromosomal sequence. Pink boxes represent IS26 and they contain an arrow indicating their 
orientation. Arrows below the central line show the position and orientation of genes. The origin of different DNA 
segments is shown above the line. 
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5.6 Variants of AbGRI2 in completed GC2 genomes 
Completed genomes of other GC2 isolates, that were available at the time this work was undertaken 
(August 2013), were examined for the presence of either an IS26 or a GRI at the location where 
AbGRI2-1 was observed. The genomes studied are listed in Table 5.9 
 
Table 5.9 Completed GC2 genomes in GenBank as of August 2013. 
Isolate Accession 
No. 
Country Submission  
year 
Size  
(Mb) 
ACICU CP000863 Italy 2008 4 
1656-2 CP001921 South Korea 2011 4.02 
AB0715 CP002522 Taiwan 2011 4.22 
MDR-ZJ06 CP001937 China 2012 4.01 
MDR-TJ CP003500 China 2012 4.15 
TYTH-1 CP003856 Taiwan 2012 3.96 
BJAB07104 CP003846 China 2013 4.04 
BJAB0868 CP003849 China 2013 4.01 
 
5.6.1 AbGRI2-2 in MDR-TJ 
The isolate MDR-TJ, a GC2 from China (110), had a resistance island located at the same position 
as AbGRI2-1 that was very closely related and designated AbGRI2-2. It had identical junctions 
with the chromosome on the left and right, but lacked regions A and C (Figure 5.18), which 
suggests that there were two IS26 mediated deletion events that removed these regions. 
Interestingly, according to the genome sequence of MDR-TJ this IS26 (the white box in Figure 
5.18) contains an additional 3 bp and a single 1 bp deletion relative to the standard IS26 sequence 
found in ISFinder (https://www-is.biotoul.fr), which would cause a frame-shift in the transposase. 
Though this may be a sequence error. Region D was almost identical in structure to that seen in 
AbGRI2-1, but there was a third copy of orfP, giving MDR-TJ an unusual aacC1-P-P-P-Q-aadA1 
cassette array. Whether the third copy of orfP is actually present remains to be unequivocally 
established. 
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Figure 5.18 Structure of AbGRI2-2 in MDR-TJ. The central coloured lines represent the resistance island, while the 
dotted blue lines show the adjacent chromosomal sequence. Pink boxes represent IS26 and they contain an arrow 
indicating their orientation, while a grey box represents IS6100∆. The white box shows the IS26 that would have an 
inactive transposase. IR are shown as vertical lines. Arrows below the central line show the position and orientation of 
genes. The origin of different DNA segments is shown above the central line. 
 
5.6.2 AbGRI2-3 in MDR-ZJ06 
Another resistance island, designated AbGRI2-3, was also located at the same position in the GC2 
isolate MDR-ZJ06 (263), also originating in China. While AbGRI2-3 had an identical junction 
between IS26 and the chromosome on the right, there was a deletion, relative to AbGRI2-1, that 
removed 7.8 kb of chromosomal DNA adjacent to the left of the island corresponding to positions 
1,250,581-1,258,356 in AB0057 (Figure 5.19). Furthermore, AbGRI2-3 contained a modified form 
of region D from AbGRI2-1. This fragment harbours the class 1 integron but the aacC1-P-P-Q-
aadA1 cassette array was replaced by aacA4-catB8-aadA1 and the segment is inverted relative to 
the orientation in AbGRI2-1 (Figure 5.19). 
 
 
Figure 5.19 Structure of AbGRI2-3 in MDR-ZJ06. The central green line represents the resistance island, while the 
dotted blue lines show the adjacent chromosomal sequence. Pink boxes represent IS26 and they contain an arrow 
indicating their orientation, while the grey box represents IS6100∆. IR are shown as vertical lines. Arrows below the 
central line show the position and orientation of genes. The origin of different DNA segments is shown above the line. 
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5.6.3 1656-2 
The genome of 1656-2 (178), a GC2 isolate from South Korea, contains a remnant of region D 
harbouring the class 1 integron directly adjacent to the same junction with the chromosome to the 
right of AbGRI2-1. There is a second IS26 that flanks this integron remnant, but it is adjacent to a 
piece of chromosomal DNA that is located approximately 1.4 Mb away in the genomes of MDR-TJ 
and MDR-ZJ06. The fragment of the integron contained a truncated intI1 followed by aacC1, orfP 
and a truncated orfQ, and was in the opposite orientation relative to AbGRI2-1 (Figure 5.20).  
 
 
Figure 5.20 Structure of the AbGRI2 fragment in 1656-2. The central green line represents the piece of the resistance 
island, the dotted blue line indicates the same chromosomal sequence of AbGRI2-1 and the solid blue line represents 
chromosomal DNA that is in a  different position in isolates with other AbGRI2 variants. Pink boxes represent IS26 and 
they contain an arrow indicating their orientation. Arrows below the central line show the position and orientation of 
genes. 
 
5.6.4 TCDC-AB0715 
In TCDC-AB0715 (34), a GC2 isolate from Taiwan, there is also an insertion at exactly the same 
position as AbGRI2-1. However, while there is a complete copy of IS26 with a junction identical to 
that in AbGRI2-1, there is only a partial copy of IS26 adjacent to the junction with the chromosome 
to the left. The region in between the complete IS26 and junction to the left is comprised of 
additional fragments of IS26 and the non-coding DNA from the internal segment of Tn6020. It is 
possible this region in TCDC-AB0715 has not been assembled correctly, but without the isolate this 
could not be investigated further. 
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5.6.5 ACICU 
In the genome of ACICU, the first GC2 sequenced, a single IS26 that is 3,009 bp away from the 
junction of AbGRI2-1 with the chromosome on the left has replaced a 38.2 kb segment in AB0057 
(Figure 5.21), corresponding to positions 1,263,138-1,301,378. There are no other fragments of 
AbGRI2 at this location, which suggests that the island may have been deleted and all that remains 
is a single copy of IS26. The junction with the chromosome on the right also differs, with a small 
2.1 kb fragment to the right of the AbGRI2-1 junction removed (Figure 5.21).  
 
 
Figure 5.21 Extent of the region removed in ACICU relative to AB0057. The portion of the chromosome replaced by 
IS26 in ACICU is shown by the lines in between the genomes of ACICU and AB0057, with the chromosomal positions 
of the deletion region indicated in AB0057. The extent of the deletion to the right of AB57_1209 is shown below the 
AB0057 line as well as the segment that is replaced by AbGRI2-1. 
 
5.6.6 TYTH-1 
TYTH-1 was isolated in Taiwan in 2008 (141) and contained a variant of AbGRI2 that shared the 
same junction to the left as AbGRI2-1, but there was a 3.2 kb deletion, corresponding to positions 
1,299,261 to 1,302,472 in AB0057, that altered the junction to the right and has truncated the IS26 
on this side (Figure 5.22). Furthermore, this IS26 is in the opposite orientation to the one that is 
adjacent to the chromosome to the right in AbGRI2-1. The island itself does not contain any 
resistance genes and only region B is present (Figure 5.22). 
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Figure 5.22 Structure of the AbGRI2 variant in TYTH-1. The central purple line represents the piece of the resistance 
island and the dotted blue lines indicate the chromosomal sequence flanking the island. Pink boxes represent IS26 and 
they contain an arrow indicating their orientation. Arrows below the central line show the position and orientation of 
genes. The origin of different DNA segments is shown above the line. 
 
5.6.7 BJAB0868 and BJAB07104 
Both BJAB0868 and BJAB07104 were isolated in China during 2008 (264). BJAB0868 contained a 
variant of AbGRI2 that shared the same junction to the chromosome on the left with AbGRI2-1. 
However, 13.7 kb of sequence to the right was missing and the IS26 at this location is in the 
opposite orientation to that in AbGRI2-1 (Figure 5.23a). This is the largest deletion on this side of 
an AbGRI2 that has been observed so far. The island itself contained the blaTEM gene in region A 
and a truncated piece of region B (Figure 5.23a). In contrast, BJAB07104 only had a single IS26 
that shared the same junction to the chromosome to the right with AbGRI2-1 (Figure 5.23b). The 
sequence to the left of this IS26 was found 13.6 kb from the junction to the chromosome on the left 
of AbGRI2-1. Like in the sequence of C1, this deletion extends into a region that is not present in 
AB0057 and corresponds to positions 2,676,386-2,689,960 in the genome of MDR-TJ. This 
indicates that there might have been a large deletion in this isolate that removed its variant of 
AbGRI2 along with the 13.6 kb of chromosomal DNA to the left. 
 
Figure 5.23 Structure of the AbGRI2 variant in (a) BJAB0868 and (b) the region in BJAB07104. Pink boxes represent 
IS26 and they contain an arrow indicating their orientation. The dotted blue lines represent the adjacent chromosomal 
sequence. Arrows below the central line show the position and orientation of genes. In (a), the central coloured lines 
represent the resistance island and the origin of different DNA segments is shown above the line. 
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5.7 Discussion 
The AbGRI2 islands identified here represent a new family of antibiotic resistance island so far 
found only within GC2 A. baumannii. AbGRI2 is also made up of pieces of other transposons that 
harbour resistance genes. The 9 kb region spanning the fragments A-B-C, which contain Tn1, 
Tn1000-like, Tn5393c and Tn6020 in AbGRI2 is identical in structure and sequence to the 
equivalent region in AbaR0, which interrupts comM in GC1. This suggests that this portion of 
AbGRI2 and AbaR0 may have originated from a common ancestor and then diverged separately 
within GC1 and GC2. 
 
Though AbGRI1 has the same structure in most members of the Australian GC2 collection, 
AbGRI2 has shown much more diversity with 7 different variants. Each of these variants can be 
formed from AbGRI2-1, which appears to be the ancestral structure of AbGRI2 in the collection of 
Australian GC2 isolates studied here. In the isolates that contained an integron, there were three 
variants, AbGRI2-1a, -7 and -8 (Figure 5.24b). The AbGRI2-1a and -7 variants had all the 
fragments of AbGRI2-1, but had gained additional sequence as well. For AbGRI2-1a, there was an 
additional copy of Tn6020. However, in AbGRI2-7 there was an additional IS26 inserted in the 
sequence of the chromosome to the right, which has likely caused an inversion (Figure 5.24a). The 
simplest explanation for this structure is that the sixth copy of IS26 is now next to region C in 
AbGRI2-7 while the copy of IS26 that would usually be part of Tn6020 (4 in Figure 5.24a) is now 
adjacent to the chromosome on the right. The only deletion variant for an isolate that contains an 
integron was AbGRI2-8, which was only in the isolate C1. In this case, it is probable that the first 
IS26 of Tn6020 (3 in Figure 5.24a) has deleted the 23.2 kb of sequence to the left, removing regions 
A and B along with 16.4 kb of chromosomal DNA to the left of the island. 
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Figure 5.24 Variants of ABGRI2-1 in isolates with an integron. In (a), coloured lines represent different segments 
separated by IS26, where IS26 is shown as a pink box that contains an arrow indicating its orientation. The defined 
regions, A-D, are shown above their respective segment and each copy of IS26 is numbered from left to right. Grey 
dashed lines represent the extent of deletions relative to AbGRI2-1, with the total size of the deletion indicated above 
and the missing amount of AbGRI2-1 in brackets. 
 
All of the variants in isolates that do not contain an integron, AbGRI2-9, -10 and -11, are deletion 
derivatives of AbGRI2-1 (Figure 5.25b) that have arisen via the deletion of DNA adjacent to IS26 
that has removed region D or the portion of region D that harbours the integron. The AbGRI2-9 
variant has the smallest deletion, removing region C and most of region D (Figure 5.25a). However, 
AbGRI2-9 has retained a 2,220 bp fragment of region D, which suggests that IS26 3 (as shown in 
Figure 5.25a) is responsible for removing the 8.8 kb of sequence to the right, and it would be 
interesting to sequence across this IS26 in AbGRI2-9 to see if it has the same 3 base changes that 
are in the third IS26 of AbGRI2-1. In AbGRI2-10, all of regions C and D have been deleted, with 
only a small fragment of IS26 3, adjacent to region B, retained. This would arise if IS26 5 is 
responsible for deleting the 11.8 kb to its left, including the majority of IS26 3 (Figure 5.25a). The 
largest deletion occurred in AbGRI2-11, which has lost all of regions B, C and D. Recombination 
between IS26 2 or 5 could be responsible for the deletion, precisely removing the 15.4 kb and one 
copy of the IS (Figure 5.25a). 
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Figure 5.25 Variants of ABGRI2-1 in isolates without an integron. In (a), coloured lines represent different segments 
separated by IS26, where IS26 is shown as a pink box that contains an arrow indicating its orientation. The defined 
regions, A-D, are shown above their respective segment and each copy of IS26 is numbered from left to right. Grey 
dashed lines represent the extent of deletions relative to AbGRI2-1, with the size of the deletion indicated above. 
 
The most widespread variant was AbGRI2-10, which was observed in all hospitals throughout 
2001-2010 (Table 5.10). AbGRI2-10 was seen in groups 1, 2 and 3, suggesting that the acquisition 
of aadB in pRAY, group 2, and TnaphA6 in group 3 (Chapter 3) occurred after the IS26 mediated 
deletion event that formed AbGRI2-10. AbGRI2-10 was seen in isolates as early as 2001, indicating 
it was likely an early event and subsequently spread to different hospitals. While the AbGRI2-7 
variant was also observed in 2001, it was only seen in two isolates from Brisbane, and it is possible 
that this variation occurred there. It would be interesting to study additional isolates from Brisbane 
to see if this variant was present in any other hospitals or if it has persisted in hospital F. Group 1 
can be subdivided based on the presence of AbGRI2-9, -10 and -11 (Table 5.10). Both AbGRI2-9 
and -11 corresponded with outbreaks in different hospitals. AbGRI2-11 was only observed in B1-
B8, which caused an outbreak in St George Hospital in 2007. These isolates also contained the only 
variant of AbGRI1-2, which had acquired an additional ISAba125 (Chapter 4). The isolate B10, 
observed 3 years later, was clearly not a descendant of this outbreak strain and was most likely 
acquired from another Sydney hospital as it contained AbGRI2-10 and had an unaltered AbGRI1-2.  
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Table 5.10 Variants of AbGRI2 identified in the Australian GC2 genomes. 
Group AgR genes Isolates Year City AbGRI2-X 
1 None A73 2001 Sydney 10 
  A111 2010 Sydney 10 
  B1-B8 2007 Sydney 11 
  B10 2010 Sydney 10 
  D1, D5 2006 Sydney 10 
  D24 2008 Sydney 9 
  D51, D52, D54, D56, D57 2010 Sydney 9 
  D58 2010 Sydney 10 
  D101, D112 2011 Sydney 10 
2 aadB A72 2001 Sydney 10 
  A87 2004 Sydney 10 
  C2-C5, C8 2007 Sydney 10 
  C15 2006 Sydney 10 
  C18 2002 Sydney 10 
  D8, D9 2006 Sydney 10 
  D12 2007 Sydney 10 
  D37 2008 Sydney 10 
  E1 2006 Canberra 10 
  E16 2009 Canberra 10 
  F1, F18, F45 2002 Brisbane 10 
  F38 2000 Brisbane 10 
3 aphA6 C13, C14 2006 Sydney 10 
4 aacC1, aphA1 F11, F36 2001 Brisbane 7 
  A74, A78, A81, A84 2002 Sydney 1 
  A75-A77, A79, A80, A82 2002 Sydney 1 
  A91, A93, A94, A96, A97 2005 Sydney 1 
  C1 2007 Sydney 8 
  MH50 NK Brisbane 1 
  WM99c 1999 Sydney 1 
5 aacC1 aphA1 aphA6 C20 2002 Sydney 1 
  D72 2010 Sydney 1a 
  D77, D79, D84, D85, D87 2010 Sydney 1a 
  D88 2011 Sydney 1a 
  D92, D93, D96-D98, D107, D114 2011 Sydney 1a 
The genomes of the isolates in grey were not sequenced and their AbGRI2 designation is a prediction based on PCR 
mapping. NK, not known. 
 
Generally, the AbGRI2 variants corresponded with the previously determined aminoglycoside 
subgroups (Table 5.10; Chapter 3). The removal of pieces of the island that contain aminoglycoside 
resistance genes appears to explain the susceptible group, which have variants that have lost regions 
C and D (Table 5.10). Furthermore, the members of groups 2 and 3 have regained resistance to 
select aminoglycosides through the acquisition of either aadB or aphA6. However, the isolate C20, 
which harbours AbGRI2-1, could be placed in group 4 based upon the structure of this island, but it 
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has been placed in group 5 because it also contains aphA6, which was not found in either AbGRI1 
or AbGRI2 and may be on a plasmid. 
 
Two variants of AbGRI2-1 were specific to hospital D and correspond to separate outbreaks. 
During 2010 there was an outbreak primarily in a severe burns ward (SBIU) and all the isolates in 
this outbreak harboured AbGRI2-9. A single isolate from 2008, D24, may be the progenitor of the 
2010 outbreak as it also harbours AbGRI2-9. However, using AbGRI2 as a marker it is clear that 
D58, also in group 1 and isolated in 2010 but from a different hospital (Section 3.2.2; Table 5.11), 
was not part of this outbreak as it harboured AbGRI2-10. The second outbreak occurred during 
2010-2011 and many of the isolates, particularly from 2011, were also from a single ward (7D; 
Table 5.11). All of these outbreak isolates contained AbGRI2-1a, which confirmed that the isolates 
not in 7D or RRC were also part of the outbreak. There were also a number of isolates that 
contained AbGRI2-10 that were sporadically present between 2006 and 2011, but they did not 
appear to correspond to a single outbreak or be specific to a ward (Table 5.11).  
Table 5.11 Variants of AbGRI2 in isolates from hospital D. 
Group Isolates Year Ward1 AbGRI2-X 
1 D24 2008 8B 9 
 D51 2010 6NI 9 
 D52, D54, D56, D57 2010 SBIU 9 
 D1, D5 2006 9B 10 
 D58 2010 MON 10 
 D101 2011 MON 10 
 D112 2011 RNSP 10 
2 D8 2006 7D 10 
 D9 2006 EA 10 
 D12 2007 7D 10 
 D37 2008 7C 10 
5 D72 2010 7D 1a 
 D77 2010 RRC 1a 
 D79 2010 EA 1a 
 D84, D87 2010 7D 1a 
 D85 2010 6NI 1a 
 D88 2011 7D 1a 
 D92, D93, D96-D98, D107 2011 7D 1a 
 D114 2011 6NI 1a 
1 MON (Mona Vale Hospital) and RNSP (Royal North Shore Private Hospital) are separate institutions, but samples 
isolated from them are screened at Royal North Shore Hospital (Hospital D). 
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The current iterations of AbGRI2 are in the same chromosomal location, thus it is possible that the 
acquisition of AbGRI2 occurred once early in the history of the clonal group and that all GC2 
isolates that contain it, or a variant, have descended from this single ancestor. Furthermore, the 
location of AbGRI2-1 cannot be the original insertion site, as there is no direct repeat at the site of 
insertion, suggesting a deletion event has altered one, or both, junction(s). None of the AbGRI2 
variants in the completed genomes harbour an island in the original location, with some sharing the 
same left and right junctions as AbGRI2-1 and other having additional deletions to the left or right 
(Table 5.12). 
 
Table 5.12 Extent of deletions on either side of the position of AbGRI2-1. 
Variant/isolate1 Country Chromosomal deletion (kb) Accession No. Left  Right  
AbGRI2-1 Australia 0 0 JX869489 
AbGRI2-7 Australia 0 0 - 
AbGRI2-8 Australia 16.42 0 - 
AbGRI2-9 Australia 0 0 - 
AbGRI2-10 Australia 0 0 - 
AbGRI2-11 Australia 0 0 - 
AbGRI2-2 China 0 0 CP003500 
AbGRI2-3 China 7.8 0 CP001937 
1656-2 South Korea 03 0 CP001921 
TCDC-AB0715 Taiwan 0 0 CP002522 
ACICU Italy -34 2.1 CP000863 
TYTH-1 Taiwan 0 3.2 CP003856 
BJAB0868 China 0 13.7 CP003849 
BJAB07104 China 13.62 0 CP003846 
1 References for the completed genomes are listed in Section 1.6. 
2 Homology to AB0057 ends after 12.9 kb of sequence to the left of the junction with AbGRI2-1. 
3 There was an inversion caused by IS26 in this isolate and the remainder of AbGRI2 is located elsewhere on the 
chromosome, with the left junction intact (Grace Blackwell, unpublished). 
4 ACICU contains a 3 kb portion of the region from AB0057 that is usually replaced by AbGRI2-1. 
 
The precise structure of AbGRI2 is a valuable epidemiological marker that could be used to track 
the spread of GC2 A. baumannii within or between hospitals. It has proven more effective at 
distinguishing outbreaks in the collection than the aminoglycoside resistance phenotypes alone, 
particularly among isolates that were aminoglycoside susceptible. 
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6.1 Introduction 
The AbGRI1 and AbGRI2 that were characterised in Chapters 4 and 5 contained almost all of the 
antibiotic resistance genes that were identified in the Australian GC2 isolates. However, the aadB 
and aphA6 aminoglycoside resistance genes were not found on either island. The aadB gene was 
located within a fragment of the small plasmid pRAY, but it was not determined whether the 
isolates that contained this gene harboured the entire plasmid (Chapter 3). A recent study has shown 
that there are two main variants of pRAY, pRAY* and pRAY*-v1. In pRAY*-v1 a segment of 
1,359 bp has been replaced by a segment that is 95% identical to pRAY*, with pRAY*-v1 found in 
C2 (92). The location of TnaphA6, be it in the chromosome or on a plasmid, was not determined. 
As described in Chapter 1, the aphA6 gene was first identified within a 66 kb conjugative plasmid 
(128), which suggests it could reside on a plasmid within the Australian isolates that contain 
TnaphA6.  
 
The aim of the work presented in this chapter was to use the whole genome data of the Australian 
GC2 isolates to examine what plasmids were present and to determine, in the case of the amikacin 
resistant isolates with TnaphA6, whether any of these plasmids harboured the TnaphA6 transposon. 
The plasmids present were initially identified using a heat map supplied by Kathryn Holt (April 
2012). This heat map was generated by BLAST searches against publicly available sequences of 
Acinetobacter plasmids that were included on the European Bioinformatics Institute plasmid list 
(http://www.ebi.ac.uk/genomes/plasmid.html).  
 
6.2 Cryptic plasmids 
The A320 reference strain did not include any sequences that matched any of the listed plasmids. 
Every Australian GC2 isolate had sequences that matched three related cryptic plasmids, pAB0057, 
p2ABAYE and pABVA01 (Table 6.1). However, of these three, pAB0057 shared the highest level 
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of coverage and sequence identity with the sequences in the Australian GC2 genomes. A total of 9 
GC2 isolates from hospital C and two from hospital E had a weaker match to these plasmids, which 
indicated that the plasmids found in these genomes were either more diverged or that there was less 
coverage of the query plasmid sequence.  
 
Table 6.1 Cryptic plasmids that matched sequences in the Australian GC2 genomes. 
Plasmid Strain Length (bp) Accession number 
pAB0057 AB0057 8,729 CP001183 
p2ABAYE AYE 9,661 CU459138 
pABVA01 VA-566/00 8,963 FM210331 
 
 
Plasmid pAB0057 was used as a query sequence in a BLAST search of a database comprised of the 
contigs assembled from the Australian GC2 genomes. 17 of them had a single 11 kb contig that 
shared 96.4% identity with pAB0057 (Table 6.2 and Figure 6.1), but there was 3.6 kb of sequence 
in the contigs that was not present in pAB0057 (red line in Figure 6.1). A total of 43 GC2 isolates 
had a 7.2 kb contig that shared 97.2% identity with pAB0057 and an additional 2.7 kb contig that 
only shared approximately 80% identity with a 336 bp portion of pAB0057 (Table 6.2 and Figure 
6.1). However, the combined sequence of the 7.2 and 2.7 kb contigs was identical to that in the 11 
kb contig. This suggested that there was a single plasmid in these GC2 isolates that was similar to 
pAB0057 and its relatives, but contained a unique region of DNA. This plasmid was named pA91.  
 
Figure 6.1 Linear representation of pA91. The black line represents the extent of the plasmid, while the thicker red 
portion shows the 3.6 kb segment not found in pAB0057. The extent of the different contigs is shown above the central 
line. Primers used to span the ISAba125 are shown below along with PCR amplicon size. 
 
The 7 isolates from hospital C (C2-C5, C8, C15 and C18) and the two isolates from hospital E (E1 
and E16) that had a weaker hit to pAB0057, p2ABAYE and pABVA01 in the plasmid heat map 
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also returned two contigs. However, the contigs were 4.3 and 2.7 kb (Figure 6.1 and Table 6.2). The 
2.7 kb contig was identical to the contig of the same size in pA91 and the sequence of the 4.3 kb 
contig was identical to a portion of the 11 and 7.2 kb contigs (Figure 6.1). This smaller plasmid was 
named pC2. 
 
Table 6.2 Contigs with sequence related to pAB0057. 
Group Isolates Isolation year 
Contigs (kb) 
11 7.2 4.3 2.7 
1 A73 2001 + - - - 
 A111 2010 - + - + 
 B1-B8 2007 - + - + 
 B10 2010 - + - + 
 D1, D5 2006 + - - - 
 D24  2008 - + - + 
 D51, D52, D54, D56-D58 2010 - + - + 
2 A72 2001 - + - + 
 A87 2004 - + - + 
 D8, D9  2006 - + - + 
 D12 2007 - + - + 
 D37 2008 - + - + 
 F1, F18, F45 2002 - + - + 
 F38 2000 - + - + 
3 C13, C14 2006 - + - + 
4 F11 2001 + - - - 
 F36 2001 - + - + 
 A74-A82, A84 2002 + - - - 
 A91, A93, A94, A96, A97 2005 - + - + 
 C1 2007 + - - - 
 MH50 NK + - - - 
 WM99c 1999 + - - - 
5 C20 2002 - + - + 
 D72, D77, D79, D84, D85, D87 2010 - + - + 
 D88 2011 - + - + 
2 C2-C5, C8 2007 - - + + 
 C15 2006 - - + + 
 C18 2002 - - + + 
 E1 2006 - - + + 
 E16 2009 - - + + 
NK, not known. 
6.2.1 pA91 
In the 17 isolates where the single 11 kb contig of pA91 was present, it had split approximately 270 
bp upstream from the start of the rep gene. This was caused by the presence of multiple copies of a 
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22 bp iteron (Figure 6.2a). A PCR using primers RH1349 and RH1350 on the ends of the contig 
produced an amplicon of approximately 475 bp (Figure 6.2b), indicating that the 11 kb contig could 
be circularised to form a plasmid. The 43 isolates with the 7.2 and 2.7 kb contigs had also split in 
the same location and also amplified a product of 475 bp using primers RH1349 and RH1350 
(Figure 6.2b). The 475 bp amplicon from A91 was then sequenced, which confirmed that the iteron 
region was comprised of 3 copies of a 22 bp iteron followed by a single copy that was only 21 bp 
(Figure 6.2a). This iteron region was located 56 bp upstream of the rep gene (Figure 6.2a).  
 
 
Figure 6.2 Sequence of the iteron region in pA91 (a) and the amplicons produced using RH1349 and RH1350 (b). In 
(a), the sequence of each repeated iteron sequence is shown in either green or blue with the extent of each repeat shown 
above the sequence. The rep gene is shown in orange and the arrow below the sequence shows its orientation. In (b), 
sizes of the molecular marker are shown to the left, in bp. Isolates are shown above their lanes. 
 
There was a single copy of ISAba125 in the 17 isolates that contained the plasmid in the 11 kb 
contig. In 16 of these 17 isolates the ISAba125 in this plasmid was the only copy in the entire 
genome. In F11, there was a second copy of ISAba125 within a 214 kb contig that contains a 
segment of chromosomal DNA. This suggests that there was exceptionally good coverage across 
both copies of ISAba125 in the sequence of this isolate. In the 43 GC2 isolates with pA91 in two 
contigs, one end of the 7.2 and 2.7 kb contigs contained a fragment of ISAba125, which suggested 
that there were multiple copies of ISAba125 in the genome of these isolates and that this had caused 
the second split in the contigs. Searching the Australian GC2 genomes with the sequence of 
ISAba125 confirmed that there were multiple copies of this IS in these isolates, but the exact 
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number in each isolate was not determined. Primers RH1348 and RH1322, on either side of 
ISAba125 in pA91, produced an amplicon of 1.2 kb in the 60 GC2 isolates with 11 and 7.2 kb 
contigs listed in Table 6.2 (Figure 6.1). The size of this amplicon suggested that there was only a 
single ISAba125 at this location in the plasmid (Figure 6.1). This was confirmed by sequencing the 
amplicon of a representative isolate, A91. This PCR result indicated that all GC2 isolates with the 
11 kb or 7.2 and 2.7 kb contigs had an identical plasmid, pA91, regardless of whether it was split 
into two contigs or not. The assembly of the sequences of the PCR products with the genome data 
revealed that pA91 was 10,967 bp in length (Figure 6.3). 
 
 
Figure 6.3 Circular representation of pA91. The repAci2 gene is represented with an orange arrow while the mob genes 
are shown as purple arrows. The green box preceding repAci2 represents the iteron region. Grey arrows show open 
reading frames that encode hypothetical proteins and the red arrow shows an orf that encodes an outer membrane 
protein (OMP). ISAba125 is shown as a blue box with its orientation shown within. The numbers on the outside of the 
circle represent the length in kb at those points in the plasmid. 
 
The closest match to the rep gene in pA91 was found in pABVA01 and shared 99.26% (944/951 
bp) nucleotide identity (Figure 6.4). The rep of pABVA01 has been used as a reference type in an 
A. baumannii replicon-typing scheme, where it was named repAci2 (16). Thus, the replicase of 
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pA91 was classified as belonging to this rep group and was annotated as repAci2 (Figure 6.4). A 
second gene that has been annotated in other related A. baumannii plasmids as being involved in 
DNA replication was also identified, but it is unclear whether this gene actually plays a role in the 
replication of pA91 and was annotated as rep2 here (Figure 6.3). While the replicase gene in 
pAB0057 only shared approximately 80% identity with repAci2 in pA91, the remainder of the 
pAB0057 backbone shared 99.9% identity with that of pA91 (Figure 6.4). A large 2,412 bp gene in 
the backbone of pA91 corresponded to one that had been annotated in pAB0057 as a gene that 
encodes an 804 aa TonB-dependant receptor protein or outer membrane protein (OMP) (Figure 
6.3). This OMP gene is well conserved in the plasmids related to pAB0057 and the OMP gene in 
pA91 is identical to that in pAB0057. 
 
 
Figure 6.4 Comparison of pA91 with pAB0057 and pABVA01. Plasmids have been linearised and opened at the same 
location. Arrows beneath the lines show the extent and orientation of selected genes.  The green portions of pAB0057 
and pABVA01, and the red portion of pA91 represent regions unique to each plasmid and the orange box preceding rep 
represents the iterons. The ISAba125 in pA91 is shown as a blue box that contains an arrow showing its orientation. 
The highlighted areas between pA91, pAB0057 and pABVA01 show the extent of nucleotide identity between the 
plasmids.  
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conserved domain database (CDD) revealed that it contained a MobA/MobL domain (pfam03389). 
Comparison with the 709 aa MobA of RSF1010 (210), which is a defining member of the MOBQ 
family (64, 70), revealed that it shared approximately 32% amino acid identity with the first 226 
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residues in the 478 aa protein. There was no significant match to the remaining 252 residues outside 
of sequences that originated from draft genomes of Acinetobacters. Hence, the gene that encodes 
this protein was annotated as mobA (Figure 6.3 and Figure 6.4). There was only a single DNA 
match to the mobA gene within the non-redundant database in the genome of a Dendroctonus 
ponderosae isolate and it had 84% sequence coverage of mobA with approximately 88% identity, 
but there was no annotation. There were no conserved domains identified in the CDD for the 101 aa 
protein. However, there were a number of near identical matches to proteins annotated as MobS-
like or mobilisation proteins that were translated from Acinetobacter draft genome sequences, but 
the basis of these annotations was unknown. Furthermore, the only match to the gene that encodes 
this protein was from the genome of the same D. ponderosae and it had 97% coverage and shared 
approximately 93% identity, but it also lacked annotation. Thus, the gene that encodes the 101 aa 
protein in pA91 was tentatively annotated as orf until stronger evidence for its role in mobilisation 
can be found. The presence of mobA in pA91 suggests that it is mobilisable while pAB0057, 
p2ABAYE and pABVA01, which do not contain these genes, are not. 
 
6.2.2 pC2, a variant of pA91 
As described in Section 6.2, 7 isolates from hospital C and the two from hospital E had a smaller 
cryptic plasmid, pC2, which contained two contigs that matched with the sequence of pAB0057 and 
pA91 (Table 6.2). The 2.7 kb contig was identical to the contig of the same size described above 
and the majority of the sequence in the 4.3 kb contig was identical to the corresponding region in 
pA91, but there was a 60-63 bp fragment on one end that matched one end of ISAba1 (Figure 6.5). 
The presence of these contigs suggested that these 9 isolates contained a deletion derivative of 
pA91. This smaller variant was named pC2. 
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Figure 6.5 Linear comparison of pC2 and pA91. Arrows beneath the lines show the extent and orientation of important 
genes. ISAba125 is represented by a blue box, while ISAba1 is shown as a purple box, each containing an arrow 
indicating orientation. The thick vertical line on the left side of ISAba1∆ represents the position of the remaining 
terminal IR. The extent of the contigs that comprised pC2 are shown above it in green and purple. The extent of primers 
RH1312 and RH1322 is shown above the contigs along with the PCR amplicon size. The lines joining the two plasmids 
show the region replaced by the ISAba1 fragment in pC2.  
 
A PCR using the primers RH1322, adjacent to ISAba125 in the 2.7 kb contig, and RH1321, near the 
ISAba1 end of the 4.3 kb contig, was used to join the two contigs (Figure 6.5). This produced an 
amplicon of 1.7 kb. Analysis of the sequence of this PCR product revealed a 447 bp fragment of the 
right end of ISAba1, containing one of the terminal IRs, next to a complete copy of ISAba125. 
Hence, a 2.9 kb portion of the backbone of pA91 has been replaced by the 477 bp ISAba1 fragment 
in pC2 (Figure 6.5). This deletion removed the majority of the OMP gene. However pC2 retained 
the mobA/mobL and mobS genes. The split at the other end of the contigs occurred at approximately 
the same position observed for pA91, at the iteron region preceding the repAci2 gene. Primers 
RH1349 and RH1350, which flank the iteron region, also produced an amplicon of 475 bp in each 
isolate with pC2, closing the plasmid. The sequence of this amplicon was identical to pA91 
indicating pC2 also contained three copies of the 22 bp iteron followed by the single 21 bp copy. 
The length of pC2 was 8,511 bp (Figure 6.6). 
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Figure 6.6 Circular representation of pC2. The repAci2 gene is represented with an orange arrow while the mob gene is 
shown as a purple arrow. The truncated outer membrane protein gene (∆OMP) and second rep gene are represented 
with grey arrows. ISAba125 and ISAba1 are represented with a blue and green arrow, respectively, indicating their 
orientation. The numbers on the inside of the circle represent the length in bp at those points in the plasmid. 
 
6.3 A variant of the aadB containing plasmid pRAY 
The 19 isolates in aminoglycoside group 2, which were resistant to kanamycin, gentamicin and 
tobramycin (Table 3.9), including the 9 isolates that contain pC2, had sequence that matched 
pRAY. As described in Chapter 3, a PCR that amplified a 1 kb segment of pRAY that included 
aadB indicated that all members of this group contained the aadB gene cassette in a secondary site 
in pRAY. These 19 isolates each had a single contig of 6,140 bp that spanned the entire plasmid. In 
all 19 genomes, this contig had an overlap of approximately 60 bp on each end that allowed it to be 
circularised, closing the plasmid. The length of pRAY in each GC2 isolate was 6,078 bp and there 
was no sequence variation among the group. The sequence of pRAY*-v1 in the isolate C2 had 
previously been determined (92) and the plasmids identified here from the genome data were 
pC2
8,511 bp
repAci2
repmobA/mobL
ISAba125
ISAba1∆
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identical. The pRAY*-v1 variant differs from pRAY*, which was found in an Australian GC1 
isolate, by 66 single-base changes (92). Thus, the GC2 isolates all had the pRAY*-v1 variant of 
pRAY. 
 
6.4 Amikacin resistance plasmids 
A total of 10 amikacin resistant isolates, all from aminoglycoside resistance groups 3 (C13 and 
C14) and 5 (C20, D72, D77, D79, D84, D85, D87 and D88) had sequences that matched the cryptic 
plasmid pACICU2 (CP000865). These isolates all contained TnaphA6. 
 
The contigs that matched the pACICU2-like plasmid in these isolates were retrieved using the 
backbone sequence of pA85, which was found in an Australian GC1 isolate and is also related to 
pACICU2 (Mohammad Hamidian, personal communication). For the 7 hospital D isolates, a total 
of 6 contigs from D72 and 4 contigs from D77, D79, D84, D85, D87 and D88 matched pA85. The 
isolates from hospital D were part of an outbreak centred in a single ward and had the unique 
AbGRI2-1a island (Chapter 6). There were 8 contigs from C13, 5 from C14 and a single 68 kb 
contig from C20 that matched the backbone of pA85.  
 
6.4.1 pD72 
In D72, the contigs ranged in size from 50.5 kb to 172 bp (Table 6.3) and contigs 4 and 224 had 
fragments of ISAba125 on one end. The IS were in the same orientation relative to one another, 
suggesting that either a single ISAba125 (1,087 bp) or TnaphA6 (3,072 bp), which is bounded by 
two directly oriented copies of ISAba125, was inserted at this position in the plasmid. Primers 
RH1320 and RH1319 located near the ISAba125 fragments on contigs 4 and 224, respectively, 
produced an amplicon of 3.2 kb, joining these two contigs (Figure 6.7). This size was consistent 
with the presence of TnaphA6 rather than a single ISAba125. PCRs joining RH1320 and RH1319 to 
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primers in aphA6 produced products of 1.8 and 1.6 kb, respectively (Figure 6.7), indicating that 
TnaphA6 was indeed present at this location in D72.  
 
Table 6.3 Contigs identified for D72 using pA85 as the query sequence. 
Contig No. Size (bp) Description 
2 50,520 Backbone 
4 11,069 Flanks TnaphA6 
48 4,440 Backbone  
224 473 Flanks TnaphA6 
230 283 Repeat region 
61 172 Repeat region 
 
 
Figure 6.7 Assembly of TnaphA6 and the first 424 bp repeat region into the plasmid backbone. The contigs that flank 
TnaphA6 (4 and 224) are shown above the central line, with a blue box on one end representing the fragment of 
ISAba125, along with the internal TnaphA6 contig (97). The blue boxes represent ISAba125 and contain arrows 
indicating their orientation and the red box shows the repeat region. The aphA6 gene is shown below the central line 
with an arrow indicating its orientation. The primer pairs used to assemble the region are shown below at their 
respective locations and amplicon sizes in bp. 
 
The remaining contigs that comprised this plasmid in D72 were broken apart due to the presence of 
three separate repeat regions in the backbone (Red boxes in Figure 6.8). Two of these regions were 
424 bp, while the third is 225 bp. The sequences of the 424 bp regions are identical to one another, 
with the 225 bp region being a truncated version. These repeat regions were also present in the 
backbone of pA85 and primer pairs on either side of each repeat sequence had been designed 
previously (Mohammad Hamidian, personal communication). A PCR spanning the first 424 bp 
repeat region, which was 352 bp away from TnaphA6, and amplified a product of 1.4 kb, joining 
contigs 224 and 48 (Figure 6.7 and 2 in Figure 6.8). Contigs 48 and 2 that were separated by the 
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second 424 bp repeat region were joined with the primers RH1503 and RH1397, that produced a 
PCR amplicon of 1.6 kb (3 in Figure 6.8). Primers RH1398, on contig 2, and RH1399, on contig 4, 
amplified a PCR product of 1 kb, joining these contigs and crossing the 225 bp repeat region (1 in 
Figure 6.8). Each of these amplicons was sequenced, closing the plasmid. The 70,102 bp plasmid 
was named pD72 (Figure 6.8). 
 
 
Figure 6.8 Circular representation of pD72. The repAci6 gene is shown as an orange arrow, while the res is represented 
with a grey arrow. Transfer genes are represented with light blue arrows. The position of TnaphA6 is shown, with the 
aphA6 represented by a white arrow and ISAba125 by blue arrows. The position of the repeat regions are shown as red 
boxes. The segments amplified using PCR crossing these repeats are indicated outside the circle, with 1 crossing the 
225 bp repeat, while 2 and 3 cross the 424 bp repeats. Primers RH1398 and RH1399 were used for 1, RH1395 and 
RH1394 for 2 and RH1503 and RH1397 for 3. 
 
The plasmid pA85 is a closer relative to pD72 than the other pACICU2-like plasmids that are in 
GenBank, and its backbone shares approximately 98% sequence identity with that of pD72. There 
are also several deletions in the backbone of pD72 relative to pA85 along with areas of poor 
sequence identity (Figure 6.9). However, comparison with the backbone of the recently released 
plasmid pAb-G7-2 (GenBank Accession No. KF669606) (91), which also harbours TnaphA6 
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though it is in a different location, revealed that the backbones of pD72 and pAb-G7-2 shared 
99.9% identity (Figure 6.9). The rep of pD72 shares 99.75% identity with that of pACICU2 
(1,175/1,178 bp) though there were two single nucleotide gaps, which corresponded to two 
additional bases in the sequence of pACICU2. These two extra bases in pACICU2 would cause a 
frameshift, as its annotated rep is only 1,112 bp, compared to the 1,176 bp rep of pD72 and may be 
an error in the sequence of pACICU2. Two additional pACICU2-like plasmids, p2ABTCDC0715 
and ABKp1, each contained a rep that did not contain the frameshift and shared 99.4% (1,169/1,176 
bp) identity with that in pD72. The rep of pACICU2 was used as the representative of repAci6 in an 
A. baumannii replicon typing scheme (16), which indicated that pD72 also has a rep of this type. In 
addition, 15 genes involved in plasmid transfer were identified, suggesting that pD72 should be 
conjugative (light blue arrows in Figure 6.8) and the successful transfer of pAb-G7-2 has been 
demonstrated (91), which provides further evidence that pD72 should also be transferable. 
 
 
Figure 6.9 Comparison of the backbone sequences of pA85, pD72 and pAb-G7-2. The resistance transposons have 
been removed. Shared regions in blue represent identical, or almost identical, sequence in both plasmid backbones. 
Areas in white that are shared between both plasmids are regions of low or no sequence identity. 
 
Though the remaining 6 aphA6 containing isolates from hospital D only had four contigs that made 
up the plasmid backbone (Table 6.4), each of them was identical to a portion of pD72. The four 
contigs, ranging in size from 61.6 kb to 424 bp, were identical in length in each of the 6 isolates and 
were named A-D (Table 6.4). Contig A contains the 225 bp repeat region that, unlike in D72, did 
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not split these contigs. Hence contig A corresponds to contigs 2 and 4 in D72. Primers RH1320 and 
RH1319, spanning TnaphA6, produced an amplicon of 3.4 kb and joined contigs A and C, 
indicating that these 6 other isolates from hospital D harboured TnaphA6 in the same position 
observed in pD72. The primer pairs spanning the two 424 bp repeat regions also produced 
amplicons of 1.4 and 1.6 kb, respectively, joining contigs B to C and C to A. These amplicons 
indicated that each of the other 6 aphA6 containing isolates from hospital D, which were part of the 
same outbreak as D72, harboured a plasmid identical to pD72. 
 
Table 6.4 Contigs identified for D77, D79, D84, D85, D87 and D88 using pD72. 
Contig Size (bp) Description 
A 61,637 Flanks TnaphA6 
B 4,440 Backbone 
C 473 Flanks TnaphA6 
D 424 Repeat region 
E 1,018 Internal TnaphA6 
 
6.4.1.1 Additional isolates from hospital D 
As described in Chapters 5 and 6, there were 7 additional isolates from hospital D that were 
acquired later in the project and did not have whole genome data available. These isolates were 
otherwise identical to D72, D77, D79, D84, D85, D87 and D88, indicating that they were part of the 
same outbreak. Thus, it was predicted that they also contained a plasmid identical, or almost 
identical, to pD72. To determine if this was the case, the PCRs spanning the three repeat regions 
and the TnaphA6 were also performed on these 7 isolates. In each case, these isolates produced 
PCR amplicons identical in size to D72, suggesting that they harboured a plasmid identical to pD72 
with TnaphA6 in the same position. 
 
6.4.2 pC20 
The single contig, contig 41, in C20 that matched pA85 was 68,177 bp in length and contained a 
single complete copy of ISAba125 within the contig. This indicated that C20 also contained a 
 CHAPTER 6 
 
169 
plasmid similar to pACICU2, pA85 and pD72, which was named pC20. Analysis of the sequence of 
contig 41 revealed that it contained the 225 bp and one of the 424 bp repeat regions that had 
separated the contigs of pD72. However these two regions did not cause a split in pC20. The ends 
of contig 41 corresponded to the position of the second 424 bp repeat in pD72 (3 in Figure 6.8). 
Primers RH1397 and RH1503, which flank this repeat region, produced a product of 1.5 kb, which 
was identical to the size observed in pD72. However, the sequence of this amplicon revealed that in 
pC20 this repeat region was only 423 bp. In light of this difference, the sequence of the other two 
repeat regions was rechecked. Both sets of primers bordering each repeat produced an amplicon 
identical in size to pD72 and the sequence of each product was identical to that in contig 41.  
 
To determine if there was only a single ISAba125 in pC20 primers RH1501 and RH1502, flanking 
the ISAba125 in contig 41, were used. The amplicon was 4.2 kb, much larger than the 2.2 kb 
predicted using the sequence of contig 41, which only had a single ISAba125 at this position. This 
size corresponds with that of TnaphA6, which is flanked by two directly oriented copies of 
ISAba125, indicating that the placement of a single ISAba125 into contig 41 was a misassembly. 
RH1501 and RH1502 were paired with primers in aphA6 and produced PCR amplicons of 1.9 and 
2.5 kb, respectively, indicating that TnaphA6 was present in pC20. Each of these amplicons was 
then sequenced and a contig harbouring the internal fragment of aphA6 was assembled with pC20. 
The location of TnaphA6 in pC20 is different from that in pD72, indicating that each plasmid 
acquired TnaphA6 separately (Figure 6.10). 
 
 
Figure 6.10 Linear comparison of pD72 and pC20. The central line represents the plasmid backbone with the red boxes 
showing the positions of the three repeat regions. The location and orientation of important genes is shown below the 
lines along with the transfer region. The blue arrows above the lines indicate the positions of TnaphA6 in each plasmid. 
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 Interestingly, there is a single nucleotide change in the sequence of aphA6 in pC20 relative to 
pD72. This corresponds to a single amino acid change at position 154 in AphA6, where C20 has 
leucine while the isolates with pD72 have phenylalanine. With the inclusion of TnaphA6, pC20 was 
70,100 bp in length (Figure 6.11). 
 
 
Figure 6.11 Circular representation of pC20. The repAci6 gene is shown as an orange arrow, while the res is 
represented with a grey arrow. Transfer genes are represented with light blue arrows. The position of TnaphA6 is 
shown, with the aphA6 represented by a white arrow and ISAba125 by blue arrows. The position of the repeat regions 
are shown as red boxes. 
 
Comparison of the backbone of pC20 with that of pD72 revealed that they shared 99.91% 
(66,698/67,029 bp, with 6 gaps) identity. There were several SNPs in 6 of the transfer genes, 
relative to pD72, and there is a single base change in the rep (Table 6.5). However, it was recently 
shown that a GC1 isolate from a Melbourne hospital harboured a conjugative plasmid that also 
contained TnaphA6, named pAb-G7-2 (91). Comparison of the sequence of pC20 with pAb-G7-2 
revealed that these plasmids were identical and contained TnaphA6 in the same position. 
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Table 6.5 Location of single nucleotide changes in pC20 relative to pD72. 
Gene Function No. of SNPs 
rep Replication 1 
trwC Transfer 1 
traB Transfer 5 
traV Transfer 1 
traC Transfer 6 
traU Transfer 4 
traH Transfer 1 
 
6.4.3 pC13 
The remaining two isolates, collected from hospital C in 2006, C13 and C14, had 8 and 5 contigs, 
respectively, which matched with the sequence of pA85. Assembly of these contigs using pC20 as a 
scaffold revealed that both C13 and C14 harboured plasmids that were almost identical. In C13, the 
contigs were split near the positions of the 3 repeat regions observed in pC20, while the contigs in 
C14 had only split across the 424 and 423 bp repeats. Furthermore, both isolates contained two 
contigs with fragments of ISAba125 on one end that had split at the exact position where TnaphA6 
was located in pC20. The primer pairs described above were used to close these gaps in C13 and 
C14. In each case, the size of the PCR amplicon was identical to that from pC20. The sequence of 
each amplicon that crossed one of the repeat regions was also identical to the sequence of pC20. 
However, there was a single base change in the sequence of aphA6 relative to both pC20 and pD72 
(Figure 6.12a). This base difference occurs at the same position as the difference between pC20 and 
pD72, but C13 and C14 have a G at this position while there is an A in pC20 and a T in pD72. 
However, the base difference in C13 and C14 did not result in an amino acid change relative to 
pC20, as they have a leucine residue at position 154 in AphA6 (Figure 6.12b). 
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Figure 6.12 Comparison of the DNA (a) and amino acid (b) sequences of aphA6 in pC20, pC13 and pD72. The 
sequence of pC20 is shown as the top line in both (a) and (b) with dots below representing matching bases and amino 
acid residues. Where the base or amino acid differs, the alternate is shown. The bases highlighted in yellow in (a) 
correspond to the presence of leucine at position 154 in (b). 
 
However, there was another break in the contigs of both C13 and C14 that was not present in the 
contigs that comprised pC20 or pD72.  When compared with the sequence of pC20, there was 62 bp 
on the end of two contigs in both C13 and C14 that did not match any region in pC20 or pD72. 
Examination of these 62 bp fragments revealed that the first 26 bp on each contig corresponded to 
an imperfect IR (24/26 bp) and that there was a 5 bp DR adjacent to each IR. This suggested that 
there was either an IS or transposon inserted at this location. When the 62 bp segment at the end of 
each contig was compared with the ISFinder database, there were no significant matches, indicating 
the insertion was probably not an IS or a composite transposon, which would be flanked by two IS. 
 
The 62 bp fragments were then used as query sequences against the draft genomes of C13 and C14 
to determine if there were any other contigs that contained overlapping sequence, which could 
indicate that they were part of the plasmids in C13 and C14. This search identified an additional 
14,192 bp contig that had the left IR on one end and a second 19,387 bp contig that had the right 
hand IR on one end, in both C13 and C14 (Figure 6.13). Primers RH1552, near the left IR, and 
RH1554, in the 14,192 bp contig produced an amplicon of 360 bp while RH1553, next to the right 
hand IR, and RH1555, on the 19,387 bp contig, produced an amplicon of 340 bp in both C13 and 
C14. These products indicated that these contigs made up the transposon inserted into the plasmids 
(a) !
pC20     ATTGATAACCAACTCCTTGACGATATAGATCAAGATGATTTAGACACTGAATTATGGGGA 480 
pC13     .........................................G.................. 480 
pD72     .........................................T.................. 480          
 
 
(b) 
 
pC20     IIDCPFISNIDHRLKESKFFIDNQLLDDIDQDDLDTELWGDHKTYLSLWNELTETRVEER 180 
pC13     ............................................................ 180 
pD72     .................................F.......................... 180 
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in C13 and C14. Primers RH1556 and RH1557, on the other end of the 14,192 and 19,387 bp 
contigs, respectively, amplified a 600 bp product, joining the two additional contigs (Figure 6.13). 
The sequence of this amplicon revealed that there was an additional 227 bp between the 14,192 and 
19,387 bp contigs. The two contigs had been split due to the presence of a repeat region made up 4 
directly oriented copies of the same 87 bp sequence. 
 
 
Figure 6.13 Assembly of the 33 kb transposon in pC13. The central black line represents the plasmid backbone while 
the thick green line shows the transposon. Red vertical lines represent the IR on each end of the transposon. The extent 
of different contigs is shown above the line. The extent of PCR products that cover the splits between contigs are shown 
below the central line along with their primers. The amplicon size of RH1552-RH1554 is 362 bp, RH1556-RH1557 is 
602 bp and RH1555-RH1553 is 344 bp. 
 
The sequence of the closed plasmids in C13 and C14 were identical to one another, and the plasmid 
was named pC13. The final length of pC13 was 103,871 bp and it contained TnaphA6, in the same 
position observed in pC20, along with a 33,766 bp transposon (Figure 6.14a). Compared with the 
backbone of pC20, there was only a single base difference that occurred in the traL gene in pC13. 
However this SNP did not result in an amino acid change. The close relationship between the 
backbones of pC20 and pC13 indicates that pC13 was most likely derived from pC20, or a plasmid 
almost identical to it, and diverged upon the acquisition of the transposon (Figure 6.14b). 
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Figure 6.14 Circular representation of pC13 (a) and linear comparison of pD72, pC20 and pC13 (b). In (a), the repAci6 
gene is shown as an orange arrow, while the res is represented with a grey arrow. Transfer genes are represented with 
light blue arrows. The position of TnaphA6 is shown, with the aphA6 represented by a white arrow and ISAba125 by 
blue arrows. The positions of the repeat regions are shown as red boxes. The location of the 33 kb transposon is shown 
in green, with red bars on either side indicating the imperfect IRs. The approximate positions of the tni genes and 
copper resistance genes in the transposon are indicated within the circle. In (b), the central lines represent the plasmid 
backbone with the red boxes showing the positions of the three repeat regions. The location and orientation of important 
genes is shown below the lines along with the transfer region. The blue arrows above the lines indicate the positions of 
TnaphA6 in each plasmid, while the green arrow below pC13 shows the location of the 33kb transposon. 
 
The 33 kb transposon contains 5 tni genes adjacent to the IRl (Figure 6.14a). The protein sequences 
predicted from 5 orfs at one end of the transposon share approximately 40% amino acid identity 
with the Tni proteins encoded by the 5 tni genes in Tn6022 (tniC, tniA, tniB, tniD and tniE). 
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Furthermore, the tni genes are in the same order observed in Tn6022 and AbaR-type islands, which 
suggests that the transposon present in pC13 is a member of the same group. Transposons in this 
group generally have imperfect IRs of 26 bp and generate a 5 bp duplication at the point of insertion 
(87, 197). The transposon in pC13 has imperfect 26 bp IR and also generated a 5 bp DR, which is 
further evidence that it is also a member of this family of transposons. However, the IR in the 33kb 
transposon only shared 15/26 bp and 14/26 bp with the IRl and IRr of Tn6022 (Figure 6.15). A 
preliminary BLAST search using the sequence of the transposon revealed that it contained genes 
that confer resistance to copper, but this analysis was not taken any further. 
 
 
Figure 6.15 Comparison of the IRl (a) and IRr (b) of the 33 kb transposon and Tn6022/AbaR-type islands.  
 
6.5 Discussion 
In Chapter 5, several groups based on the variations in AbGRI2 were found in the otherwise closely 
related collection of Australian GC2 isolates. The AbGRI2 variations were caused by IS26 
mediated deletions of the likely ancestor, AbGRI2-1. Here it was shown that all of the Australian 
GC2 isolates harbour a cryptic plasmid, while subsets have acquired additional plasmids, either 
pRAY*-v1, pD72, pC20 or pC13, that have provided additional aminoglycoside resistance genes. 
In combination, these two data sets have revealed additional subdivisions within the collection 
(Table 6.6). 
 
(a)
IRl – Tn6022/AbaR3-type
TGTCATTTACAGCAATAGAATAGAGT
||||||||||| | | ||
TGTCATTTACAAAGAACTATGCGACA
IRl – 33 kb transposon
(b)
IRr – Tn6022/AbaR3-type
ACTCTGATTTATTTGTGGAACTGACA
|| || | | || || | |||
TGTCGCATAGTTGTTTGTAAATCACA
IRr – 33 kb transposon
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Table 6.6 AbGRI2 variant and plasmid content of the Australian GC2 isolates. 
Group Isolates Year AbGRI2-X Cryptic 
plasmid 
AkR 
plasmid 
pRAY*-v1 
1 D24 2008 9 pA91 - - 
 D51, D52, D54, D56, D57 2010 9 pA91 - - 
 A73 2001 10 pA91 - - 
 A111 2010 10 pA91 - - 
 B10 2010 10 pA91 - - 
 D1, D5 2006 10 pA91 - - 
 D58 2010 10 pA91 - - 
 D101, D112 2011 10 pA91 - - 
 B1-B8 2007 11 pA91 - - 
2 A72 2001 10 pA91 - + 
 A87 2004 10 pA91 - + 
 D8, D9 2006 10 pA91 - + 
 D12 2007 10 pA91 - + 
 D37 2008 10 pA91 - + 
 F1, F18, F45 2002 10 pA91 - + 
 F38 2000 10 pA91 - + 
 C2-C5, C8 2007 10 pC2 - + 
 C15 2006 10 pC2 - + 
 C18 2002 10 pC2 - + 
 E1 2006 10 pC2 - + 
 E16 2009 10 pC2 - + 
3 C13, C14 2006 10 pA91 pC13 - 
4 F11, F36 2001 7 pA91 - - 
 A74-A82, A84 2002 1 pA91 - - 
 A91, A93, A94, A96, A97 2005 1 pA91 - - 
 C1 2007 8 pA91 - - 
 MH50 NK 1 pA91 - - 
 WM99c 1999 1 pA91 - - 
5a C20 2002 1 pA91 pC20 - 
5b D72, D77, D79, D84, D85, D87 2010 1a pA91 pD72 - 
 D88 2011 1a pA91 pD72 - 
 D92, D93, D96-D98, D107, D114 2011 1a pA91 pD72 - 
NK, Not known. Isolates in grey did not have genome data available. 
 
In particular, the difference between pD72 and pC20 has highlighted the differences in the isolates 
that were initially grouped together based on their aminoglycoside resistance phenotype. The 
isolates from hospital D that harbour pD72 were part of an outbreak centred around a specific ward 
in that hospital and also had the unique AbGRI2-1a variant. However, C20 can now be clearly 
separated from the AbGRI2-1a containing isolates from hospital D as it has acquired its amikacin 
resistance in a separate event via a related, yet different plasmid, pC20 (Table 6.6). Furthermore, the 
plasmid pD72 appears to be confined to a recent outbreak at Royal North Shore Hospital, and this is 
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supported by the presence of a unique AbGRI2, namely the AbGRI2-1a variant that has only been 
observed in the isolates that carry pD72 (Table 6.6). So far, pD72 appears not to have spread to 
other hospitals or strains. There is currently no comparable information on plasmids that contain 
TnaphA6 from other countries; hence it is not yet possible to speculate on the origin of these 
plasmids. 
 
It is now possible to propose a potential evolutionary path for the Australian GC2 isolates that 
stems from a common ancestor, though the pathway presented here is merely the simplest of many 
possible alternatives. Through either deletion within AbGRI2 and/or the acquisition of different 
plasmids, and aminoglycoside resistance genes, every isolate in the Australian GC2 collection can 
be derived from an ancestor containing AbGRI2-1 and pA91 (Figure 6.16).  
 
Figure 6.16 Proposed evolutionary pathway of the Australian GC2 isolates. The aminoglycoside resistance phenotypes 
and gene content are shown at the same level as the groups that contain them. 
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WM99c is the oldest isolate in the Australian collection studied here and could potentially represent 
the ancestor of the other Australian GC2s that have spread to other hospitals and cities. A possible 
evolutionary pathway stemming from WM99c is summarised in Figure 6.16. The ubiquity of 
cryptic plasmids within the Australian GC2 collection suggests that the acquisition of these 
plasmids predates the variation of AbGRI2. Furthermore, the deletion event that resulted in pC2 has 
only been observed in isolates from hospital C and E, suggesting that the deletion event occurred in 
one of these hospitals and has likely spread to the other via patient transfer. 
 
The pRAY variant, pRAY*-v1, that was present in the 19 aadB containing Australian GC2 isolates 
was not found in any other isolates that were present in either the nucleotide or wgs databases. The 
pRAY*-v1 variant was identical in all isolates that contained it, and it was probably acquired by a 
single isolate that was then able to spread to other hospitals and cities rather than being acquired in 
separate events. Two members of GC1 had been previously shown to contain pRAY*, one of these 
was the GC1 reference strain, RUH875, which was isolated in Europe in 1982 (92). Furthermore, 
there were only 3 draft genomes in the wgs database that contained a contig matching the pRAY* 
variant. This suggests that pRAY*-v1 may be specific to Australia, but analysis of additional 
isolates from other countries is needed to confirm this.  
 
The aphA6 containing transposon TnaphA6 was found in three different plasmids, pD72, pC20 and 
pC13. While the backbones of these three plasmids are almost identical, the insertion point of 
TnaphA6 differs between pD72 and pC20/pC13. This suggests that pD72 and pC20/pC13 have 
diverged from a common ancestor and that TnaphA6 has been acquired on separate occasions 
(Figure 6.17).  
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Figure 6.17 Evolution of the amikacin resistance plasmids. The arrows separating each plasmid represent the addition 
of a transposon. The blue boxes represent TnaphA6 and the green portion of pC13 indicates the position of the copper 
resistance transposon. 
 
It has recently been reported that a plasmid identical to pC20, named pAb-G7-2, was in a MAR 
GC1 isolate collected from Alfred Hospital in Melbourne during 2002 (91). This indicates that 
either pC20/pAb-G7-2 may have been imported prior to 2002 and had spread into at least two 
Australian cities, or it has been spreading throughout other countries and has been imported into 
Australia on separate occasions. However, it is impossible to determine where the plasmid 
originated with the current data available. It is unclear whether pC13 arose within Concord Hospital 
by the addition of the 33 kb transposon to pC20 or whether this happened elsewhere and the 
plasmid was imported. Like pD72, pC13 appears to have been specific to a single hospital, as it has 
not been observed since. However, additional, more recent, isolates from Concord Hospital would 
be required to determine whether pC13 has persisted in A. baumannii isolates from this institution.  
 
Furthermore, a recent analysis of the sequence of pACICU2 revealed that it did in fact harbour 
TnaphA6, in the same position as pC20, pC13 and pAb-G7-2, and that the presence of only a single 
ISAba125 in this position in the published sequence was incorrect (89). This error in the sequence 
Cryptic
ancestor
+TnaphA6+TnaphA6
+CuR Tn
pD72pC20
pC13
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would have been easily detected during conjugation experiments if a wider array of antibiotics were 
used during previous studies that use this plasmid as a reference sequence (16, 237). 
 
A previous study developed a plasmid-typing scheme based on rep gene sequences (16). A total of 
19 different replicon groups were identified. The most diverse group in this collection, GR2, was 
made up of 6 related rep genes. This group included repAci2, observed in pA91 and pC2, as well as 
the replicase genes from pAB0057 and p2ABAYE. Also included in this group was repAci1, which 
was found on pACICU1 but was not used for comparison in this chapter. While GR2, particularly 
repAci2, was ubiquitous in the Australian GC2 isolates, this was not the case in European isolates. 
In 96 MAR A. baumannii collected from different countries in Europe, 70 contained a GR2 plasmid 
and 67 of those were repAci1 (237). This collection of European isolates contained isolates from 
GC1 and GC2 as well as other STs. Not all members of GC2 had a GR2 plasmid and A320, which 
was examined here, also lacked one. 
 
The most common plasmid replicon type observed in European A. baumannii was repAci6 (GR6), 
which was seen in 93 out of 96 isolates in a collection studied by Towner et al. (237). The 
archetype of this group was pACICU2, which has been recently shown to be related to pAb-G7-
2/pC20 (91). The repAci6 type was identified in pD72, pC20 and pC13. No other replicon groups 
had a full suite of transfer genes, like those identified in pACICU2, pD72, pC20 and pC13 (16). 
Several members of GR2 were shown to successfully conjugate and it was found that they 
transferred carbapenem resistance, harbouring either oxa23 or oxa58 (16). A correlation between 
carbapenem resistance genes and plasmids with repAci6 was also observed in a subsequent study 
that used the replicon-typing scheme on a collection of MAR European isolates (237). While this 
does suggest that repAci6 plasmids play a role in the dissemination of carbapenem resistance genes 
in European populations of A. baumannii, it is not an accurate account of the true numbers of 
repAci6 plasmids within the whole population of this organism, as these collections were chosen 
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because they were resistant to carbapenems. Carbapenem resistance genes were not found on pD72, 
pC20 or pC13, rather the amikacin resistance gene aphA6 was found to be present. It is possible that 
the repAci6 plasmids circulating throughout Europe also harbour amikacin and/or other resistance 
genes but this was not examined in the European studies as they were focused on only carbapenem 
resistance. This highlights the importance in the maintenance of screening for other antibiotics in 
addition to carbapenems, as they may still yield useful epidemiological data. 
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7.1 Introduction 
It has been recently observed that clonal lineages other than GC1 or GC2 are causing carbapenem 
resistant A. baumannii infections in multiple countries (46, 104). During the global dissemination of 
these clones, they have acquired various carbapenemase genes, including oxa23 (104). 
 
The isolate D46 was described in Chapter 3 as a non-GC1/GC2 (Figure 7.1;Table 3.3) MAR isolate. 
D46 was collected from an emergency admission at RNSH (D) in 2010, and it is possible that it 
originated from the community, another hospital or a traveller recently returned from overseas.  
 
Figure 7.1 GC2 specific PCR for D46. Amplicons of 702, 559 and 355 bp represent the GC2 specific alleles of csuE, 
oxaAb and ompA, respectively. The contents of each well are shown above, where M is the molecular weight marker. 
 
D46 shared many of the features that were characteristic of the Australian MAR GC2s, and was 
screened with them. The aim of the work presented in this chapter was to identify the resistance 
genes and their contexts in D46, in order to understand how resistance emerged in this strain. 
 
7.2 Features of D46 
Though D46 was not a member of GC2 (Figure 7.1), it was resistant to imipenem, meropenem, 
ampicillin, Timentin (ticarcillin-clavulanate), cefotaxime, ceftazidime, streptomycin, 
spectinomycin, sulphamethoxazole, tetracycline, trimethoprim, chloramphenicol, florfenicol, 
kanamycin, neomycin, gentamicin, amikacin, tobramycin, ciprofloxacin and naladixic acid (Table 
7.1; Appendix I). The zone sizes for each of these antibiotics were similar to those seen in the GC2 
collection. The oxaAb and recA genes were sequenced and D46 was found to have the recA-28 
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allele (http://pubmlst.org/abaumannii/) and an allele of oxaAb that encodes OXA-64. Neither of 
these alleles has been associated with GC1 or GC2 (56). It was later shown to be ST110 using the 
Oxford based MLST scheme (92). A significant difference from GC1 and GC2 isolates was that the 
chromosomal comM gene was found to be uninterrupted in D46 and the J1 and J2 junction PCRs 
failed to amplify, indicating that a genomic island is not present at this location. 
 
7.2.1 Resistance gene content and context in D46 
The blaTEM gene was not detected in D46, but it had an ISAba1 upstream of the chromosomal ampC 
gene, which has been shown to provide a promoter for ampC (38, 88, 215), causing resistance to 
ampicillin and cephalosporins. The carbapenem resistance in D46 was caused by oxa23 with an 
ISAba1 located directly upstream (Table 7.1), which supplies oxa23 with the same promoter known 
to increase expression of ampC. Primers oxa23-likeF in the oxa23 gene and ISAba1B in ISAba1 
produced an amplicon of 2.7 kb, which was consistent with oxa23 being in Tn2006 (Figure 3.4).  
 
Table 7.1 Detected resistances in D46 with the genes responsible and their contexts. 
Resistance(s) Gene Additional information 
IPM MEM TIM oxa23 Flanked by 2 ISAba1s, in Tn2006 
Ap CTX CAZ ampC ISAba1 upstream 
Sm strA Directly adjacent to strB 
Sm strB Directly adjacent to strA 
Su sul2 Associated with CR2 
Tc tetA(B) Associated with CR2 
AkKmNm aphA6 Flanked by 2 ISAba125s, in TnaphA6 
GmKmTm aadB In pRAY 
Ak, amikacin; Ap, ampicillin; CAZ, ceftazidime; CTX, cefotaxime; Gm, gentamicin; IPM, imipenem; Km, kanamycin; 
MEM, meropenem; Ne, netilmicin; Nm, neomycin; Rif, rifampicin; Sm, streptomycin; Su, sulphamethoxazole; TIM, 
Timentin; Tm, tobramycin. 
 
The tet(B), sul2 and strA-strB genes were present, conferring resistance to tetracycline, 
sulphamethoxazole and streptomycin (Table 7.1). The CR2 element was also detected. The PCR 
used to link sul2 and CR2 in the GC2 collection produced the same 3.4 kb amplicon in D46 (Figure 
7.2), suggesting that tet(B) was between sul2 and CR2 (Figure 7.2). A PCR joining tetA(B) to CR2 
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produced an amplicon of 2.5 kb, while primers ISAba1B and sul2R produced a product of 1.3 kb, 
indicating that the ISAba1-sul2-CR2∆-tet(B)-CR2 configuration was present in D46. PCR mapping 
was then used to determine if this resistance region was in a structure similar to AbGRI1-2. Primers 
RH702 and RH790 that join CR2 to the non-coding region between orf4b and IRr both produced an 
amplicon of the size predicted for AbGRI1-2 (Figure 7.2). This indicated that fragments of 
AbGRI1-2 were present in D46. However, tetA(B) could not be linked to strB using PCR, even 
under long-range conditions, which suggests that these fragments were separated. 
 
 
Figure 7.2 Fragments of AbGRI1-2 identified in D46 using PCR mapping. The arrows beneath the line represent the 
orientation of genes, while inverted repeats are shown as vertical lines. ISAba1 and CR2 are represented by open boxes, 
with a thickened like representing the ori end of CR2. 
 
 
The aminoglycoside resistance profile of D46 was attributed to the presence of both aadB and 
aphA6, which confer resistance to gentamicin, kanamycin and tobramycin, and amikacin, neomycin 
and kanamycin, respectively. D46 did not contain a class 1 integron, and the aadB gene cassette 
was found in the small plasmid pRAY, using primers located in the plasmid backbone flanking 
aadB. The aphA6 gene was shown to be flanked by two copies of ISAba125 in the transposon 
TnaphA6 using the linkage PCRs described in Chapter 3 (Figure 3.10). Both of these contexts were 
also found in the Australian GC2s that contained these genes. While aadB was found on a plasmid, 
initially it was not possible to determine if TnaphA6 or the fragments of AbGRI1-2 were located in 
the chromosome or on a plasmid. However, this information was deduced from the genome data 
when it became available, as described below. 
 
strB strA
IR5393
orf4b
IRrIS26
rcr2∆
tniCb tniAb tniB∆2
IRl
strBrcr2 strA
CR2 IR5393
orf4b
IRr
tetA(B) tetR(B)
CR2∆
ISAba1
sul2
5∆ 6 7 8 int 9 10 11 500
26
5∆
IS26
tniCb tniAb tniB∆2
IRl
rcr2∆
CR2
tetA(B) tetR(B)
CR2∆ISAba1
sul2
5∆ 6 7 8 int 9 10 11 500
IS26
5∆
strB strA
IR5393
orf4b
IRrCR2 terCR2
tetA(B) tetR(B)
CR2∆ISAba1
sul2
ori
RH553RH603
tetB-R RH553
RH702 RH790
3,430 bp
2,581 bp
4,527 bp
IS26
?
ISAba1B sul2R1,325 bp
 CHAPTER 7 
 
186 
7.2.2 The genome sequence of D46 
Whole genome sequencing was performed on D46 (Chapter 2) and reads were assembled into 115 
contigs by Kathryn Holt. A summation of the contig lengths revealed that there was a total of 4.2 
Mb in the genome (Table 7.2). 15 contigs greater than 100 kb contained approximately 2.76 Mb. A 
total of 14 contigs between 50-100 kb accounted for an additional 0.98 Mb. The remaining 86 
contigs comprised the final 504 kb.  
 
Table 7.2 Summary of the genome assembly of D46. 
Contig size (kb) No. Size Range (bp) Median (bp) Average size (bp) Total (bp) 
>100 15 115,340-271,602 172,883 184,254.6 2,763,819 
50-100 14 50,408-95,247 70,744.5 70,089.07 981,247 
10-50 16 10,365-45,549 22,115.5 22,819.75 365,116 
1-10 31 1,018-9,749 3,712 4,028.52 124,884 
<1 39 125-936 274 356.54 13,905 
Total: 115   Total: 4,248,971 
 
The STs for both A. baumannii schemes were determined from the genome data, as described in 
Chapter 2 (Section 2.6.3). D46 was ST25 in the Institut Pasteur scheme, and ST229 using the 
Oxford scheme. ST229 is a single locus variant of ST110 where the gpi allele is different (gpi-52 in 
ST110àgpi-107 in ST229). These gpi alleles only differ by a single base (TàC) at position 3 of 
the region analysed, which is part of the amplification primer (described in Chapter 3).  
 
7.3 A resistance island related to AbGRI1-2 
As described above, D46 harboured fragments of AbGRI1-2 (Tn6167) containing the sul2-CR2∆-
tet(B)-CR2 resistance region and segments of the backbone, as determined using PCR (Figure 7.2). 
To determine whether D46 included AbGRI1-2 or a related transposon, the genome of D46 was 
searched to find contigs containing fragments of AbGRI1-2. A total of 5 contigs were identified 
(Table 7.3) and these are shown aligned with the right end of AbGRI1-2 in Figure 7.3.  
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Table 7.3 Contigs that were assembled into the resistance island in D46. 
Contig no. Size (bp) Description 
71 9,749 Adjacent DNA with orf5 and IS26 fragments 
28 9,183 IS26 fragment, orf region and IRl-tniCb-tniAb-tniB∆2, ISAba1 fragment 
16 3,869 ISAba1 fragment, sul2, CR2∆, tet(B), CR2 fragment 
47 1,254 Internal CR2 fragment 
53 936 CR2 fragment and non-coding region before IR5393 
10 17,073 IR5393, strB, strA, orf4b, IRr and adjacent DNA 
 
 
Figure 7.3 Alignment of RI contigs with a AbGRI1-2 reference sequence. Arrows beneath the central line indicated the 
genes present in AbGRI1-2, while ISAba1 is shown as a purple box and CR2 is an orange box with a black bar 
representing the ori end. The extent of each contig is shown beneath the genes. Contigs 71 and 10 continue into 
adjacent DNA that does not match AbGRI1-2, in the direction indicated by the arrow.  
 
7.3.1 The left portion of the resistance island 
The portion of the resistance region found in contig 16 contained part of ISAba1 at one end, sul2-
CR2∆-tetA(B)-tetR(B) in the centre and a 62 bp fragment of CR2 at the other end. Contig 28 
included the majority of the orf region (containing orf5-orf11 along with an int gene; Figure 7.3) 
followed by the Tn6022-like fragment containing IRl-tniCb-tniAb-tniB∆2, with tniB∆2 290 bp 
away from an ISAba1. The sequence of the Tn6022-like fragment is identical to the equivalent 
region in AbGRI1-2. In these two contigs, the piece of ISAba1 was flanked by GIsul2 derived 
sequence also seen in AbGRI1-2. A PCR linking tniB∆2 to sul2, crossing the ISAba1, produced an 
amplicon of 2 kb, which is consistent with the configuration in AbGRI1-2 and joined contigs 28 and 
16. This PCR product was sequenced and there were no SNPs when compared to the ISAba1 at this 
position in AbGRI1-2.  
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The majority of the orf region was directly adjacent to the IRl in contig 28. However, an IS26 has 
been inserted in the 3'-end of orf5 (Figure 7.4). This caused orf5 to be separated into two contigs, 
and the remainder of orf5 was found in contig 71 (Table 7.3). Contig 71 was paired with contig 28 
due to the presence of an 8 bp duplication caused by the insertion of IS26. This assembly was 
confirmed by PCR and sequencing. Comparison with the orf region in AbGRI1-2 and ATCC 17978 
revealed that in D46 this region has lost 153 bp of non-coding DNA that separates orf5 from the IRr 
of Tn6022 in AbGRI1-2. However, the 6,063 bp orf region in D46 shares only 98.53% identity 
(5,975/6,064 bp, with two 1 bp gaps and a 3 bp gap) with AbGRI1-2 and 98.52% identity with 
ATCC 17978, which differs by 1 SNP from the AbGRI1-2 version. However, the majority of these 
differences are found in orf5 and the 3'-end of orf6, which are only 92.5% identical. This indicates 
that the structure in D46 has arisen by recombination between the orf region from AbGRI1-2 and a 
version of it that is substantially diverged. 
 
Figure 7.4 The left portion of the resistance island in D46. The arrows underneath the central line indicate the 
orientation of genes or orfs. The numbers 5-11 represent orfs of unknown function. The orange boxes represent CR2, 
with a thickened line at one end indicating the ori end. IS26 and ISAba1 are represented by pink and purple boxes, 
respectively, with the arrows on the inside showing the orientation. The blue highlighting represents the resistance 
region, while the cream/tan highlighting shows the regions with similarity to the Tn6022 backbone. The sequence 
adjacent to the left resistance island is shown as a blue dotted line. 
 
7.3.2 The strA-strB containing portion of the resistance island 
It had been previously shown that the ter end of CR2 was linked to strB (Section 7.2.1), hence 
contigs 53 and 10 could be joined. The remainder of the resistance region, which contained strB-
strA in the same configuration as AbGRI1-2, was in contig 10. IRr was also present next to orf4b in 
contig 10 and defined the right-hand boundary of a potential resistance island. The remaining 12.9 
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kb of contig 10, adjacent to IRr, shared 99% identity with bases 760,834 to 773,770 in the 
chromosome of ATCC 17978 that are part of the genomic island pA4 (223).  
 
There was a 62 bp overlap between contigs 53 and 10 (Figure 7.3). This overlap included 60 bp of 
the 330 bp adjacent to the ter end of CR2 as well as the first two bp of IR5393. Usually when there is 
a 60 bp fragment at the end of a contig that overlaps with another contig, this indicates that there are 
multiple copies of the second contig within the genome. This suggests that contig 53, which is only 
936 bp long and overlaps with the end of the much larger contig 10, contains sequence that is 
repeated in the genome of D46.  
 
7.3.3 What separates the left and right portions of the AbGRI1-like island 
Parts of CR2 were found in 3 of the contigs that were identified (16, 47 and 53), and 47 was an 
internal fragment. Contigs 47 and 53 had a 10 bp overlap (Figure 7.5a). Such a small overlap 
suggested that it was in fact a direct repeat caused by the insertion of an IS or transposon, but no IS 
fragments were found on the ends of any of these contigs. To determine if an IS was present, a 
database comprised of the 4,640,281 raw 100 bp reads from the D46 genome was searched using 
BLAST with CR2 as a query. The 2,804 reads identified with this search were filtered by 
assembling them onto a scaffold comprised of the sequence of CR2 and its flanking DNA in 
AbGRI1-2. This revealed the presence of a complete copy of CR2. However, there were also reads 
that failed to assemble onto the scaffold, as they contained a fragment of CR2 along with a 
fragment of an IS. Inspection of this IS-derived sequence revealed that it was IS26. These reads 
were then assembled using IS26 as a reference (Figure 7.5b). The reads assembled on both ends of 
the IS26 with sequence of CR2 directly adjacent on each side, indicating that IS26 had interrupted 
CR2. The insertion point of the IS26 was at the exact split point seen in contigs 47 and 53, and the 
10 bp overlap included the 8 bp direct repeat generated by the IS26.  
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Figure 7.5 The assembly of the resistance region in the AbGRI1-2 fragment in D46. The initial assembly to CR2 is 
shown in (a), with the 10 bp overlap, indicating an insertion, highlighted in the green box. An example of the output for 
the assembly of the raw reads against IS26 is shown in (b), where IS26 is shown as the white box with an arrow 
indicating its orientation and CR2 is represented by the yellow boxes. The extent of PCR products used to confirm the 
structure of the resistance region are shown in (c) below the genes with their corresponding primer pairs and sizes. The 
arrows under the central line indicate the orientation of genes. CR2∆ and CR2 are shown as yellow rectangles with the 
ori end indicated by a thickened line. IS26 is shown as a pink box with an arrow inside, indicating its orientation.  
 
Initially, PCRs joining the ori and ter ends of CR2 to IS26 produced amplicons of 1.9 and 1.3 kb, 
respectively, which were the sizes predicted if an IS26 was present. Furthermore, IS26 was linked 
to both sul2 and orf4b using PCR, confirming that the CR2 interrupted by IS26 was adjacent to both 
sides of the two partial resistance islands in D46 (Figure 7.5c). However, primers RH892 and strBF 
linking tetR(B) to strB failed to amplify a product. Also, the internal CR2 PCR using primers 
LECR2 and RECR2 only produced a product of 1.8 kb, which is the size predicted for an 
uninterrupted CR2 consistent with the presence of an intact CR2 elsewhere in the genome. If only a 
single IS26 had interrupted CR2 here, an amplicon 800 bp larger would have been observed. These 
results suggest that a large insertion, flanked by two directly oriented copies of IS26, has interrupted 
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CR2 (Figure 7.4c). So far, all approaches used to identify the structure of this insertion have been 
unsuccessful and its content is yet to be determined.  
 
7.3.4 Overall structure and location of the fragments from resistance islands 
The sequence from the IRl to the IRr bordering the right hand boundary, with the exception of the 
IS26 insertion, was identical to AbGRI1-2 (Figure 7.6). However, a direct repeat was not found on 
either side of the IRl and IRr. 
 
 
Figure 7.6 The assembled pieces of the resistance islands in D46. The arrows underneath the central line indicate the 
orientation of genes or orfs. The numbers 5-11 represent orfs of unknown function. The yellow boxes represent CR2, 
with a thickened line at one end indicating the ori end. IS26 and ISAba1 are represented by pink and purple boxes, 
respectively, with the arrows on the inside showing the orientation. The sequences adjacent to the resistance island are 
shown as blue dotted lines. 
 
 
Contig 71, which has the left hand end of the resistance island identified so far, contained 9,448 bp 
that includes 3 segments that shared 96.3% identity with bases 674,531 to 682,322 in the genome of 
ATCC 17978 and had a fragment of ISAha2 on one end (Figure 7.7a). Contig 10, which has the 
right hand boundary of the resistance island, had 12,935 bp that shared 99% identity with positions 
760,834 to 773,770 in the ATCC 17978 genome and had a fragment of IS1006/IS1007/IS1008 on 
the other end. This region is within the alien island pA4 and is also adjacent to the orf4b and IRr of 
the genomic island that contains the majority of GIsul2 in ATCC 17978 (Figure 7.7b). In the 
chromosome of ATCC 17978 these regions are 78.5 kb apart. 
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Figure 7.7 Comparisons of sequence adjacent the genomic island in D46 in (a) contig 71 and (b) contig 10 with the 
genome of ATCC 17978. Arrows beneath the lines indicate the length and orientation of genes. The CR2 element, 
ISAba1 and IS26 are shown as orange, purple and pink boxes, respectively, with internal arrows indicating orientation. 
The fragment of ISAha2 in (a) is shown as a thin blue box, while the piece of IS1007 in (b) is represented by a thin 
green box. Dashed blue lines in (a) represent sequence unique to D46. Regions shared between D46 and ATCC 17978 
are shown by the grey outlined segments between the bold lines in both (a) and (b) with the per cent identity of the 
match indicated within. 
 
7.4 A macrolide resistance region 
A search of the available contigs for parts of IS26 only identified three contigs, in addition to those 
associated with the resistance island fragments described above (Table 7.4). This showed that there 
were two additional copies of IS26 in the genome of D46. This adds up to a total of 3 copies of 
IS26 that could be identified by finding IS26 fragments on the end of contigs, while the analysis of 
the raw reads of CR2 (Section 7.3.3) revealed that there are another two that are adjacent to CR2. 
Any additional copies of IS26 should be identified by analysing all of the reads with a piece of 
IS26, though due to time constraints this was not examined. 
 
Table 7.4 Additional contigs with fragments of IS26. 
Contig No. Size (bp) Description 
3 4,656 Macrolide resistance region flanked by 2 IS26s 
54 1,155 Contains resG and IS26 fragment 
48 1,422 60 bp fragment of CR2 (ori) at one end and IS26 at the other end 
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Contig 3 contained a 4,535 bp region with two genes associated with macrolide resistance, mel and 
mph, and fragments of IS26 at both ends. The product of the mel gene shared 36.2% amino acid 
identity with the Msr(A) efflux pump, and confers resistance to erythromycin (71). The mph gene 
encodes a macrolide 2’-phosphotransferase that is responsible for the inactivation of macrolide 
antibiotics (177). Contig 3 was flanked by two directly oriented copies of IS26, which formed a 
composite transposon (Figure 7.8).  
 
Figure 7.8 The assembled macrolide resistance region. The arrows beneath the central line show the orientation of 
genes and orfs. The extent of PCR products used to map this region are shown, with their specific primer pairs and 
sizes, below the genes. 
 
The putative transposon containing the mel and mph genes was found in the E. coli IncA/C plasmid 
pPG010208 (GenBank accession No. HQ023861) (58). However, there was a 14 bp duplication in 
the mph of pPG010208, resulting in a frameshift, that was not present in D46. Part of this 
transposon with only a single IS26 was observed in plasmids from several species (Table 7.5), 
including Klebsiella pneumoniae, Citrobacter freundii, K. oxytoca and Providencia stuartii, with 
100% identity, none of which contained the 14 bp duplication seen in pPG010208. Each of these 
plasmids had a single copy of ISEc29 (14) adjacent to the mel gene instead of a second IS26. 
Table 7.5 Plasmids containing the macrolide resistance region. 
Plasmid Bacterium Accession No. 
pNDM-HK Escherichia coli HQ451074 
pMUR050 Escherichia coli AY522431 
pNDM-OM Klebsiella pneumoniae JX988621 
pKP048 Klebsiella pneumoniae FJ628167 
pNDM-CIT Citrobacter freundii JX182975 
pCTX-M3 Citrobacter freundii AF550415 
pKOX_R1 Klebsiella oxytoca CP003684 
pMR0211 Providencia stuartii JN687470 
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The positions of the two remaining contigs with fragments of IS26 relative to contig 3 were 
predicted based on the orientations of each IS26. Duplications were not detected flanking either 
IS26 or at the potential site of insertion of the putative transposon. The assembly of contigs 54 and 
3 was confirmed when primers RH1333 and RH1332 produced an amplicon of 1.1 kb, which was 
then sequenced. Primers RH1331 and RH1330 spanning the second IS26, linking contigs 3 and 48, 
produced a product of approximately 1.1 kb, which the size predicted from the assembly shown in 
Figure 7.8.  
 
Analysis of contig 48 revealed that there was a fragment of the ori end of CR2 on one end. This 
suggested that the second uninterrupted copy of CR2, identified in Section 7.3.3 may be present at 
this location. Primers RH1331 and LECR2, linking the macrolide resistance region to the ter end of 
CR2, produced an amplicon of approximately 3.8 kb (Figure 7.8), which was sequenced. An 
uninterrupted copy of CR2 was indeed present 1,031 bp away from the transposon (Figure 7.8). 
However, the sequence adjacent to the ter end of this copy of CR2 remains to be established. A 
search of any remaining reads after the process described in Section 7.3.3 should identify this. 
 
A closer analysis of contig 54 revealed that it contained an 810 bp segment from GIsul2 that 
contained the resG gene (Figure 7.8). The 550 bp in contig 54 preceding this segment from GIsul2 
was present in a number of IncA/C plasmids, including pPG010208, always adjacent to the resG in 
the segment from GIsul2 (Figure 7.8). However, there are no coding regions in this 550 bp. In 
GIsul2, resG is separated by 330 bp from the ter end of CR2. This 330 bp segment is also found 
between the ter end of CR2 and IR5393 in AbGRI1-2 and the right portion of the resistance island in 
D46. This suggested that the GIsul2-derived resG region in D46 might also be adjacent to another 
copy of CR2. Primers RH1332 in contig 3 and RH702 near the ter end of CR2, produced an 
amplicon of 2.8 kb, confirming that the 330 bp segment followed by the ter end of CR2 was 
adjacent to the resG in contig 54 (Figure 7.8). However, a PCR using the same primer in contig 3 
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with RECR2, which is near the ori end of CR2, failed to amplify a product, suggesting that only a 
fragment of CR2 is present near the end of resG in contig 54. It was hypothesised that this region 
may be part of the insertion that interrupted CR2, separating the partial resistance islands, but initial 
attempts to join these regions with PCR failed and further work is needed to determine if the 
macrolide region is associated with the other resistance region(s). 
 
 
A putative rep gene was located within the 4,535 bp macrolide resistance region, overlapping with 
the adjacent IS26 (Figure 7.8). An identical rep was also observed at the same position in all the 
plasmids listed in Table 7.5 and in each case the start codon of the rep overlaps with the sequence 
of IS26, as in D46 (Figure 7.8). This rep had been previously shown to be non-functional in pCTX-
M3 (154), which is listed in Table 7.5. In a recent study of pNDM-CIT, a plasmid listed in Table 
7.5, this rep gene was found to be identical to the sole replicase in another A. baumannii plasmid, 
pMDR-ZJ06 (51), and it was named repAciN. RepAciN was found to share greater than 60% amino 
acid identity with Rep3 family replicase proteins encoded by more than 20 different plasmids from 
various Acinetobacter species (51). However, a comparison of repAciN with replicase genes that 
were included in the A. baumannii replicon-typing scheme (16) revealed that it shared 
approximately 72-74% identity to a 691 bp portion from members of the GR2 group, including 
repAci1 (951 bp) and repAci2 (951 bp). This comparison also revealed that repAciN had been 
truncated relative to the members of GR2 and that the first 174 bp were missing, due to the insertion 
of IS26, and that a replacement start codon was located 73 bp within the IS26. The repAciN gene, 
with the same replacement start codon in IS26, has been recently identified in two plasmids found 
in separate GC2 A. baumannii isolated in China, p3BJAB0868 (CP003908) and p2BJAB07104 
(CP003907) (264). These plasmids also contain mel (annotated as msr(E)) next to mph, but the 
region containing them is not bordered by an IS26 on either side.  
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7.5 Fluoroquinolone resistance 
Mutations in the gyrA and parC genes lead to resistance to fluoroquinolones (Section 1.3.4.2). The 
sequence of D46 predicts that there is a leucine at position 83 in GyrA and a leucine at position 80 
in ParC, and these amino acid residues are associated with resistance to naladixic acid and 
ciprofloxacin. A complete genome for an ST25 isolate was not available and there were no perfect 
matches for either the gyrA or parC genes of D46 in the non-redundant database. The sequences of 
the entire gyrA and parC of D46 were compared with those in the draft genome of another 
Australian ST25 isolate in our collection, D4, which was only resistant to naladixic acid. The gyrA 
of D4 differed from that in D46 by 31 bp, but it also encodes a leucine at position 83, which 
correlates with the naladixic acid resistant phenotype. However, the parC gene of D4 only differed 
from that in D46 by a single base, which causes D4 to have a serine at position 80 in ParC, also 
correlating with the larger annular radius of inhibition observed for ciprofloxacin in D4. 
 
That the gyrA of D46 and D4 differed so greatly suggested that a replacement event had occurred in 
one of these isolates. To determine the extent of the region replaced around gyrA, 10 kb of sequence 
on either side of gyrA in D46 and D4 were compared. A 7,703 bp recombination patch was 
identified (Figure 7.9). The length of this patch was defined as between the first and last sequence 
differences between D46 and D4. Within the patch, D46 and D4 shared 98% identity, with a total of 
136 SNPs and two 1 bp deletions, one 2 bp deletion, three 1 bp insertions and a 25 bp insertion in 
D46 relative to D4. Outside of the patch, the sequence of the region studied was identical in D46 
and D4. 
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Figure 7.9 Schematic representation of the recombination patch that includes the gyrA gene in D46. The ‘standard’ 
ST25 sequence is shown in black while the hypothesised origin of the patch, ST136, is shown in red. The size and 
relative location of the patch in D46 is shown in the middle line. An arrow beneath each line represents the position and 
orientation of gyrA. 
 
7.5.1 The origin of gyrA in D46 
The gyrA of D46 was also compared to sequences in the whole genome shotgun (wgs) database. 
The closest match for the gyrA of D46 in the wgs database was in the draft genome of isolates IS-
116 and OIFC065, which differed by only a single base (99.96% identity). The single base 
difference was in codon 83, so that IS-116 and OIFC065 have a serine residue at this position and 
therefore they should be susceptible to naladixic acid. However, by analysing the relevant regions 
of the draft genomes (as described in Section 2.6.3) both of these isolates were found to belong to 
ST136 (Pasteur), which only shares 2 MLST loci with ST25 (Table 7.6).  
 
Table 7.6 Nucleotide differences in the gyrA sequences most closely related to that in D46. 
 Isolate STa Nxb 1 2 3 Accession No. 
1 D46 25 R - 1 1 - 
2 IS-116 136 S  - 0 AMGF01000003 
3 OIFC065 136 S   - AMFV01000009 
a ST determined using the Institut Pasteur scheme. 
b Predicted phenotype, except for D46. 
 
Comparison of the patch in D46 with the corresponding region in IS-116 and OIFC065 revealed 
that they only differed by 2 bases, one of which is the SNP in gyrA. Hence it is likely that D46 had 
acquired this 7.7 kb from an ST136 strain (Figure 7.9). However, if D46 acquired the patch from 
either IS-116 or OIFC065 it must have developed the mutation causing naladixic acid resistance 
D46 (ST25)
D4/NIPH 146 (ST25)
IS-116/OIFC065 (ST 136)
7,703 bp
gyrA
gyrA
gyrA 1 kb
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after the recombination event, as both of these isolates are predicted to be susceptible. It is also 
possible that D46 acquired the patch from an as yet unidentified member of ST136 that was already 
naladixic acid resistant. 
 
7.5.1.1 The sequences of gyrA in available ST25 draft genomes 
To determine whether other members of ST25 had the same sequence as D46 or D4 or had acquired 
a different gyrA sequence, all ST25s in the wgs database (July, 2013) were identified by 
bioinformatically performing MLST (Pasteur) using the method described in Section 3.4. A total of 
seven ST25 A. baumannii were identified. None had the D46 gyrA sequence. The sequences of 
gyrA among the ST25s shared 98.8-99.15% identity with that of D46 and four different alleles were 
identified (Table 7.7). This indicates that there has been a great deal of recombination in this region 
within many of the ST25 isolates observed so far, not only D46. Two isolates, Naval-18 and 
OIFC143 contained a gyrA sequence identical to that observed in D4 and NIPH 146 differed from 
D4 by only a single base, the SNP at codon 83, indicating that NIPH 146 would be susceptible to 
naladixic acid. Furthermore, 10 kb on either side of gyrA in NIPH 146 was also compared with the 
equivalent region in D4 and D46 and the sequence was identical (Figure 7.9). This suggests that 
NIPH 146 harbours an ancestral ST25 gyrA sequence. 
 
Table 7.7 Nucleotide differences between gyrA (2,715 bp) alleles of ST25s.  
 Isolate Nxa 1 2 3 4 5 6 7 8 9 Accession No. 
1 D46 R - 23 26 27 27 31 31 31 32 - 
2 AB_5256 R  - 29 22 22 30 30 30 31 AHAI01000044 
3 4190 R   - 25 25 37 37 37 38 AEPA01000223 
4 2008-15-69 R    - 0 38 38 38 39 AMHN01000009 
5 UMB003 R     - 38 38 38 39 AEPM01000013 
6 D4 R      - 0 0 1 - 
7 Naval-18 R       - 0 1 AFDA02000004 
8 OIFC143 R        - 1 AFDL01000002 
9 NIPH 146 S         - APOU01000024 
a Predicted phenotype, except for D46 and D4. 
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7.5.2 The sequences of parC in ST25 A. baumannii 
In contrast to gyrA, there was almost no variation in the sequence of parC (Table 7.8). The parC 
present in the draft genomes of 3 ST25 isolates was identical to that in D46 (Table 7.8). The single 
nucleotide difference observed between D46 and three further ST25s is in codon 80, which encodes 
a serine residue at this position in these isolates. This indicates they are likely to be susceptible to 
ciprofloxacin. In Naval-18 there appears to be an additional single base relative to D46, but this 
could be a sequence error, as it occurs in a run of A’s. The isolate 4190 contained a parC that only 
shared 99% (2206/2221 bp) identity with D46, indicating that it may have acquired a different allele 
via recombination and replacement, but this allele should also confer ciprofloxacin resistance. 
 
Table 7.8 Nucleotide differences between parC (2,220 bp) alleles of ST25s. 
 Isolate CIPa 1 2 3 4 5 6 7 8 9 
1 D46 R - 0 0 0 1 1 1 1 15 
2 AB_2008-15-69 R  - 0 0 1 1 1 1 15 
3 AB_5256 R   - 0 1 1 1 1 15 
4 UMB003 R    - 1 1 1 1 15 
5 Naval-18b R     - 2 2 2 16 
6 D4 S      - 0 0 16 
7 NIPH 146 S       - 0 16 
8 OIFC143 S        - 16 
9 4190 R         - 
a Predicted phenotype, except for D46 and D4 
b The additional base change may be a sequence error 
 
7.6 Plasmids 
The plasmids present in D46 were identified using a plasmid heat map (supplied by Kathryn Holt, 
April 2012). Sequences in the genome of D46 had strong matches to the small cryptic plasmids 
pAB0057, p2ABAYE and pABVAO1, which are all closely related to one another (Section 6.2; 
Table 6.1). There were also matches to pRAY and pACICU2. 
 
 CHAPTER 7 
 
200 
7.6.1 pD46-1, a small cryptic plasmid 
The sequence that matched pAB0057 was on a single contig. The sequence at each end of this 
contig overlapped allowing it to be circularised without further assembly, generating an 8,731 bp 
plasmid, named pD46-1. This plasmid was almost identical to pAB0057 (8,729/8,731) with a single 
2 bp gap. It is possible that this gap is an error in the sequence of pAB0057 because pD46-1 was a 
perfect match to p1ABTCDC0715. pD46-1 is related to pA91, which was observed in the 
Australian GC2 isolates, but the backbone only shares approximately 97% sequence identity with 
pA91. However, almost all of these sequence differences occur in the rep gene (see Figure 6.4). 
 
7.6.2 pRAY* in D46 
The 6 kb aadB containing plasmid pRAY was also found in a single contig. D46 contained pRAY* 
(JQ904627), which has been observed only in two GC1 isolates (92). However, pRAY* in D46 has 
a single base difference relative to that observed in these two GC1 isolates. This is in contrast to the 
Australian GC2 isolates that harbour the pRAY*-v1 variant in all cases where aadB is present 
(Section 6.3).  
 
7.6.3 pD46-2 carries oxa23 and aphA6 
The contigs that made up the third plasmid, pD46-2, were identified using the backbone of pA85, 
which was also used to identify the plasmids pD72, pC20 and pC13 in the GC2 collection 
(described in Chapter 6). A total of 7 contigs that matched pA85 were identified, ranging in size 
from 50.5 kb to 172 bp (Table 7.9).  
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Table 7.9 Contigs identified using pA85 as a query sequence. 
Contig No. Size (bp) Description IS piece 
9 50,520 Backbone - 
247 11,067 Flanks TnaphA6 ISAba125 
22 3,712 Flanks Tn2006 ISAba1 
94 861 Flanks Tn2006 ISAba1 
221 473 Flanks TnaphA6 ISAba125 
208 283 Repeat region - 
222 172 Repeat region - 
 
However, while pA85 was initially used to identify the contigs, the sequence of these contigs was 
almost identical to that of the backbone of pD72. However pD46-2 had more contigs. Two of these 
contigs (22 and 94) in pD46-2 had identical fragments of ISAba1 on one end, indicating that there 
are two inversely oriented copies of ISAba1 in pD46-2. This suggested that Tn2006, which is 
flanked by inversely oriented copies of ISAba1, might be present in pD46-2 at this position, causing 
the additional split in the contigs relative to pD72. The internal segment of Tn2006 flanked by 
pieces of ISAba1 was found in contig 30. The primers RH1503, in the plasmid backbone, and 
oxa23like-F, in Tn2006, produced a PCR amplicon of 3.5 kb, confirming that Tn2006 was in pD46-
2 and joining contigs 22 and 30 (Figure 7.10). Tn2006 was then linked to the plasmid backbone on 
the other side using primers oxa23likeR and RH1397, which amplified a product of 3.3 kb. This 
amplicon was sequenced, joining contigs 30, 94 and 9 (Figure 7.10).  
 
 
Figure 7.10 Linear representation of pD46-2. The three repeat regions are indicated by red boxes, with The extent of 
PCR products used to cover them and join Tn2006 to the backbone indicated below. The locations of TnaphA6 and 
Tn2006 are indicated above the line, with blue arrows representing ISAba125 and green arrows representing ISAba1. 
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The analysis of this sequence revealed that Tn2006 was inserted 737 bp away from one of the 424 
bp repeat regions present in the plasmid backbone (Figure 7.10). This 424 bp repeat region was 
identical to those observed in pD72. Using primers described in Chapter 6 (Figure 6.8), the contigs 
separated by the 225 bp repeat region, 9 and 247, and second 424 bp repeat region, 221 and 22, 
were joined (Figure 7.10). These amplicons were sequenced and these regions were also identical to 
their counterparts in pD72.  
 
Two contigs (247 and 221) had fragments of ISAba125 on one end and contained sequence 
identical to that surrounding TnaphA6 in pD72 (described in Chapter 6), suggesting that TnaphA6 
was located in the same position in pD46-2. The internal TnaphA6 segment and fragments of 
ISAab125 were found on contig 4 in the D46 draft genome. PCRs linking TnaphA6 to the plasmid 
backbone (Section 6.4.1; Figure 6.7) confirmed that they were in the locations predicted using 
pD72, and this joined contigs 247 to 4 to 221 for TnaphA6 (Figure 7.10). The remaining amplicons 
were sequenced and this completed the assembly of pD46-2, revealing that the plasmid pD46-2 was 
74,916 bp long (Figure 7.11). Comparison of the assembled backbone of pD46-2 to that of pD72 
confirmed that they were almost identical (99.99% identity, with 5 base differences) and that they 
contained TnaphA6 in the same position.  
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Figure 7.11 Circular representation of pD46-2. The transfer genes are shown in light blue, while the replicase gene is 
orange. The positions of the repeat regions are shown as red boxes. The positions of Tn2006 and TnapA6 are indicated 
above each transposon. A green arrow represents ISAba1, while ISAba125 is shown as a dark blue arrow. Numbers on 
the inside of the circle represent nucleotide positions in kb. 
 
The large transfer region shared by pD46-2 and pD72 (Figure 7.11), suggests that pD46-2 should be 
conjugative, allowing it to transfer resistance to carbapenems, amikacin, kanamycin and neomycin 
in a single event. To determine if pD46-2 could conjugate, it was plated with a rifampicin resistant 
mutant of ATCC 17978 (also sulphamethoxazole resistant). Potential transconjugants were 
successfully recovered using kanamycin and rifampicin selection. The resistance profiles of four 
colonies that were chosen at random were determined using disk diffusion (Table 7.10). The only 
changes relative to the ATCC 17978 recipient were that the transconjugants had become resistant to 
imipenem, meropenem and Timentin (ticarcillin-clavulanate), and to kanamycin, neomycin and 
amikacin. The zone size for ampicillin was also reduced. This phenotype is indicative of the 
presence of oxa23 and aphA6 in the rifampicin resistant ATCC 17978 recipient, demonstrating that 
pD46-2 was conjugative. 
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Table 7.10 CDS results for the donor (D46), recipient and transconjugants. 
Isolate Annular radii of the zone of inhibition (mm) 
 Rif IPM MEM TIM Ap Km Nm Gm Ne Ak Tm CIP Nx 
D46 7 4 2.5 0 0 0 3 0 6 2 1.5 0 0 
17978-RifR 0 12 9 8 3.5 7.5 7 7 9 8 8 9 6.5 
Colony 1 0 4 3.5 0 0 0 4 9 10 3.5 9 10 6.5 
Colony 2 0 4 3.5 0 0 0 4 9.5 9.5 3 9 10 6.5 
Colony 3 0 4 3.5 0 0 0 4 10 10 3.5 9 10 6.5 
Colony 4 0 4 3.5 0 0 0 4 9.5 10 3 9 10 6 
Ak, amikacin; Ap, ampicillin; CIP, ciprofloxacin; Gm, gentamicin; IPM, imipenem; Km, kanamycin; MEM, 
meropenem; Ne, netilmicin; Nm, neomycin; Rif, rifampicin; TIM, Timentin; Tm, tobramycin. 
 
7.7 Additional insertion sequences in D46 
The number and location of ISAba1 and ISAba125 was determined bioinformatically. Using the 
sequence of each IS as a query sequence in a BLAST search, all contigs that contained a fragment 
of the IS were identified. These contigs were then paired if they would normally form a continuous 
segment of the chromosome and a direct repeat of the correct length was present. These predicted 
assemblies were then confirmed using PCR and the resulting amplicons were sequenced (Table 
7.11). Three copies of ISAba1 and 6 copies of ISAba125 were found in addition to the 2 copies of 
ISAba1 and the 2 copies of ISAba125 located on pD46-2 (described in Section 7.6.3). One ISAba1 
was associated with sul2, in a fragment of GIsul2 as discussed in Sections 4.4.2 and 7.3.1. One of 
the chromosomal ISAba1s was located directly upstream of ampC, causing the high level of 
cephalosporin resistance. The remaining copies of ISAba1 and ISAba125 were not associated with 
known resistance genes.  
 
The locations of each IS26 were discussed in sections 7.3 and 7.4. There were possibly two 
additional IS26s located in the resistance region that had to be identified using the raw reads rather 
than the contigs. The location of these two potential copies of IS26 is yet to be investigated. 
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Table 7.11 The contigs joined by assembly with IS and their assembled sizes. 
Contig 
1 
Size 
(bp) IS 
Contig 
2 
Size 
(bp) 
Direct Repeat 
sequence 
Assembled 
size (bp) 
Associated 
genes 
28 9,183 ISAba1 16 3,869 ATTATTATT 14,110 sul2 
136 264,849 ISAba1 163 172,883 GATTAGCTC 438,694 ampC, gyrA 
195 44,662 ISAba1 24 26,903 ATAATATTT 72,623 - 
76 202,246 ISAba1 72 23,090 AGATTACGG 226,393 - 
125 6,014 ISAba125 115 125,193 CTC 132,173 - 
141 125,426 ISAba125 143 45,549 ACT 171,939 oxaAb 
68 21,141 ISAba125 131 19,480 CAC 41,586 - 
177 25,452 ISAba125 183 95,247 CTT 121,668 rplB 
186 4,032 ISAba125 188 115,340 CTG 120,338 - 
85 158,732 ISAba125 43 10,365 GCG 170,062 - 
     Total: 1,495,694  
 
Other IS were also identified, most notably ISAha2 (www-is.biotoul.fr) and IS1007 (120). There 
were multiple copies of each of these IS, but the exact number has not yet been determined. 
7.8 Discussion 
Almost all of the resistance genes identified in D46 were found associated with various mobile 
elements, located either in the chromosome or on plasmids. The contexts of these genes are similar 
to those observed in the Australian GC2s. D46 had sul2, tet(B), strA, strB in the same context as in 
AbGRI1-2. However, they could not be shown to form a single resistance island. The oxa23 gene 
was in Tn2006, aphA6 was in TnaphA6 and aadB was in pRAY (Table 7.12).  
Table 7.12 Summary of the resistance regions, determinants and plasmids in D46.  
Location Genes Phenotype Notes 
Chromosome ISAba1+ampC Ap CTX CAZ Assembled into a 439 kb contig 
 gyrA Nx Leu83 in GyrA 
 parC CIP Leu80 in ParC 
Resistance 
islands 
sul2, tet(B), CR2  SuTc orf5 and CR2 interrupted by IS26s 
 strAB, CR2 Sm CR2 interrupted by IS26 
 mel, mph ND Linked to uninterrupted CR2 
    
pRAY* aadB GmKmTm 1 SNP relative to pRAY* in GC1s 
pD46-1 - - Identical to p1ABTCDC0715, cryptic 
pD46-2 oxa23, aphA6 IPM MEM TIM 
AkNmGm 
99.99% identical to pD72 
Ak, amikacin; Ap, ampicillin; CAZ, ceftazidime; CTX, cefotaxime; Gm, gentamicin; IPM, imipenem; Km, kanamycin; 
MEM, meropenem; Ne, netilmicin; Nm, neomycin; Rif, rifampicin; Sm, streptomycin; Su, sulphamethoxazole; TIM, 
Timentin; Tm, tobramycin; ND, not determined. 
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The region that contained the gyrA gene in D46 has been replaced with the equivalent region from 
an unrelated isolate via homologous recombination. As a consequence, D46 harboured a gyrA allele 
that was distinctly different from that observed in other members of ST25 (Table 7.13). However, 
as there were a total of 5 different gyrA alleles observed in the ST25 isolates in the wgs database, it 
appears that recombination in this region has been frequent in the ST25 group. The gyrA allele in 
D46 was within a 7.7 kb patch that originated from a member of ST136. It has also been shown that 
D46 has acquired its copy of ampC, with an ISAba1 upstream, via the replacement of a 23.3 kb 
region (Mohammad Hamidian and Ruth Hall, personal communication). The origin of this ampC 
allele was determined to also be an A. baumannii belonging to ST136, though they could not have 
originated from the same patch as ampC and gyrA are approximately 260 kb apart. However, the 
replacement of regions that contain ampC and parC appears to be far less common among ST25 
isolates, D46 was the only isolate to harbour a different ampC and only 4190 contained a different 
parC (Table 7.13). 
 
Table 7.13 Alleles of ampC, gyrA and parC in the ST25 isolates studied. 
Isolate Country Year CTXa Nxb CIPb ampC gyrA parC 
D46 Australia 2010 R R R 2 5 1 
D4 Australia 2006 S R S 1 1 1 
Naval-18 USA 2006 R R R 1 1 1 
OIFC143 USA 2003 S R S 1 1 1 
NIPH 146 USA NK S S S 1 1 1 
2008-15-69 USA 2008 S R R 1 2 1 
UMB003 USA 2008 S R R 1 2 1 
4190 Italy 2009 S R R 1 3 2 
AB_5256 USA 2009 R R R 1 4 1 
a Phenotype predicted, except for D46 and D4. Isolates are predicted to be resistant if there is an ISAba1 upstream of 
ampC, while those with no ISAba1 in this position are predicted to be susceptible. 
b Phenotype predicted, except for D46 and D4. 
 
A resistance island is not located in comM and there was no sequence corresponding to Tn6022 or 
Tn6022∆1 in the genome of D46. Instead, regions related to the right hand portion of AbGRI1-2 
were in two fragments with an IS26 on one end that could not be joined using PCR mapping. It is 
possible that the two regions are located in separate positions or that there is an uncharacterised 
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insertion separating the two parts and further work is needed to determine this and how IS26 is 
involved. Furthermore, both parts of the island border a section of DNA that has so far only been 
seen in the genome of ATCC 17978 (223) and also 11 A. baumannii draft genomes, three belonging 
to members of ST25 and two ST136 isolates, that lack annotation. However, as the contigs 
containing the adjacent DNA are only approximately 10 kb on either side and no linkages to regions 
known to be in the A. baumannii core genome were found, it is not yet possible to be sure that it is 
the chromosome.  
 
D46 did not have Tn2006 within the orf region present in one fragment of the resistance island, 
which was a feature of the Australian GC2 isolates. Tn2006 was instead found in a plasmid, pD46-
2, that was almost identical to pD72. Indeed, pD72, which was seen in GC2 isolates responsible for 
an outbreak mostly from a single ward in hospital D during 2010-2011, is clearly the progenitor of 
pD46-2. The transfer of Tn2006 onto a conjugative plasmid that already harboured amikacin 
resistance is alarming, as this plasmid can now be easily transferred to other susceptible A. 
baumannii that sporadically inhabit hospitals, allowing them to become resistant to two of the most 
important antibiotics used for the treatment of infections caused by this organism. The spread of 
carbapenem resistance genes, including oxa23, via conjugative plasmids has been reported in 
Europe, where many carbapenem resistant isolates were shown to harbour a plasmid containing 
repAci6 (16), which is also present in pD72 and pD46-2 and plasmids that harbour oxa23 appear to 
be globally disseminated (158). 
 
The 3 plasmids accounted for 11 contigs and 85 kb. Assembling the resistance regions and locating 
all copies of ISAba1 and ISAba125 further reduced the number of contigs in the assembly of the 
D46 chromosome. Originally at 115, the genome of D46 is now in 85 pieces along with the 3 
plasmids (Table 7.13). While the number of contigs greater than 100 kb is the same, the amount of 
DNA covered by these contigs only increased by approximately 220 kb to 2.98 Mb. However, there 
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was a large reduction in the number of contigs between 1-50 kb (Table 7.14). The total size of the 
chromosome has also fallen to 4.18 Mb, after the removal of the plasmids. This is still slightly 
larger than most A. baumannii genomes, which are typically 3.8-4 Mb. However, it is still possible 
that there is a large plasmid that was not identified or several genomic islands in D46, which are 
inflating the size of the chromosome. 
 
Table 7.14 Summary of the chromosome of D46, after partial assembly. 
Contig size (kb) No. Size range (bp) Median (bp) Average size (bp) Total (bp) 
>100 15 115,478-438,694 171,939 198,694.47 2,980,417 
50-100 13 50,408-90,287 72,623 69,854.08 908,103 
10-50 9 10,892-44,514 23,377 24,147.33 217,326 
1-10 16 1,105-9,704 3,179 4,272.13 68,354 
<1 32 125-925 226.5 319.09 10,211 
Total: 85   Total: 4,184,411 
 
D46 belongs to ST25 according to the Pasteur MLST scheme. The earliest reported member of 
ST25, isolated from Rotterdam in The Netherlands in 1985, was susceptible to all antibiotics tested 
and was not responsible for an outbreak (46). However, MAR and carbapenem resistant ST25 
isolates have caused outbreaks in Italy, Greece and Turkey (45). The ST25s in each country had 
acquired a different carbapenemase gene, oxa58 in Greece, oxa23 or oxa58 in Turkey and oxa72 in 
Italy. In Greece and Italy, ST25 was responsible for less than 15% of infections, but in Turkey it 
was responsible for 85% (45), suggesting that this clone can predominate under the right conditions. 
This work presented here is the first report of an ST25 isolate in Australia. While GC1 and GC2, 
particularly GC2, are responsible for the majority of MAR A. baumannii infections worldwide and 
within Australia, ST25 may represent a new MAR clonal lineage that is becoming increasingly 
prevalent throughout the world. 
  
  
 
 
 
 
 
 
 
 
 
 
 
CHAPTER 8  
 
General discussion 
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8.1 Overview 
A set of 83 GC2 isolates, all MAR, was identified among collections of A. baumannii from 9 
Australian hospitals. The common resistance genes, sul2, tetA(B), strA and strB were always 
present and clustered together alongside ISAba1 and CR2 in a conserved resistance region in the 
majority of isolates. Eight distinct groups were identified based on their aminoglycoside resistance 
profiles and resistance genes. Though there was variation in the aminoglycoside genes, almost all of 
the isolates were ST92/208 (Oxford scheme). A single SLV, ST425, otherwise belonged in this 
main group. A small group of isolates were ST69/423 and there was a single ST195, but these 
isolates were not examined extensively. 
 
In the ST92/208 collection, which includes the ST425, most of the resistance genes were found in 
two separate chromosomal resistance islands, AbGRI1 and AbGRI2. AbGRI1 had a backbone 
related to Tn6019, which is in AbaR3-type islands that are in the same location in GC1 isolates. The 
Australian GC2 isolates all carried the same AbGRI1 variant, AbGRI1-2, except for one outbreak 
group that had a variant with an additional ISAba125. AbGRI1-2 contained the common resistance 
region ISAba1-sul2-∆CR2-tet(B)-CR2-strB-strA. It also harboured Tn2006, which contains the 
oxa23 carbapenemase, and a novel IS named ISAba17. An AbGRI1 was also found in the A320 
reference strain. A320 had AbGRI1-1, which was smaller than AbGRI1-2 and represents a different 
subgroup of AbGRI1-type islands. Most of the remaining resistance genes were in AbGRI2, which 
was found at a different position in the chromosome. AbGRI2-1, the largest form of this island in 
the Australian isolates, contained blaTEM, aphA1, aacC1, aadA1 and sul1. Six variants of AbGRI2-1 
were identified. Four of these variants involved deletions mediated by IS26, which had removed 
portions of AbGRI2-1 that contain resistance genes. Another variant had an additional IS26 and an 
inversion, while the final variant had at least one additional copy of aphA1 and IS26-IS26∆. Further 
variants were found in publicly available GC2 genomes, and there was always at least a single copy 
of IS26 in the vicinity of AbGRI2-1. 
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 The resistance genes not present in a chromosomal resistance island were found on plasmids. The 
plasmid that contained aadB was a unique variant of pRAY known as pRAY*-v1 and was only 
observed in isolates with AbGRI2-10. Hence, pRAY*-v1 was acquired by a single ancestor that has 
since spread. The aphA6 gene had been acquired by three different groups of isolates via three 
closely related plasmids that contained aphA6 at separate locations in the plasmid backbone. These 
three plasmids had a complete transfer region, which indicated that they should be conjugative. In 
addition, all isolates harboured a cryptic plasmid, either pA91 or its deletion derivative pC2.  
 
An ST25 (Pasteur scheme) isolate, D46, shared a number of resistance genes with the main GC2 
collection. It contained the resistance region found in AbGRI1, but in D46 it was in two parts and 
neither fragment was located in comM. There was also an additional resistance region containing 
macrolide resistance genes and CR2, but its location was not determined. D46 harboured 3 
plasmids, pRAY* containing the aadB gene, a cryptic plasmid identical to p1ABTCDC0715, and 
pD46-2, which contained aphA6 in the same position as pD72 but also contained Tn2006. It was 
shown to be conjugative and was the only plasmid containing multiple resistance genes found in 
this study. Hence, this isolate had a resistance profile almost indistinguishable from the Australian 
GC2s. 
 
8.2 Chromosomally located resistance islands 
The Australian GC2 isolates studied here had two distinct genomic resistance islands belonging to 
the AbGRI1 and AbGRI2 families. Each type of island was always found in a conserved location in 
the chromosome in all of the Australian isolates studied here. This was also the case for all the 
published GC2 genomes, except for ACICU, which contains AbaR2 in comM instead of an 
AbGRI1 (114). These types of islands appear to be specific to GC2. A recent study of whole 
genome sequences of A. baumannii isolates, mostly belonging to GC2, also found AbGRI1 and 
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AbGRI2 in all the GC2 isolates, with all non-GC2s lacking AbGRI1 and AbGRI2 (261). A third 
resistance island was also identified at a separate position in the chromosome (261) and it would be 
interesting to see if there was a related structure or a remnant in the same position in the sequences 
of the Australian isolates studied here. 
 
8.2.1 AbGRI1 
Very little was known about the structure of AbGRI1 in GC2 isolates at the onset of the work 
presented here. AbGRI1-1 (Tn6166) in the A320 reference strain (Chapter 4) was the first structure 
of this family of islands to be published and the first with the complete sequence of the island fully 
annotated and released in the GenBank database (JN247441). AbGRI1-2 (Tn6167) is the only 
island of this type to be found in an Australian isolate and no other published structures contain 
ISAba17. The position of Tn2006 had been previously investigated in a number of isolates from 
different countries (158), and it was shown here that one of the positions they identified 
corresponded with the location of Tn2006 in AbGRI1-2.  
 
In contrast, a great deal of diversity can be found in the structures reported by others (109, 110, 217, 
263) and these structures contain conserved segments that are present in AbGRI1-1 and -2. All the 
published sequences of GC2 A. baumannii, except for ACICU, also have an AbGRI1 but the 
structure was not always analysed. For instance, the description of the genome of 1656-2 (178), 
does not mention any resistance islands and the structure of the variant AbGRI1-3 was examined 
here.  
 
After carefully analysing all known AbGRI1 forms, it was then proposed here that all the variants 
of AbGRI1 were formed from two common ancestors, AbGRI1-A and AbGRI1-B, with AbGRI1-B 
derived from AbGRI1-A by the addition of Tn6022. All AbGRI1 forms can thus arise via 
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homologous recombination between the multiple copies of Tn6022 (Figure 4.19). Huang et al. 
(110) also compared AbGRI1 variants in published genomes available at the time and also 
concluded that recombination between homologous sequences played a key role in the evolution of 
these islands, though they did not speculate on what structure was ancestral. 
 
8.2.2 AbGRI2 
A number of variants of AbGRI2 were characterised in both the Australian collection and the 
sequences of published genomes, ranging in size from 3.2 to 21.7 kb (Figures 5.24 and 5.25). 
AbGRI2 had not been characterised previously and the structure of AbGRI2-1, described here, was 
the first island of this type that was found. Though it was possible to find variants or remnants of 
AbGRI2 in all complete genomes of GC2 A. baumannii released so far, AbGRI2 had not been noted 
previously (Section 5.6). The variation in AbGRI2 is due to deletions, additions or inversions 
caused by IS26 (Sections 5.4 and 5.5). This echoes what has been observed in the MARR of AbaR 
islands (196, 197), which contain a region identical to that observed in AbGRI2-1 (Section 5.3). 
However, one published sequence had a different cassette array in the segment containing the 
integron (see Section 5.6).  
 
The ancestral AbGRI2 in the Australian GC2 collection was AbGRI2-1, as all the variants could be 
derived from it (Figures 5.24 and 5.25) and it was seen in the earliest isolates studied (Table 5.10). 
AbGRI2-1 was made up of fragments of transposons that were already truncated, presumably by 
IS26 mediated deletions. The same fragments were also seen in the MARR of AbaR islands. It 
would be interesting to study older isolates to determine whether they contain larger, or complete 
pieces of the transposons that make up AbGRI2-1 and determine whether all of the AbGRI2 islands 
stemmed from a common ancestor. A possible ancestor may be in the A320 reference strain, which 
was isolated in 1982 (47) and has many of the genes that are present in AbGRI2-1, indicating that it 
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also contains an island related to AbGRI2. A320 is the oldest GC2 isolate available and if it 
contains an ancestral from of AbGRI2, it would indicate that these resistance genes were acquired 
earlier than 1982 and that AbGRI2 was formed during the 1970s, which is when antibiotic 
resistance in Acinetobacters was first noticed (15). 
 
The insertion point of all the AbGRI2 variants studied here cannot be the original site, as there is no 
direct repeat and the copies of IS26 that flank the island are inversely oriented. Moreover, relative 
to GC1 a large segment of the chromosome is missing, having been replaced by AbGRI2 in the 
GC2 isolates (Section 5.2.1). Additional deletions of chromosomal DNA, relative to the position of 
AbGRI2-1, were observed, removing portions either to the left or to the right of AbGRI2 (Table 
5.12). ACICU contains a portion of the chromosome to the left that is usually removed by AbGRI2 
(Figure 5.21). The presence of this additional sequence on one side suggests that the right hand 
junction of AbGRI2-1 may represent the initial insertion point of the island. However, the position 
of AbGRI2 in older isolates, such as A320, must be examined to determine the original insertion 
site of this island. 
 
8.3 Plasmids 
While many of the isolates in the collection lost resistance to aminoglycosides after portions of 
AbGRI2-1 were lost, in some cases this was followed by the gain of different aminoglycoside 
genes, aadB or aphA6, which restored resistance to gentamicin or amikacin (Figure 6.16). There 
were also isolates that contained the complete suite of genes in AbGRI2-1 and had acquired 
additional aminoglycoside resistance genes (Figure 6.16). In all cases where these genes were 
gained, they were acquired via plasmids.  
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The aphA6 gene was found on four closely related conjugative plasmids, pD72, pC20, pC13 and 
pD46-2. All of these plasmids are related to pACICU2, and this family of Acinetobacter plasmids is 
the only one identified so far that contains a conjugation region (16). Although pACICU2 was 
originally reported to be cryptic (114), plasmids containing the same rep gene (repAci6) have been 
previously implicated in the spread of carbapenem resistance genes such as oxa23 and oxa58 (16, 
237). However, three of the four plasmids identified here with repAci6 did not harbour a 
carbapenemase gene, and only contained a single resistance gene that was responsible for amikacin 
resistance.  
 
pC20 was found to be identical to pAb-G7-2 (Section 6.4.2), which had been recently reported in a 
GC1 isolate from Melbourne and had been shown to be transferrable (91). Here it was demonstrated 
that pD46-2, carrying oxa23 and aphA6, was also shown to be conjugative (Section 7.6.3). By 
extension pC13 and pD72 should be conjugative and thus also facilitate the spread of amikacin 
resistance. Interestingly, it was recently reported that there were errors in the sequence of pACICU2 
and that it did in fact contain aphA6 in the same position as pAb-G7-2 (89), and thus also pC20. 
Hence, pC20 and pAb-G7-2 are probably identical to pACICU2, which indicates that this plasmid 
has spread between GC1 and GC2 as well as between Australia and Europe, possibly more than 
once.  
 
Only one plasmid identified here, pD46-2, contained more than one resistance gene, namely aphA6 
and oxa23. This combination of antibiotics is particularly worrisome as amikacin and carbapenems 
are front-line treatments for A. baumannii infections. To date, pD46-2 is the only A. baumannii 
plasmid containing multiple resistance genes that has been fully sequenced and shown to be 
conjugative. 
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The cryptic plasmids pA91 or pC2, which are present in every Australian GC2 that is ST92/208 and 
ST425 (Table 6.6), are the only plasmids related to pAB0057 so far that contain a mobilisation 
region. They therefore have the potential to be transferred alongside one of the pACICU2-like 
plasmids into another host. This could be problematic if either pA91 or pC2 acquired resistance 
genes. 
 
While it has been demonstrated that various plasmid types found in Enterobacteriaceae can be 
transferred from E. coli into A. baumannii (35), it had also been observed that A. baumannii 
plasmid replicons appear to be distinct from those of Enterobacteriaceae (16). Thus, these A. 
baumannii plasmids are likely unable to replicate in another genus. This has been demonstrated for 
the small plasmid pRAY, which was unable to replicate in E. coli (211). The conjugative plasmid in 
which aphA6 was first identified had been shown to conjugate into other Acinetobacter species 
(129), which indicates that A. baumannii plasmids can transfer to other members of the same genus. 
It is probable that this aphA6-containing plasmid is a relative of the pACICU2-like plasmids 
described in Chapters 6 and 7, thus they are likely transferrable to other members of the genus as 
well. It would be interesting to see whether these conjugative A. baumannii plasmids could be 
transferred to a more closely related genus such as Pseudomonas and, if transfer was successful, 
whether they could be maintained. 
 
8.4 Epidemiology  
The main collection of GC2 isolates studied here were quite homogeneous, with variation due to 
differences in aminoglycoside resistance genes caused by deletions in AbGRI2. AbGRI1 contained 
two markers that were useful in distinguishing the Australian isolates, namely the specific locations 
of ISAba17 and Tn2006. This location for Tn2006 had been previously reported in 6 GC2 isolates 
in a study of the global spread of oxa23 (158). Though each of these isolates had been found in a 
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different country, with one isolate from Australia, they were all reported as members of ST92 
(named as ST22 in (158), using an old numbering scheme). Hence, these isolates are related to the 
main group of Australian isolates studied here. The 6 isolates studied by Mugnier et al. were 
isolated between 2003 and 2006 (158), while the earliest isolate in the collection studied here is 
from 1999. This indicates that either this lineage had become globally disseminated and arrived in 
Australia in or prior to 1999, or that the lineage acquired Tn2006 at the position in AbGRI1 in 
Australia and then subsequently spread to other countries. It would be interesting to examine the 
structure of AbGRI1, particularly the position of ISAba17, in the 6 isolates studied by Mugnier et 
al. and other members of ST92/ST208 isolated outside of Australia, to determine whether they are 
truly descendants or relatives of the ST92/ST208 isolates that were studied here.  
 
No other studies have identified an IS identical to ISAba17 within AbGRI1 or anywhere in the 
genome of an A. baumannii, though a related IS, ISAba16, has been observed interrupting the 
oxaAb gene of an A. baumannii isolate (143). A preliminary search of the wgs database using the 
sequence of ISAba17 revealed that it was present in over 15 A. baumannii draft genomes, though 
none appeared to harbour it in the same position of ISAba17 as seen in AbGRI1-2. The majority of 
these isolates were from the United States, though there was one from Iraq and another from 
France. Hence, ISAba17 has indeed spread outside of Australia, but using ISAba17 in the context of 
AbGRI1-2 could identify isolates that are related to the Australian isolates that contain AbGRI1-2. 
 
These markers could be valuable when used alongside MLST in determining whether isolates have 
a shared lineage. The Oxford based MLST scheme is able to differentiate sub-lineages of GC2 (94, 
158, 206), with most of the variation in ST due to the gpi allele. The gpi gene is part of the capsule 
locus and it has been observed that within both GC1 and GC2, the portion of the chromosome 
containing the capsule region can be replaced (1, 2, 119), which would cause a change in ST due to 
the different gpi in the new capsule locus (KL). All of the Australian GC2 isolates studied here that 
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are ST92/208 have the KL2 region (Johanna Kenyon, personal communication). KL2 had also been 
seen in ACICU, but four of the other fully sequenced GC2 strains available in GenBank each had a 
different KL (119) and none of them were ST92/208. It was shown here that they all had a variant 
of AbGRI1 and AbGRI2, which indicates that the replacement of capsule loci occurred after the 
acquisition of AbGRI1 and AbGRI2. This capsule switching can also be seen in the Australian 
collection, in the isolate C20, which is ST425 and has KL4. C20 has AbGRI1-2 and AbGRI2-1, 
which indicates that the replacement of its capsule locus occurred recently. KL4 has only otherwise 
been observed in GC1 isolates (Johanna Kenyon, personal communication) suggesting that the 
recombinant region containing KL4 in C20 originated from a GC1 isolate. It would be interesting to 
examine whether other isolates that differ from ST208/92 at the gpi allele contain AbGRI1-2 or 
whether they represent other lineages of GC2 that harbour a different variant of AbGRI1, that is 
perhaps specific to another country or geographic region. This highlights the possibility that other 
portions of the chromosome may also be replaced by corresponding regions from members of other 
clonal groups. If portions of the chromosome are being frequently replaced, this could lead to 
difficulties in accurately performing phylogenetic analyses of isolates that are based upon SNPs. 
 
8.5 Concluding remarks 
This study revealed that the majority of antibiotic resistance genes in GC2 isolates are found in two 
chromosomal resistance islands, AbGRI1 and AbGRI2, while additional resistance genes were 
acquired via the uptake of plasmids. These islands accounted for the majority of the resistance 
genes in these isolates and any variants could be traced to a common ancestor. Thus, the spread and 
divergence of a single strain is responsible for the majority of MAR A. baumannii infections in 
hospitals across the eastern cities of Australia. Features of AbGRI1 and AbGRI2 proved to be 
valuable epidemiological markers and variation in the islands can be used to track specific 
outbreaks, between or within hospitals. 
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While PCR mapping was useful in initially determining the structures of the islands, the true 
amount of variation in the larger collection would not have been easily ascertained without the 
availability of whole genome sequences. Using a draft genome sequence, it was possible to 
determine the position of the novel island AbGRI2 and compare it with other publicly available 
genomes. With the knowledge gained from the whole genome sequences, it was possible to predict 
the structures of the islands in isolates that do not have sequence data available using refined PCR 
mapping schemes. This will prove useful in the characterisation of future isolates that belong to 
GC2.  
 
As next generation sequencing technology improves, it may be possible to characterise complex 
resistance regions without the need for extensive PCR mapping. Current technologies, such as 
PacBio sequencing, are able to generate reads of greater than 10 kb and these are often long enough 
to completely cover some resistance regions. However, as of 2014 these technologies are 
prohibitively expensive for use in common laboratories and hospitals, and they have much higher 
error rates when compared to technologies such as Illumina. Hence, for the short- to mid-term, 
efficient PCR mapping strategies are still highly valuable in diagnaostics for problem pathogens. 
 
The collection studied here contained isolates primarily from the eastern seaboard of Australia and 
it would be interesting to collect isolates from other areas of Australia and apply the same mapping 
strategies devised here to see if all Australian isolates have evolved from a common ancestor or 
whether those in other areas of Australia represent different sub-lineages of GC2 that are yet to be 
characterised. This could also be extended to the analysis of isolates from other countries, 
particularly from South-East Asia, where ST92/208 is also dominant. 
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Table 0.1 Results of CDS disk diffusion for members of GC2. 
Isolate Year GC 
Annular Radius of the zone of inhibition (mm) 
IPM MER Ap CTX CAZ Sm Sp Su Tc Tp Cl Fl Km Nm Gm Ne Ak Tm CIP Nx Rif TIM SAM 
A72 2001 2 3.5 3 0 0 1 0 0 0 2 0 0 0 3 7 0 5 6.5 2 0 0 7 0 3 
     0 0 1 0 0 0 3 0 1 2 3 6.5 0 5.5 7 2 0 0    
A73 2001 2 3 2.5 0 0 1 0 0 0 1.5 0 0 0.5 7 6 5 4 7 7 0 0 6 0 3 
     0 0 1 0 0 0 2 0 1 1 7.5 7 6 3.5 7 7 0 0    
A74 2002 2 2.5 1.5 0.5 0 2 0.5 0.5 0.5 3 0.5 0 1 0 3 0 2 7 6.5 0 0 7 0 5 
     0 0 2 0 0 0 3 0 0.5 1.5 0 3 0.5 2.5 7 6 0 0    
A75 2002 2 3 2 0 0 1.5 0 0 0 2.5 0 1 1 1 4 3 6 7 7.5 0 0 7 0 3 
     0 0 1.5 0 0 0 3 0 1 2.5 1 4 3 6 7 7.5 0 0    
A76 2002 2 3.5 2.5 0 0 1 0 0 0 2.5 0 1 1 1 4 3 6.5 7 7 0 0 7 0 3 
     0 0 1 0 0 0 3.5 0 3 3 1 4.5 3 6 7 7 0 0    
A77 2002 2 3 2 0 0 1 0 0 0 2.5 0 1 1 1 4 3 6 7 7 0 0 6.5 0 2.5 
     0 0 1 0 0 0 2.5 0 2 1.5 1 4.5 4 6 7 7 0 0    
A78 2002 2 3 2.5 0 0 1 0 0 0 2 0 1 1 1 4 2.5 3.5 7.5 7 0 0 6.5 0 2.5 
     0 0 1 0 0 0 3 0 1.5 1.5 1 4.5 2.5 4 7 7 0 0    
A79 2002 2 3.5 2.5 0 0 1 0 0 0 2.5 0 1 2 1 4.5 3 7 8 7.5 0 0 6.5 0 3 
     0 0 1.5 0 0 0 2.5 0 1 2 1 4.5 3 7 7.5 7.5 0 0    
A80 2002 2 3 2 0 0 1 0 0 0 2.5 0 1 1 1 4 3 6 7 7 0 0 6.5 0 3 
     0 0 1 0 0 0 2.5 0 1.5 2 1 4.5 3 6 7 7 0 0    
A81 2002 2 3 2.5 0 0 1 0 0 0 3 0 1 1 1 4 3 4 7 7 0 0 6.5 0 3 
     0 0 1 0 0 0 2.5 0 1.5 1.5 1 4.5 2 4 7 7 0 0    
A82 2002 2 3.5 2.5 0 0 1 0 0 0 3 0 1 1 1 4.5 3 6.5 7 7.5 0 0 7 0 3 
     0 0 1.5 0 0 0 4 0 2 1 0.5 4.5 3 6 7 7 0 0    
A84 2002 2 3 2.5 0 0 1 0 0 0 3 0 1 1 1 4 2 4 7 7.5 0 0 6.5 0 2.5 
     0 0 1 0 0 0 3 0 2 1.5 1 4 2.5 4.5 7.5 7 0 0    
A87 2004 2 4 3 0 0 1 0 0 0 1 0 0 0 2.5 6 0 4.5 6 1 0 0 7 0 4.5 
     0 0 2 0 0 0 1 0 0 0.5 2.5 6 0 4 6 1 0 0    
A91 2005 2 4 4 0 0 2 0 0 0 0 0 1 0 0 4 1.5 6 7 7 0 0 5 0.5 3 
A93 2005 2 3 2 0 0 2 0 0 0 0 0 0 0 0 3 1 4 6 5 0 0 5 0 3 
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Isolate Year GC 
Annular Radius of the zone of inhibition (mm) 
IPM MER Ap CTX CAZ Sm Sp Su Tc Tp Cl Fl Km Nm Gm Ne Ak Tm CIP Nx Rif TIM SAM 
A94 2005 2 3 3 0 0 2 0 0 0 0 0 0 0 0 3 1 5 6 5 0 0 5.5 0 3 
A96 2005 2 2.5 2.5 0 0 2 0 0 0 0 0 0 0 0 3 1 4 6 5 0 0 5 0 2.5 
A97 2005 2 3 2.5 0 0 2 0 0 0 0 0 0 0 0 3 1 4 5 5 0 0 5 0 3 
A111 2010 2 3 2.5 0 0 1 0 0 0 4 0 1 0 8 7 7 6 8 8 0 0 6 0 4 
     0 0 2 0 0 0 5 0 2 1.5 8 8 7 6.5 8 7.5 0 0    
                          
B1 2007 2 2.5 2 0 0 3 0 0 0 2 0 0 0 7 6 5 5 6 6 0 0 6 0 2.5 
B2 2007 2 2.5 2.5 0 0 2 0 0 0 3 0 0 0 8 6 6 6 8 8 0 0 6 0 3 
B3 2007 2 2.5 2.5 0 0 2 0 0 0 1 0 0 0 9 7 6 6 8 7 0 0 5.5 0 3 
B4 2007 2 3 2 0 0 2 0 0 0 3 0 0 0 8 6 6 6 7 7 0 0 5.5 0 3 
B5 2007 2 3 2 0 0 2 0 0 0 2 0 0 0 9 8 7 7 8 7 0 0 6 0 3 
B6 2007 2 2.5 2.5 0 0 2 0 0 0 2 0 0 0 8 7 7 6 7 7 0 0 6 0 3 
B7 2007 2 2.5 2 0 0 2 0 0 0 3 0 1 0 9 7 7 7 8 8 0 0 5.5 0 3 
B8 2007 2 3 2 0 0 2 0 0 0 3 0 1 1 9 7 7 6 7 7 0 0 6 0 3 
B10 2010 2 2.5 2 0 0 1 0 0 0 1 0 0 0 8 7.5 7 6.5 7.5 7.5 0 0 6 0 3 
                          
C1 2007 2 2.5 2 0 0 2 0 0 0 0 0 1 0 0 2 0 3 4 3 0 0 5.5 0 4.5 
C2 2007 2 3 2 0 0 2 0 0 0 3 0 1 0 4 8 3 8 8 4 0 0 6 0 3.5 
C3 2007 2 2.5 2.5 0 0 2 0 0 0 2 0 0 0 4 7 0 6 8 3 0 0 6 0 3 
C4 2007 2 2.5 2.5 0 0 2 0 0 0 3 0 1 1 5 8 3 7 7 3 0 0 6 0 3 
C5 2007 2 2.5 2.5 0 0 2 0 0 0 4 0 1 1 4 6 0 6 7 3 0 0 6 0 4 
C8 2007 2 3 2 0 0 2 0 0 0 3 0 1 1 4 8 0 6 7 3 0 0 6 0 3 
C13 2006 2 3 3 0 2 1 0 2 0 5 0 1 0 0 5 8 7 4 9 0 0 6 0 4.5 
C14 2006 2 3.5 2.5 0 2 1 0 1 0 4 0 1 0 0 4 8 8 4 8 0 0 6.5 0 4 
C15 2006 2 3 2 0 0 2 0 0 0 2 0 1 0 4 6 0 6 7 3 0 0 5.5 0 3 
C18 2002 2 3 2 0 0 2 0 0 0 2 0 1 1 4 6 0 6 7 3 0 0 6 0 3 
C20 2002 2 2 2 0 0 1 0 0 0 0 0 2 2 0 0 0 5 0 6 0 0 6 0 2 
                          
D1 2006 2 3 2 0 0 3 0 0 0 2 0 1 1 7 6 6 6 6 7 0 0 6 0 3.5 
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Isolate Year GC 
Annular Radius of the zone of inhibition (mm) 
IPM MER Ap CTX CAZ Sm Sp Su Tc Tp Cl Fl Km Nm Gm Ne Ak Tm CIP Nx Rif TIM SAM 
D5 2006 2 2.5 2.5 0 0 2 0 0 0 3 0 1 1 8 7 6 7 7 7 0 0 6 0 3 
D8 2006 2 3 2 0 0 2 0 0 0 2 0 0 0 3 7 0 6 7 2 0 0 0 0 2.5 
D9 2006 2 3 2 0 0 3 0 0 0 3 0 0 0 3 7 0 6 7 2 0 0 0 0 3 
D12 2007 2 3 2 0 0 2 0 0 0 2 0 0 0 4 7 0 6 7 3 0 0 6 0 4 
D24 2008 2 1.5 1 0 0 2 0 0 0 0 0 0 0 6 6 5 6 6 6 0 0 6 0 2 
     0 0 2 0 0 0 0 0 0 0 6 7 5.5 6 6 7 0 0    
D37 2008 2 2.5 2 0 0 2 0 0 0 0 0 6 5 3 6 2 7 9 3 0 0 6 0 3 
     0 0 2 0 1 0 2 0 7 6 4 6 2 8 6 3 0 0    
D51 2010 2 2 1 0 0 0.5 0 0 0 0 0 0 0 8 7.5 7 6.5 8 7.5 0 0 6 0 2 
     0 0 2 0 0 0 0 0 0 0 8 7 7 7 8 7.5 0 0    
D52 2010 2 2 1 0 0 0 0 0 0 0 0 0 0 9 8 7.5 7 8 8 0 0 6 0 2 
     0 0 1.5 0 0 0 0 0 0 0 8 7 7 6 8 6 0 0    
D54 2010 2 2 1 0 0 0.5 0 0 0 0 0 0 0 8.5 7.5 7 6.5 7 8 0 0 6 0 2 
     0 0 1.5 0 0 0 0 0 0 0 9 7.5 7 7 8 9 0 0    
D56 2010 2 2 1 0 0 0 0 0 0 0 0 0 0 9 8 7 7 7.5 8 0 0 6 0 2.5 
     0 0 2 0 0 0 0 0 0 0 8 7.5 7 7 7.5 8 0 0    
D57 2010 2 2 1 0 0 2 0 0 0 0 0 0 0 7.5 8 7 7 7.5 7 0 0 6 0 2.5 
     0 0 2 0 0 0 0 0 0 0 8 7 6 7 8 7 0 0    
D58 2010 2 3 2.5 0 0 0 0 0 0 0.5 0 0 0 9 7 7 7 8 8 0 0 6 0 3 
     0 0 2 0 0 0 0 0 0 0 8 8 7 6 7 7 0 0    
D72 2010 2 3.5 3 0 2 0 0 0 0 0 0 0 0 0 0 2 2 2 8 0 0 2.5 0 3.5 
     0 0 2 0 0 0 0 0 0 0 0 2 2 2 2.5 8 0 0    
D77 2010 2 3 3 0 0.5 2 0 0 0 1 0 0 0 0 1 2 6 2 6.5 0 0 2.5 0 4.5 
   4 3 0 0.5 2 0 0 0 1 0 1 1 0 0.5 2 6 1.5 7.5 0 0    
D79 2010 2 2 2 0 0 1 0 0 0 0 0 0 0 0 2 2 5 2 6 0 0 2 0 3 
   3 2 0 0 1 0 0 0 1 0 0 0 0 1.5 1.5 6 3 6.5 0 0    
D84 2010 2 2.5 2 0 0 1 0 0 0 0.5 0 0 0 0 1 2 6 2 6.5 0 0 2 0 3 
   2.5 2 0 0 1 0 0 0 1 0 0 0 0 2 1.5 6 2 7 0 0    
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Isolate Year GC 
Annular Radius of the zone of inhibition (mm) 
IPM MER Ap CTX CAZ Sm Sp Su Tc Tp Cl Fl Km Nm Gm Ne Ak Tm CIP Nx Rif TIM SAM 
D85 2010 2 2.5 2 0 0 1 0 0 0 0.5 0 0 0 0 1 1.5 6 1.5 6 0 0 2 0 3 
   2.5 2 0 0 1 0 0 0 1.5 0 0 0 0 1.5 2 6 2 7 0 0    
D86 2010 2 1 1 0 0 0 0 0 0 0 0 0.5 0 0 2 0(5) 4 6 5 0 0 7 0 2.5 
   1.5 1 0 0 0 0 0 0 0 0 0 0 0 1.5 0(5) 0(4) 1(7) 0(5) 0 0    
D87 2010 2 3 3 0 0 1 0 0 0 2.5 0 0 0 0.5 4 4 7.5 4 8 0 0 2 0 3.5 
   3.5 3 0 0 1.5 0 0 0 4.5 0 0 0 0.5 5 4 8 4.5 8.5 0 0    
D88 2011 2 2.5 2 0 0 1 0 0 0 0.5 0 0 0 0 2.5 3 7 3 7 0 0 0 0 3.5 
   2.5 2 0 0 1 0 0 0 1 0 0 0 0 3 3.5 8 3.5 8 0 0    
D92 2011 2 2.5 2 0 0 1.5 0 0 0 2 0 0 0 0 2 1.5 5.5 2 6 0 0 2.5 0 3.5 
   3 2.5 0 0 2 0 0 0 2 0 0 0 0 2 1 5 2.5 6 0 0    
D93 2011 2 3 2.5 0 0 2 0 0 0 1.5 0 1 0 0 2 2 6.5 2.5 7 0 0 2 0 3.5 
   3 2 0 0 1 0 0 0 2 0 0 1 0 1.5 1.5 6.5 2 6.5 0 0    
D96 2011 2 3 2.5 0 0 2 0 0 0 2 0 0 1 0 2 1.5 6 3 6.5 0 0 2 0 3.5 
   3 2 0 0 1.5 0 0 0 2.5 0 0 0 0 2 2 6 2.5 6 0 0    
D97 2011 2 2.5 2 0 0 2 0 0 0 1.5 0 0 0 0 2 1.5 6 2.5 6.5 0 0 2 0 3 
   2 2.5 0 0 1 0 0 0 2 0 0 0 0 1.5 1 6 2 6 0 0    
D98 2011 2 2.5 2 0 0 1 0 0 0 1 0 0 0 0 2 1.5 5.5 2 6 0 0 2 0 3 
   2.5 2 0 0 1 0 0 0 1 0 0 0 0 2 1.5 5 2 6 0 0    
D101 2011 2 3 2 0 0 1.5 0 0 0 1.5 0 0 0 7.5 7 6 6 7 6 0 0 6.5 0 3.5 
   2.5 2 0 0 1 0 0 0 2 0 0 0 8 8 6.5 6 7 7 0 0    
D107 2011 2 2 2 0 0 1 0 0 0 1.5 0 0 0 0 1 1 5 2 5.5 0 0 2 0 3 
   2 2 0 0 1 0 0 0 1 0 0 0 0 1 1 5 2 5.5 0 0    
D112 2011 2 2 1.5 0 0 1 0 0 0 3 0 0 0 8 7 6 6 7 7 0 0 2 0 3 
   2 1.5 0 0 1.5 0 0 0 4 0 0 0 9 8 7 7 8 8 0 0    
D114 2011 2 2 2 0 0 2 0 0 0 5 0 0 0 0 3 3 7 4 8 0 0 0 0 5 
   2 2 0 0 2 0 0 0 5 0 0 0 0 3 3 7 3.5 7.5 0 0    
                          
E1 2006 2 3.5 2.5 0 0 2 0 0 0 1 0 0 0 4 8 0 7 8 2 0 0 0 0 4 
E16 2009 2 3 2 0 0 1.5 0.5 2 0 3.5 0 1 0.5 4 7 4 8.5 9 3.5 0.5 0 6 0 5 
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Isolate Year GC 
Annular Radius of the zone of inhibition (mm) 
IPM MER Ap CTX CAZ Sm Sp Su Tc Tp Cl Fl Km Nm Gm Ne Ak Tm CIP Nx Rif TIM SAM 
F46 1999 2 11 10 0 0.5 5 0 0 0 0 2 0 0 0 4.5 5 1.5 4.5 2 0 0 6 5.5 5 
F38 2000 2 3 2.5 0 0 0 0 0 0 0.5 0 0 0 1 7 0 4 6 0 0 0 7 0 2.5 
     0 0 0 0 0 0 1 0 0 0 1 6.5 0 4 6 0 0 0    
F11 2001 2 3 2 0 0 0 0 0 0 1 0 0 0 0 4 2 6 6.5 6 0 0 6 0 2.5 
     0 0 0 0 0 0 1 0 0 0 0 4 2 6 7.5 7 0 0    
F36 2001 2 3 2.5 0 0 0 0 0 0 0.5 0 0 0 0 3 2 5.5 6 6 0 0 6 0 3 
     0 0 0 0 0 0 0.5 0 0 0 0 3 2 5.5 6 6 0 0    
F1 2002 2 3 2.5 0 0 2 0 0 0 1 0 0 0 2 6 0 4 5 1 0 0 7 0 3 
     0 0 0 0 0 0 1 0 0 0 2 5.5 0 4 6 1 0 0    
F4 2002 2 11 9 0 0 2.5 0 0 0 0 0 0 0 1 5.5 1 0 3 0 0 0 6 4.5 4.5 
     0 0 2 0 0 0 0 0 0 0 1 6 1 0 3.5 1 0 0    
F18 2002 2 3 2.5 0 0 1 0 0 0 1 0 0 0 3 7 0 5 6.5 1 0 0 7 0 3 
F44 2002 2 7.5 6.5 0 0 4.5 0 0 0 0 0 0 0 1 6.5 2 0 4 1 0 0 6 0 4.5 
F45 2002 2 3 2 0 0 1 0 0 0 1.5 0 1 1 2 7 0 6 7 1.5 0 0 7 0 3 
     0 0 1 0 0 0 2 0 1 1 2 7 0 5 6 1 0 0    
F48 NK 2 8 5 0 0 1 0 0 0 0 0 0 0 0 3 1 0 4 1.5 0 0 6 0 3 
     0 0 1 0 0 0 0 0 0 0 0 3 1 0 3.5 1 0 0    
                          
MH50 NK 2 3 2 0 0 0 0 0 0 1 0 2 4 0 4 2.5 5.5 6 6.5 0 0 7.5 0 3 
     0 0 0 0 0 0 0.5 0 0 0 1 4.5 3 7 7 7 0 0    
                          
WM99c 1999 2 2 1.5 0 0 1 0 0 0 0.5 0 0 0 0 4.5 2.5 6 7 7 0 0 6.5 0 2 
   2 2 0 0 1.5 0 0 0 0 0 0 0 0 4 2 6.5 7 7 0 0    
                          
A320 1982 2 13 9.5 0 4 6 0 0 9 0 0 0 1 0 4 2 6 7 6 7 6 2.5 5 4 
   12.5 9.5 0 5 7 0 0 10 0 0 0.5 1 0 4 3 7 9 8 9 6 2.5 5  
Isolates in blue and orange were screened previously. NK, not known. 
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Table 0.2 Results of CDS disk diffusion for members of GC1. 
Isolate Year GC 
Annular Radius of the zone of inhibition (mm) 
IPM MER Ap CTX CAZ Sm Sp Su Tc Tp Cl Fl Km Nm Gm Ne Ak Tm CIP Nx Rif TIM SAM 
A83 2002 1 12 10 3 5 5.5 4.5 0 0 4.5 1 1 1 0 3 2 6.5 7 7 0 0 0 7 10 
     3 5 6 4 0 0 5.5 1 1 1 0 3.5 2 6.5 7 7 0 0    
A85 2003 1 3 3 0 0 0 3.5 0 0 0 0 0.5 1 0 3 2 6 7 7 0 0 8 0 2.5 
     0 0 0 4 0 0 0 0 1 1 0.5 3.5 2 6.5 7 7 0 0    
                          
D45 2010 1 8.5 8 0 0 0 4.5 0 0 3 6 0.5 0.5 0 3.5 2 6 7 7 0.5 0.5 6 5 7 
     0 0 1 4 0 0 3.5 5 0.5 0.5 0 3.5 3 12 7 7 0 0    
D48 2010 1 10 9 0 0 0 4 0 0 3 6 0 0 0 3 2 7 7 7.5 0 0 7 6 8 
     0 0 1 4 0 0 3 5 0.5 0.5 0 3 2.5 7 7 7 0 0    
D62 2010 1 15 11 10.5 12 12 9 0 14 7 9 0 0 0 6.5 4.5 9.5 11 10 0 0 6 8 12 
     11 12 12 9 0 14 7 8.5 0 0 0 5 4 10 10 9 0 0    
D78 2010 1 3.5 3.5 0 0 3 4 0 0 0 3 0 0 0 2 2 6 0.5 6.5 0 0 7 0 3 
   4 4.5 0 0 1.5 0 0 0 0 0 0 1 0 1.5 2 6 0.5 6.5 0 0    
D81 2010 1 3 3 0 0 3 4.5 0.5 0 0 3 0 0 0 2 2 6 0.5 6.5 0 0 7.5 0 3.5 
   3 4 0 0.5 3.5 4.5 0.5 0(1) 0 3.5 0 1 0 2 1.5 7 1 7 0 0    
D108 2011 1 4 3 0 0 1 4.5 0 13 4 4.5 0.5 0 7 6.5 6 6 6.5 6 0 0 2.5 0 5 
   4 3 0 0 1 4.5 0 13.5 4 4.5 0.5 0 8 7 6 6 7 6 0 0    
                          
F3 2002 1 11 10 0 0 0 3.5 0 0 0 3 0 0 0 3 1 6 6.5 7 0 0 7 3.5 3 
     0 0 0 3.5 0 0 0 2.5 0 0 0 3 1 6 6.5 6 0 0    
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Table 0.3 Results of CDS disk diffusion for non-GC MAR A. baumannii. 
Isolate Year 
Annular Radius of the zone of inhibition (mm) 
IPM MER Ap CTX CAZ Sm Sp Su Tc Tp Cl Fl Km Nm Gm Ne Ak Tm CIP Nx Rif TIM SAM 
D46 2010 4 2.5 0 0.5 4 0 0 0 0 0 0 0 0 3 0 6 1.5 1 0 0 7 0 5 
    0 1 5 0 0.5 0 2 0.5 0 0 0 2.5 0 5 2 1.5 0 0    
D4 2006   0 0 0 0 0 0 6 3 0 0 0 4 3 7 7 4 4 1    
F2 1999   0 0 0 0 0 0 2 0 0 0 0 2 0 2.5 0 1 1 0    
    0 0 0 0 0 0 2 0 0 1 0 1 0 2.5 0 1 1 0    
RCH51 NK   0 5 6 5.5 5 0 1 5 0 0 2 2.5 2 9 8 2 10 7    
RCH52 NK   0 4.5 2 0 0 0 0 0 0 0 2 5.5 3 6 7 6 10 7.5    
A88 1999   1 2 11 3 4.5 0 6.5 14 9.5 12.5 1 6.5 6.5 7 7 0 12 5.5    
    1.5 3 12 4 4 1 7 15 9 13 3 7.5 7 8 8.5 0 13 6    
NK, not known. Isolates obtained earlier in the project were not screened for IPM, MER, Rif, TIM and SAM. 
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Table 0.4 Results of CDS disk diffusion for susceptible non-GC A. baumannii. 
Isolate Year 
Annular Radius of the zone of inhibition (mm) 
IPM MER Ap CTX CAZ Sm Sp Su Tc Tp Cl Fl Km Nm Gm Ne Ak Tm CIP Nx Rif TIM SAM 
A89 2005   2 5 5 4.5 0 11 6 1 1 1 6.5 6 4 4 6 6 8 4.5    
    2.5 5.5 6 5 0 10 6 1 1.5 2 7 6 4.5 5 6 5.5 7 4.5    
B9 2010   5 5 6 7 5 9 7 4 0 0 8 8 8.5 9 8 8 10 8    
B14 2010   6 6 7.5 8 6 8 7 4 0 0 9 8 9 10 8 8 10 6.5    
    9 11 12 11 7 11.5 11 6 0 0 12 11.5 12 12 11.5 11 12 10    
D44 2010   3.5 4.5 6 8 5 14 6 3.5 0 0 8 7.5 8 8.5 7.5 7.5 10 7    
    5.5 6 7 9 6 15 7 4 0 0.5 8 8 8 9 8 7.5 10 7.5    
D49 2010   1 3 5 7 4 11 4.5 0 0 0 7.5 8 8 9 7 7 8.5 5    
    2.5 2.5 5 6 4 11 4 0.5 0 0 7 7 9 9 7.5 8 7.5 5    
D59 2010   5.5 6.5 8 4 6 0 8.5 4 0 0 8 8 9 9 8.5 8 12 9    
    5 6.5 8 1 4 0 6 4 0 0 8 7.5 9 9 8 8 11.5 8    
D63 2010   5 4.5 7 7 5 12 7 3.5 0 0 9 8 9 9 8 8 10 8    
    5 6 8 8 5 12.5 7 4 0 0 9 8 9 9 8.5 9 10 8    
D65 2010   5.5 5 8 8 4 12 6 4 0 0 8.5 7.5 9 10 8 8 10 8    
    7 7.5 10 8 6 12 6 3 0 0 9 9 9 10.5 8 8 10 8.5    
D66 2010   3 4.5 7 7 5 12 7.5 3.5 0 0 8.5 8 9 9.5 8.5 8.5 10.5 8    
    5 5 7 7 5 13 7 3 0 0 9 8 9 9 8 7.5 9 7    
D68 2010   6 5.5 9.5 8 6 15 8 5 11.5 9 10 9.5 10 11 9 9.5 11.5 8    
    9 7.5 9 8 6.5 14 6.5 4.5 12 10 10 9 10 11 8 8 11 9    
D69 2010   2 3 6 7 4.5 16 6 2 0 0 10 9 10 11 9.5 9.5 10 6.5    
    5 5 7 6 4.5 15 7 3 0 0 9 8 10 10 9 9 10 6    
D70 2010   3 6 6 6 0 14 5 3 0 0 7.5 6 4.5 4 6 6 7.5 6    
    4.5 7 7 5 0 14 5 2 0 0 8 6 5 4 6 6 7 5    
D73 2010   4 4 5.5 8.5 6 13.5 7 3 0 0 9 8.5 9 10 9 8 10.5 7.5    
    6 5.5 7 8 5 12 8 3 0 0 10 9 9 10 8 8 11 8    
D76 2010 10 9 5.5 6 6 5 4 10 8 1(4.5) 1 1 7 6 8 8 6.5 6.5 8 6.5    
  10 11 6 6.5 7 6 4.5 10 8.5 1(5) 1(4) 1 7.5 7 8 8 7 7 8 7.5    
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Isolate Year 
Annular Radius of the zone of inhibition (mm) 
IPM MER Ap CTX CAZ Sm Sp Su Tc Tp Cl Fl Km Nm Gm Ne Ak Tm CIP Nx Rif TIM SAM 
D82 2010 4 3 0 4 5 6.5 4 10 7 4 0 0 8 7 8.5 9 7.5 7 9.5 7    
  4 3 0 4.5 6 7 5 11 7 4.5 1 0.5 8 7.5 8 7.5 9 9 10 7.5    
D83 2010 10.5 9 5 5 5 6.5 5 11 8 6 1 1 7.5 6.5 8 8 7 7 10 7.5    
  11 9 4.5 5 6.5 7.5 5 13.5 9(7) 6.5 1 1 8.5 7.5 8.5 9 8 8 11 8.5    
D90 2011 12 10 5 4.5 5 5.5 5 13 7 4 1 0 6 7 8 8.5 7 7 9 7    
  12 11 5 4.5 5 5 6 12 8 4 1 0 7.5 7 7 7.5 7 7 8 6.5    
D91 2011 12 10 5 6 6 6 5 13 8 6 2 3.5 8 7 8 8 7 7 10 8    
  12 11 6 5.5 6.5 6.5 5.5 13 8.5 5 2 2.5 8 7 8.5 9 8 7.5 11 9    
D95 2011 11 9 5 5 6 6 4.5 11 8 5 1 1 7 6.5 7 8 7 5.5 8.5 7    
  10 10 5.5 5 5.5 6 4 12 8 5 1 1 7.5 6 7.5 8 7 6 9 7    
D99 2011 13 10 5.5 3.5 6 6.5 5 11 6 2 0 0 8 8 8 8 8.5 7 9 7    
  12 10 6 4 6 7 5 12 7 3 0 0 8 7.5 8 8 7 7 9 7    
D106 2011 11 10 4.5 4.5 5 7 4.5 12 8 2.5 1 0.5 7 6.5 7 7.5 7 6 8 6    
  10 9 4 4 4 6.5 4.5 10 8 2.5 1 0.5 7 6 6.5 7 7 6 8 5.5    
D113 2011 11 10 5 5.5 6 7.5 4.5 11 7.5 2 0 0 7 7 7 8 7 6.5 9 6.5    
  11 10 5 5 6 7 4 10.5 7.5 3 1 0 7 6.5 6.5 7.5 7 6 9 6    
D115 2009 10 9 5.5 5 6 6.5 4.5 11 7 3.5 1 0 7 7 7 8 7.5 7 9 7    
  10 8 5.5 5 6 7 5 12 7 3.5 1 0 7 7 7 8 7.5 7 9 7    
Isolates obtained earlier in the project were not screened for Rif, TIM and SAM. 
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Table 0.5 Results of CDS disk diffusion for Acinetobacter spp. isolates. 
Isolate Year 
Annular Radius of the zone of inhibition (mm) 
IPM MER Ap CTX CAZ Sm Sp Su Tc Tp Cl Fl Km Nm Gm Ne Ak Tm CIP Nx Rif TIM SAM 
B11 2010   0 10 12 0 4 10 0 11 9.5 7 7 5 2.5 4 5 3.5 10 6.5    
    0 13 16 0 6.5 15 0 14 13 10.5 11 9 6 7 9 7 13 10    
B12 2010   8 9 9 8 5.5 11 6 2 7 6.5 4 8 8 4 4.5 3 12.5 9    
    12 12 11.5 11.5 9 15 9 6 10 9 7.5 11 11 6.5 7.5 6 14 13    
B13 2010   11 10 9 9 7.5 12 7.5 4 11 11 9 9 9.5 10 9 8.5 11 6    
    13 13 12 12 10 13 11 6.5 15 14 12 11.5 13 13 12 12 14 9    
D47 2010   3.5 5.5 7 9 6 15 8.5 7 2 3 9 9 9 9.5 9 8 11 8.5    
    5 6 7 8 5.5 14 9 6 5 4 8 8.5 8 9.5 8.5 8 11 8    
D50 2010   3.5 6 7 7.5 4 11 7 3 1 0 8 8 8 8.5 8 7.5 8 7    
    4 6.5 8 7 5 10 7.5 3 0.5 1 8 8 8.5 8 8 7.5 9 7    
D53 2010   3 6 7 9 5 12 7 8 1 0.5 9 9 9 9.5 8 7.5 11 7    
    4 5.5 6 8 5 12 7 6 1 0 8 8 8 8 8 8 9 7    
D55 2010   5 7 8 7 5 13 8.5 5 3 2.5 9.5 9 9.5 10 9 9 11 9    
    6 7 8.5 7 4 14 9 5.5 5 4 9 8 9.5 9 10 10 11 7    
D60 2010   5 5 2 8.5 6 8 7 2.5 0 0 9 9 9 10 8.5 8.5 10 7    
    5 5 7 8 7.5 12 7 3 0 1 9 8 9 9 8 7 9 7    
D61 2010   3 5 8 9.5 4.5 15 8 3.5 1 1.5 11 11 10 10 11 10 12 8    
    3 5.5 7 8 3 14 8 4 0 2 10 9 8.5 9 9 9 11 7    
D64 2010   3 5 7.5 9 5 13.5 8 3 0 0 9 8 9 9 8 8 10 9    
    11 11 12 6 0 6 9 3 11 14 10 9 11 12 11 11 14 10    
D67 2010   5 7 9 7 4 13 9 4 2 4 9.5 8 9 10 9.5 9 11 8    
    6 7 9 6 4 13 9 4.5 4.5 4 10 9 8.5 9 9 8 10 7    
D71 2010   4 5 6 8 5 13 8 1.5 1 1 9 9.5 9.5 10 9 9 11 8    
    5 6 7.5 8 5 13 8 3 1.5 1 10 9 10 10 9 9 10.5 8    
D74 2010 14 12 4.5 6 7 8 7 12.5 8.5 4.5 0 1 9 9 9.5 9.5 8 8.5 11 8    
  13 11 4.5 6 6 9 7 12 8.5 5.5 1 1 8.5 8 8 9 8 9 10.5 8    
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Isolate Year 
Annular Radius of the zone of inhibition (mm) 
IPM MER Ap CTX CAZ Sm Sp Su Tc Tp Cl Fl Km Nm Gm Ne Ak Tm CIP Nx Rif TIM SAM 
D75 2010 13 11 4 5 5 7.5 5.5 12 8 6 1 1 7.5 7.5 8 8 7.5 7 9.5 7    
  11 12 4 6 5.5 7.5 6(4) 12 7.5 6(4) 1 1 7.5 7 8 8 7.5 7 11 7.5    
D80 2010 11 13 9.5 13 11 6 5 11 8.5 11 8.5 7 7 6.5 7(11) 9 7 7 12 8    
  12 13 10 12.5 11 6.5 5.5 10.5 8 10.5 8 8 8 11(7) 8(13) 14(9) 11(8) 6.5 16(12) 9    
D89 2011 10(14) 10(12) 5 6 6 6 3.5 13 8 4.5 1 1 8 7 9 8 8 7.5 9 8    
  11 10 5 7 8 7 5 13 9 5 0 0 9 7.5 8 10 8.5 8 12 8.5    
D100 2011 12 10 0(4) 3 5 8 7 11 10 0(2) 0 1 9 7 7 7.5 7.5 7 8 6    
  11 12 0(3) 3 5 8.5 8 9 9 0(2) 0 0 8 8.5 7 8 7 7.5 8 6    
D102 2011 11 8 4 6 6 11 5 11 8 0 4 4 11 10 9 10 9 9 11 8    
  10 8 5 5 6 9 6 11 8 0 5 4 10 10 9 9 10 8.5 10 9    
D103 2011 10.5 9 4.5 3.5 4 7 6 9 6 1.5 1 0 6.5 6.5 7 7 6 6 6.5 5    
  10 8.5 5 4 4 7 6.5 9 6 2 1 1 7 6.5 7 7 6 6 7 5    
D104 2011 10 9 3 3.5 4 7 4 11 6 3.5 1.5 1 7 7 7 7 6.5 6 7 5    
  11 10 3.5 3.5 4 8 4 12 6 3.5 2 1 7.5 8 7.5 8 7 7 7.5 5    
D105 2011 12 8 3.5 3 4 9 5 10 7 2 1 0 7 7 7.5 8 7 7 8 5.5    
  12 9 4 3 4 9 5 9 6.5 2 1 0 7.5 7.5 7.5 7 7 7 7 5.5    
D109 2011 11 9.5 4 5 5 8 7 10 8 2 1 0 7.5 6.5 7.5 8 7 7 8.5 6    
  11 10 4 5 5 8 8 10 8 2 1 0 7 6.5 8 8 7.5 7 9 6    
D110 2011 9 9 3 3.5 4 8 4.5 10 7.5 1.5 1.5 1 8 7.5 8.5 9 8 8 8.5 6    
  10 9 3.5 3.5 4 8 4 11 7.5 1.5 1.5 1 8 7 8.5 9 8 8 8.5 6.5    
D111 2011 11.5 9.5 5 6 6 6 4.5 12 8 5 0 1 8 7 7 8 7.5 7.5 9 8    
  11.5 9.5 5 6 6 6 4 12 8.5 5.5 0.5 0.5 8 7 7.5 8 8 7 9 7.5    
Isolates were classified only as Acinetobacter spp. if they amplified recA but not oxaAb. Isolates obtained earlier in the project were not screened for IPM, MER, Rif, TIM and SAM.  
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Table 0.6 Comparison of MIC and CDS zone sizes for carbapenems and cephalosporins in the 
collection characterised by Mak et al. 
Isolate Isolation 
date 
Imipenem Meropenem Ceftazidime Cefotaxime 
 MIC 
(mg/L)a 
Zone 
(mm)b 
MIC 
(mg/L)a 
Zone  
(mm)b 
MIC 
(mg/L)a 
Zone  
(mm)b 
MIC 
(mg/L)a 
Zone  
(mm)b 
A91 13/5/05 8 4 8 4 128 2 >128 0 
A93 17/5/05 8 3 8 2 128 2 >128 0 
A94 18/5/05 8 3 8 3 128 2 >128 0 
A96 23/5/05 8 2.5 8 2.5 128 2 >128 0 
A97 27/5/05 8 3 8 2.5 128 2 >128 0 
          
B1 2007 16 2.5 16 2 128 3 >128 0 
B2 2007 16 2.5 16 2.5 128 2 >128 0 
B3 2007 16 2.5 16 2.5 128 2 >128 0 
B4 2007 16 3 16 2 128 2 >128 0 
B5 2007 16 3 16 2 128 2 >128 0 
B6 2007 16 2.5 16 2.5 128 2 >128 0 
B7 2007 16 2.5 16 2 128 2 >128 0 
B8 2007 16 3 16 2 128 2 >128 0 
          
C1 16/2/07 16 2.5 16 2 ND 2 ND 0 
C2 15/2/07 16 3 16 2 128 2 >128 0 
C3 14/2/07 16 2.5 16 2.5 128 2 >128 0 
C4 14/2/07 16 2.5 16 2.5 128 2 >128 0 
C5 29/1/07 16 2.5 16 2.5 128 2 >128 0 
C8 24/1/07 16 3 16 2 128 2 >128 0 
C13 11/9/06 16 3 16 3 128 1 64 2 
C14 4/9/06 16 3.5 16 2.5 128 1 64 2 
C15 8/9/06 16 3 16 2 128 2 >128 0 
C18 1/11/02 16 3 16 2 128 2 >128 0 
C20 2002 16 2 16 2 128 1 >128 0 
          
D1 29/6/06 16 3 16 2 128 3 >128 0 
D5 10/7/06 16 2.5 16 2.5 128 2 >128 0 
D8 28/8/06 16 3 16 2 128 2 >128 0 
D9 30/8/06 16 3 16 2 128 3 >128 0 
D12 1/5/07 16 3 32 2 32 2 >128 0 
          
E1 16/7/06 ND 3.5 >16 2.5 64 2 ND 0 
E16 12/11/09 ND 3 ≥16 2 ≥64 1.5 ND 0 
          
A320 1982 0.12 13 0.5 9.5 ND 7 ND 5 
a MICs for isolates from hospitals A-D were obtained from Mak et al. (149), while those for hospital E were obtained 
from Dr. Peter Collignon (personal communication). 
2 This is a measure of the annular radius from the edge of the antibiotic disk, not the diameter of the zone of inhibition. 
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Table 0.1 Primer pairs used for the detection of class 1 integrons and associated gene cassettes. 
Target Primer Sequence (5'-3') Annealing 
Temperature (°C) 
Amplicon 
Size (bp) 
Reference 
Class 1 integrons     
intI1 HS463a CTGGATTTCGATCACGGCACG 58 472 (8) HS464 ACATGCGTGTAAATCATCCGTCG   (8) 
 L2 GACGATGCGTGGAGACC 60 297 (136) 
 L3 CTTGCTGCTTGGATGCC   (136) 
5'-CS L1 GGCATCCAAGCAGCAAGC 57 Variable (136) 
3'-CS R1 AAGCAGACTTGACCTGAT   (136) 
Sulphonamide resistance genes     
sul1 HS549 ACTAAGCTTGCCCCTTCCGC 60 1,100 (226) 
 HS550 CTAGGCATGATCTAACCCTCG   (226) 
Gene cassettes and cassette arrays    
aacC1 RH935 GCAGTCGCCCTAAAACAAAG 60 457 Hall lab 
 RH936 CCCGTATGCCCAACTTTGTA   Hall lab 
aadA1/2 RH522 GTGGATGGCGGCCTGAAGCCA 60 516 Hall lab 
 RH531 GGCAGCGACATCCTTCGGCGC   Hall lab 
aacC1-aadA1/2 RH935 GCAGTCGCCCTAAAACAAAG 60 Variable Hall lab 
 RH531 GGCAGCGACATCCTTCGGCGC   Hall lab 
aac(6')-Im RH569 GGATTAAGGCCGATGTACGA 60 430 This study 
 RH570 GATTTCTGCGTCCCAGGATA   This study 
aadA1-IS26 RH522 GTGGATGGCGGCCTGAAGCCA 60 1,018 Hall lab 
 RH601 GATGGAGCTGCACATGAACC   Hall lab 
IS26-aadA1 IS26F ACCTTTGATGGTGGCGTAAG 60 941 Hall lab 
 RH531 GGCAGCGACATCCTTCGGCGC   Hall lab 
aac(6')-Im-IS26 RH569 GGATTAAGGCCGATGTACGA 60 1,600 Hall lab 
 RH601 GATGGAGCTGCACATGAACC   Hall lab 
5'-CS-aac(6')-Im L1 GGCATCCAAGCAGCAAGC 60 796 (136) 
 RH570 GATTTCTGCGTCCCAGGATA   This study 
aac(6')-Im-3'-CS RH569 GGATTAAGGCCGATGTACGA 60 2,202 This study 
 R1 AAGCAGACTTGACCTGAT   (136) 
intI1-aadA1 L2 GACGATGCGTGGAGACC 60 2,572 (136) 
 RH531 GGCAGCGACATCCTTCGGCGC   Hall lab 
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Table 0.2 Primer pairs used for resistance genes and associated genes. 
Target Primer Sequence (5'-3') Annealing Temperature (°C) 
Amplicon 
Size (bp) 
Reference 
Aminoglycoside resistance genes    
aphA1 RH880 CAACGGGAAACGTCTTGCTC 60 454 Hall lab 
 RH881 ATTCGTGATTGCGCCTGAG   Hall lab 
aphA6 aphA6F ATACAGAGACCACCATACAGT 55 234 (254) aphA6R GGACAATCAATAATAGCAAT   (254) 
aadB RH212-R GCATATCGCGACCTGAAAGC 60 524 Hall lab 
 RH377-R GACACAACGCAGGTCACATTGAT   Hall lab 
aadB in pRAY RH561 GGGAAGAATCAATACCGCAA 65 998 Hall lab 
 RH562 AATTTCACCCCAAACAATCG   Hall lab 
aacC2 aacC2-F GGCAATAACGGAGGCAATTCGA 65 698 (63) aacC2-R CTCGATGGCGACCGAGCTTCA   (63) 
aacA4 RH532 GTTAGGCATCACAAAGTACAGC 60 518 Hall lab 
 RH533 CATCTGGGGTGGTTACGGTACC   Hall lab 
strA strA-F CTTGGTGATAACGGCAATTC 58 548 (72) 
 strA-R CCAATCGCAGATAGAAGGC   (72) 
strB strB-F ATCGTCAAGGGATTGAAACC 58 509 (72) 
 strB-R GGATCGTAGAACATATTGGC   (72) 
strA-strB strA-F CTTGGTGATAACGGCAATTC 58 1,190 (72) 
 strB-R GGATCGTAGAACATATTGGC   (72) 
Tetracycline resistance genes    
tetA(B) tetB-F TTGGTTAGGGGCAAGTTTTG 60 658 (171) 
 tetB-R GTAATGGGCCAATAACACCG   (171) 
tetR(B) RH892 ACAGCGCATTAGAGCTGCTT 60 528 Hall lab 
 RH893 AGAAGGCTGGCTCTGCACCT   Hall lab 
Sulphonamide resistance gene    
sul2 sul2-F GGCAGATGTGATCGACCTCG 60 407 (135) 
 sul2-R ATGCCGGGATCAAGGACAAG   (135) 
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Table II.2 Primer pairs used for resistance genes and associated genes. (cont.) 
Target Primer Sequence (5'-3') Annealing Temperature (°C) 
Amplicon 
Size (bp) 
Reference 
β-lactamase genes    
oxaAb OXA-69A CTAATAATTGATCTACTCAAG 57 975 (101) 
 OXA-69B CCAGTGGATGGATAGATTATC   (101) 
 oxa51L-F TAATGCTTTGATCGGCCTTG 52 535 (259) 
 oxa51L-R TGGATTGCACTTCATCTTGG    (259) 
oxa23 oxa23L-F GATCGGATTGGAGAACCAGA 52 501 (259) 
 oxa23L-R ATTTCTGACCGCATTTCCAT   (259) 
 OXA23F GATGTGTCATAGTATTCGTCG 60 1,065 (243) 
 OXA23R TCACAACAACTAAAAGCACTG   (243) 
blaTEM RH605 TTTCGTGTCGCCCTTATTCC 60 690 Hall lab 
 RH606 CCGGCTCCAGATTTATCAGC   Hall lab 
ampC PW51 CGGGCAATACACCAAAAGAC 60 1,050 (149) 
 PW52 CCTTAATGCGCTCTTCATTTGG   (149) 
Other      
recA rA1 CCTGAATCTTCTGGTAAAAC 57 425 Hall lab 
 rA2 GTTTCTGGGCTGCCAAACATTAC    
CR2 LECR2 CACTGGCTGGCAATGTCTAG 60 1,793 (233) 
 RECR2 CTTTGGACCGCAGTTGACTC   (233) 
CR2-sul2 RH553 GGCTCAAGCGTGTTTTCAAT 60 851 Hall lab 
 RH603 ACTTCATCCGCACACACGAG   Hall lab 
J1 RH927 CAACCCTGTCTTTGCATTTG 60 846 Hall lab 
 RH792 TTCGAGCTTGAAAACTGCAC   Hall lab 
J2 RH928 GCCAGCAAGCTCAGCATAA 60 796 Hall lab 
 RH916 CCCAAATACTGCCATGTTGA   Hall lab 
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Table 0.3 Primer pairs used for the detection of insertion sequences. 
Target Primer Sequence (5'-3') Annealing temperature (°C) 
Amplicon 
size (bp) 
Reference 
IS26 RH601 GATGGAGCTGCACATGAACC 60 616 Hall lab 
 IS26F ACCTTTGATGGTGGCGTAAG   Hall lab 
IS6100 IS6100-RV2 AATGGTGGTTGAGCATGCC 60 356 (138) 
 DB-T1 TGCCACGCTCAATACCGAC   (22) 
ISAba1 ISAba1A GTGCTTTGCGCTCATCATGC 60 435 (39) 
 ISAba1B CATGTAAACCAATGCTCACC   (39) 
ISAba17 RH1308 CCGTCAGTTGATGTTGGTTG 60 1,312 This study 
 RH1309 GTCATGAATACGCTGCCTGA   This study 
ISAba125 RH573 AAGAAGGCTTTTCAGCCAGA 60 952 This study 
 RH574 CAAACATGAGGTGCGACAGT   This study 
 
 
Table 0.4 Primer pairs used to identify A. baumannii global clones. 
PCR Primer Sequence (5'→3') Annealing  
temperature (°C) 
Amplicon  
Size (bp) 
Reference 
Group 1      
 ompAF306 CCCAAATACTGCCATGTTGA 57 355 (240) 
 ompAR660 CAACTTTAGCGATTTCTGG   (240) 
 csuEF GATGGCGTAAATCGTGGTA 57 702 (240) 
 csuER CTTTAGCAAACATGACCTACC   (240) 
 OXA66F TACACCCGGGTTAATCGT 57 559 (240) 
 OXA66R GCGCTTCAAAATCTGATGTA   (240) 
Group 2      
 ompAF378 GACCTTTCTTATCACAACGA 57 343 (240) 
 ompAR660 CAACTTTAGCGATTTCTGG   (240) 
 csuEF GGCGAACATGACCTATTT 57 580 (240) 
 csuER CTTCATGGCTCGTTGGTT   (240) 
 OXA69F169 CATCAAGGTCAAACTCAA 57 162 (240) 
 OXA69R330 TAGCCTTTTTCCCCCATC   (240) 
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Table 0.5 Primer pairs used to detect composite transposons. 
Tn PCR Primer Sequence (5'→3') Annealing  
temperature (°C) 
Amplicon  
Size (bp) 
Reference 
Tn2006 ISAba1-oxa23 ISAba1B CATGTAAACCAATGCTCACC 60 1,369 (39) 
  oxa23L-R ATTTCTGACCGCATTTCCAT   (259) 
 oxa23-ISAba1 oxa23L-F GATCGGATTGGAGAACCAGA 60 2,725 (259) 
  ISAba1B CATGTAAACCAATGCTCACC   (39) 
Tn6020 IS26-aphA1 RH601 GATGGAGCTGCACATGAACC 60 2,121 Hall lab 
  RH880 CAACGGGAAACGTCTTGCTC   Hall lab 
 aphA1-IS26 RH881 ATTCGTGATTGCGCCTGAG 60 1,199 Hall lab 
  IS26F ACCTTTGATGGTGGCGTAAG   Hall lab 
 aphA1L-aphA1R RH881 ATTCGTGATTGCGCCTGAG 60 1,972 Hall lab 
  RH830 CAAAAATATGGTATTGATAATCCTG   Hall lab 
TnaphA6 ISAba125-aphA6 RH573 AAGAAGGCTTTTCAGCCAGA 60 1,427 This study 
  aphA6R GGACAATCAATAATAGCAAT   (254) 
 aphA6-ISAba125 aphA6F ATACAGAGACCACCATACAGT 60 1,745 (254) 
  RH574 CAAACATGAGGTGCGACAGT   This study 
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Table 0.6 Primer pairs used for mapping AbGRI1-1 (Tn6166). 
PCR Primer Sequence (5'-3') Annealing temperature (°C) 
Amplicon 
size (bp) 
Reference 
comM-tniB∆ RH791 TGCTGCAATGAGCTGAAAGT 60 3,119 Hall lab 
 RH909 GCGATTCAAAATATCGGTCAA   Hall lab 
tniB-tniD RH910 GCGATAGTGAACGGATTGAGA 60 2,010a Hall lab 
 RH584 TCAATATGCCTCGCTCCACT   Hall lab 
tniD-uspA RH583 TCCTGTCTCTCGTGTAGCAAT 60 3,577a Hall lab 
 RH919 TGTCAAAAATTATTGCATGT   Hall lab 
comM-orf/uspAa RH791 TGCTGCAATGAGCTGAAAGT 60 4,632 Hall lab 
 RH592 AAGCTTATCGAAAAGGCGTAGA   This study 
tniB-tniE RH910 GCGATAGTGAACGGATTGAGA 60 560 Hall lab 
 RH587 TTGCCCATTAAGCACAACAG   This study 
uspA-sup RH793 CCCAAGAGAGCTGATTTTGC 60 1,280 Hall lab 
 RH771 TGTAAAATCTGGTGGTCGTAC   Hall lab 
tniB∆-sup RH910 GCGATAGTGAACGGATTGAGA 60 3,267 Hall lab 
 RH771 TGTAAAATCTGGTGGTCGTAC   Hall lab 
uspA-orf4 RH589 CATAAGCCCCAACCACAATC 60 3,388 This study 
 RH788 ATACTATTTCAAAGCCTGATGAG   Hall lab 
orf4b-comM RH594 GGCGGATTATCAGTTGTTTCA 60 1,844 This study 
 RH928 GCCAGCAAGCTCAGCATAA   Hall lab 
sup-tetA(B) RH772 GCAGCCATAGGAATGACTTTTA 60 3,961 Hall lab 
 tetBF TTGGTTAGGGGCAAGTTTTG   (171) 
orf4-CR2 RH916 CCCAAATACTGCCATGTTGA 60 4,466 Hall lab 
 LECR2 CACTGGCTGGCAATGTCTAG   (233) 
strB-orf4b strBR GGATCGTAGAACATATTGGC 60 2,620 (72) 
 RH599 ATACTGTTTCAAAAACTGATGAA   This study 
strA-comM strAR CCAATCGCAGATAGAAGGC 60 3,509 (72) 
 RH928 GCCAGCAAGCTCAGCATAA   Hall lab 
CR2-comM RH702 CTCGTCAACGATCTGATAGAGAAGGG 60 5,021 Hall lab 
 RH928 GCCAGCAAGCTCAGCATAA   Hall lab 
a Predicted sizes based on Tn6022, failed to amplify in AbGRI1-1. 
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Table 0.7 Primer pairs used for mapping of AbGRI1-2 (Tn6167). 
PCR Primer Sequence (5'-3') Annealing temperature (°C) 
Amplicon 
size (bp) 
Reference 
comM-tniB∆ RH791 TGCTGCAATGAGCTGAAAGT 60 3,119 Hall lab 
 RH909 GCGATTCAAAATATCGGTCAA   Hall lab 
comM-orf/uspA RH791 TGCTGCAATGAGCTGAAAGT 60 7,234 Hall lab 
 RH592 AAGCTTATCGAAAAGGCGTAGA   This study 
tniB∆-tniE∆ RH910 GCGATAGTGAACGGATTGAGA 60 560 Hall lab 
 RH587 TTGCCCATTAAGCACAACAG   This study 
tniB∆-orf/uspA RH910 GCGATAGTGAACGGATTGAGA 60 4,213 Hall lab 
 RH592 AAGCTTATCGAAAAGGCGTAGA   This study 
tniB∆-ISAba17 RH910 GCGATAGTGAACGGATTGAGA 60 2,673 Hall lab 
 RH1309 GTCATGAATACGCTGCCTGA   This study 
ISAba17-uspA RH1308 CCGTCAGTTGATGTTGGTTG 60 3,744 This study 
 RH588 CAAAAGCAAAAGCACCACAA   This study 
ISAba17 RH1308 CCGTCAGTTGATGTTGGTTG 60 1,312 This study 
 RH1309 GTCATGAATACGCTGCCTGA   This study 
orf-orf4 RH1310 TTGCTCAAGTGTACCCCTTTG 60 3,436 This study 
 RH773 GGGCGAAAATTATTGTTCTTA   Hall lab 
uspA-orf4 RH589 CATAAGCCCCAACCACAATC 60 3,378 This study 
 RH788 ATACTATTTCAAAGCCTGATGAG   Hall lab 
uspA-orf4/IRr RH589 CATAAGCCCCAACCACAATC 60 4,415 This study 
 RH790 CTAGAGCAAGAATAAAAATTATA   Hall lab 
ISAba1-sul2 ISAba1B CATGTAAACCAATGCTCACC 60 1,125 (39) 
 sul2R ATGCCGGGATCAAGGACAAG   (135) 
ISAba1-CR2 ISAba1B CATGTAAACCAATGCTCACC 60 6,156 (39) 
 LECR2 CACTGGCTGGCAATGTCTAG   (233) 
tetR(B)-strB RH892 ACAGCGCATTAGAGCTGCTT 60 3,983 Hall lab 
 strB-F ATCGTCAAGGGATTGAAACC   (72) 
orf4b-comM RH594 GGCGGATTATCAGTTGTTTCA 60 1,844 This study 
 RH928 GCCAGCAAGCTCAGCATAA   Hall lab 
CR2-comM RH702 CTCGTCAACGATCTGATAGAGAAGGG 60 5,021 Hall lab 
 RH928 GCCAGCAAGCTCAGCATAA   Hall lab 
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Table II.7 Primer pairs used for mapping of AbGRI1-2 (Tn6167). (cont.) 
PCR Primer Sequence (5'-3') Annealing temperature (°C) 
Amplicon 
size (bp) 
Reference 
orf4-orf6 RH585 TTCCATTCATCAGGTGTTGC 60 3,460 This study 
 RH596 GGGCGGCAAATATAAAGGTT   This study 
orf6-orf7 RH1302 CAAATCGGGAAGGTTCAAAA 60 1,573 This study 
 RH1303 CGGGAAAATTACTGCGATTG   This study 
orf6-ISAba1 RH1302 CAAATCGGGAAGGTTCAAAA 60 2,199 This study 
 RH1301 TGGCAATTTTAAGAAGGCAGA   This study 
orf7-Tn2006 RH1304 TTAGCCAGCAGTCTAGCGTTAT 60 2,908 This study 
 OXA23R TCACAACAACTAAAAGCACTG   (243) 
oxa23-int oxa23LF GATCGGATTGGAGAACCAGA 60 4,268 (259) 
 RH1305 TTTCTTCTCTTAAAGGCAACCA   This study 
 ISAba1-tniCb RH1301 TGGCAATTTTAAGAAGGCAGA 60 3,680 This study 
 RH1314 TCCCTCATAACCAACAACCA   This study 
int-orf11 RH1306 GCATACTCATGTGGTTTAAGACTTG 60 1,638 This study 
 RH1307 TTAATTGCTTCATCATTTGAGC   This study 
orf9-tniCb RH597 TTTGAAGAAATTGAGCATGAGG 60 1,566 This study 
 RH792 TTCGAGCTTGAAAACTGCAC   This study 
tniCb-ISAba1 RH590 GCACTAGTGGCAAAGCGAAT 60 3,460 This study 
 ISAba1A GTGCTTTGCGCTCATCATGC   (39) 
tniCb-sul2 RH590 GCACTAGTGGCAAAGCGAAT 60 4,150 This study 
 sul2R ATGCCGGGATCAAGGACAAG   (135) 
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Table 0.8 Primer pairs used for mapping AbGRI2. 
PCR Primer Sequence (5'-3') Annealing temperature (°C) 
Amplicon 
size (bp) 
Reference 
AB57_1175a- tnpR1 RH1315 AGGAGATCTTCTTGGCAGTCA 60 1,051 This study 
 RH539 CCAGCCCTTCCCGATCTGTTG   Hall lab 
blaTEM- tnpA1000 RH605 TTTCGTGTCGCCCTTATTCC 60 2,650 Hall lab 
 RH759 GCCAGCTCATTTACCTTGCCGA   Hall lab 
tnpR5393c- aphA1 RH520 CATGGCCCAGCGCGATACTTCAG 60 2,297 Hall lab 
 RH880 CAACGGGAAACGTCTTGCTC   Hall lab 
aphA1- sul1 RH881 ATTCGTGATTGCGCCTGAG 60 2,712 Hall lab 
 RH751 GCGGAACTTCACGCGATC   Hall lab 
tnpA21-AB57_1209a RH668 CACCAGAACCGCCTGCTCAA 60 1,219 Hall lab 
 RH1316 CATCTGCCATCCAGTTTGTG   This study 
tnpR5393-AB57_1209 RH520 CATGGCCCAGCGCGATACTTCAG 60 1,211 Hall lab 
 RH1316 CATCTGCCATCCAGTTTGTG   This study 
blaTEM-AB57_1209 RH605 TTTCGTGTCGCCCTTATTCC 60 1,844 Hall lab 
 RH1316 CATCTGCCATCCAGTTTGTG   This study 
tnpR5393-tnpM21 RH520 CATGGCCCAGCGCGATACTTCAG 60 1,362 Hall lab 
 RH754 CGGCATCGAGCGGGATTTCCTT  Or 9654 Hall lab 
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Table 0.9 Primer pairs used to join the contigs that made up plasmids. 
Target Primer Sequence (5'-3') Annealing temperature (°C) 
Amplicon 
size (bp) 
Reference 
pA91     
ISAba125 gap RH1348 CACATTGTGGACAGGTTGGA 60 1,251 This study 
 RH1322 ATTGCCGATGGAATGAAGAT   This study 
Iteron region RH1349 CGAAAATATGAACCAAAAATTGC 60 476 This study 
 RH1350 GCATGTACTTCAAGGGGATCA   This study 
pC2      
Iteron region RH1349 CGAAAATATGAACCAAAAATTGC 60 476 This study 
 RH1350 GCATGTACTTCAAGGGGATCA   This study 
ISAba125/ISAba1 RH1321 CTTTACGGGCAGAAGGGTTA 60 1,712 This study 
gap RH1322 ATTGCCGATGGAATGAAGAT   This study 
pD72      
Repeat 1 RH1398 TTTGACGTTGCTCTTGTTGC 60 987 Hall lab 
 RH1399 TTCTCCCAAGTGGTCAGGTC   Hall lab 
Repeat 2 RH1395 TCAAACGATGCAATGGAAGA 60 1,373 Hall lab 
 RH1394 TGGTTGGCAGAACAAGATGA   Hall lab 
Repeat 3 RH1503 GAAGATCCAGAAGCGGGATA 60 1,576 Hall lab 
 RH1397 CCATGTTCTTTTCCACATGC   Hall lab 
TnaphA6 flanking RH1320 TTTACGATAATTGCATGGATGT 60 3,245 This study 
 RH1319 TTCCATTGCATCGTTTGAGA   This study 
Plasmid-aphA6 RH1320 TTTACGATAATTGCATGGATGT 60 1,829 This study 
 aphA6-F ATACAGAGACCACCATACAGT   (254) 
aphA6-plasmid aphA6-R GGACAATCAATAATAGCAAT 60 1,651 (254) 
 RH1319 TTCCATTGCATCGTTTGAGA   This study 
pC20      
Repeat 1 RH1398 TTTGACGTTGCTCTTGTTGC 60 987 Hall lab 
 RH1399 TTCTCCCAAGTGGTCAGGTC   Hall lab 
Repeat 2 RH1395 TCAAACGATGCAATGGAAGA 60 1,373 Hall lab 
 RH1394 TGGTTGGCAGAACAAGATGA   Hall lab 
Repeat 3 RH1503 GAAGATCCAGAAGCGGGATA 60 1,575 Hall lab 
 RH1397 CCATGTTCTTTTCCACATGC   Hall lab 
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Table II.9 Primer pairs used to join the contigs that made up plasmids. (cont.) 
Target Primer Sequence (5'-3') Annealing temperature (°C) 
Amplicon 
size (bp) 
Reference 
TnaphA6 flanking RH1501 CTTGAGGAAGGGATGGTTGA  60 4,235 Hall lab 
 RH1502 TTGCTTTAATCGGTGGTTCC    Hall lab 
Plasmid-aphA6 RH1501 CTTGAGGAAGGGATGGTTGA  60 1,930 Hall lab 
 aphA6-R GGACAATCAATAATAGCAAT   (254) 
aphA6-plasmid aphA6-F ATACAGAGACCACCATACAGT 60 2,540 (254) 
 RH1502 TTGCTTTAATCGGTGGTTCC    Hall lab 
pC13      
Repeat 1 RH1398 TTTGACGTTGCTCTTGTTGC 60 987 Hall lab 
 RH1399 TTCTCCCAAGTGGTCAGGTC   Hall lab 
Repeat 2 RH1395 TCAAACGATGCAATGGAAGA 60 1,373 Hall lab 
 RH1394 TGGTTGGCAGAACAAGATGA   Hall lab 
Repeat 3 RH1503 GAAGATCCAGAAGCGGGATA 60 1,575 Hall lab 
 RH1397 CCATGTTCTTTTCCACATGC   Hall lab 
TnaphA6 flanking RH1501 CTTGAGGAAGGGATGGTTGA  60 4,235 Hall lab 
 RH1502 TTGCTTTAATCGGTGGTTCC    Hall lab 
Plasmid-aphA6 RH1501 CTTGAGGAAGGGATGGTTGA  60 1,930 Hall lab 
 aphA6-R GGACAATCAATAATAGCAAT   (254) 
aphA6-plasmid aphA6-F ATACAGAGACCACCATACAGT 60 2,540 (254) 
 RH1502 TTGCTTTAATCGGTGGTTCC    Hall lab 
Plasmid-Tn RH1552 CATTGGCGGCAATACATAAA 60 362 This study 
 RH1554 GATTCAAAAGCAACTGCAGAA   This study 
Tn-Plasmid RH1553 AAGTTTAATGTGTGCAGTTGGAA 60 344 This study 
 RH1555 TGATTGGCTAAAAGCTCTTGAT   This study 
Internal Tn RH1556 TTGTGGAACCTAAACAAGCAAA 60 602 This study 
 RH1557 TTGACCAACTGGAGTCGATG   This study 
pD46      
Repeat 1 RH1398 TTTGACGTTGCTCTTGTTGC 60 987 Hall lab 
 RH1399 TTCTCCCAAGTGGTCAGGTC   Hall lab 
Repeat 2 RH1395 TCAAACGATGCAATGGAAGA 60 1,373 Hall lab 
 RH1394 TGGTTGGCAGAACAAGATGA   Hall lab 
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Table II.9 Primer pairs used to join the contigs that made up plasmids. (cont.) 
Target Primer Sequence (5'-3') Annealing temperature (°C) 
Amplicon 
size (bp) 
Reference 
Repeat 3/Tn2006 oxa23L-R ATTTCTGACCGCATTTCCAT 60 3,347 (259) 
 RH1397 CCATGTTCTTTTCCACATGC   Hall lab 
TnaphA6 flanking RH1320 TTTACGATAATTGCATGGATGT 60 3,245 This study 
 RH1319 TTCCATTGCATCGTTTGAGA   This study 
Plasmid-aphA6 RH1320 TTTACGATAATTGCATGGATGT 60 1,829 This study 
 aphA6-F ATACAGAGACCACCATACAGT   (254) 
aphA6-plasmid aphA6-R GGACAATCAATAATAGCAAT 60 1,651 (254) 
 RH1319 TTCCATTGCATCGTTTGAGA   This study 
 
